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The construction of bonds in a controlled and selective manner and the development of 
operationally simple, general and reliable methods to achieve these aims remains a key goal 
of chemical synthesis and the countless industries it impacts upon. With this in mind, the 
chemo-, regio- and stereoselective introduction of a number of functionalities into small 
molecules was investigated. 
Traditionally the majority of functionalisations have used precious metals; the scope of 
transformations that can be achieved using these catalysts is remarkable. Palladium in 
particular has found widespread application in new bond-forming processes and, in addition 
to cross-coupling reactions, palladium catalysis has been used to effect a wide variety of 
asymmetric reactions.  
This work describes investigations into the palladium-catalysed enantioselective 
electrophilic fluorination of azaarylacetates and amides A2 and the oxidative annulation of 
ferrocene derivatives A4 (Scheme A1). Both products have structural significance; 
heterocycles and stereogenic fluorinated centres, present in A3, are important motifs in the 
pharmaceutical industry, and ferrocenes are important rigid scaffolds in chiral ligands such 
as those in the Josiphos family e.g. A7. 
 
Scheme A1. Palladium catalysis for a) enantioselective fluorination and b) oxidative annulation 
Whilst a general catalyst remained elusive for the asymmetric fluorination of azaarylacetates 
and amides, benzoxazole-containing substrates were consistently fluorinated with excellent 
enantioselectivity (up to 96% ee) using palladium catalyst A1 (Scheme 1a). The oxidative 
annulation of ferrocene derivatives proved challenging and although the reaction was 
successful, the product could only be isolated in up to 24% yield (Scheme 1b). In order to 
determine the yield-limiting step of the reaction, mechanistic studies were conducted and 
palladacycle A6 was synthesised as a possible reaction intermediate. 
Recently there has been a shift towards the development of more sustainable, 
environmentally benign and economic catalyst systems and iron is quickly becoming 
recognised as a viable alternative owing to its high natural abundance and low toxicity. A 
general iron-catalysed hydrofunctionalisation procedure is described that was used to form a 
wide variety of carbon-carbon and carbon-heteroatom bonds (Scheme A2). 
Scheme A2. Iron catalysis for carbon-carbon and carbon-heteroatom bond formation 
With just 0.5 mol% iron catalyst, the broad scope formal hydrofunctionalisation of styrene 
derivatives was achieved using commercially available and bench-stable catalysts and 
reagents. An iron-catalysed highly regioselective hydromagnesiation gave a common 
benzylic Grignard reagent, which was reacted with an array of electrophiles in a highly 
chemo- and regioselective manner. Significantly, the products of formal hydroboration, 
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Chapter 1. Introduction 
Palladium and iron are two highly valued metals, each with its own unique properties but 
increasingly overlapping applications. Palladium is primarily used in catalytic converters 
with minor applications in jewellery, electronics, dentistry, and chemistry
1
 yet the relatively 
high cost and limited supply of the metal is a growing concern for many industries.
2
 
Recently, there has been a drive towards the use of more sustainable metals, for example 
iron, which are not only inexpensive and abundant (iron is the fourth most common element 
in the Earth’s crust) but also environmentally benign.
3
 Whilst there is no known biological 
role for palladium, iron has many roles in nature and for example, is found in haemoglobin, 
cytochrome P450, and the enzymes hydrogenase and nitrogenase (Figure 1.01). 
Consequently, there is a higher concentration of iron allowed in an active pharmaceutical 




Figure 1.01. Iron-containing haem b in haemoglobin 
1.1 Catalysis 







 However, it was the development of palladium-catalysed 
cross-coupling reactions that firmly established it as a versatile and reliable catalyst, with 
Heck, Negishi and Suzuki being awarded the Nobel prize in chemistry in 2010 in recognition 
of their pioneering work on the subject.
9
 Palladium- and nickel-catalysed cross-coupling 




In comparison, iron-catalysed reactions have been considerably less well studied and 
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developed. Despite early applications of iron catalysis, for example the Haber-Bosch process 
uses a doped iron catalyst to synthesise ammonia from nitrogen and hydrogen from which 
454 million tonnes of nitrogen fertiliser are produced every year,
12
 the full potential of iron 
catalysis is only just being realised.
13-15
 
Cross-coupling and hydrogenation are two reactions which demonstrate the development and 
increasing overlap of palladium and iron catalysis in both bond construction and functional 
group manipulation. Traditionally palladium catalysis has been used in cross-coupling and 
heterogeneous hydrogenation reactions but more recently iron catalysis has become a viable 
contender in the search for more sustainable catalysts and in some cases, the reactivity and 




Cross-coupling reactions can be defined as the formation of a carbon–carbon or carbon–
heteroatom bond between two different partners, often catalysed by a transition metal 
(Scheme 1.01). Common transition metals used are palladium, copper and nickel. 
 
Scheme 1.01. Cross-coupling reaction 
Cross-coupling reactions are now widely applied in the synthesis of natural products, 
pharmaceuticals, liquid crystals, and conjugated polymers, amongst other compounds of 
interests.
16
 Suzuki-Miyaura coupling is the most widely used cross-coupling reaction in the 
syntheses of pharmaceuticals and one of the earliest industrial applications of the reaction 
was in the synthesis of SB-245570 1.04, a drug candidate for the treatment of depression 
(Scheme 1.02).
17
 Excellent yields were consistently obtained with low catalyst loadings and 2 
× 6.3 kg batches were prepared using this reaction, each containing negligible palladium 
residue. 




Scheme 1.02. Suzuki-Miyaura cross-coupling in the synthesis of antidepressant SB-245570 1.04  
1.1.1.1 Palladium-Catalysed Cross-Coupling 
In addition to the Heck, Negishi and Suzuki reactions, there are several other widely applied 
cross-coupling reactions, including the Sonogashira, Stille, Tsuji-Trost, Hiyama and 
Kumada, and the Buchwald-Hartwig amination for the formation of carbon–nitrogen bonds. 
All of these reactions use an organohalide (or equivalent) substrate but they differ in the 




Scheme 1.03. Palladium-catalysed cross-coupling reactions 
In general, the mechanism for cross-coupling involves oxidative addition, transmetallation 
and reductive elimination and the active catalyst is Pd(0) (either a Pd(0) catalyst is used 
directly or a Pd(II) precatalyst is used, which is most commonly reduced in situ with 
phosphine ligands) (Scheme 1.04).
19
  For Heck reactions, which involve an alkene and not an 
organometallic as a coupling partner, transmetallation is replaced by carbopalladation and β-
hydride elimination.  




Scheme 1.04. (a) Standard mechanism for the palladium-catalysed cross-coupling of organohalides 
with organometallics and (b) Heck reaction 
The Tsuji-Trost reaction and Buchwald-Hartwig amination allow the construction of carbon–
heteroatom bonds, thus greatly expanding the scope of palladium-catalysed cross-coupling 
reactions. Recently, there has been an increase in the number of palladium-catalysed 
cross-coupling reactions using aryl chloride substrates.
20
 Although the C–Cl bond is more 
chemically inert than the C–Br or C–I bond (experimental bond enthalpies DH298 PhCl: 97, 




 aryl chlorides are less expensive and the commercially 
available compounds more diverse than the corresponding aryl bromides and iodides. The 
use of electron-rich phosphine and carbene ligands was found to be essential for reactivity. 
For example, in the first Suzuki-Miyaura cross-coupling of electron-rich aryl chlorides, 
4-chloroanisole 1.05 underwent coupling with phenylboronic acid 1.06 in an excellent 92% 




Scheme 1.05. Suzuki-Miyaura cross-coupling with an aryl chloride 
The relative ease with which palladium can interconvert between Pd(0) and Pd(II), required 
for oxidative addition and reductive elimination, has undoubtedly contributed to the success 
of the metal as a catalyst in cross-coupling and other reactions. In comparison, alternative 
cross-coupling catalysts based on copper, nickel and iron, competitively undergo 
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one-electron redox reactions to generate carbon radicals, which have the potential to increase 
the number of byproducts formed. Nevertheless, there has recently been great interest in the 
use of these more sustainable metals for cross-coupling reactions.
23-27
 
1.1.1.2 Iron-Catalysed Cross-Coupling 
In the seminal report of iron-catalysed cross-coupling, which predates the corresponding 
palladium-catalysed reaction, Tamura and Kochi demonstrated that FeCl3 could catalyse the 
coupling of alkenyl bromides 1.08 with Grignard reagents 1.09 to form alkene products 1.10 
(Table 1.01);
28-29
 the reaction is remarkably efficient with high yields being obtained using 






MgBr Product Yield (%) 
1    
83 







Table 1.01. First iron-catalysed cross-coupling reaction 
Despite showing early promise, iron-catalysed cross-coupling remains underdeveloped and 
less well understood than the corresponding palladium-catalysed reaction. However, research 
has shown that in addition to the economic and environmental benefits of using iron, 
different reactivity is also possible. For example, high yields of diene ligand (R,R)-1.12 were 




Entry Catalyst (x mol%) Temperature (°C) Time (h) (R,R)-1.12/1.13 Yield (%) 
1 NiCl2(dppe), 1 40 1 41:59 44 
2 PdCl2(dppf), 1 40 1 38:62 45 
3 Co(acac)3, 5
a 
0 0.25 38:62 28 
4 Fe(acac)3, 5
a 
0 0.25 93:7 98 
a
 NMP (1 equiv. with respect to BnMgCl) used as cosolvent 
Table 1.02. Metal dependence of cross-coupling 
With palladium and nickel the major product of the reaction was alkane 1.13, resulting from 
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homocoupling of the Grignard reagent. Whilst the ligand and loading of the catalyst may 
also have played a part in the reaction outcome, as a catalyst for cross-coupling reactions, 
iron clearly has potential. 
Iron-catalysed cross-coupling reactions generally involve the coupling of an organohalide 
(or equivalent) with a Grignard reagent, although organozinc or organomanganese coupling 
partners have been used (Scheme 1.06).
31-32
 The instability and sensitivity to air and moisture 
of the active iron catalyst has made characterisation and the determination of its exact 
oxidation state difficult. However, a range of oxidation states have been proposed. 
 
Scheme 1.06. Iron-catalysed cross-coupling 
Reduction of the iron precatalyst by the Grignard reagent is known to occur and in the initial 
report of iron-catalysed cross-coupling, Kochi suggested that the active iron catalyst is an 
Fe(I) species (although Fe(0) is also plausible). The resultant Fe(I)/Fe(III) cycle resembles 
that for palladium-catalysed cross-coupling and involves oxidative addition, transmetallation 
and reductive elimination (Scheme 1.07 (a)).
28
 More recently, Norrby and co-workers have 
conducted extensive experimental and computational studies into iron-catalysed 




Scheme 1.07. Two-electron iron-catalysed cross-coupling mechanisms 
(a) Original Fe(I)/Fe(III) mechanism proposed by Kochi and (b) Fe(−II)/Fe(0) mechanism proposed 
by Fürstner 
Thirty years after Kochi’s initial mechanistic hypothesis, Bogdanović and co-workers helped 
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revise the mechanism for iron-catalysed cross-coupling,
34-35
 suggesting that the iron 
precatalyst first underwent a four-electron reduction to give the “inorganic Grignard reagent” 
[Fe(MgX)2]n containing Fe(−II) (Scheme 1.07 (b)). Fürstner and Leitner then went on to 
suggest that σ-bond metathesis occurs to give [R
1
–Fe(MgX)], but owing to the absence of an 
iron-halide bond, transmetallation does not occur and instead alkylation of organoiron 
species [R
1







elimination then gives the cross-coupled product and returns the Fe(−II) iron species to the 
catalytic cycle. Significantly, this means that a formal Fe(−II)/Fe(0) catalytic cycle is 
operating. Whilst there is no direct evidence for this mechanism, related iron complexes, 
which are themselves able to catalyse cross-coupling reactions, have been isolated in which 
iron is in a formal oxidation state of Fe(−II) or Fe(0).
37-38
 However, this mechanism only 
applies to EtMgX or higher alkyl Grignard reagents; for MeMgX and PhMgX that are unable 
to undergo β-hydride elimination, Fürstner et al. have proposed the existence of 
organoferrate complexes such as [(Me4Fe)(MeLi)][Li(OEt2)]2. These complexes are prepared 
from exhaustive alkylation of the iron centre and are only able to catalyse the cross-coupling 
of highly activated substrates such as acid chlorides and enol triflates. 
A representative example of iron-catalysed cross-coupling is the coupling of aryl chloride 
1.14 with organomagnesium, -zinc and -manganese nucleophiles in excellent yield (with the 
exception of phenylmagnesium bromide) (Scheme 1.08).
39
 In contrast, aryl bromides and 
iodides did not undergo cross-coupling and instead underwent protodehalogenation, owing to 
the highly reducing nature of the active iron catalyst. 
 
Scheme 1.08. Iron-catalysed cross-coupling of aryl chloride 1.14 with different nucleophiles 
In addition to mechanisms based on two-electron redox processes, radical mechanisms have 
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also been proposed (Scheme 1.09). Following generation of the active iron catalyst, Bedford 
et al. suggest a single-electron transfer occurs with the alkyl halide to give an alkyl 
radical/[Fe
n+1
X] pair (Scheme 1.09 (a)).
40
 Transmetallation with the aryl Grignard reagent 
then leads to an aryl iron complex, which undergoes elimination to release the cross-coupled 
product. Nakamura and co-workers have also proposed a single-electron transfer mechanism, 
specifically for the iron-catalysed cross-coupling between aryl Grignard reagents and alkyl 
halides with TMEDA as an additive (Scheme 1.09 (b)).
41
 However, the order of the reaction 
steps differs to that suggested by Bedford. 
 
Scheme 1.09. One-electron iron-catalysed cross-coupling mechanisms proposed by a) Bedford and b) 
Nakamura 
Overall, the mechanism for iron-catalysed cross-coupling remains controversial and it has 
been suggested that more than one catalytic cycle may be operating at a time.
38
 The nature of 
the coupling partners and ligands may influence which catalytic cycle is operating and, in 
addition to the mechanisms discussed above, several other variants have been proposed, 
including the involvement of iron nanoparticles.
42-45
 
Directly comparing palladium and iron in cross-coupling reactions, palladium-catalysed 
reactions are better understood and the reaction scope more established. They are also 
relatively insensitive to air and moisture and are tolerant of a wider range of functional 
groups (including hydroxyl and carbonyl groups) compared to iron-catalysed reactions. At 
present, iron-catalysed cross-coupling reactions are mainly limited to Grignard reagents and 
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thus the reaction is intolerant of air, moisture, and acidic and electrophilic functionalities. 
However, iron has the potential to become a highly successful cross-coupling catalyst in the 
coming years, as has been demonstrated in the cross-coupling of traditionally challenging 
electrophiles such as aryl chlorides
36




The value of being able to selectively reduce functional groups, such as alkenes, alkynes, 
aldehydes, ketones and imines, in both academic and industrial settings, cannot be 
understated. The Monsanto synthesis of L-DOPA, a drug used to treat Parkinson’s disease, 
famously features an enantioselective hydrogen using an enantiopure rhodium catalyst 
(Scheme 1.10),
46
 with Knowles and Noyori being awarded half the Nobel Prize in chemistry 
in 2001 for their work on catalytic asymmetric hydrogenation reactions.
47
 
Scheme 1.10. Monsanto synthesis of L-DOPA 
1.1.2.1 Precious Metal-Catalysed Hydrogenation 
Typically, the homogenous reduction of functional groups has been achieved using precious 
metal catalysts, such as Wilkinson’s rhodium catalyst (Ph3P)3RhCl
48
 and Crabtree’s iridium 
catalyst [(COD)Ir(PCy3)(py)]PF6
49
 (COD = cyclooctadiene and py = pyridine) 
(Scheme 1.11). Crabtree’s catalyst has since been modified with enantioenriched ligands to 









Scheme 1.11. Common hydrogenation catalysts and an enantioselective hydrogenation by Pfaltz 
Ruthenium-based catalysts have also been widely used for reduction owing to the 
inexpensive nature of ruthenium relative to other precious metals. Perhaps the most famous 
family of catalysts was developed by Noyori for the asymmetric hydrogenation (1.19)
53-54
 
and transfer hydrogenation (1.20)
55
 (using iso-propanol or formic acid/triethylamine as a 
hydrogen donor) of ketones (Scheme 1.12). Hydrogenation using a hydrogen transfer reagent 
has been shown to be more useful, as this method negates the use of flammable hydrogen gas 
and pressure vessels. These catalysts are currently some of the most active and selective 
catalysts for the chemoselective reduction of ketones; for example, propargylic ketone 1.21 
is reduced to alcohol 1.22 in an excellent 97% ee with transfer hydrogenation catalyst 1.20.
56
 
Recent mechanistic studies have revealed asymmetric transfer hydrogenation proceeds via a 
nonclassical metal-ligand bifunctional mechanism involving ruthenium hydridoamido 




Scheme 1.12. Noyori’s hydrogenation and transfer hydrogenation catalysts 
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Both palladium-catalysed hetero- (palladium metal on a support) and homogenous (soluble 




Heterogeneous systems have mainly been applied to three classes of substrate: alkenes and 
alkynes, carbonyl compounds, and nitrogen-containing multiple bonds. Whilst palladium can 
catalyse a wide range of reductions, other commonly used precious metals such as platinum, 
rhodium, ruthenium and nickel, are sometimes more effective. 
For heterogeneous catalysis, palladium is dispersed on a support such as activated carbon, 
alumina, silica and alkaline earth metal carbonates and sulphates. The reactivity of the 
catalyst can be modified through the addition of additives; for example, Lindlar’s catalyst 
consists of lead-poisoned Pd/CaCO3 and is used for the chemo- and stereoselective reduction 
of alkynes to cis-alkenes. In the reduction of phenylacetylene 1.24 to styrene 1.25, quinoline 
is also added to further improve the selectivity of the reaction (Scheme 1.13). 
 
Scheme 1.13. Palladium-catalysed reduction of phenylacetylene 1.24 to styrene 1.25 
Whilst homogeneous palladium-catalysed hydrogenation is unsuited to the reduction of 
alkenes, it has been shown to effectively catalyse the reduction of alkynes to alkenes, with 
the first example being reported in 1989 using tetramethyldihydrosiloxane (TMDHS) as a 
hydrogen donor (Scheme 1.14).
62
 In general, alkynes 1.26 were reduced to cis-alkenes 1.27. 
Notably, alkynes in conjugation with an ester could be selectively reduced and nitro groups, 
which can be reduced using heterogeneous palladium catalysis, remained intact.  
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Scheme 1.14. First homogenous palladium-catalysed reduction of alkynes 
Recently, owing to sustainability issues and potential novel reactivity, iron is being 
increasingly valued as an alternative reduction catalyst.
63
 
1.1.2.2 Iron-catalysed Hydrogenation 
Early iron-catalysed reduction focused on the isomerisation, hydrogenation and 
hydrosilylation of alkenes using iron carbonyl compounds (Scheme 1.15).
64-65
 The active 
catalyst in these reactions was proposed to be Fe(CO)3, accessible from Fe(CO)5 and 
Fe3(CO)12 by UV irradiation. 
 
Scheme 1.15. Iron carbonyl compounds as early reduction catalysts 
Following these seminal reports, Grant and co-workers conducted mechanistic studies into 
the gas-phase hydrogenation of ethylene and proposed (η
2
-CH2=CH2)Fe(CO)3 1.28 to be the 
active catalytic species (Scheme 1.16).
66-68
 Coordination of a second molecule of ethylene 
would lead to the resting state (η
2
-CH2=CH2)2Fe(CO)3 1.29 and coordination of an additional 
carbon monoxide ligand would be a deactivation pathway leading to the inactive 
(η
2
-CH2=CH2)Fe(CO)4 1.30. Therefore, the only productive pathway would involve 
coordination of hydrogen to give H2(η
2
-CH2=CH2)Fe(CO)3 1.31, which can undergo 
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hydroferration (1.32) and reductive elimination to release ethane and the active catalyst. 
 
Scheme 1.16. General mechanism for the hydrogenation of alkenes with iron carbonyl complexes 
Interest in iron-catalysed reduction waned in the following years and it is only recently that 
this area has been reinvestigated. Inspired by the early iron-catalysed reductions, Chirik and 
co-workers designed iron bis(imino)pyridine complexes 1.33, which are isolobal with 
Fe(CO)3 (the proposed active catalyst in reductions using iron carbonyl compounds) 
(Scheme 1.17).
69
 The choice of bis(imino)pyridine (BIP) as a ligand was twofold; iron 
bis(imino)pyridine complexes has precedence in catalytic carbon–carbon bond forming 
reactions
70-72
 and bis(imino)pyridine is classed as a non-innocent ligand and can accept 
between one and three electrons.
73-76
 It was hoped that this ability to accept electron density 
would enable iron to undergo the two-electron redox changes required (e.g. oxidative 
addition, reductive elimination) and suppress any side reactions arising from one-electron 
redox changes. 
 
Scheme 1.17. Isolobal relationship between Fe(CO)3 and iron bis(imino)pyridine complex 1.33, and 
redox activity of complex 
The formally Fe(0) complex 1.35 was prepared by the sodium-amalgam reduction of 
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iron(II) bis(imino)pyridine dibromide or chloride 1.34 under a nitrogen atmosphere 
(Scheme 1.18).
69
 Although Fe(0) complex 1.35 is highly air and moisture sensitive,
77
 it 
nevertheless successfully catalysed the hydrogenation of a range of unfunctionalised and 
electron-deficient olefins 1.36 at low catalysts loadings. Through deuterium labelling studies, 
it was shown that both deuterium atoms were delivered to the same face of the alkene, 
consistent with syn-hydrogenation.  
 
Scheme 1.18. Synthesis of iron(0) bis(imino)pyridine complex 1.35 and application in the 
hydrogenation of olefins 
Iron catalysts have also been used successfully for the hydrogenation of polar functionalities. 
The current state-of-the-art catalysts for the asymmetric hydrogenation of carbonyls are the 
iron amine(imine)bisphosphine complexes 1.40, developed by Morris and co-workers (Table 
1.03).
78
 Using iso-propanol as a hydrogen source, a range of aldehydes, ketones and imines 
1.38 underwent transfer hydrogenation to the corresponding enantioenriched alcohols and 
amines 1.39. Remarkably high turnover frequencies (TOF) were observed with some 
substrates, for example, 119 s
-1
 at 50% conversion with acetophenone (Table 1.03, entry 1). 
In contrast, with RuCl2((R)-tol-binap)[(R,R)-DPEN] (Noyori’s hydrogenation precatalyst), 
acetophenone underwent hydrogenation (at 45 atm., 30 °C and in basic iso-propanol) to (S)-





















(at 10 s) 
1 
 
180 s 82 119 78 (88) 
2 
 
180 s 84 158 83 (92) 
2 
 
1 h 73 4 33 (34) 
4 
 
10 min 88 38 - 
5 
 
1 h 67 3 54 (57) 
6 
 




25 s 99 242 - 
8 
 
4 min 55 14 40 (40) 
9 
 
20 s 100 10 >99 (>99) 
Table 1.03. Iron-catalysed transfer hydrogenation of ketones 
The mechanism for the transfer hydrogenation is postulated to involve initial deprotonation 
of precatalyst 1.40 to form a mixture of isomers 1.41 and 1.42 (Scheme 1.19). These isomers 
can then formally accept a molecule of hydrogen from iso-propanol to give iron hydride 
complex 1.43 as the major isomer. The ketone substrate can then accept a hydride from iron 
hydride complex 1.43 by forming a hydrogen bond with the N–H functionality and 
orientating the large substituent towards the less bulky diamine side of the catalyst (1.44) to 
give enantioenriched alcohol. 




Scheme 1.19. Mechanism for transfer hydrogenation of ketone substrates catalysed by 
amine(imine)bisphosphine complex 1.40 
At the boundary between heterogeneous and homogeneous catalysis, de Vries and 
co-workers have recently demonstrated that Fe(0) nanoparticles are active for the reduction 
of terminal, 1,1- and 1,2-disubstituted alkenes and alkynes 1.45 (Scheme 1.20).
80-81
 Trans 
alkenes were more challenging to hydrogenate than cis isomers and required higher 
temperatures to achieve full conversion, whilst tri- and tetrasubstituted alkenes did not 
undergo hydrogenation. The Fe(0) nanoparticles were generated from the reduction of iron 
salts with alkyl Grignard or alkyl lithium reagents according to a procedure previously 




Scheme 1.20. Hydrogenation of olefins catalysed by iron nanoparticles. Conversions shown 
Based on kinetic experiments for the hydrogenation of 1-octyne 1.48, a mechanism is 
proposed in which initially, octane 1.50 is not formed from the reduction of 1-octene 1.49, 
but from rearrangement of alkenyl iron species 1.52 to alkylidene iron species 1.54 followed 
by hydrogenation (Scheme 1.21). 





Scheme 1.21. Mechanism for hydrogenation of alkynes by Fe(0) nanoparticles 
Although precious metal-catalysed hydrogenations are more robust, the recent progress in 
the field of iron-catalysed hydrogenation reveals that unprecedented activity and selectivity 
can be achieved with iron catalysis. As this field is still in its infancy compared to rhodium-, 
iridium- and palladium-catalysed hydrogenations, much more can be expected of iron 
catalysis and perhaps an increasing number of industrial syntheses will feature an 
iron-catalysed step in the coming years. 
1.1.3 Novel Palladium and Iron-Catalysed Reactions 
It was hoped that the unique properties of palladium and iron catalysis could be exploited to 
effect the construction of a variety of bonds in a controlled and selective manner. As 
exemplified in the cross-coupling and hydrogenation reactions discussed above, palladium 
and iron have been used as catalysts in a wide range of reactions, yet there remains untapped 
reactivity. In an age where sustainability is becoming of increasing importance, attention is 
turning to iron catalysis. Three classes of reaction were explored, namely asymmetric 
fluorination, C–H functionalisation and hydrofunctionalisation. For each of these reactions, a 
key aim was the development of an operationally simple, general and reliable protocol. 
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Chapter 2. Enantioselective Fluorination of Azaarylacetates 
and Amides 
2.1 Introduction 
Compared to the scarcity of fluorine-containing natural products, the number of fluorinated 
synthetic molecules is phenomenal; it is estimated that up to 35% of current agrochemicals 
and 20% of pharmaceuticals contain fluorine, including 4 of the top 10 best-selling drugs.
82
 
Lipitor and Advair Diskus are two of these drugs and contain aromatic and aliphatic 
fluorines respectively (Figure 2.01). Although the replacement of a hydrogen atom with a 
fluorine atom has a minimal steric effect on the compound (van der Waals radius of 
hydrogen: 1.2 Å; fluorine: 1.47 Å), it can have a profound beneficial effect on many of its 
other properties.
83
 These include an electronic influence on neighbouring groups, improved 
lipophilicity, increased stability, and resistance to metabolic degradation, and as such 
fluorination has received considerable attention over the last decade. 
 
Figure 2.01. Examples of fluorinated best-selling drugs 
Asymmetric fluorination is of particular importance in the pharmaceutical industry, as it is 
well known that stereoisomers behave differently within the chiral environment of a 
biological receptor.
84
 For example, out of the three fluorines in Advair Diskus, two are 
attached to stereogenic centres and so their synthetic introduction must be carefully 
controlled. 
2.1.1 Construction of Fluorinated Stereocentres 
The generation of a fluorinated stereogenic centre can be achieved in two ways, either 
through the direct asymmetric introduction of fluorine (e.g. via a stereospecific SN2 
displacement at a pre-formed stereocentre), or through the conversion of prochiral 
                                Chapter 2. Enantioselective Fluorination of Azaarylacetates and Amides 
-19- 
 
fluorinated substrates (where the fluorinated sp
2





 Asymmetric fluorination itself can be realised in two ways: through either 
substrate-controlled diastereoselective reactions, or reagent- or catalyst-controlled 
enantioselective reactions. In the first instance, an existing non-racemic stereocentre controls 







 Davis and co-
workers showed that Evans’s oxazolidinones could be used to prepare α-fluorinated imides 
2.02 in excellent diastereoselectivity, based on the approach of N-fluoro-o-benzene-
disulfonimide (NFOBS) or N-fluorobenzenesulfonimide (NFSI) from the less hindered si 
face of the imide enolate (Scheme 2.01).
86
 Despite the high diastereoselectivities observed, 
removal of the chiral auxiliary sometimes proved problematic, as exposure to base resulted 
in racemisation of the stereocentre owing to the enhanced acidity of the α-fluoro proton in 
the product. 
 
Scheme 2.01. Use of oxazolidinones in diastereoselective fluorinations 
In the case of reagent- or catalyst-controlled enantioselective fluorinations, the substrate is 
exposed to a chiral fluorinating reagent, or a chiral catalyst in combination with an achiral 
fluorine source, respectively. Shibata and Cahard independently developed a series of chiral 
fluorinating agents based on cinchona alkaloids and Selectfluor
®
 (transfer fluorination from 
Selectfluor
®
 onto the cinchona alkaloids generates the N-fluoroammonium salts).
91-92
 For 
example, the N-fluoroammonium salt of dihydroquinine-4-chlorobenzoate (DHQB) was used 
to prepare fluorinated indanones and tetralones 2.04 in up to 91% ee (Scheme 2.02). 
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However, this particular example uses stoichiometric cinchona alkaloid and it is only 




Scheme 2.02. Use of cinchona alkaloids in reagent-controlled enantioselective fluorinations 
Early work focussed on substrate-controlled diastereoselective reactions, but in recent years 
there has been growing interest in reagent- and catalyst-controlled enantioselective reactions 
and this can be further divided into nucleophilic and electrophilic fluorination. Out of 
nucleophilic and electrophilic fluorination, the latter has been the most exploited and hence 
electrophilic fluorination will form the main focus of this discussion. 
2.1.2 Asymmetric Electrophilic Fluorination 
Within the field of asymmetric electrophilic fluorination, a wide variety of methods have 



















































































































































- 88 35 88 - 91 54 87 - - 94 76 87 40 88 96 - 
Transition-
metal catalysis 
- - 99 - 88 - - 99 99 98 - - 99 - 96 - 99 
Organocatalysis 99 36 - - - - - 70 - - - - 76 - - - - 
Table 2.01. Enantiomeric excesses reported for a variety of substrates using three different 
electrophilic fluorination methods; reproduced from a review by Cahard and co-workers
94
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Out of the three approaches explored, transition-metal catalysis is the one that is most 
consistently able to generate products in excellent enantiomeric excess, and as such this 
approach is considered in more detail in the following section. 
2.1.2.1 Transition-Metal Catalysis 
In 2000, Togni and co-workers reported the pioneering example of transition-metal catalysed 
asymmetric electrophilic fluorination; using  titanium TADDOLate complex 2.05 and achiral 
fluorine source Selectfluor
®




Scheme 2.03. First transition-metal catalysed asymmetric electrophilic fluorination 
Although the ee was generally moderate with the exception of specific substrates e.g. 2.06, 
the stage for transition-metal catalysis was set. In the years that followed numerous catalysts 
were developed and applied to a wide variety of substrates in which a chiral, non-racemic 
catalyst and an achiral fluorine source such as Selectfluor
®
, NFSI or N-fluoropyridinium 
salts were used. It is noteworthy that only those substrates containing a highly activated 
methine moiety have been successfully fluorinated, including β-ketoesters, β-
ketophosphonates,α-cyanoacetates, α-cyanophosphonates and oxindoles. 
2.1.2.1.1 Fluorination of β-Ketoesters and β-Ketophosphonates 
In 2002, the Sodeoka group developed aqua and -hydroxo palladium bisphosphine 
complexes 2.08 and 2.09 that benefitted the field greatly in terms of both substrate scope and 
enantioselectivity (Scheme 2.04). These catalysts enabled the preparation of fluorinated 
β-ketoesters 2.11 in up to 94% ee,
97-98
 β-ketophosphonates 2.13 in up to 98% ee,
98-99
 and 
oxindoles in up to 96% ee (see section 2.1.2.1.3).
100
   




Scheme 2.04. Fluorination using the Sodeoka group’s state-of-the-art catalyst 
Figure 2.02 depicts the proposed transition state for the fluorination of β-ketoester 2.10 with 
(R)-DM-BINAP palladium catalyst 2.08b and explains the origin of the (R) 
enantioselectivity.
97
 β-Ketoester 2.10 first forms a palladium enolate with catalyst 2.08b to 
give complex 2.14—the substrate binds to palladium through both oxygens in its 
1,3-dicarbonyl motif to form a six-membered chelate. In the distorted square planar 
transition state, the ester tert-butyl moiety points away from the bulky phosphine aryl groups 
and this determines which enantiotopic face NFSI approaches. The ester tert-butyl moiety 
effectively shields the si face from NFSI and forces fluorination to occur on the sterically 
less hindered re face. Sodeoka states that phosphine phenyl groups were insufficiently bulky 
to force the tert-butyl group into a conformation capable of completely shielding the si face 
from fluorination and phosphine dimethyl or di(tert-butyl) substituted phenyl groups were 
essential for a high degree of enantiomeric excess in the product. 




Figure 2.02. Sodeoka’s proposed transition state for the fluorination of β-ketoesters 
Bis(oxazolines) (BOX) 2.15 are a class of N,N-ligands that have been employed with a 
variety of metals to effect asymmetric enantioselective fluorination, with Shibata and 
co-workers demonstrating their broad scope in the development of an enantiodivergent route 
to fluorinated β-ketoesters 2.17 and 2.18 (Scheme 2.05).
101
 They showed that the opposite 
configuration of the fluorinated stereocentre could be achieved using Ni(II)- and 
Cu(II)-dimethyldiphenylbis(oxazoline) (DMDP-BOX) complexes, as a result of the two 
different coordination geometries adopted by the complexes. 
Scheme 2.05. Use of BOX ligands in asymmetric electrophilic fluorination 
In 2005, Shibata and co-workers extended their methodology to include 
(dibenzofuran-4,6-diyl)-2,2'-bioxazoline (DBFOX) ligands, in the hope of improving upon 
the BOX system. It was shown that Ph-DBFOX 2.19 did provide better enantioinduction 
than DMDP-BOX 2.15, and Ni(II)-Ph-DBFOX was used to prepare fluorinated β-ketoesters 
2.21 and oxindoles in up to 99% ee (Scheme 2.06).
102
 Simultaneously, Jørgensen and 
co-workers developed an analogous Zn(II)-Ph-DBFOX system to catalyse the fluorination of 








Scheme 2.06. Use of DBFOX ligands in asymmetric electrophilic fluorination 
During their research into the fluorination of -ketoesters, Shibatomi and Iwasa showed that 
the order in which the reagents were added had a significant effect on the enantioselectivity 
of the reaction (Scheme 2.07).
104
 They found that slow addition of NFSI to a solution of 
Ni(II)-2.24 and substrate 2.25 (method A) gave product 2.26 in higher enantiomeric excess 
(up to 99% ee) than if all the reagents were added simultaneously (up to 94% ee).
105
 
Conversely when substrate 2.25 was added to a solution of Ni(II)-2.24 and NFSI (method B), 
the ee of product 2.26 was substantially reduced (up to 44% ee). 
 
Scheme 2.07. Effect of order of addition of reagents on enantioselectivity 
With this in mind, Shibatomi and Iwasa proposed the existence of a second mechanistic 
pathway, in which the chiral metal complex activates NFSI—both NFSI and substrate 
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possess the requisite 1,3-dicarbonyl motif (Figure 2.03).
104, 106
 The fluorinated β-ketoester 
will thus be formed in lower enantiomeric excess owing to the reduced influence of the 
catalyst—enantioinduction decreases with increasing distance between the reaction centre 
and source of chirality. 
 
Figure 2.03. Proposed existence of second fluorination mechanistic pathway 
Various N,N-ligands have also been used for the enantioselective fluorination of 
β-ketoesters, including bis(thiazoline) 2.27, BOX 2.28, spirooxazoline 2.29 and 




Figure 2.04. Alternative ligands for enantioselective electrophilic fluorination of β-ketoesters 
2.1.2.1.2 Fluorination of α-Cyanophosphonates 
In terms of substrate scope, Sodeoka and Kim raised the bar for asymmetric electrophilic 
fluorination in 2007, when they simultaneously reported the fluorination of 
α-cyanophosphonates 2.32 (Scheme 2.08).
111-113
 Both groups made the observation that 
α-cyanophosphonates were a substantially less reactive class of substrates than β-ketoesters 
and β-ketophosphonates, and an external base was required to assist formation of the enolate. 
Nevertheless, Sodeoka successfully isolated fluorinated α-cyanophosphonates in up to 78% 
ee, and Kim in up to 91% ee. In addition to the lower reactivity of α-cyanophosphonates, 
only α-aryl substituted substrates underwent successful fluorination; α-alkyl substituted 
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substrates were unreactive. The absolute configuration of the products was not given. 
Scheme 2.08. Enantioselective fluorination of α-cyanophosphonates 
α-Cyanophosphonates cannot bind in the same way to the catalyst as β-ketoesters owing to 
the absence of the 1,3-dicarbonyl motif. Two modes of catalyst-substrate binding can be 
envisaged, either invoking the lone pair of the cyano nitrogen (2.34, monodentate binding), 
or a lone pair on the P=O oxygen in addition to the -bond of the nitrile functionality (2.35, 
bidentate binding) (Figure 2.05). 
 
Figure 2.05. Proposed catalyst binding for α-cyanophosphonates 
In the following years, α-cyanoacetates and -sulfones have also proven viable fluorination 




2.1.2.1.3 Fluorination of Oxindoles and Ketones 
All of the substrates discussed so far have contained a methine group activated by two 
flanking electron-withdrawing groups. The fluorination of substrates in which a methylene 
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group is activated by only one electron-withdrawing group has also been well documented. 
However, a second coordinating group is usually required elsewhere in the molecule to 
facilitate bidentate binding of the catalyst. This was apparent during investigations into the 
fluorination of oxindoles by Sodeoka and co-workers (Scheme 2.09).
100
 Unprotected 
oxindole 2.36 was poorly reactive towards fluorination, whereas Boc-protected oxindole 
2.38 gave intended product 2.39 in good to excellent enantioselectivity. However, the lower 
reactivity observed for unprotected oxindole 2.36 compared to Boc-protected oxindole 2.38 
could also be as a result of the lower acidity of the α-proton. 
Scheme 2.09. Fluorination of unprotected and Boc-protected oxindoles 
A catalyst system compatible with unprotected oxindoles was subsequently developed and 





Scheme 2.10. Synthesis of MaxiPost™ involving fluorination of an unprotected oxindole 
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Similar fluorinations have since been performed on ketones. Thiazolidin-2-one derivatives 
2.42 were successfully fluorinated by Sodeoka and co-workers in up to 88% ee (using a 
Ni(II)-(R)-BINAP catalyst),
117
 and Shibata and Toru in up to 98% ee (using their 




Scheme 2.11. Enantioselective fluorination of thiazolidin-2-one derivatives 
Sodeoka showed that α-ketoesters 2.44 could also engage in bidentate binding with the 
catalyst (forming a five-membered chelate as opposed to the previously explored 
six-membered chelate) to give rise to fluorinated products 2.45 in up to 95% ee 
(Scheme 2.12).
120
 Alcohol 2.45 was subsequently converted to α-fluoroamine 2.46 in three 
steps. 
Scheme 2.12. Enantioselective fluorination of α-ketoesters 
It is noteworthy that in the two previous examples (Scheme 2.11 and 2.12), the methylene 
group of the substrate was unsubstituted and only monofluorination was observed with no 
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erosion of enantiomeric excess, owing to the lower acidity of the α-fluoro proton in these 
systems in comparison to 1,3-dicarbonyl compounds. 
2.1.3 2-Fluoroazaarylacetates and Amides 
At present, the majority of asymmetric electrophilic fluorinations have been performed on 
1,3-dicarbonyl containing substrates and it was envisaged that other activating groups, 
specifically a C=N functionality, could be used in place of a carbonyl group. Keeping within 
the framework of biologically active compounds, it was hoped to utilise a C=N functionality 
within a nitrogen-containing heterocycle, as these are prevalent structures in a wide variety 
of natural products and pharmaceuticals. In 2010, 18 of the top 20 small molecule-drugs 
contained at least one nitrogen heterocycle.
121
 Nexium contains both a pyridine ring and 
benzimidiazole functionality and Crestor is a good example of a drug that contains both a 
nitrogen heterocycle (pyrimidine) and a fluorinated moiety (Figure 2.06). 
 
Figure 2.06. Examples of top-selling drugs containing heterocycles 
In addition to the desirable fluorinated and heterocyclic components of a drug, it is also 
important to retain flexibility to enable subsequent manipulation and facilitate the 
preparation of a series of analogues. 
To this end, it was envisaged that the above methodology could be extended to the 
preparation of 2-fluoroazaarylacetates and amides (Figure 2.07), which contain a carbonyl 
functionality to provide a handle for further manipulation. Ultimately, it was hoped that these 
could act as useful building blocks for the preparation of therapeutic agents or other 
molecules of interest. 
 
Figure 2.07. 2-Fluoroazaarylacetates and amides 
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2.2 Results and Discussion 
2.2.1 Aims 
Previous work in the Lam group has shown azaarenes to be capable activating groups in a 
variety of stereochemistry-generating reactions and it was anticipated that this might be 
extended to fluorination (Scheme 2.13). 
122-123
 A range of azaarenes could be prepared to 
explore the scope of fluorination, yet substrates containing a second activating group (R
1
) 




Scheme 2.13. Fluorination concept 
2.2.2 Initial Fluorinations 
To test the viability of azaarenes in fluorination reactions, alkyl benzoxazole 2.49 was 
selected, owing to its success in a series of diastereoselective imine additions (Scheme 
2.14).
124
 Most importantly, benzoxazole 2.49 had shown that it could tautomerise to the 
enamine and that a transition-metal catalyst could control the stereochemistry of addition. 
 
Scheme 2.14. Diastereoselective addition of azaarenes to imines 
The fluorination of benzoxazole 2.49 was attempted with various catalysts, fluorine sources, 
basic additives, solvents and temperatures, but the crude 
1
H NMR spectra from these 
reactions showed only starting material (Scheme 2.15). 
 
Scheme 2.15. Initial fluorinations 
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It may be that benzoxazole 2.49 is insufficiently activated for fluorination. Since the 
mechanism for electrophilic fluorination would involve metal enamide 2.52 formation, it was 
hoped that an additional electron-withdrawing group would promote its formation 
(Scheme 2.16). Substrate 2.53 containing a phenyl group was chosen to test this hypothesis. 
 
Scheme 2.16. Consideration of metal enamide intermediate 2.52 
We were pleased to observe fluorination of benzyl benzoxazole 2.53 with AgOAc, although 
the conversions were low and heating the reaction to 100 °C did not result in an increase in 
conversion (Table 2.02, entries 1-3). Catalyst 2.55, which had been used successfully in the 
enantioselective Michael addition of azaarylacetates and amides to nitroalkenes,
125
 was 
ineffective and no reaction occurred (entry 4). These observations suggested that two 
coordinating C=X functionalities were required for fluorination. 
 
Entry Catalyst Temperature Conversion (%)
a 
1 AgOAc-2,2'-bipyridyl rt 7% 
2 AgOAc-(±)-BINAP rt 3% 
3 AgOAc-2,2'-bipyridyl 100 °C 4% 
5 2.55 rt no reaction 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
Table 2.02. Initial results 
2.2.3 Substrate Synthesis 
As opposed to amides, esters are more electrophilic and undergo functional group 
interconversions more readily. Therefore, we decided to concentrate on the synthesis and 
fluorination of azaarylacetates 2.58, with a substituent at the 2-position to prevent either 
difluorination or racemisation of the monofluorinated product. 
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The majority of substrates 2.58 were prepared in one step through the reaction of readily 
available heterocyclic chlorides 2.56 with the enolates of simple esters 2.57, using the 
methodology developed by Shen and co-workers (Scheme 2.17).
126
 This allowed the 
preparation of a broad range of substrates 2.59-2.68, including benzoxazoles, 
benzimidazoles, and various other azaarenes, in good yield. 
 
 
Scheme 2.17. General procedure for the preparation of azaarylacetates 
However, in general this methodology was limited to the preparation of tert-butyl esters 
from an appropriate heterocyclic chloride and tert-butyl propionate owing to a competing 
Claisen condensation when other esters were used e.g. with ethyl propionate (Scheme 2.18). 
 
Scheme 2.18. Competing Claisen condensation for methyl and ethyl propionate 
Nevertheless, substrates containing a broad range of functionalities were prepared using this 
strategy. Replacing the heterocyclic oxygen in benzoxazole 2.60 with nitrogen in 
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benzimidazole 2.63 would allow a direct comparison of the two azaarenes to be made. 
Quinoline 2.64 and isoquinoline 2.65 were designed to test the activating potential of a 
heterocyclic imine that is not in conjugation with another heteroatom. Furthermore these 
structural isomers would allow the position of the nitrogen in relation to the neighbouring 
aryl ring to be explored. Finally quinoxaline 2.66 and pyrazines 2.67 and 2.68 would probe 
the effect that an additional inductively stabilising heteroatom (2.66-2.68) and aryl ring 
(2.66) would have on activation and subsequent fluorination. 
A variety of additional azaarylacetates were also prepared according to literature procedures. 
For example, pyridyl ester 2.70 was accessed through the methylation of commercially 




Scheme 2.19. Synthesis of pyridyl ester 2.70 
Using an opposite strategy to the one used for the preparation of the majority of substrates 
(2.59-2.68), the preparation of pyridyl ester 2.72 involved the addition of the lithium enolate 
of 2-benzylpyridine 2.71 to ethyl chloroformate (with the azaarene acting as the nucleophilic 
synthon and the ester the electrophilic synthon) (Scheme 2.20). Pleasingly this alternative 
strategy worked well and pyridyl ester 2.72 was prepared in 76% yield. Pyridyl esters 2.70 
and 2.72 are identical apart from the substituent at the 2-position, allowing the effect of the 
phenyl substituent on both the reactivity and the stereoselectivity of the fluorination reaction 
to be explored. 
 
Scheme 2.20. Synthesis of pyridyl ester 2.72 
Benzisoxazole 2.74 was isolated from the reaction of corresponding commercially available 
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acid 2.73 with TMS diazomethane in 66% yield (Scheme 2.21), which was subsequently 
treated with LDA and methyl iodide to yield benzisoxazole acetate 2.75 in 36% yield. 
Careful monitoring of the methylation was required as intermediate 2.74 also underwent 
double methylation, reducing the yield. 
 
Scheme 2.21. Synthesis of benzisoxazole 2.75 
Quinoxaline derivative 2.78 was prepared from diamine 2.76 and diester 2.77 in refluxing 




Scheme 2.22. Synthesis of quinoxalinone 2.78 
The preparation of thiadiazole 2.81 enabled access to the literature known compounds 
thiadiazole esters 2.82 and 2.83 in both keto and enol forms (Scheme 2.23). Refluxing neat 
thiadiazole 2.79 with morpholine 2.80 gave morpholine thiadiazole 2.81 in 68% yield.
129
 A 
divergent ester synthesis was then pursued: reaction with LiHMDS and ethyl propionate 
gave both keto and enol ethyl ester thiadiazole 2.82 in good yield, whilst with LiHMDS in 




Scheme 2.23. Synthesis of thiadiazoles 2.82 and 2.83 
As the main aim of the project focused on azaarenes as potential activating groups for 
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fluorination, substrates containing two azaarenes in a 1,3-relationship were also investigated. 
Pyridyl benzoxazole 2.86 was targeted, as substrates containing pyridine and benzoxazole 
heterocycles had already been synthesised (Scheme 2.24). Unfortunately, the reaction of the 
lithium enamide of 2-ethyl pyridine 2.84 with 2-chlorobenzoxazole 2.85 proved more 
difficult than expected, with a number of different conditions failing to yield any of the 
intended product. Eventually, the nitrile analogue (2.88) was prepared in excellent 97% 
yield. It is noteworthy that nitrile 2.88 existed purely in enamine form, identifiable in the 
1
H NMR spectrum by the absence of an aliphatic CH peak and the presence of a broad NH 
singlet at 15.52 ppm. 
Scheme 2.24. Pyridyl benzoxazole 2.88 synthesis 
2.2.4 Initial Screening 
At this point, it was of the utmost importance to check for a background reaction that would 
give rise to racemic fluorinated products. If a background reaction was found to be 
occurring, then the stereoselectivity of an asymmetric fluorination would suffer under such 
conditions and any ee values obtained with an enantioenriched catalyst would not be a true 
reflection of the system. 
2.2.4.1 Monitoring of Background Reaction 
Esters 2.59 and 2.70 were treated with NFSI in THF at room temperature and a background 
reaction was observed for both substrates by TLC analysis. To suppress, or at the very least 
minimise this reaction, the temperature at which the background reaction occurred and the 
solvent which most suppressed the background reaction were investigated. 
The reaction temperature was first investigated in ethanol, iso-propanol and acetonitrile— 
solvents commonly used for fluorination (Table 2.03).
97
 No background reaction was 
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observed for substrates 2.59 and 2.70 in ethanol and iso-propanol at −10 °C after thirty 
minutes (Table 2.03, entries 1 and 2). In addition, only a negligible conversion was recorded 







Entry Solvent Conversion (%)
a Conversion (%)
a 
1 EtOH 0 0 
2 i-PrOH 0 0 
3 MeCN 4 2 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
Table 2.03. Monitoring of background reaction in different solvents 
As the background reaction was determined to be inconsequential at –10 °C, it was decided 
for the sake of practicality to perform the solvent screen for ester 2.59 at 0 °C using an ice 
bath (Table 2.04). The solvent screen was conducted by measuring the % conversion of the 
uncatalysed and catalysed reaction and calculating the relative conversion. 
 
Entry Solvent 
Conversion without 2.55 
(%)
a 





1 EtOH 7 77 11 
2 i-PrOH 0 50 - 
3 MeCN 23 77 3.3 
4 Et2O 7 50 7.1 
5 THF 9 83 9.2 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
Table 2.04. Solvent screen for ester 2.59 
Ethanol had a comparatively high relative conversion whereas one could not be calculated 
for iso-propanol owing to complete suppression of the background reaction (Table 2.04, 
entries 1 and 2); however, iso-propanol also reduced the conversion of the catalysed 
reaction. Acetonitrile was a poor solvent choice for fluorination as the relative conversion 
                                Chapter 2. Enantioselective Fluorination of Azaarylacetates and Amides 
-37- 
 
was small (entry 3). However, the relative conversions for diethyl ether and THF were 
comparable to ethanol (entries 4 and 5). 
During screening it became apparent that NFSI had differing solubility in the various 
solvents screened. For example, NFSI was only partially soluble in ethanol and iso-propanol 
whereas it was completely soluble in acetonitrile. This might explain the high conversion 
observed for the uncatalysed reaction in acetonitrile (entry 3). With this in mind, ethanol was 
used in the following screening reactions. 
2.2.5 Catalyst Screening 
Substrates 2.59, 2.62, 2.64 and 2.66 were chosen as model substrates for screening as they 
contain a variety of heterocycles, which would potentially enable us to develop a general and 
highly enantioselective catalytic system (Scheme 2.25). All fluorinations were performed in 
ethanol or dichloromethane at room temperature (lactone 2.62 underwent ring-opening if the 
fluorination was performed in ethanol, and dichloromethane has previously been used to 




Scheme 2.25. Catalyst screening for selected substrates 
A variety of transition metal salts were screened, including those containing nickel, copper, 
silver, cobalt, iron and manganese, in combination with N,N-, P,P- and N,P-ligands 
(Figure 2.08). The majority of successful catalysts for enantioselective electrophilic 
fluorination rely on C2-symmetric ligands, such as DPDM-BOX, Ph-PyBOX and BINAP, 
and thus these ligands provided a good starting point. However non-C2-symmetric ligands 
were also explored, including (S)-t-BuPyOx and (S)-i-Pr-PHOX. 




Figure 2.08. Ligand classes screened 
The majority of catalysts screened gave racemic products in low conversion, but amongst the 
metals screened there were high expectations for azaphilic nickel and copper, in the hope 
that these metals would successfully coordinate to the heterocyclic nitrogen to allow the 
creation of a well-defined chiral environment. 
A variety of Ni(II) salts were screened with different ligand classes against benzoxazoles 
2.59 and 2.62 (Table 2.05). The use of Ni(ClO4)2 in enantioselective electrophilic 
fluorinations is well documented,
101-102
 and an excellent conversion of 99% for ethyl ester 
2.59 with racemic ligand bipy was promising but switching to enantioenriched ligands 
(S)-t-BuPyOx and (R)-BINAP failed to induce any enantioselectivity (Table 2.05, entries 
1-3). The results obtained with Ni(OAc)2·4H2O are perhaps the most insightful as this salt 
was screened against the widest variety of ligands. In the literature, Ni(OAc)2·4H2O has 




anions are more weakly 
coordinating than acetate anions (anion dissociation must occur prior to substrate 
association), and this is presumably the reason for the preferential use of Ni(ClO4)2. 
Pleasingly, with (S,S)-DPDM-BOX as ligand, a 75% conversion and 26% ee—the highest 
enantiomeric excess obtained during screening with Ni(II)—was observed using substrate 
2.59 (entry 4). Unfortunately, switching from bidentate (S,S)-DPDM-BOX to tridentate 
(R,R)-Ph-PyBOX resulted in the loss of enantioselectivity (entry 5). 
 

















 - - 
2 (S)-t-BuPyOx - - 80% 4% 
3 (R)-BINAP 70% 0% - - 
4 
Ni(OAc)2·4H2O 
(S,S)-DPDM-BOX 75% 26% - - 
5 (R,R)-Ph-PyBOX 67% 0% - - 
6 (R)-BINAP 95% 0% - - 





 - - 
9 (R)-BINAP 62% 0% - - 
10 Ni(OTf)2 (R)-BINAP 49% 0% - - 
a 
conversion determined by GLC or 
1
H NMR spectroscopy based on remaining substrate 
b 
achiral ligand gave racemic product 
Table 2.05. Selected screening results of Ni(II) salts 
Owing to the different denticity of (S,S)-DPDM-BOX and (R,R)-Ph-PyBOX, these 
fluorinations will proceed through different transition-state structures. With Ni(II)-(S,S)-
DPDM-BOX, it has been proposed that the fluorination of β-ketoester 2.90 proceeds through 
square pyramidal transition-state structure TS-2.91,
101
 whereas with Ni(II)-(R,R)-Ph-DBFOX 
(another tridentate ligand), fluorination proceeds through octahedral transition-state structure 
TS-2.92 (Figure 2.09).
102
 For substrate 2.59, TS-2.92 may not provide adequate distinction 
between its enantiotopic faces. 
 
Figure 2.09. Different transition-state structures for 2.90 with BOX and DBFOX ligands 
(S)-t-BuPyOx, a non-C2-symmetric ligand, also fared poorly with Ni(OAc)2·4H2O; of the 
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three substrates tested, only one (2.62) gave rise to non-racemic product and even then in 
only 10% ee (Scheme 2.26). 
 
Scheme 2.26. Screening with (S)-t-BuPyOx 
Screening with (R)-BINAP again gave rise to racemic product and matters did not improve 
greatly with N,P-ligand (S)-i-Pr-PHOX, as stereoinduction was poor giving the product in 
only 6% ee (Table 2.05, entries 6 and 7). 
Ni(acac)2 and Ni(OTf)2 gave similarly disappointing results with (R)-BINAP, and only 
served to highlight the incompatibility of Ni(II) with P,P-ligands (entries 8-10). 
At this point attention turned to copper in the hope that this similarly azaphilic metal would 






















- - - - nd
b - 
3 TPDM-BOX 82% 28% 100% 0% 49% 0% 
4 (S)-t-BuPyOx 82% 26% 100% 0% 54% 0% 
5 Cu(OAc)2 (S)-t-BuPyOx 76% 10% 100% 8% 67% 0% 
a
 conversion determined by GLC or 
1
H NMR spectrometry based on remaining substrate 
b 
complex mixture of products 
Table 2.06. Selected screening results of Cu(II) salts 
In addition to the ligands given in Figure 2.08, TPDM-BOX was also screened. TPDM-BOX 
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contains two more phenyl groups than (S,S)-DPDM-BOX and it was hoped that this 
additional steric bulk would improve the level of stereoinduction. 
Again, Cu(OTf)2 was chosen owing to its success in previous enantioselective electrophilic 
fluorinations.
101
 Unfortunately, no meaningful results could be obtained with (R)-BINAP and 
(S,S)-DPDM-BOX as the crude 
1
H NMR spectrum revealed a complex mixture of products 
for substrates 2.59, 2.60 (not shown in Table 2.06) and 2.66 (Table 2.06, entries 1 and 2). 
Switching to TPDM-BOX pleasingly gave rise to non-racemic products; 82% of lactone 2.62 
underwent fluorination to generate product in 28% ee (entry 3). It was also gratifying to 
observe that the non-C2-symmetric ligand (S)-t-BuPyOx performed equally as well as the 
C2-symmetric TPDM-BOX (entry 4). Switching the Cu(II) source to Cu(OAc)2 gave mixed 
results; whilst the ee of fluorinated lactone 2.62 decreased from 26% to 10%, some ee was 
now obtained for fluorinated quinoline 2.64 (entry 5). 
Palladium is generally more compatible with phosphorus containing ligands than either 
nickel or copper, and as i-Pr-PHOX is a N,P-ligand, this ligand was screened with Pd(OAc)2 
(Scheme 2.27). Esters 2.59 and 2.60 were fluorinated in 67% conversion with 68% ee, and in 
47% conversion with 62% ee respectively. Enantioselectivity was also conferred in the 
fluorination of pyridine 2.70, but the reaction had to be performed at 40 °C in order to 
observe an appreciable conversion of 56%. 
  
Scheme 2.27. Screening with (S)-i-Pr-PHOX ligand 
Whilst a general catalyst remained elusive, spurred on by the success of the 
palladium-catalysed system, all substrates were fluorinated with palladium-BINAP catalyst 
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2.08a developed in 2002 by Sodeoka and co-workers (Figure 2.10).
97
 This catalyst is relied 
upon for the preparation of fluorine stereocentres in excellent yield and selectivity
97
 and is 




Figure 2.10. Catalyst 2.08a developed by the Sodeoka group 





We began by screening all substrates that had been prepared to date (see section 2.2.3) with 
catalyst 2.08a (Table 2.07). As well as enabling a comparison between azaarylacetates and 
amides with the substrates reported in the literature, performing such a thorough screen 
would allow the reactivity of individual substrates to be accurately compared. Once again, 
the fluorinations were conducted in ethanol with the exception of lactone 2.62, which was 
performed in dichloromethane. 
Benzoxazole ethyl ester 2.59 was fluorinated at 0 °C (maintained using a cryostat) with 
complete conversion of starting material and in 90% ee (Table  2.07, entry 1); a similarly 
excellent conversion and enantioselectivity (82% ee) was observed for benzoxazole 
tert-butyl ester 2.60 (entry 3). Lowering the reaction temperature to –20 °C pleasingly 
resulted in an increase in ee (92% for the fluorination of ethyl ester 2.59 and 90% for 
tert-butyl ester 2.60) (entries 2 and 4). When methyl was switched for a phenyl substituent 
(2.61), a 100% conversion of substrate was again apparent, but to the detriment of the 
enantioselectivity (8% ee) (entry 5). Presumably, the phenyl substituent enhances the acidity 
of the α-phenyl proton to such an extent that the uncatalysed background reaction proceeds 
at a much faster rate than the catalytic fluorination, reducing the enantiomeric excess of the 
product. In an effort to minimise the background reaction, the reaction was repeated at 
−20 °C and this allowed the preparation of the product in 80% yield and 76% ee (entry 6). 




Entry Substrate Solvent Temperature Conv. (%)
a 





0 °C 100% nd 90% 




0 °C 100% nd 82% 





rt 100% nd 8% 





rt 100% 63% 93% 








rt 89% nd 0% 









rt 88% nd 0% 









rt 100% nd 4% 




EtOH –20°C 56% nd 86%
 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
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Lactone 2.62 underwent smooth conversion into product (100%) and the product was 
obtained in 63% yield and a remarkable 93% ee at room temperature (entry 7); lowering the 
temperature resulted in an increase in ee to 96% (entry 8). This excellent result is 
presumably because the transition state for a substrate with a five-membered lactone is more 
rigid than one for an acyclic ester substrate.  
Attention then turned to the remaining azaarylacetates, but disappointingly low conversion 
and stereoinduction was apparent for all these substrates. Benzimidazole 2.63 proved 
unreactive at room temperature and it was only after raising the reaction temperature to 50 
°C that a poor 19% conversion and 10% ee was observed (entry 9). Although 89% of 
quinoline 2.64 underwent fluorination at room temperature, the product was racemic 
(entry 10). The background reaction could be significant in this case, and the fluorination 
was repeated at –20 °C (entry 11), but this only resulted in a reduction in conversion (47%) 
with no stereoinduction. 
The fluorination of pyridine 2.70 served to highlight the reactivity difference between itself 
and the benzannulated derivative 2.64 (entry 12): pyridine 2.70 proved to be much less 
reactive than quinoline 2.64, with only 22% of substrate undergoing fluorination in 14% ee. 
Given this result, it was hoped phenyl derivative 2.72 would be more reactive due to the 
enhanced acidity of the α-phenyl proton. Although an improved conversion was observed, 
pyridine 2.72 was fluorinated with poor enantioselectivity, at both room temperature and –
20 °C (entries 13 and 14). Quinoxaline 2.66 was also poorly reactive and only 45% of 
substrate underwent fluorination to generate racemic product (entry 15). 
Pyridyl benzoxazole 2.88 was then tested (entries 16 and 17). At room temperature, all 
starting material was consumed (discernible by the disappearance of the NH signal at 15.52 
ppm in the crude 
1
H NMR spectrum) but the product was formed in 4% ee. Lowering the 
reaction temperature to –20 °C resulted in a slight drop in conversion (90%) and increase in 
ee to 12%.  The low enantioinduction is presumably as a result of the high background 
reaction for a substrate which is predominately the enamine tautomer. 
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Finally, amide 2.93 (which was readily available within the group) was subjected to 
fluorination and although only 56% of the starting material underwent conversion, the 
product was generated in 86% ee (entry 18). However, we were mindful that the product 
might be subject to racemisation under the reaction conditions, as the ee of fluorinated ester 





 over 16 hours (Scheme 2.28). 
 
Scheme 2.28. Racemisation of fluorinated amide under the reaction conditions 
Other examples of poorly reactive substrates which are not given in the table include 
pyrazines 2.67 and 2.68, isoquinoline 2.65, benzisoxazole 2.75, quinoxalinone 2.78 and 
thiadiazoles 2.82 and 2.83 (Figure 2.11). Certainly for isoquinoline 2.65 and benzisoxazole 
2.75, steric clashing between the methyl group and the aryl hydrogens in the planar 
intermediate may be of significance and discourage the formation of the enamine 
intermediate. Enamine 2.95 depicts the perceived and unfavourable steric interactions for the 
isoquinoline 2.65 intermediate. 
 
Figure 2.11. Unreactive substrates 
From screening with the commercial palladium catalyst, one clear observation regarding 
substrate scope can be drawn: only benzoxazoles are capable of being fluorinated with high 
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enantioselectivity, raising the possibility that these substrates are coordinating to palladium 
through oxygen and not through nitrogen. 
In 1983, Massacesi and co-workers came to a similar conclusion when investigating the 
binding of benzoxazole and 2-methylbenzoxazole in Pd(II) and Pt(II) complexes.
132
 From IR 
analysis, they found that in ML2X2 complexes (where M = Pd(II), Pt(II); L = benzoxazole, 2-
methylbenzoxazole; X = Cl, Br, I, NO3, SCN), both L ligands were monodentate but 
benzoxazole behaved as N-bound whereas 2-methylbenzoxazole behaved as O-bound. Their 
findings gained further support during the investigation of Pd(mal)L complexes (mal = 
malonate, L = benzoxazole, 2-methylbenzoxazole) where IR analysis once again showed 
benzoxazole to be binding through nitrogen, and 2-methylbenzoxazole through oxygen.
133
 
With this mind, a tentative transition state for the fluorination of benzoxazole lactone 2.62 is 
proposed (Figure 2.12), based on the one suggested by Sodeoka and co-workers for 
fluorination of β-ketoesters.
97
 If lactone 2.62 orientates itself so that the benzoxazole moiety 
minimises any steric interactions with the phosphine aryl groups and fluorination occurs on 
the re face, then this would lead to fluorinated lactone 2.96 as a single enantiomer 
(the absolute stereochemistry of the fluorinated stereocentre has not been determined). 
 
Figure 2.12. Proposed transition-state structure for lactone 2.62 
In an effort to further explore substrate-catalyst binding, a series of targeted 
oxygen-containing substrates were synthesised. 
2.2.5.1.1 Synthesis of Targeted Substrates and their Fluorinations 
Substrates 2.97-2.99 were targeted, which would probe the role of both the heterocycle and 
ester moiety (Figure 2.13). Lactam 2.97 would explore whether a lactam could be 
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substituted for a lactone, and lactone 2.98 would investigate the effect of a six-membered 
lactone ring on the fluorination transition-state structure and the resultant stereochemical 
outcome of the reaction. To probe whether the heterocyclic oxygen was in fact responsible 
for the high enantioselectivity described for the benzoxazoles in section 2.2.5.1, 
benzothiazole 2.99 was targeted (where the oxygen in benzoxazole has been replaced with 
sulfur). 
 
Figure 2.13. Targeted substrates 
These substrates were synthesised using the same method as that described for the synthesis 
of substrates 2.59-2.68 (see section 2.2.3), namely the addition of esters and amides 2.100 to 
heterocylic chlorides 2.56 (Scheme 2.29). Using this general method, lactam 2.97 was 
successfully prepared from 2-chlorobenzoxazole 2.85 and the common laboratory solvent 
N-methylpyrrolidine in 52% yield. However, the yields obtained for the lactones 2.98 and 
2.99 were not as gratifying. Although the successful synthesis of lactone 2.98 was apparent 
from the crude 
1
H NMR spectrum, purification by column chromatography failed to separate 
it from an unknown impurity and recrystallisation of this material was required to give 2.98 
as a pure white powder in 25% yield. Benzothiazole lactone 2.99 was only prepared in 36% 
yield; from previous attempted syntheses, we suspect benzothiazole esters are an unstable 
class of compounds and the low yield is probably a reflection of this. With this 
foreknowledge, 2.99 was fluorinated immediately following its preparation.   




Scheme 2.29. Synthesis of targeted oxygen-containing substrates 




(Scheme 2.30). As expected, lactam 2.97 was fluorinated enantioselectively but with only 
47% conversion and 28% ee at room temperature. This is in stark contrast to the fluorinated 
five-membered lactone 2.62—product 2.96 was isolated in 63% yield and 93% ee. All things 
considered, an enantiomeric excess of 28% is still in support of the argument that 
benzoxazoles bind to the catalyst through oxygen, given that the nitrogen-containing 
substrates were only fluorinated in up to 14% ee with the same catalyst. However, the 
reduction in ee could be a consequence of the N-methyl group in the transition state—
additional steric interactions could distort the proposed transition state for lactone 2.62 so 
that the two enantiotopic faces of the enamide are less distinguishable. Pleasingly, lowering 
the reaction temperature resulted in an increase in ee to 66% but with only an accompanying 
14% conversion. 
 
Scheme 2.30. Fluorination of targeted substrates 
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The fluorination of six-membered lactone 2.98 was initially somewhat disappointing as the 
product was only prepared in 8% ee. However the 
1
H NMR spectrum of lactone 2.98 in 
CDCl3 had previously revealed it to be a mixture of keto-enol form and so it would not be 
surprising if the background reaction for this substrate occurred at a competitive rate. 
Pleasingly, lowering the reaction temperature to –20 °C resulted in an increase in ee to 58%, 
again providing support for the benzoxazole binding argument. For this substrate there is an 
even greater reactivity difference between the five- and six-membered lactones (2.62 and 
2.98) than between lactone 2.62 and lactam 2.97. Whereas the five-membered lactone 2.62 is 
fluorinated in 93% ee at room temperature, only at –20 °C is an appreciable level of 
enantioselectivity (58% ee) achieved for the six-membered analogue 2.98. The lower ee can 
be explained in two ways: either the background reaction is still occurring at –20 °C, or the 
transition state is less rigid than the one proposed for the five-membered lactone 2.62, owing 
to the presence of a longer and more flexible lactone tether. 
Finally, benzothiazole lactone 2.99 was subjected to fluorination and gave product in poor ee 
(10%). Whilst this could be attributed to the absence of oxygen in the heterocycle, sulfur 
could also be poisoning the palladium catalyst.
134
 
2.2.5.1.2 Screening with Alternative Fluorinating Agents 
Alternative fluorinating agents Selectfluor
®





 (Table 2.08). The N-fluoropyridinium salt was 
generated in situ from Selectfluor
®
 and pyridine, and all reactions were conducted in CH2Cl2 
at room temperature. Remarkably in all reactions using Selectfluor
®
, the enantiomer obtained 
was of the opposite configuration to that obtained using NFSI. In some cases, the magnitude 
of the ee was substantially different. For example, the fluorinated product for lactam 2.97 
was isolated in 28% ee of one configuration using NFSI and 60% ee of the opposite 
configuration using Selectfluor
®
 (Table 2.08, entry 1). Similarly, there was a marked 
difference for ester 2.60 (66% and 93% ee of the two enantiomers, entry 2). Low conversion 
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for ester 2.60 was observed using pyridine and Selectfluor
®
 and so this fluorinating agent 
was not investigated any further. Consistent magnitudes of enantioselectivity were recorded 
with some substrates; lactone 2.62 gave both enantiomers in excellent ee whilst pyridine 2.70 
gave both enantiomers in low ee, using NFSI and Selectfluor
®
 (entries 3 and 4). 
 







































24 38% - - 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
b
 opposite enantiomer obtained with Selectfluor
® 
c
 reaction conducted in EtOH 
Table 2.08. Alternative fluorination sources 
These differences in product configuration could be explained if different steric interactions 
are operating between the substrate-catalyst and fluorinating agent in the transition-state 
structure (see Figure 2.12). Smaller fluorinating agents may be able to approach the substrate 
from one face whilst bigger fluorinating agents may be forced to approach the substrate from 
the opposite face, owing to more significant steric interactions in the transition-state 
structure. 
2.2.5.2 Screening Palladium with Other Ligands 
Owing to the success of the palladium-catalysed fluorination of benzoxazole-containing 
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substrates, other ligands for palladium were explored in the hope of developing a more 














1 (S)-SEGPHOS 14% 
- - 
2 (S)-DTBM-SEGPHOS 7% 
- 4% 
3 (R)-hexaPHEMP 12% 0% 0% 
4 (R)-BIPHEP 10% 0% 0% 
5 SL-J011-1 0% 0% 0% 
6 SL-J013-1 0% 0% 0% 
7 (R)-Ph-PHOX 12% 0% 0% 
8 (S)-i-Pr-PHOX 8% 0% 0% 
Table 2.09. Screening palladium with other ligands 
Only challenging substrates were screened that did not contain heterocyclic oxygen and only 
ee values for products were obtained to increase screening efficiency. Palladium acetate was 
used as the Pd(II) source throughout. Low enantioselectivities were observed for all ligands 
screened and quinoline 2.64 and quinoxaline 2.66 generally gave racemic products. Pyridine 
2.70 was the only substrate to consistently yield non-racemic products, although the 
maximum ee was only 14%, obtained using (S)-SEGPHOS (Table 2.09, entry 1). 




Finally, α-ketoazaarene 2.103 was investigated as an alternative substrate to β-ketoazaarenes. 
Sodeoka and co-workers had previously demonstrated the successful enantioselective 
fluorination of α-ketoesters and it was hoped that the five-membered chelate in the transition 
catalyst would lead to a product in high ee.
120
 Ketone 2.103 was synthesised in 72% yield 




Scheme 2.31. Synthesis of α-ketoazaarene 2.106 





 that had been successfully applied to 
benzoxazole β-ketoazaarenes and the second using Ni(OAc)2 and TPDM-BOX, a catalyst 
that had been applied in the highly enantioselective Michael addition reactions of similar 
substrates with nitroalkenes.
136
 Both sets of conditions were low yielding but the 
enantioselectivities were appreciable, with Ni(OAc)2·4H2O-TPDM-BOX giving an ee of 
45%. Although these results were promising, α-ketoazaarenes were not pursued any further, 
but they remain a possible future area of investigation. 
 






 25 37% 
2 Ni(OAc)2·4H2O-TPDM-BOX 10 45% 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
Table 2.10. Fluorination of α-ketoazaarene 2.103 
2.2.7 Fluorination of Enamides 
After the completion of this project, Toste and co-workers reported the use of an enamide 
functionality for the activation and enantioselective fluorination of benzoyl-protected 
enamides 2.106 to α-fluoroimines 2.107 using anionic phase transfer catalysis 







Scheme 2.32. Anionic phase transfer catalysis for the enantioselective fluorination of enamides 2.106 
In this strategy the fluorinating agent Selectfluor
®
, which is insoluble in non-polar solvents, 
is solvated by phase transfer catalyst TRIP to generate chiral fluorinating agent 2.105 in situ, 
which is soluble in non-polar solvents. The choice of nitrogen protecting group was critical, 
as in addition to giving the product in high ee, it was essential that the resultant imine 
functionality remain intact to allow subsequent manipulation. A range of fluorinated 
products were consistently generated in excellent ee but for 2-alkyl cyclohexanone 
derivatives, enantioselectivity was poor. To demonstrate the utility of this methodology, 
product 2.108 was subsequently reduced to amine 2.109. 
2.3 Conclusions 




, 2-fluorobenzoxazolyl acetates 
have been prepared in up to 96% ee, although this high level of stereoselectivity did not 
extend to non-benzoxazole containing azaarenes (Scheme 2.33). 




Scheme 2.33. Enantioselective fluorination of azaarylacetates and amides 
From these results, the substrate is proposed to bind to the catalyst through the oxygen of the 
benzoxazole and not through the nitrogen as might be expected (Figure 2.13). A series of 
targeted substrates were prepared and fluorinated, which provided further support for the 
argument. However, other factors could be at play for those products prepared in poor 
enantioselectivity. 
 
Figure 2.13. Benzoxazole binding to catalyst through heterocyclic oxygen 
Screening with alternative fluorinating agents revealed that opposite enantiomers could be 
accessed using NFSI and Selectfluor
®
, thus further demonstrating the potential of this 
methodology (Scheme 2.34).  
 
Scheme 2.34. Enantioselectivity switch with NFSI and Selectfluor
®
 
To conclude, a highly enantioselective fluorination method was developed for the 
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preparation of novel 2-fluorobenzoxazolyl acetates in which both enantiomeric products 
could be accessed. Attention then turned to another palladium-catalysed reaction, the 
oxidative annulation of ferrocene derivatives, for the preparation of novel highly 
functionalised products. 
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Chapter 3. Oxidative Annulation of Ferrocene Derivatives 
3.1 Introduction 
3.1.1 C–H Functionalisation 
In recent years, C–H functionalisation has become an important strategy in organic synthesis 
and is rapidly becoming a realistic alternative to traditional cross-coupling reactions 
(Scheme 3.01).
138-149
 Unlike cross-coupling, C–H functionalisation rarely requires substrate 
prefunctionalisation making it a potentially more efficient approach.
138
 The majority of 








however, there is a growing appreciation for the use of first-row transition-metal catalysts.
159
 





functionalisation, owing to the compatibility of Pd(II) with oxidants (often needed for the 
regeneration of Pd(II) in the catalytic cycle) and ambient air and moisture. 
 
Scheme 3.01. Cross-coupling and C–H functionalisation 
Depending on the metal used, in addition to the ligand, substrate, solvent, and additives, 
different mechanisms for the C–H activation step have been proposed (Scheme 3.02).
160-161
 
For electron-rich late transition-metals, oxidative addition is the most likely pathway as the 
changes in oxidation state and geometry of the metal in the product are energetically 
feasible. σ-Bond metathesis is favoured for early transition-metals in which a d
0
 electronic 
configuration negates oxidative addition. Similarly, for electron-poor late transition-metals, 
electrophilic metallation (a formal equivalent of σ-bond metathesis) is more likely. Catalysts 
bearing Lewis basic ligands, such as a carboxylate, can facilitate C–H functionalisation via 







Scheme 3.02. C–H activation mechanisms 
3.1.1.1 Directing Groups 
Ideally, an unactivated C–H bond is transformed into a carbon–carbon or carbon–heteroatom 
bond.
145
 However, a directing group is often required to coordinate the metal catalyst to 
effect C–H functionalisation. Coordination enhances the rate of reaction by increasing the 
proximity of the metal to the C–H bond and governs the regioselectivity of reaction—the 
majority of C–H functionalisation occur ortho to the directing group (Scheme 3.03). One 
disadvantage of using this strategy is that installation and manipulation of the directing group 
is often required. 
 
Scheme 3.03. Directed C–H functionalisation 
A variety of directing groups have been used, mainly nitrogen, sulfur and phosphorus based 
(for example, pyridine, oxazoline, sulfide and phosphine directing groups), which are strong 
σ-donors and/or π-acceptors. These are considered strong directing groups, as the 
corresponding metallacycles (e.g. 3.03) are thermodynamically stable and less reactive 




Scheme 3.04. Pyridine as a strong directing group 
Directing groups based on oxygen heteroatoms (for example, alcohol, ketone and carboxylic 
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acid directing groups), are considered weak directing groups and have typically not been as 
well studied (Scheme 3.05).
165-167
 The analogous metallacycles (e.g. 3.07) are more 
challenging to form but less thermodynamically stable than 3.03, making them more reactive 
towards functionalisation. 
 
Scheme 3.05. Alcohol as a weak directing group 
Owing to the often oxidative nature of C–H functionalisation, the catalyst often has to be 
regenerated in the catalytic cycle (e.g. Pd(0) to Pd(II)), and this is most commonly achieved 














 This is not only atom inefficient but can limit the substrate scope of the reaction, owing to 
the incompatibility of certain functional groups with strong oxidants.
143
 
An alternative to a stoichiometric external oxidant is a directing group which can itself act as 
an oxidant (an internal oxidant). In addition to waste minimisation, reactivity and selectivity 
can also be improved.
180
 
3.1.1.1.1 Oxidising Directing Groups 
The redox-neutral strategy of oxidising directing groups was independently realised by the 






 and Guimond and Fagnou.
184
 For example, Cui 
and Wu demonstrated that N-oxide can both act as a directing group and an oxidant in the 
alkenylation of quinoline N-oxide 3.09 (Scheme 3.06). 
 
Scheme 3.06. N-Oxide as an oxidising directing group 
The internal oxidant can oxidise the catalyst at different points of the catalytic cycle, as 
demonstrated by the contrasting reports of Hartwig,
182
 and Guimond and Fagnou.
184
 In 
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Hartwig’s intramolecular amination reaction in which an acyl oxime acts as the oxidising 
directing group, the first step of the reaction is the oxidative addition of Pd(0) into the N–O 
oxime bond (Scheme 3.07). Following tautomerisation of imine 3.15 to enamide 3.16, C–H 
activation gives palladacycle 3.17. Reductive elimination then gives indole 3.14 and Pd(0). 
The N–O bond cleavage was postulated to be the first step in the reaction mechanism after 
isolating analogous reaction intermediate 3.18 in which Pd(0) had undergone oxidative 
addition into the N–O bond of the corresponding acyl oxime. 
 
Scheme 3.07. Oxime ester as an oxidising directing group 
In contrast, Guimond and Fagnou propose catalyst oxidation in the last step of their rhodium-
catalysed oxidative annulation work (Scheme 3.08). Initially, C–H functionalisation of 
N-methoxycarboxamide 3.19 leads to five-membered rhodacycle 3.21. Following insertion 
of alkyne 3.22 to give seven-membered rhodacycle 3.23, simultaneous N–O bond cleavage 
and reductive elimination of Rh(III) allows rhodium to maintain the +3 oxidation state 
required for catalytic activity. 




Scheme 3.08. Oxidative annulation using N-methoxycarboxamide as an oxidative directing group 
Following the seminal reports on the use of N-methoxycarboxamide as a directing group, 
Guimond and Fagnou undertook a study of related directing groups.
185
 After extensive 
optimisation, it was found that N-pivaloxyamide (pivaloxy = OCO2t-Bu) was a superior 
directing group and facilitated oxidative annulation with dialkylalkynes—alkynes that had 
been largely unreactive using the N-methoxycarboxamide directing group (Table 3.01). 
Moreover, high yields could be achieved at room temperature with lower catalyst loadings. 
For alkylarylalkynes, the reaction was regioselective, with the aryl group being installed 
closest to nitrogen. 
The mechanism of the reaction was thought to resemble that for N-methoxycarboxamide 
3.19 (see Scheme 3.08) but in the case of N-pivaloxycarboxamide 3.24, the final step of the 
reaction is assisted by the pivaloxy group (Scheme 3.09). DFT calculations provided support 
for a mechanism that involves reductive elimination (RE) of Rh(III) in rhodacycle 3.25 to 
give Rh(I) species 3.26, followed by oxidative addition (OA) of Rh(I) into the N–O bond to 
give Rh(III) species 3.27. Subsequent dissociation of species 3.27 then gives product 3.21 
and returns the active Rh(III) catalyst to the catalytic cycle. 































 yield determined by 
1
H NMR spectroscopy 
Table 3.01. Comparison of N-methoxycarboxamide 3.19 with N-pivaloxycarboxamide 3.24 
Scheme 3.09. Pivaloxy assisted reductive elimination of Rh(III) 
The reaction using N-pivaloxycarboxamide was also extended to terminal alkynes 
(which were subject to Glaser coupling
186-187
 when using a Cu(II) salt as an external oxidant 
in previous systems) and alkenes. 
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The use of oxidising directing groups was elegantly demonstrated in the total synthesis of a 
series of natural products based on the indolizidine core (Scheme 3.10).
188
 Using a tethered 
alkyne, carboxamide 3.28 underwent an intramolecular oxidative annulation to give 
isoquinolone derivative 3.29, which was subsequently subjected to a Mitsunobu reaction to 
give indolizidine derivative 3.30. 
 
Scheme 3.10. Intramolecular oxidative annulation using an oxidising directing group 
This redox-neutral strategy for the synthesis of heterocycles has since been employed by 
numerous groups, most recently by Glorius and co-workers who used α-OMs/-OTs/-Cl 




Scheme 3.11. Recent redox-neutral strategy in oxidative annulation 
Over the last decade or so, there has been an unprecedented amount of interest in C–H 
functionalisation and countless research groups are now investigating the field. A variety of 
substrates have been explored and the C–H functionalisation of organometallics, such as 
ferrocene, provides its own unique challenges. 
3.1.2 Ferrocene 
Ferrocene was first discovered in 1951 by Pauson and Kealy,
190
 with the aromatic structure 
being independently determined the following year by Fischer and Pfab,
191
 and Wilkinson et 
al..
192
 This groundbreaking discovery ultimately led to Fischer and Wilkinson being awarded 
the Nobel Prize in chemistry in 1973
193
 and changed the face of modern organometallic 
chemistry, providing a deeper understanding of structure, bonding and reactivity. Since then, 
extensive research has been conducted into the unique structure and properties of ferrocene 
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Compared to other aromatic compounds such as benzene, ferrocene has some remarkably 
different properties; for example, ferrocene undergoes electrophilic aromatic substitution 
3   106 times faster than benzene, by virtue of the negatively charged cyclopentadienyl 
ligands.
199
 However, the most obvious difference is the three-dimensional structure of 
ferrocene, which gives rise to planar chirality in 1,2- and 1,3-disubstituted ferrocenes 




Figure 3.01. Planar chirality in 1,2-disubsituted ferrocenes (priority X > Y) 
3.1.2.1 Applications 
Ferrocene is an important rigid scaffold in chiral ligands such as Josiphos, Taniaphos, 
Mandyphos, and Xyliphos (Figure 3.02).
201
 In addition to planar chirality, these ligands also 
contain central chirality. 
 
Figure 3.02. Selected ferrocene-based ligands 
The Josiphos family of ligands have been used in countless asymmetric reactions; for 
example (R,Sp)-Xyliphos is used in the highly efficient catalytic enantioselective 
hydrogenation of imine 3.34, a precursor in the synthesis of the herbicide (S)-metolachlor 
(Scheme 3.12). More than 10,000 tons of (S)-metolachlor are produced by 






Scheme 3.12. Enantioselective synthesis of (S)-metolachlor 
Owing to the low and readily reversible redox potentials of ferrocene, ferrocene and its 
derivatives are commonly used in electron transfer processes.
194, 203
 Ferrocene undergoes a 
reversible one-electron oxidation to give ferrocenyl cation (Equation 3.01) and the redox 








  Fc 
         E° = + 0.44 V (vs SCE in MeCN) 
Equation 3.01 
The favourable redox properties, stability in aqueous aerobic media and the variety of 
derivatives that can be synthesised has made ferrocene and its derivatives good candidates 
for therapeutic agents. Ferrocene derivatives exhibit a wide range of biological activity and 
include the antibiotic ferrocenyl penicillin,
205
 the cytotoxic ferrocifen
206





Figure 3.03. Examples of bioactive ferrocene complexes 
3.1.2.2 Functionalisations 
Ferrocene derivatives have been functionalised using a variety of strategies, mainly aromatic 
electrophilic substitution (for an example, see Scheme 3.13) and metallation reactions (for an 
example, see Scheme 3.14), and a recent review summarises the selective syntheses of planar 
chiral ferrocenes.
208
 The first diastereoselective synthesis of a planar chiral ferrocene was 
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most likely the intramolecular Friedel-Crafts acylation of 3.36 in 1965 (Scheme 3.13).
209
 
Positioning the ferrocenyl and phenyl groups antiperiplanar results in the lowest energy 
intermediate 3.38, leading to a highly diastereoselective cyclisation. 
 
Scheme 3.13. Diastereoselective Friedel-Crafts acylation 
The ferrocene ligands commonly used in asymmetric catalysis (see Figure 3.02) are 
generally accessed using a diastereoselective directed ortho-metallation (DoM) 
(Scheme 3.14). Metallation of enantioenriched Ugi’s amine (R)-3.39 preferentially gives 
organolithium (R,Sp)-3.40, which minimises the interaction between the α-methyl substituent 
and the ferrocene backbone. This can then be trapped with a range of electrophiles, including 




Scheme 3.14. Diastereoselective directed ortho-metallation 
Metallation is undisputedly the most common method for the functionalisation of the 
ferrocene backbone, yet these reactions involve a stoichiometric amount of metal. Catalytic 
methods for the synthesis of ferrocene derivatives remains an underexplored area and 
recently there have been several reports that aim to address this. 
3.1.2.2.1 Catalytic C–H Functionalisation 
Although the C–H functionalisation of arenes is well established, ferrocene derivatives 
remain challenging substrates, likely owing to the unfavourable C–H deprotonation of the 
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electron rich cyclopentadienyl rings. Nevertheless, there have been numerous reports on the 
synthesis of ferrocene metallacycles using stoichiometric metal.
212
 
Siegel and Schmalz were the first to report the catalytic C–H functionalisation of ferrocene 
derivatives in 1997, using a copper-catalysed intramolecular carbene insertion into a Cp–H 
bond (Scheme 3.15).
213
 Using a bis(oxazoline) (BOX) ligand, enantioselectivites up to 78% 
ee were obtained. However, substrate scope was limited owing to the intramolecular nature 
of the reaction. 
 
Scheme 3.15. First catalytic C–H functionalisation of ferrocene 
Another early example focussed on the iridium-catalysed borylation of ferrocene derivatives 
3.46.
214
 However, regioselectivity was poor owing to the absence of a directing group and for 
monosubstituted ferrocenes, a mixture of 1,3- and 1,1'-disubsituted products was obtained. In 
addition, the reaction was only high yielding for ferrocene derivatives bearing electron-
withdrawing substituents (Scheme 3.16). 
Scheme 3.16. Iridium-catalysed borylation of ferrocene derivatives 
From the above example, it is obvious that the regioselectivity of the reaction can be 
complicated by the presence of the second cyclopentadienyl ring. Generally, for the 
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monofunctionalisation of a monosubstituted ferrocene e.g. 3.49, three regioisomeric products 
are possible: 1,2-, 1,3- and 1,1'-disusbstituted ferrocenes 3.50 (Scheme 3.17). 
 
Scheme 3.17. Regioselectivity for the functionalisation of monosubstituted ferrocene 3.49 
Directing groups can be used to control regioselectivity (see section 3.1.1.1); for example, 
Takebayashi and Shibata used iridium catalysis to effect the dialkenylation and dialkylation 
of ferrocene derivatives 3.51 using pyridine as a directing group (Scheme 3.18).
215
 The scope 
of the directing group could also be extended to an imine, quinoline and phosphine oxide. 
With the use of the more sterically bulky quinoline or diphenylphosphine oxide directing 
group, selective monoalkenylation could be achieved to give racemic functionalised products 
(±)-3.54 and (±)-3.55. 
 
Scheme 3.18. Iridium-catalysed alkenylation and alkylation of ferrocene derivatives 
The alkenylation of ferrocenyl ketones 3.56 has also been achieved using ruthenium catalysis 
(Scheme 3.19),
216
 with the ketone functionality acting as an efficient “weak” directing group. 
Interestingly, the regioselectivity of the alkenylation was dependent on the ketone 
substituent: for alkyl ketones, the ferrocene underwent selective alkenylation to give 
1,2-disusbtituted ferrocenes 3.57, whereas for aryl ketones alkenylation preferentially 
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occurred on the benzene ring to give ferrocenyl ketones 3.58 and 3.59. When the reaction 
temperature was increased to 50 °C for aryl ketones, further alkenylation of intermediate 
3.58 occurred on the ferrocene ring to give double alkenylation product 3.60. These results 
suggest that the C–H functionalisation of ferrocenes derivatives is more challenging than for 
arenes. 
Scheme 3.19. Ruthenium-catalysed alkenylation of ferrocenyl ketones 3.56 
The enantioselective synthesis of planar chiral ferrocene derivatives has recently been 
achieved by You,
217
 and Cui and Wu.
218
 Both methodologies use a 
N,N-dimethylaminomethyl ortho-directing group and an enantiopure monoprotected amino 
acid ligand to differentiate between the two ortho protons. You and co-workers first reported 
the enantioselective arylation of ferrocene derivative 3.61 using arylboronic acids 
(Scheme 3.20). A range of aryl substituents were compatible and the products were 
consistently generated in excellent ee.
217
 




Scheme 3.20. Enantioselective arylation of ferrocenyl amine 3.61 
Cui and Wu subsequently reported the enantioselective alkenylation of the same ferrocene 




Scheme 3.21. Cui and Wu’s alkenylation of N,N-dimethylaminomethyl ferrocene 3.61 
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The Boc-L-Phe-OH ligand, coordinated to palladium in transition-state structure 3.64, 
minimises the steric interactions between the ligand substituents and the ferrocene backbone 
thus selectively activating one proton ortho to the directing group to give intermediate 3.65. 
Following coordination of the alkene and subsequent syn-carbopalladation to give ferrocene 
3.66, reductive elimination of the catalyst gives the alkene product (Sp)-3.63 and Pd(0). 
Significantly, the substrate (3.61) acts as the oxidant for the regeneration of Pd(0) from 
Pd(II), following oxidation by air to form ferrocenium ion 3.67. Two control experiments 
and HRMS evidence provided support that ferrocenium ion 3.67 acted as the terminal 
oxidant. Presumably, the arylation reaction described above also proceeds by this 
mechanism, with the substrate acting as the oxidant for Pd(0).
217
 
Very recently, the first example of the enantioselective alkylation of ferrocene derivatives 
3.69 was reported using iridium catalysis and a chiral diene ligand 3.68 (Scheme 3.22).
219
 A 
range of alkenes were tolerated, although there were no examples of alkenes bearing 
electron-donating substituents. For styrene derivatives, the reaction was complicated by a 
mixture of linear and branched derivatives products (not shown). 
 
Scheme 3.22. Enantioselective alkylation of (isoquinolin-1-yl)ferrocene 3.69 
To summarise, the enantioselective arylation, alkenylation and alkylation of ferrocene 
derivatives have all recently been achieved, greatly contributing to the methods available for 
the synthesis of planar chiral ferrocenes. 
3.1.3 Oxidative Annulation of Ferrocene Derivatives 
Clearly, the C–H functionalisation of ferrocene derivatives is more challenging than for 
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arenes owing to the unique properties of ferrocene and consequently, the yields and 
regioselectivities of these reactions are often lower. However, the inherent planar chirality of 
1,2- and 1,3-disusbtituted ferrocene derivatives and their diverse applications makes the 
stereoselective synthesis of these compounds a worthwhile pursuit. 
At the onset of this work, there were no reports on the oxidative annulation of ferrocene 
derivatives 3.71 to generate 1,2-disusbstituted ferrocenes 3.72 (Scheme 3.23). Using this 
strategy, regioselectivity would be controlled, as ring closure would occur ortho to the 
directing group. There would also be the possibility to develop an enantioselective method to 
generate 1,2-disusbstituted planar chiral ferrocenes. 
 
Scheme 3.23. Oxidative annulation of ferrocene derivative 3.71 
3.2 Results and Discussion 
3.2.1 Aims 
With the aim of exploring the oxidative annulation of ferrocenes, 
N-alkoxyferrocenecarboxamide substrates 3.73 were investigated (Scheme 3.24). Using an 
N-alkoxycarboxamide directing group would negate the use of an external oxidant, thus 
allowing the development of a mild and general protocol as shown by Guimond and Fagnou 




Scheme 3.24. Oxidative annulation of N-alkoxyferrocenecarboxamide 3.73 
3.2.2 Substrate Synthesis 
N-Methoxy- 3.77 and N-pivaloxycarboxamide 3.78, containing the two directing groups used 
by Guimond and Fagnou,
184-185
 were synthesised from commercially available 
ferrocenecarboxylic acid 3.75 via acid chloride 3.76 (Table 3.02). 




Entry Amine Base Product Yield (%) 








Table 3.02. Synthesis of substrates 3.77 and 3.78 
3.2.3 Initial Results with Rhodium 
Inspired by the work of Fagnou and co-workers on the rhodium-catalysed synthesis of 
isoquinolones,
184
 the reaction conditions used in this report were directly applied to 
N-methoxycarboxamide 3.77 and 1-phenyl-1-propyne 3.22 (Table 3.03, entry 1). A 30% 
conversion of amide 3.77 into annulation product 3.79 was observed over 16 h, but in 
contrast to the transformation reported by Fagnou, the product contained an intact N–O 
bond. Since the observed 30% conversion matched the cesium acetate loading, the reaction 
was repeated with 1.1 equivalents of cesium acetate, but no improvement in conversion was 
observed (entry 2). It was clear that N–O bond cleavage was not responsible for catalyst 
turnover and so it was reasoned that another species present in the reaction was performing 
this function. As the reaction was conducted in an open flask, it was postulated that air could 
be acting as the oxidant to regenerate the active catalyst. As a control experiment, the 
reaction was performed in degassed methanol under an atmosphere of nitrogen and no 
product was detected (entry 3), thus supporting the hypothesis that oxygen was responsible 
for catalyst turnover. 




Entry Additive Amount Conversion (%)
a 
1 CsOAc 30 mol% 30 
2 CsOAc 1.1 equiv. 30 
3 CsOAc 30 mol% 0
b
 
4 - - 0 
5 NaOAc 30 mol% 35 
6 KOAc 30 mol% 30 
7 NaOAc 2.1 equiv. 22 
8 CF3CO2Na 2.1 equiv. no reaction 
9 NaOAc 1.1 equiv.
c 22 
10 K2CO3 2.0 equiv. trace 
11 K2CO3, MesCO2H 2.0 equiv., 30 mol% trace 
12 K2CO3, PivOH 2.5 equiv., 30 mol% trace 
13 K2CO3, AcOH 2.5 equiv., 30 mol% trace 
14 K2CO3, NaOAc 2.5 equiv., 30 mol% trace 
15 KOPiv, NaOAc 1.1 equiv., 30 mol% trace 
16 KOPiv 1.1 equiv. trace 
17 NaOH 1.1 equiv. trace 
18 NaOMe 1.1 equiv. trace 
19 NaOBn 1.1 equiv. trace 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
b
 reaction performed in degassed methanol under an atmosphere of nitrogen 
c
 added over 1 h 
Table 3.03. Additive screening 
Based on the mechanism for the oxidative annulation of N-methoxycarboxamide 3.19 (see 
Scheme 3.08), the only difference with the ferrocene analogue 3.77 is the final step. Instead 
of the N–O bond cleaving to regenerate free Rh(III), the N–O bond remains intact and after 
reductive elimination to give product 3.79 and Rh(I), oxygen in the air oxidises Rh(I) back to 
Rh(III) (Scheme 3.25). 




Scheme 3.25. Proposed mechanism for oxidative annulation of N-methoxycarboxamide 3.77 
In an attempt to improve conversion, different additives were screened. No conversion to 
annulation product 3.79 was observed when the reaction was performed without an additive 
(entry 4), highlighting the crucial role that an additive plays in this reaction. Disappointingly, 
conversions similar to the 30% obtained with cesium acetate were observed with sodium and 
potassium acetate—35% and 30% respectively (entries 5 and 6). Since two protons are 
removed per molecule of starting material, the reaction was also performed using 2.1 
equivalents of NaOAc, but the conversion was again poor at only 22% (entry 7). Replacing 
sodium acetate with the less basic sodium trifluoroacetate (by virtue of the 
electron-withdrawing trifluoro moiety) suppressed the reaction altogether (entry 8), revealing 
that the reaction is highly sensitive to the basicity of the additive. 
In 2006, Fagnou and Lafrance reported the palladium-catalysed arylation of benzene 3.83 
with aryl bromides 3.82, which used stoichiometric potassium carbonate and catalytic pivalic 
acid additives (Scheme 3.26).
220
 Stoichiometric potassium carbonate alone gave <5% 
conversion and it was only by using stoichiometric potassium carbonate in conjunction with 
catalytic pivalic acid that 100% conversion was achieved. It was reasoned that pivalic acid 
acted as a proton shuttle between benzene and potassium carbonate thus facilitating the 
reaction. Furthermore, it was crucial for potassium carbonate to remain insoluble in the 
reaction, as excess carboxylate base was found to interfere with reactivity.   




Scheme 3.26. Benzene arylation using catalytic pivalic acid 
With this observation in mind, 1.1 equivalents of sodium acetate were added over one hour 
to minimise the concentration of acetate present at any one time, but this only gave a 
conversion of 22% (entry 9). Therefore, taking inspiration directly from Fagnou and 
Lafrance’s arylation work, the reaction was performed with potassium carbonate (entry 10), 
and potassium carbonate in combination with three different organic acids (entries 11-13); 
no product was observed using any of these conditions. Based on the success of sodium 
acetate as an additive, the reaction was performed using catalytic sodium acetate and 
stoichiometric potassium carbonate (entry 14), in the hope that the acetic acid generated in 
situ would be deprotonated by K2CO3, again minimising the concentration of acetate present 
in solution. Unfortunately no product was observed in this reaction, or when potassium 
carbonate was replaced with alternative base potassium pivalate (entry 15). Finally, four 
different bases were screened based on their range of basicity (entries 16-19) but no product 
was observed in any case. 
Due to the marginally higher conversion obtained using sodium acetate compared with 
cesium acetate, combined with the lower cost of sodium acetate, the majority of future 
experiments were performed using sodium acetate as an additive. 
In an attempt to improve the turnover of the catalyst and hence the yield of the reaction, a 
range of oxidants were screened (Table 3.04). Cu(OAc)2 and K2S2O8, oxidants commonly 
used in C–H activation, both appeared to suppress the reaction (Table 3.04, entries 1 and 2). 
Interestingly, when Ag2O was employed in the reaction, no annulation product 3.79 was 
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detected and a product with NMR spectroscopic data consistent with methyl ester 3.85 was 
isolated (entry 3). Suspecting that methyl ester 3.85 could have arisen through nucleophilic 
attack of methanol on an activated molecule of amide 3.77, the reaction was repeated in 
different solvents. However all solvents gave methyl ester 3.85, suggesting that it originates 
from an intramolecular rearrangement of substrate 3.77. Of the oxidants screened, only 
oxygen facilitated the annulation reaction, albeit in low yield (entry 4). Two further oxidants 
were investigated, 1,4-benzoquinone and benzoyl peroxide, but no product was detected 
(entries 5 and 6). From the proposed catalytic cycle (see Scheme 3.25) Rh(I) needs to be 
oxidised to Rh(III), yet puzzlingly oxidising conditions seemed detrimental to the reaction. 
 













O2 19% 3.79 
5 1,4-benzoquinone 0 
6 benzoyl peroxide 0 
a
 conversion determined by 
1




 methyl ester 3.85 also obtained in t-AmOH, THF and DCE 
d
 isolated yield 
Table 3.04. Screening of oxidants 
Catalyst loading and conversion should be directly proportional if catalyst turnover was a 
problem, but unfortunately this was not the case and similar conversions were achieved with 
three different catalyst loadings (Scheme 3.27). It is important to note that all three reactions 
were performed in the same volume of solvent so the concentration of catalyst would be 
different in each, but nevertheless these results suggested that another variable was limiting 
the reaction.  




Scheme 3.27. Investigating catalyst turnover 
The choice of solvent for the reaction was also investigated, but very little or no product was 
observed when the reaction was conducted in any solvent other than MeOH (Table 3.05). 
Both polar solvents, including alternative alcohols ethanol and t-butanol, and non-polar 
solvents were ineffective for the reaction. Methanol was also added as an additive to a 
reaction conducted in THF, but no reaction occurred (entry 8). 
 
Entry Solvent Conversion (%)
a 
1 MeOH 35 
2 EtOH trace 
3 t-BuOH no reaction 
4 MeCN 9 
5 PhMe trace 
6 CHCl3 no reaction 
7 THF no reaction 
8 THF, MeOH (2.1 equiv.) no reaction 
a
 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
Table 3.05. Solvent screening 
The inclusion of ligands is sometimes critical for a reaction to succeed, as they change the 
electronic and steric nature of the catalyst and can stabilise active catalytic species. To this 
end, the reaction was performed using the diene 1,5-cyclooctadiene (COD), which is a 
common ligand used in rhodium catalysis, and racemic 2,2'-bis(diphenylphosphino)-
1,1'-binaphthyl (BINAP) (Scheme 3.28). Unfortunately, no reaction occurred with either 
ligand, suggesting that additional rhodium ligands are detrimental to reactivity. 
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Scheme 3.28. Reactions conducted with ligands 
The reaction was also conducted at room temperature, in an attempt to prolong the life of the 
catalyst and thus increase the yield of the reaction (Scheme 3.29). A lower conversion was in 
fact observed, suggesting a higher temperature is required for the reaction to overcome the 
activation energy for the reaction.  
 
Scheme 3.29. Reaction conducted at room temperature 
In addition to 1-phenyl-1-propyne 3.22, dialkylalkyne 4-octyne 3.86 and diarylalkyne 
diphenylacetylene 3.87 were screened in the reaction (Scheme 3.30). Only a trace amount of 
annulation product was observed when 4-octyne 3.86 was used, and no reaction occurred 
with diphenylacetylene 3.87. 
 
Scheme 3.30. Screening 4-octyne and diphenylacetylene 
Reverting to 1-phenyl-1-propyne 3.22, alkyne stoichiometry was then investigated. It was 
hoped that increasing the number of equivalents would improve the yield of product 3.79 
(Scheme 3.31). Increasing the alkyne stoichiometry from 1.1 to 2.1 equivalents did not affect 
the conversion (35% for 1.1 compared to 36% for 2.1), but further increasing this to 10 
reduced the conversion to 19%. 




Scheme 3.31. Screening number of alkyne equivalents 
Finally, the oxidative annulation of N-pivaloxycarboxamide 3.78 was attempted using the 
conditions developed by Guimond and Fagnou for the oxidative addition of the analogous 
N-pivaloxycarboxamide 3.24 (see Table 3.01)
185
 (Scheme 3.32). In contrast to Fagnou’s 
findings, N-pivaloxycarboxamide 3.78 did not prove a superior substrate to 
N-methoxycarboxamide 3.77, and instead the N–O bond of the substrate cleaved to give free 
amide 3.89 in 44% isolated yield with no accompanying annulation product. 
 
Scheme 3.32. Reaction of N-pivaloxycarboxamide 3.78 
3.2.4 Initial Results with Palladium 
After investigating a wide range of different reaction conditions with [RhCp*Cl2]2 and 
achieving a maximum conversion of about 35%, alternative metal catalysts were screened, 
focusing initially on Ru(II), Ir(III), Rh(I) and Pd(II) sources (Table 3.06). No reaction was 





 (both Rh(I) sources in comparison to Rh(III) source [RhCp*Cl2]2 
previously investigated) (Table 3.06, entries 1-3). Earlier reactions with COD and BINAP 
ligands had proven unsuccessful so it perhaps not surprising that both Rh(I) sources, which 
contain COD, did not catalyse the reaction (see Scheme 3.28). [IrCp*Cl2]2, a catalyst 
electronically similar to [RhCp*Cl2]2, was also ineffective (entry 4). 




Entry Catalyst Conversion (%)
a 
1 [RuCl2(p-cymene)]2
b no reaction 





 no reaction 
4 [IrCp*Cl2]2








 conversion determined by 
1
H NMR spectroscopy based on remaining substrate 
b 
CsOAc (30 mol%) used as additive 
c
 2.1 equiv. NaOAc 
d
 10 mol% Na2PdCl4 
e
 diphenylacetylene 3.87 used instead of 1-phenyl-1-propyne 3.22 
f
 no additive 
Table 3.06. Screening of other metal catalysts 
Inspired by the 1975 paper by Gaunt and Shaw,
221
 which reported the stoichiometric 
cyclopalladation of N,N-dimethylaminomethyl ferrocene 3.61 using Na2PdCl4 and sodium 
acetate (Scheme 3.33), the same catalyst was screened in the oxidative annulation of 
N-methoxycarboxamide 3.77 and pleasingly, Na2PdCl4 gave rise to a 42% conversion (entry 
5).  Since Shaw had only observed successful cyclopalladation in the presence of sodium 
acetate, the reaction was repeated in the absence of sodium acetate and only a trace amount 
of product was formed (entry 6). Again, these results serve to highlight the crucial role that 
an additive can play in C–H functionalisation. 
 
Scheme 3.33. C–H activation using Na2PdCl4 
It was subsequently found that the oxidative annulation of ferrocenecarboxamide 3.77 could 
also be performed in DMF, and using diphenylacetylene 3.87 as the alkyne, a 20% isolated 
yield of annulation product 3.91 was obtained (Scheme 3.34) (in this experiment and in all 
future experiments, 2.1 equivalents of sodium acetate were used, as two protons per 
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molecule of substrate are formally removed). Interestingly, free amide 3.89 was also 
obtained in 20% yield alongside 4% of the annulation product 3.92, in which the N–O bond 
had cleaved. Annulation product 3.91 was crystalline and X-ray crystallography was used to 
unambiguously confirm the structure. 
  
Scheme 3.34. Oxidative annulation of 3.79 with diphenylacetylene 3.87 and X-ray crystal structure of 
3.91 
It is interesting to contrast the oxidative annulation of N-methoxycarboxamide 3.77 with 
diphenylacetylene 3.87 using rhodium and palladium catalysis. No reaction was observed 
with this alkyne using [RhCp*Cl2]2, yet a 20% yield of product 3.91 was isolated using 
Na2PdCl4. Pleasingly, Na2PdCl4 also catalysed the oxidative annulation of 
N-methoxycarboxamide 3.77 with 1-phenyl-1-propyne 3.22 (Scheme 3.35), but in contrast to 
the 20% isolated yield of annulation product 3.91 obtained with diphenylacetylene 3.87, a 
lower yield of 15% of the analogous product 3.79 was isolated.  
The lower reactivity of alkylarylalkynes compared with diarylalkynes and the 
regioselectivity of the reaction was consistent with the literature,
185
 with the aryl substituent 
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being incorporated closest to nitrogen; through 1D nOe analysis of the product, a mutual 
enhancement was observed between the vinyl methyl protons and Ha.  
 
Scheme 3.35. Oxidative annulation of N-methoxycarboxamide 3.77 with 1-phenyl-1-propyne 3.22 
Given that both product 3.91 and free amide 3.89 were isolated in equal yield using 
diphenylacetylene 3.87 (see Scheme 3.34), it was speculated that the N–O bond of the 
substrate itself was cleaving and turning over the catalyst. Therefore, in an effort to prevent 
this sacrificial loss of substrate, a range of oxidants were screened (Table 3.07). AcNHOMe 
and BocNHOPiv were chosen to resemble substrate 3.77 in the hope that the N–O bond of 
the additives would preferentially cleave over the equivalent bond in the substrate 
(Table 3.07, entries 1 and 2), but only a 12% yield by 
1
H NMR spectroscopy was obtained 
using AcNHOMe and no reaction was observed with BocNHOPiv. Both AcNHOMe and 
BocNHOPiv could potentially act as polydentate ligands for palladium so it is perhaps not 
surprising that the reactions were low yielding. 
Next, oxidants commonly used in C–H activation were screened (entries 3-9) and all either 
prevented the reaction, gave product 3.77 in low yield or converted N-methoxycarboxamide 
3.77 into methyl ester 3.85, which had previously been observed when using silver oxidants 
with rhodium catalysis (see Table 3.04). 
Finally, catalytic ferrocene was screened as an oxidant (entry 10) in the hope of using the in 
situ generated ferrocenium ion as an oxidant, similar to that observed by Wu (see 
Scheme 3.21).
218
 However, no improvement in yield was observed and annulation product 
3.91 was observed in 25% yield by 
1
H NMR spectroscopy. 




Entry Oxidant Yield (%)
a 
1 AcNHOMe 12 
2 BocNHOPiv no reaction 
3 Cu(OAc)2 9 + 3.85 
4 (BzO)2 no reaction 
5 PhI(OAc)2 3.85 
6 K2S2O8 no reaction 
7 AgOAc 3.85 
8 NFSI no reaction 




 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 10 mol% under air 
Table 3.07. Oxidant screening 
Next, additives were screened (Table 3.08). No reaction occurred in the absence of an 
additive, but a 37% yield by 
1
H NMR spectroscopy was obtained using 2.1 equivalents of 
sodium acetate (Table 3.08, entries 1 and 2). 
 
Entry Oxidant Yield (%)
a 
1 - no reaction 
2 NaOAc 37 
3 KOAc no reaction 
4 CsOAc no reaction 
5 K2CO3 no reaction 
6 NaOAc + TBAB (1.0 equiv.) 38 
7 KOPiv no reaction 
8 K2CO3 (2.5 equiv.) + PivOH (0.3 equiv.) no reaction 
a 
yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 3.08. Additive screening 
In contrast to the screening performed with rhodium, no reaction occurred when either 
potassium or cesium acetate was used (entries 3-4). The addition of potassium carbonate did 
not facilitate the reaction and the addition of TBAB, which has been shown to increase the 
yield of some reactions,
217
 did not have a beneficial effect with only a modest 38% yield by 




H NMR spectroscopy observed (entries 5 and 6). No reaction was observed when either 
potassium pivalate or the combination of potassium carbonate and pivalic acid was screened 
(entries 7 and 8). 
A variety of palladium sources were next screened and interestingly palladium acetate, a 
common C–H functionalisation catalyst, only gave the product in 1% yield by 
1
H NMR 
spectroscopy (Table 3.09, entry 1). Switching the ligand to trifluoroacetate only gave a small 
increase in yield to 4% (entry 2). Pleasingly, palladium chloride catalysed the reaction 
successfully and a 28% yield was observed (entry 3). Related palladium sources 
Pd(PPh3)2Cl2 and Pd(MeCN)2Cl2 also facilitated the reaction and yields of 23% and 37% 
respectively were recorded (entries 4 and 5). Comparing the yields by 
1
H NMR spectroscopy 
obtained with alternative palladium sources to the one obtained with Na2PdCl4, 37% (entry 







1 Pd(OAc)2 1 
2 Pd(CF3CO2)2 4 
3 PdCl2 28 
4 Pd(PPh3)2Cl2 23 
5 Pd(MeCN)2Cl2 37 
6 Na2PdCl4 37 
a 
yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 3.09. Screening of palladium sources 
At this point, it was considered that the low yields observed could be as a result of the short 
catalyst lifetime, and a variety of ligands were screened in the hope of stabilising the catalyst 
(Table 3.10). All of the ligands screened suppressed the reaction to some extent and yields 
varied between 0 and 27%. Of the monodentate phosphorus ligands screened (Table 3.10, 
entries 1-4), P(2-furyl)3 gave the optimum yield of 27%. The bidentate phosphorus ligands 
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screened reduced the yield of the reaction to a greater extent than the monodentate ones 
(entries 5-9). A 16% yield, the highest yield recorded with a bidentate phosphorus ligand, 
was observed with dppf and no reaction was observed with racemic BINAP. 
The nitrogen-based ligands screened fared poorly and monodentate 2,6-dimethoxypyridine 
gave rise to a 17% yield whereas bidentate 2,2'-bipyridyl suppressed the reaction completely 
(entries 10 and 11). 2,6-Dimethoxypyridine was screened, as Yu had previously observed 





 Amino acids as ligands have commonly been used in a variety of C–H 
functionalisations,
217-218
 but protected amino acid Boc-L-Ala-OH only gave product 3.91 in 








1 PPh3 26 
2 PCy3 4 
3 P(o-tol)3 17 
4 P(2-furyl)3 27 
5 dppe 3 
6 dppp 9 
7 dppf 16 











12 Boc-L-Ala-OH 14 (0% ee) 
a
 monodentate ligands (20 mol%); bidentate ligands (10 mol%) 
b 
yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 3.10. Screening of palladium sources 
Finally, solvents for the reaction were screened but no improvement in yield was found 
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(Table 3.11). DMA was the only solvent, other than the structurally similar DMF, to 
facilitate product formation and the 26% yield obtained with DMA was still lower than the 
37% obtained with DMF. 
 
Entry Solvent Yield (%)
a 
1 DMA 26 
2 DMF 37 
3 Nitromethane trace 
4 MeCN trace 
5 DMSO trace 
a 
yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 3.11. Solvent screening 
3.2.5 Investigating Alternative Ferrocene Substrates 
Since screening of the reaction parameters had led to no appreciable increase in yield, 
attention turned to the substrate, and more specifically the directing group. Quinoline amide 
3.94 was synthesised in 59% yield directly from the parent carboxylic acid 3.75 using EDC 
coupling conditions (Scheme 3.36). 8-Amino quinoline has been recognised as a powerful 
directing group in recent years as it is able to bind the metal catalyst in a bidentate fashion.
223 
 
Scheme 3.36. Synthesis of quinoline amide 3.94 
Alcohol 3.95, a substrate containing a weak directing group (see Scheme 3.05), was 
synthesised in 65% yield over two steps from the parent carboxylic acid 3.75 (Scheme 3.37), 
with the intermediate ester used crude in the subsequent reduction step. 




Scheme 3.37. Reduction of carboxylic acid 3.75 to alcohol 3.95 
Some substrates were accessed using a divergent route involving common intermediate acid 
chloride 3.76, which could be isolated with minimal purification and kept in the freezer 
without noticeable degradation for up to one month (Table 3.12). Acid chloride 3.76 was 
condensed with a variety of amines to give oxidative annulation substrates 3.96-3.98 in 
moderate to good yield. 
 
Entry Amine Base Product Yield (%) 














Table 3.12. Synthesis of substrates 3.96-3.98 
The prepared substrates were then subjected to the oxidative annulation conditions which 
had given annulation product 3.91 in 20% isolated yield (Table 3.13).  




































yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 3.13. Oxidative annulation of alternative ferrocene substrates 
Carboxylic acid 3.75, which contains a weak directing group, did not undergo oxidative 
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annulation but N-pivaloxycarboxamide 3.78 did, albeit with concomitant cleavage of the N–
O bond and in only 9% NMR yield (Table 3.13, entries 1 and 2). Upon purification, it was 
discovered that the starting material had also undergone N–O bond cleavage, which 
demonstrated that pivaloxy is much more labile than a methoxy group. Substrate 3.94, with 
the promising quinoline directing group, was found to be a poor substrate and no reaction 
occurred (entry 3). Alcohol 3.95 was rapidly consumed in the reaction but upon inspection of 
the 
1
H NMR spectrum, alcohol 3.95 was found to have been oxidised to aldehyde 3.100, 
evidenced by the singlet at 9.97 ppm (entry 4). N-Methylamide 3.96 underwent oxidative 
annulation to give product 3.101 in 10% yield (entry 5). Hydrazide 3.97 was synthesised in 
the hope that the N–N bond would be less labile than the N–O bond, but no reaction 
occurred with this substrate (entry 4). Finally, N-arylcarboxamide 3.98 was subjected to the 
reaction conditions and a relatively good 27% yield of product 3.102 resulted (entry 7). 
Based on the above results a range of targeted substrates were synthesised, which would 
hopefully result in the exclusive formation of annulation product in high yield. Free amine 
3.89 was isolated from the reaction of N-pivaloxycarboxamide 3.78 and subjected to the 
annulation conditions (Scheme 3.38). Although the reaction was successful, the product 
(3.92) was only formed in a disappointing 22% yield by 
1
H NMR spectroscopy. 
 
Scheme 3.38. Oxidative annulation of free amide 3.89 
Since alcohol 3.98 was preferentially oxidised in the reaction, tertiary alcohol 3.104 (which 
is unable to undergo oxidation by virtue of the lack of α-hydroxy protons) was synthesised 
from ferrocene ketone 3.103 (Scheme 3.39). However, alcohol 3.104 proved unreactive and 
no reaction occurred. 




Scheme 3.39. Synthesis and unsuccessful oxidative annulation of alcohol 3.104 
Given that the most promising result obtained when screening the alternative ferrocene 
substrates was the oxidative annulation of N-arylcarboxamide 3.98 in 27% yield, it was 
decided to synthesise a range of electronically different N-arylcarboxamides, in the hope of 
finding a directing group with the optimum electronic properties for a high-yielding 
oxidative annulation. N-Phenylcarboxamide 3.106 and N-3,5-dimethylphenylcarboxamide 
3.107 were both accessed from the parent carboxylic acid 3.75  using EDC coupling 
conditions in 53% yield (Scheme 3.40). 
 
Scheme 3.40. Synthesis of N-arylcarboxamides 3.106 and 3.107 
With these in hand, substrates 3.106 and 3.107 were subjected to the oxidative annulation 
conditions (Scheme 3.41); N-phenylcarboxamide 3.106 underwent annulation in 21% yield 
by 
1
H NMR spectroscopy and N-3,5-dimethylphenylcarboxamide 3.107 in 13% yield. 
 
Scheme 3.41. Oxidative annulation of N-arylcarboxamides 3.106 and 3.107 
Comparing these results to the 27% yield obtained for the 
N-3,5-ditrifluoromethylphenylcarboxamide 3.98, it appeared that the carboxamide with the 
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most electron-withdrawing aryl group gave the highest annulation yield. With this in mind, 
substrate 3.111, with an extremely electron-withdrawing aryl group, was synthesised 
(Scheme 3.42). Octafluorotoluene 3.110 was first heated with ammonium hydroxide solution 
in a nucleophilic substitution reaction, which was then heated at reflux with acid chloride 
3.76 to yield substrate 3.111, albeit in a poor 9% yield over two steps.  
However, with substrate 3.111, it was disappointing to observe annulation product 3.112 in 
only 13% yield—the same yield as was observed with N-3,5-dimethylphenylamide 3.107. 
Therefore, it seemed that the trend previously observed (the more electron-withdrawing the 
N-aryl group, the higher the yield of oxidative annulation), did not hold true in this case. 
 
 
Scheme 3.42. Synthesis and oxidative annulation of N-perfluorinatedarylcarboxamide 3.111 
3.2.6 Preliminary Mechanistic Studies 
At this stage, although a wide range of reaction conditions and substrates had been explored, 
no significant progress had been made. In order to continue, a better understanding of the 
reaction mechanism was sought, which would hopefully facilitate the optimisation of the 
reaction. To this end, the proposed palladacycle intermediate 3.113 was targeted 
(Scheme 3.43). Formation of palladacycle 3.113 and subsequent reaction with 
diphenylacetylene 3.87 might allow the identification of the problematic step of the reaction. 




Scheme 3.43. Proposed synthesis of palladacycle 3.113 
Wang recently conducted some thorough mechanistic studies into the Ru(II)-, Rh(III)- and 
Ir(III)-catalysed oxidative annulation of isoquinolones 3.114 with alkynes in which 
intermediates of the type 3.115 and 3.117 were isolated (Scheme 3.44).
148, 224
 Both structures 
have pyridine ligands in addition to p-cymene and Cp* (the direct reaction of an 
isoquinolone substrate with stoichiometric metal catalyst did not result in any isolable 
product and the authors attributed this to an unstable 16 electron complex). It is only when 
the metal catalyst is first mixed with pyridine to form a catalyst of the type 
[RuCl2py(p-cymene)] (py = pyridine) and reacted with isoquinolone 3.114, that a stable 
plausible reaction intermediate could be isolated and the structure confirmed by single 
crystal X-ray crystallography. 
 
Scheme 3.44. Oxidative annulation of isoquinolones 3.114 with alkynes 
Inspired by this work, palladacycle 3.118, which contained stabilising pyridine ligands to aid 
isolation, was sought (Scheme 3.45). Heating PdCl2 with pyridine at reflux followed by 
heating with sodium acetate and N-methoxycarboxamide 3.77 pleasingly gave palladacycle 
3.118 in 27% isolated yield. A single crystal X-ray structure was obtained of 3.118, 
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confirming the structure and presence of two pyridine ligands. Interestingly, the two 
cyclopentadienyl rings of palladacycle 3.118 are eclipsed, unlike in oxidative annulation 
product 3.91 where they are staggered (see Scheme 3.34). 
 
 
Scheme 3.45. Successful isolation and X-ray crystal structure of palladacycle 3.118 
Whilst palladacycle 3.118 is not strictly a species in the reaction owing to the presence of 
two pyridine ligands, it nevertheless supports the initial C–H activation step in the 
mechanism. With this in mind, a 27% isolated yield for the formation of palladacycle 3.118 
was disappointing and suggested that the first step in the reaction could be the problematic 
one. In order to evaluate the insertion of the alkyne into palladacycle intermediate 3.118, 
palladacycle 3.118 was heated with diphenylacetylene 3.87 (Scheme 3.46). Although 
oxidative annulation product 3.91 was formed, it was only isolated in 11% yield alongside 
recovered starting material. This was again a low yield, suggesting that the alkyne insertion 
step could also be problematic. 
 
Scheme 3.46. Reaction of palladacycle 3.118 with diphenylacetylene 3.87 
At this stage, owing to the poor yields obtained for both steps of the reaction, PdCl2py2 
(the intermediate in the palladacycle synthesis) and palladacycle 3.118 itself were tested to 
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see whether either could catalyse the oxidative annulation (Scheme 3.47). Unfortunately, 
only a 3% yield by 
1
H NMR spectroscopy was observed with PdCl2py2 and no reaction was 
observed with palladacycle 3.118. This suggested that both catalysts were not viable for the 
reaction, probably due to the stability conferred to the complexes by the pyridine ligands. 
 
Scheme 3.47. Screening PdCl2py2 and palladacycle 3.118 as catalysts 
Replacing the pyridine ligands with triphenylphosphine ligands might increase the reactivity 
of the palladacycle and it had already been shown that the oxidative annulation reaction with 
Pd(PPh3)2Cl2 was relatively successful (23% NMR yield, see Table 3.09). Therefore, 
compared to pyridine ligands, triphenylphosphine ligands are not detrimental to the reaction 
and allow the palladium catalyst to turnover. Once this was established, the 
triphenylphosphine analogue of palladacycle 3.118 (3.119) was targeted (Scheme 3.48). 
Unfortunately, this reaction proved unsuccessful and the 
1
H NMR spectrum of the crude 
reaction was a complex mixture of products. 
 
Scheme 3.48. Unsuccessful synthesis of palladacycle 3.119 
In conclusion, we were unable to optimise the oxidative annulation reaction and to identify 
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the problematic step. Our brief mechanistic investigations suggested that more than one step 
of the reaction might be problematic. 
3.2.7 Successful Report of Oxidative Annulation of Ferrocenecarboxamides 
Following this work, the high-yielding oxidative annulation of ferrocenecarboxamides 3.120 
with alkynes was very recently reported using palladium catalysis (Scheme 3.49).
225
 A range 
of electronically different N-arylcarboxamides underwent successful reaction with just two 
examples of N-alkylcarboxamides. The reaction showed good scope with a variety of 
diarylalkynes; alkylarylalkyne 1-phenyl-1-propyne 3.22 was also compatible, with the 
corresponding product isolated in 60% yield, albeit as a 3:1 mixture of regioisomers. 
 
Scheme 3.49. Successful oxidative annulation of ferrocenecarboxamides 3.120 
Interestingly, during the optimisation of the reaction, DMF as a solvent proved ineffective 
and only a trace of product was observed. Furthermore, TBAB and Cu(OAc)2·4H2O were 
essential for reactivity, even though both reagents had failed to improve the yield of the 
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oxidative annulation of N-methoxyferrocenecarboxamide 3.77 in our hands, as detailed 
above. 
3.3 Conclusions 
In conclusion, the oxidative annulation of N-methoxyferrocenecarboxamide 3.77 and a 
variety of derivatives with diaryl- and alkylarylalkynes was successfully achieved 
(Scheme 3.50). With N-methoxycarboxamide 3.77 and diphenylacetylene 3.77, 20% 
annulation product 3.91 was isolated, alongside 4% of analogous product 3.92, in which the 
N–O had cleaved. 
 
3.91 
Scheme 3.50. Successful oxidative annulation of N-methoxyferrocenecarboxamide 3.91 
Although a wide range of reaction parameters were screened, the reaction proved difficult to 
optimise and no significant increase in the yield of the reaction above 30% could be made. 
However, potential reaction intermediate palladacycle 3.118 was synthesised, isolated and 
the structure of 3.118 confirmed through X-ray crystallographic analysis (Scheme 3.51). 
Unfortunately, reactions to further utilise palladacycle 3.118, which it was hoped would help 
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identify the problematic step of the reaction, were unsuccessful. 
The recent report of the successful high-yielding oxidative annulation of 
ferrocenecarboxamides,
225
  demonstrated that the reaction could be optimised through the 
careful selection and combination of reagents. The challenge now remains to render the 
oxidative annulation enantioselective. 
 
 
Scheme 3.51. Successful isolation and X-ray crystal structure of palladacycle 3.118 
Following the investigation of two palladium-catalysed reactions, the focus of research 
changed and iron catalysis was explored, in the hope of developing some more sustainable 
and environmentally benign methodology. Building on previous work in the Thomas 
group,
226
 the iron-catalysed hydrofunctionalisation of olefins was pursued. 
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Chapter 4. Hydromagnesiation for the 
Hydrofunctionalisation of Alkenes 
4.1 Introduction 
The formal addition of ‘H–MgX’ across an alkene or alkyne is known as 
hydromagnesiation
227
 (Scheme 4.01) and provides a simple method for the formation of 
Grignard reagents.
228-229
 Where Grignard reagents are difficult to synthesise via the 
conventional insertion of magnesium metal into a carbon–halogen bond, hydromagnesiation 
is an alternative. Upon reaction of the prepared Grignard reagent with an electrophile, a 




Scheme 4.01. Hydromagnesiation and formal hydrofunctionalisation of olefins 
4.1.1 Using MgH2 
MgH2 itself can be used for hydromagnesiation, although the uncatalysed reaction is poor 
yielding and requires forcing reaction conditions.
231
 In 1978 Ashby and Smith showed that 
using MgH2 with Cp2TiCl2 as a catalyst, hydromagnesiation occurs under much milder 
conditions and the product obtained after quenching the Grignard reagent with an 
electrophile can be isolated in high yield (Table 4.01).
232
 
A range of olefins underwent successful hydromagnesiation and with the exception of 
styrene (Table 4.01, entry 2), all olefins generated terminal Grignard reagents. The major 
regioisomeric product for the reaction with styrene, however, was the internal benzylic 
Grignard reagent (9:1 internal:terminal), presumably as a result of the stabilisation conferred 
to the organometallic intermediate by the aromatic ring. Compared to the other substrates, 
styrene was also more reactive—100% product was obtained in only one hour at room 
temperature. Benzylic Grignard reagents can be challenging to synthesise by conventional 
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reductive insertion owing to competing Wurtz homocoupling (Scheme 4.02),
233-234
 so 
hydromagnesiation offers an alternative and highly efficient route.  
 
Scheme 4.02. Wurtz homocoupling as a byproduct of Grignard reagent formation 
In addition to monosubstituted alkenes, 1,1- and 1,2-disubstituted alkenes also underwent 
hydromagnesiation (entries 3-5), although the yields were poorer with the latter and some 
double bond isomerisation was observed. No reaction occurred when a trisubstituted alkene 
was tested (entry 6). 
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 remaining material protonated product 
Table 4.01. Titanium-catalysed hydromagnesiation of olefins 
The substrate scope was successfully extended to alkynes and the products were consistent 
with syn addition of ‘H–MgX’ (entries 7 and 8). Competitive deprotonation occurred when 
1-octyne was subjected to hydromagnesiation, whilst 4-octyne underwent hydromagnesiation 
efficiently. For the more sterically hindered olefins, the yield of the deuterated product was 
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significantly lower than for the corresponding protonated product, with increasing amounts 
of the protonated product observed. The low yields were attributed to the relatively long 
reaction times required for the conversion of sterically hindered olefins, during which time 
the active magnesium species decomposes. 
Bogdanović and co-workers have subsequently reported the hydromagnesiation of alkyl 
alkenes using MgH2 with titanium, zirconium, hafnium and chromium catalysts.
235-236
 
4.1.2 Using β-hydrogen Containing Grignard Reagents 
Alternatively, hydromagnesiation can be achieved using β-hydrogen containing Grignard 
reagents in the presence of a transition-metal. In the 1960s Cooper and Finkbeiner observed 
a Grignard exchange reaction between a monosubstituted alkene and a Grignard reagent in 
the presence of titanium tetrachloride.
237-238
 For example, the titanium-catalysed reaction of 
1-pentene 4.01 with n-propylmagnesium bromide, followed by subsequent trapping with 
formaldehyde, led to 1-hexanol 4.03 in 45% yield (Scheme 4.03). 
 
 
Scheme 4.03. Grignard exchange reaction between 1-pentene 4.01 and n-propylmagnesium bromide 
The proposed mechanism begins with the alkylation of titanium tetrachloride to give 
alkyltitanium species 4.04. β-Hydride elimination then gives the active titanium hydride 
species 4.05; following alkene exchange, hydrometallation gives organotitanium 4.07, which 
then undergoes transmetallation with n-propylmagnesium bromide to give Grignard reagent 




Cooper and Finkbeiner went on to extend the TiCl4-catalysed hydromagnesiation to a 
number of alkenes, including styrene,
239
 and electrophiles, including aldehydes, ketones, 
carbon dioxide, orthoesters and oxygen. With the exception of styrene, terminal Grignard 
reagents were generally the sole regioisomeric product. Cp2TiCl2, Ti(O-i-Pr)4, ZrCl4 and 
VCl4 were also found to be effective hydromagnesiation catalysts. In comparison, FeCl3 was 
a poor catalyst for the hydromagnesiation of styrene, with only a 15% yield of phenylethyl 
alcohols determined following oxidation of the Grignard intermediate. 
Titanium-catalysed hydromagnesiation has also been extended to dienes and internal 
alkynes, giving allyl (4.09) and 1,2-cis-disubstituted vinyl (4.13 and 4.14) Grignard reagents, 
respectively (Tables 4.02 and 4.03).
240-241
 Following reaction with an electrophile 
(water, aldehydes, ketones, carbon dioxide, nitriles, iodine and organohalides), the product 
was generally obtained in high yield.
229
 The higher yields for dienes and disubstituted 
alkynes compared to monosubstituted alkenes (with the exception of styrene) was attributed 
to the greater stability of allyl and vinyl Grignard reagents compared to alkyl Grignard 








MgX Electrophile E Products (%)
 




2 H n-PrMgBr Me2CO Me2C(OH)- 4.11, 79 
3 Me n-PrMgBr H2O H 
4.10, 21 
4.11, 76 
4 Me n-PrMgBr Me2CO Me2C(OH)- 4.11, 95 
Table 4.02. Hydromagnesiation of 1,3-dienes 
For isoprene (R
1
 = Me), the hydromagnesiation was selective for allyl Grignard reagent 4.09 
and trapping with an electrophile gave terminal alkene 4.11 as the major product (Table 4.02, 
entries 3 and 4). 
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The hydromagnesiation of disubstituted alkynes proceeded with syn addition (Table 4.03) 
and with low regioselectivity for unsymmetrical dialkylalkynes (Table 4.03, entry 1). When 
the alkyne substituent was a trimethylsilyl or hydroxymethyl group, the regioselectivity of 
the hydromagnesiation was controlled, with the vinyl Grignard reagent generated α to the 








MgX Electrophile E Products (%)
 
1 n-Pr Me i-BuMgBr I2 I 
4.15, 42 
4.16, 58 




3 n-Bu CH2OH i-BuMgCl I2 I 4.15, 78-86 
Table 4.03. Hydromagnesiation of disubstituted alkynes  
Interestingly, the regioselectivity of the hydrofunctionalisation of silylacetylene 4.17 was 
found to depend on the electrophile used (Table 4.04).
242
 The reaction time for each 
electrophile varied owing to the different lengths of time necessary for the reaction to reach 
completion. The ratio of α-4.19:β-4.19 varied between 77:23 and >99:1 and the observed 
difference in regioisomeric ratio was rationalised by the difference in the rate of the vinyl 
Grignard reagent α-4.18 and β-4.18 interconversion with the rates of reaction of the Grignard 
reagents with electrophile. 
 
Entry Electrophile
 E Products α-4.19:β-4.19
 
1 D2O D 77:23 
2 Me3SiOTf SiMe3 77:23 
3 R1R2CO R1R2C(OH) 81-94:19-6 
4 CBr4 Br >99:<1 
Table 4.04. Electrophile dependent regioselectivity 
The majority of recent hydromagnesiation reports have focused on the transformation of 
alkylaryl- and silylarylacetylenes using titanium catalysis. These reactions were regio- and 
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stereoselective; both alkynes gave cis-α-aryl vinyl Grignard reagents. The prepared Grignard 

























Mechanistic investigations into nickel-catalysed hydromagnesiation suggested that the key 
step in the reaction involved β-hydride transfer from an alkyl group to a coordinated alkene 
within an organonickel complex (Scheme 4.03), as opposed to the formation of a distinct 
nickel-hydride species through β-hydride elimination.
252-254
 Two observations were given in 
support of this hypothesis: firstly, formation of an active homogenous catalyst required an 
alkene, and secondly, the isomerisation of (2-phenylethyl)magnesium bromide to the more 
thermodynamically stable (1-phenylethyl)magnesium bromide was promoted by the addition 
of an alkene. 
 
Scheme 4.03. β-Hydride transfer 
4.1.2.1 Iron-Catalysed Hydromagnesiation 
Following Tamura and Kochi’s seminal report of the iron-catalysed hydromagnesiation of 
monsubstituted alkenes using FeCl3,
256-257
 a number of years passed before the area was 
revisited. In 2012 however, there were three separate reports of iron-catalysed 
hydromagnesiation
258








The action of β-hydrogen containing Grignard reagents on Fe(II) salts reduces the iron 
precatalyst to a low-valent highly active species.
34-35, 38, 261
 This is considered to be the first 
step in the mechanism for all iron-catalysed hydromagnesiations using β-hydrogen 
containing Grignard reagents. Although there is no consensus as to the exact oxidation state 
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of the iron species, Bogdanović and co-workers proposed Fe(−II) (Scheme 4.04). Alkylation 
of FeX2 by the Grignard reagent results in iron dialkyl species 4.20. Following β-hydride 
elimination (4.20) and reductive elimination, Fe(0) is formally reached. Reduction with two 
more equivalents of Grignard reagent formally leads to Fe(−II) complex [Fe
−II
·(MgX)2]. 
Scheme 4.04. Generation of low-valent iron species 
Shirakawa and Hayashi recently reported the isomerisation of secondary alkyl Grignard 
reagents to the thermodynamically more stable primary alkyl Grignard reagents using 
cooperative iron-copper catalysis (Scheme 4.05);
262
 for example, 2-hexylmagnesium bromide 
4.22 was smoothly converted into terminal silane 4.25 via 1-hexylmagnesium bromide 4.23 
in 83% yield. 
 
Scheme 4.05. Isomerisation of secondary to primary Grignard reagents 
Isomerisation did not occur in the absence of FeCl3 or CuBr and it was postulated that iron 
facilitated the isomerisation and copper, the transmetallation between iron and magnesium. 
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Building on this work, if a terminal alkene was added to the reaction then an 
alkene-Grignard exchange occurred (Table 4.05).
259
 Significantly, when a secondary 
Grignard reagent such as cyclopentylmagnesium bromide 4.33 was used 
(the hydromagnesiation of the resultant cyclopentadiene 4.35 would be slow compared to the 
hydromagnesiation of a terminal alkene), the reaction was rendered irreversible and thereby 
driven to completion. A range of terminal alkenes and electrophiles were investigated. 
 
Entry Substrate Electrophile Product Yield (%) 
























































 FeCl3 (2.5 mol%), Ph2P(CH2)3NMe2 (5 mol%), [CuI(PBu3)]4 (5 mol% Cu), Et2O, −40 °C used 
Table 4.05. Hydromagnesiation of terminal alkyl alkenes and selected examples 
Notably, alcohol 4.37 and chloroarene 4.38 were compatible with the methodology, which is 
in contrast to what would be observed using the conventional insertion of magnesium metal 
                                Chapter 4. Hydromagnesiation for the Hydrofunctionalisation of Alkenes 
-106- 
 
into a carbon–halogen bond (Table 4.05, entries 4-8) (the alkyl Grignard reagent from the 
reaction of chloroarene 4.38 would be difficult to prepare selectively from the corresponding 
dihalo compound). Alkene 4.40 was isolated as the exclusive product for 4.39, whereas 
competitive radical cyclisation would occur when subjecting 4.39 to conventional Grignard 
formation conditions (entry 10). Silane 4.41 was also isolated as the sole regioisomer when a 
1:1 mixture of 1-butene and (E)- and (Z)-2-butene underwent hydromagnesiation (entry 11). 
These primary Grignard reagents were subsequently used in an iron-catalysed 
carbomagnesiation protocol where Grignard reagent 4.43 was used in the carbomagnesiation 
of 1-phenyl-1-octyne 4.44 to give alkene 4.45 in high yield (Scheme 4.06). 
Scheme 4.06. Tandem hydromagnesiation-carbomagnesiation protocol 
Interestingly, no hydromagnesiation was observed in the carbomagnesiation step even 
though a Grignard reagent bearing β-hydrogens was used. This is in contrast to that observed 
by Ready and co-workers in the iron-catalysed carbomagnesiation of propargylic and 
homopropargylic alcohols 4.46—when using ethylmagnesium bromide, small amounts of 
product (4.48) arising from competitive hydromagnesiation were observed (Scheme 4.07).
263
 
However, the iron precatalyst in this case was an Fe(III) salt (Fe(acac)3 (acac = 
acetylacetonate) or Fe(ehx)3 (ehx = 2-ethylhexanoate)). 
Scheme 4.07. Carbomagnesiation of propargylic and homopropargylic alcohols 
The second recent report of iron-catalysed hydromagnesiation, by Nakamura and 
co-workers, focused on the selective cis-hydromagnesiation of alkynes 4.51 using FeCl2 and 
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ethylmagnesium bromide (Table 4.06).
260
 No competing carbomagnesiation was observed in 
this case. 
 
Entry Alkyne Electrophile Product (%) E:Z 
1  HCl  
94 
2:98 









































Table 4.06. Cis-hydromagnesiation of alkynes 
A range of diarylalkynes bearing both electron-donating and electron-withdrawing 
substituents were tolerated and the products were consistently generated in excellent 
stereoselectivity. However, the hydromagnesiation was not regioselective, as demonstrated 
through the hydromagnesiation and subsequent trapping of unsymmetrical alkynes—a 
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roughly 1:1 mixture of regioisomers 4.55 and 4.56 was obtained when the Grignard 
intermediate generated from alkyne 4.54 was quenched with D2O (Scheme 4.08). 
 
Scheme 4.08. Hydromagnesiation of unsymmetrical alkyne 4.55 
Notably, alkylalkynes and alkenes did not undergo hydromagnesiation when subjected to the 
reaction conditions, but this methodology was successfully extended to the 
monohydromagnesiation of 1,3-diynes 4.57 (Table 4.07). In this case, the hydromagnesiation 
was regioselective and the electrophile was added to the carbon α to the intact triple bond. 
For the unsymmetrical diyne 1-phenyl-4-trimethylsilylbutadiyne, hydromagnesiation was 
selective for the phenyl-substituted alkyne (entry 5). The mechanism of this particular 
reaction is unclear but the authors suggest that a radical mechanism may be operating, as 
opposed to a purely organometallic one. 
 
Entry Substrate Electrophile Yield (%) E:Z 4.58:4.59 
1  D2O 63 14:86 >99:1 
2  DMF 50 97:3 >99:1 
3 
 
D2O 63 11:89 97:3 
4 
 
D2O 65 22:78 97:3 
5  D2O 55 17:83 98:2 
Table 4.07. Hydromagnesiation of 1,3-diynes 
The hydrocarboxylation of styrene derivatives 4.60 using a highly regioselective 
hydromagnesiation was recently reported by Thomas and co-workers (Scheme 4.09).
226
 
Using FeCl2 and bis(imino)pyridine ligand (BIP) 1.35 as a precatalyst, the reaction was 
found to be particularly well suited to substrates bearing electron-donating groups and 
substituents in all the positions of the aryl ring were tolerated. 




Scheme 4.09. Hydrocarboxylation of styrene derivatives and selected examples 
Mechanistic studies of the reaction suggested a mechanism similar to that proposed for the 
titanium-catalysed Grignard exchange reaction (see Scheme 4.10).  
 
Scheme 4.10. Proposed hydrocarboxylation mechanism 
Initial alkylation of FeCl2 by ethylmagnesium bromide followed by styrene coordination 
gives rise to iron alkyl species 4.63. Hydrometallation can now take place via two pathways 
and it has so far proven difficult to determine which pathway is operating. β-Hydride 
elimination leads to iron hydride species 4.64, which can add across styrene to give iron 
alkyl species 4.65 as a single α-regioisomer. Alternatively, iron alkyl species 4.63 can 
transfer a hydride directly from the ethyl group to styrene to give iron alkyl 4.65. Following 
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transmetallation from iron to magnesium, the resultant benzylic Grignard reagent 4.66 was 
trapped with carbon dioxide. 
The three recent hydromagnesiation reports highlight the utility of this reaction for the 
preparation of Grignard reagents that would otherwise be difficult to synthesise. 
Iron-catalysed hydromagnesiation remains a relatively underexplored area and thus further 
research into the reaction scope and mechanism will hopefully result in the reaction 
becoming commonplace in synthetic sequences. 
4.2 Results and Discussion 
4.2.1 Aims 
Building upon the iron-catalysed highly regioselective formal hydrocarboxylation of styrene 
derivatives,
226
 we aimed to exploit the iron-catalysed hydromagnesiation procedure to 
explore the range of electrophiles that could be trapped (Scheme 4.11). In doing so, we 
aimed to develop a broad hydrofunctionalisation procedure that was operationally simple to 
perform and would be capable of forming a range of carbon–carbon and carbon–heteroatom 
bonds. 
 
Scheme 4.11. Formal hydrofunctionalisation of olefins 
4.2.2 Catalyst Simplification 
As the hydrocarboxylation methodology relied on bis(imino)pyridine ligand (BIP) 1.35, 
which is either expensive to buy or requires synthesis via a Schiff base condensation reaction 
from the corresponding 2,6-diacetylpyridine and aniline,
70
 other ligands for the 
hydromagnesiation were explored. Using styrene 4.67 as a model substrate and trimethylsilyl 
chloride as a model electrophile, N,N,N',N'-tetramethylethylenediamine (TMEDA), 
2,2'-bipyridyl and 1,10-phenanthroline were tested (Table 4.08). As controls, the reaction 
was also conducted in the absence of ligand and with BIP. 




Entry Ligand Yield 4.68 (%)
a 
1 - 42 (50% 4.67) 
2 BIP 84 
3 TMEDA 92 
4 2,2'-bipyridyl 75 
5 1,10-phenanthroline 73 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.08. Ligand optimisation 
In the absence of ligand, silane 4.68 was observed in 42% yield and 50% styrene 4.67 was 
recovered, highlighting the necessity for a ligand (Table 4.08, entry 1). Using BIP 1.35, 
silane 4.68 was observed in 84% yield, providing a benchmark for the comparison of all 
other ligands (entry 2). With TMEDA, silane 4.68 was produced in an equally excellent 
yield, whereas alternative bis(amine) ligands 2,2'-bipyridyl and 1,10-phenanthroline were not 
as effective as TMEDA and silane 4.68 was observed in lower yield (entries 3-5). As 
TMEDA is readily available and can be used as purchased, it was decided to perform future 
hydrofunctionalisations with this ligand. 
BIP and TMEDA have significantly different properties and thus the role of the two ligands 
in the reaction may be different. BIP is a redox-active ligand able to accept electron density 
from a metal centre (Scheme 4.12),
73-76
 and this property has led to many applications of BIP 









Scheme 4.12. Redox activity of BIP in iron complexes 
In comparison, TMEDA has found widespread application in the iron-catalysed 
cross-coupling reactions of Grignard reagents with organohalides. In some cases, the 
intended product was not observed unless TMEDA was used as an additive (Scheme 4.13).
264
 





Scheme 4.13. Effect of additive on reaction outcome 
In our case, although no observable side reactions occur, 50% of the starting material was 
recovered in the absence of ligand, suggesting that the lifetime of the catalyst is shorter than 
the time needed for 100% conversion of the starting material. Therefore, whilst TMEDA 
may not be needed to suppress unwanted side reactions, it may help to prolong the life of the 
catalyst. 
All other reagents and reaction conditions were then screened in a bid to further improve the 
operational simplicity of the reaction. 
Firstly, different iron salts were investigated. Even though anhydrous FeCl2 is relatively 
inexpensive, iron hydrate salts are even more so and therefore various iron hydrate salts were 
screened (Table 4.09). Iron(II) chloride tetrahydrate and iron(III) chloride hexahydrate gave 
silane 4.68 in equally excellent yields, even though iron is in a different oxidation state in the 
precatalysts; however, owing to the deliquescent nature of iron(III) chloride hexahydrate, it 
was decided to use iron(II) chloride tetrahydrate as the iron precatalyst in future reactions. 




Entry [Fe] Yield (%)
a 
1 FeCl2 92 
2 FeCl2·4H2O 92 
3 FeCl3·6H2O 89 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.09. Iron salt optimisation 
The catalyst loading was screened and when the catalyst loading was lowered to 0.5 mol%, 
the yield was comparable to that obtained using 1 mol% (Table 4.10, entries 1 and 2). 
Decreasing this in 0.1 mol% increments was tolerated until the loading reached 0.1 mol% 
(entries 3-6), with a substantially reduced yield obtained in this case. This could not be 
improved by increasing the ligand loading fivefold with respect to iron salt (entry 7). In 
order to ensure an efficient hydromagnesiation, it was decided to use 0.5 mol% catalyst 
loading in future reactions. 
 
Entry FeCl2·4H2O (mol%) Ligand (mol%) Yield (%)
a 
1 1 1 92 
2 0.5 0.5 91 
3 0.4 0.4 87 
4 0.3 0.3 89 
5 0.2 0.2 86 
6 0.1 0.1 59 
7 0.1 0.5 62 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.10. Catalyst loading optimisation 
Next, the length of time of the hydromagnesiation step was examined (Table 4.11). After 
thirty minutes only 17% of styrene had undergone hydromagnesiation (assuming all benzylic 
Grignard intermediate is converted to silane), compared to 79% after one hour (Table 4.11, 
entries 1 and 2). Marginal increases in yield were observed when the hydromagnesiation 
step was further extended until the reaction was more or less quantitative after a two hour 
hydromagnesiation (entries 3 and 4). 




Entry Hydromagnesiation time ( h) Yield 4.68 (%)
a 
1 0.5 17 (43% 4.67) 
2 1.0 79 (20% 4.67) 
3 1.5 89 
4 2.0 95 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.11. Hydromagnesiation time optimisation 
It was also hoped to reduce the number of equivalents of ethylmagnesium bromide and 
electrophile required (Table 4.12) (the electrophile must always be in excess with respect to 
ethylmagnesium bromide, owing to a competitive reaction between the two reagents). 
Unfortunately, the amount of ethylmagnesium bromide could not be reduced below 1.5 
equivalents without compromising the yield of the reaction.  
 
Entry EtMgBr (equiv.) SiMe3Cl (equiv.) Yield (%)
a 
1 1.1 1.2 74 
2 1.2 1.3 72 
3 1.3 1.4 83 
4 1.4 1.5 83 
5 1.5 1.6 95 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.12. Equivalents of Grignard reagent and electrophile optimisation 
Other hydride sources, in addition to ethylmagnesium bromide, were also screened in order 
to determine whether this reaction could be extended to other hydrometalations (Table 4.13). 
Also, if the hydrofunctionalisation was ultimately to be rendered enantioselective, this might 
be more feasible with another metal, as the rate of benzylic Grignard reagent racemisation is 
appreciable at room temperature.
266
 No hydrometallation was observed with any alternative 
hydride source; with n-BuLi the starting material was completely consumed and nothing 
could be identified in the crude 
1
H NMR spectra of the reaction mixtures, suggesting 
polymerisation (Table 4.13, entry 3). 






’ Yield 4.68 (%)
a 
1 EtMgBr 95 
2 NaHBEt3 0 (35% 4.67) 
3 n-BuLi 0 
4 Et2Zn 0 (91% 4.67) 
5 L-selectride
®
 0 (96% 4.67) 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.13. Screening with alternative hydride sources 
Alternative solvents that are more industrially favoured compared with THF were also 
investigated (Table 4.14).
267
 TBME (t-butylmethyl ether) and 2-MeTHF were screened, in 
addition to diethyl ether and toluene (Table 4.14, entries 3-6). Unfortunately, no product was 
observed when the reaction was conducted in any solvent other than THF and differing 
amounts of starting material were recovered in each case. It was also found that the reaction 
could be performed in “wet” THF, further enhancing the operational simplicity of the 
reaction (entry 2). 
 
Entry Solvent Yield 4.68 (%)
a 




3 TBME 0 (44% 4.67) 
4 2-MeTHF 0 (48% 4.67) 
5 Et2O 0 (83% 4.67) 
6 toluene 0 (29% 4.67) 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 3-methoxystyrene used as substrate and THF used with no prior purification 
Table 4.14. Solvent optimisation 
With the optimised hydrofunctionalisation conditions in hand (Scheme 4.14), focus turned to 
the electrophile scope and firstly, carbon electrophiles. 




Scheme 4.14. Optimal hydrofunctionalisation conditions 
4.2.3 Carbon Electrophile Scope 
3-Methoxystyrene 4.71 was used as the model substrate, as in contrast to styrene, this could 
be visualised by UV light upon TLC analysis. 3-Methoxystyrene 4.71 was synthesised by a 
Wittig reaction,
268-269
 from m-anisaldehyde 4.70 and methyltriphenylphosphonium bromide 




Scheme 4.15. Synthesis of 3-methoxystyrene 4.71 
Next, a series of carbon electrophiles were screened in the hope of synthesising a range of 
carbon–carbon bonds. After addition of the electrophile, the reaction was left for two hours 
in order to ensure complete reaction of the in situ prepared Grignard reagent. This was 
especially important for those reactions in which the electrophile was added at −78 °C. 
Where possible the electrophile was added to the Grignard intermediate, in order to ensure 
operational simplicity. However, in cases where the electrophile was insoluble in THF, the 
benzylic Grignard intermediate was added to a 1 M suspension of the electrophile in THF via 
cannula. 
4.2.3.1 SN2 Susceptible and Cationic Electrophiles 
First, a series of alkyl halide electrophiles were screened (Table 4.15). The reaction with 
allyl bromide 4.73 was successful giving alkene 4.74 in excellent yield (Table 4.15, entry 1). 
Similarly, the reactions with benzyl bromide 4.75 and benzyl chloride 4.77 were high 
yielding (entries 2 and 3); in both cases the benzylic Grignard intermediate was cooled to 
−78 °C prior to addition of the electrophile in order to suppress competing oxidative 
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homocoupling of the Grignard intermediate. Functionalised benzyl bromide 4.78 gave 4.79 
in a moderate 54% yield owing to significant reductive homocoupling of the electrophile 
(entry 4). Nevertheless the ester functionality remained intact, highlighting the 
chemoselective nature of the addition. 1-Chloro-3-iodopropane 4.80 underwent a 
chemoselective SN2 reaction at iodine and alkane 4.81 was isolated in 62% yield (entry 5). 
 
Entry Temperature Electrophile Product Yield (%)
 





















Table 4.15. Alkyl halide electrophiles 
The electrophile scope was also extended to the ring-opening of aziridines and epoxides 
(Table 4.16). An unprotected aziridine would be susceptible to deprotonation by the 
Grignard reagent and so 2-methylaziridine 4.82 was first protected with a tosyl group to give 




Scheme 4.16. Synthesis of N-tosylaziridine 4.83 
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Racemic N-tosylaziridine 4.83 was regioselectively ring-opened at the least-substituted 
carbon and amine 4.84 was isolated in excellent yield as a 1:1 mixture of diastereomers 
(Table 4.16, entry 1). Epoxides 4.85 and 4.87 also underwent regioselective ring-opening in 
excellent yield with enantioenriched epoxide 4.87 giving alcohol 4.88 as a 1:1 mixture of 
diastereomers (racemic at the benzylic carbon) (entries 2 and 3). 
 



















Table 4.16. Ring opening of epoxides and aziridines 
Tropylium tetrafluoroborate 4.89 was also trapped successfully to give triene 4.90 in 84% 
yield (Scheme 4.17). In this case, the Grignard intermediate was added via cannula to a 1 M 
suspension of 4.89 in THF, owing to the low solubility of the electrophile in THF. 
 
Scheme 4.17. Trapping of tropylium tetrafluoroborate 4.89 
Following the success with SN2 susceptible and cationic electrophiles, attention turned to 




4.2.3.2 Carbonyl Electrophiles 
The reaction of Grignard reagents with carbonyl compounds has been well studied over the 
years and is an established method for the preparation of secondary and tertiary alcohols, 
amongst other functionalised products.
229, 271
 
It was hoped that the benzylic Grignard reagent would react with a range of carbonyl 
electrophiles. The majority of carbonyl electrophiles tested were readily available in the 
laboratory but some were synthesised. 
4.2.3.2.1 Synthesis 
Ketones were targeted using Weinreb amides;
272
 alkyl Weinreb amide 4.92 was prepared 
from N,O-dimethylhydroxylamine hydrochloride and hydrocinnamoyl chloride 4.91 in 83% 
yield,
273
 and phenyl Weinreb amide 4.94 from the same amine salt and benzoyl chloride 4.93 




Scheme 4.18. Synthesis of Weinreb amides 4.92 and 4.94 
Imine electrophiles were explored as a route to amines and aldimine 4.97 was prepared from 




Scheme 4.19. Synthesis of aldimine 4.97 
4.2.3.2.2 Reaction 
A range of carbonyl electrophiles were tested (Table 4.17). The reactions with benzaldehyde 
4.95 and paraformaldehyde 4.98 resulted in complex mixtures of products in the 
1
H NMR 
spectra of the crude reaction mixtures (Table 4.17, entries 1 and 2). However, the absence of 
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product for paraformaldehyde 4.98 could be owing to the lack of formaldehyde monomers 
present in solution. The reaction with benzophenone 4.99 was more successful and tertiary 
alcohol 4.100 was observed in 25% yield (entry 3).  
 
Entry Electrophile Product 
Yield 
(%)











































































 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 benzophenone added at −78 °C 
c
 styrene used as substrate 
Table 4.17. Carbonyl electrophiles 
Pleasingly, the reactions with ethyl chloroformate 4.101 and N,N-dimethylformamide (DMF) 
4.103 were both high yielding and ester 4.102 and aldehyde 4.104 were isolated in 75% and 
64% yield respectively (entries 4 and 5). Significantly, the ester functionality remained 
intact even though an excess of ethylmagnesium bromide was used in the 
hydromagnesiation. Initially, ketones were targeted from acid chlorides and Weinreb amides 




No successful reaction occurred with benzoyl chloride 4.93 and the reactions with Weinreb 
amides 4.92 and 4.94 were poor yielding, with the respective ketones 4.105 and 4.106 
observed in 22% and 24% yield. The poor yield for aryl Weinreb amide 4.94 was somewhat 
surprising, which in contrast to alkyl Weinreb amide 4.92, lacks acidic protons α to the 
carbonyl group. However, phenyl ketone 4.106 could be accessed using benzonitrile 4.107, 
with the imine intermediate hydrolysed on work-up to reveal phenyl ketone 4.106 in 65% 
yield (entry 9). The imine intermediate was also reduced to amine 4.108 with sodium 
borohydride (entry 10); interestingly amine 4.108 was produced as a single diastereomer—a 
racemic mixture of syn diastereomers by comparison with 
1
H NMR spectra of the syn and 
anti diastereomers in the literature.
276-277
 Using the Felkin-Anh model
278-280
 and positioning 
the larger phenyl group perpendicular to the imine (4.110a) gives anti-4.108, which is the 
opposite stereochemical outcome to that observed (Scheme 4.20). Syn-4.108 is predicted 
only if the methyl group is positioned perpendicular to the imine (4.110b) and this 
conformation could be preferred if the methoxy substituent on the aryl ring was chelating to 
a magnesium ion present in solution (4.112). However, chelate 4.112 would be 
eight-membered and thus may be challenging to form. To test this hypothesis the reaction 
was repeated using styrene and syn-4.109 was observed, suggesting that chelation control 
was not responsible for the stereochemical outcome of the reaction (Table 4.17, Entry 11). 
 
Scheme 4.20. Felkin-Anh model for the reduction of imine 4.110 
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In contrast, when aldimine 4.97 was used in the reaction in the hope of accessing the 
corresponding N-tosyl amine, no reaction occurred (Entry 12). The reductive animation 
strategy thus offers an alternative route to amines and since N-tosyl group deprotection 
generally requires harsh conditions
281
 this is perhaps a more versatile strategy. 
At present, the difference in reactivity between carbonyl electrophiles is difficult to explain. 
One possible explanation invokes the HOMO of the benzylic Grignard reagent and the 
LUMO of the carbonyl electrophile.
282
 Grignard reagents are known to be hard nucleophiles 
and thus have a low energy HOMO. A hard nucleophile with a low energy HOMO is 
generally reactive towards hard electrophiles with high energy LUMOs and this reactivity is 
governed by a large Coulombic attraction between the two species. Esters and amides are 
known to have higher energy LUMOs than aldehydes and ketones by virtue of the oxygen 
and nitrogen lone pair conjugation with the carbonyl group. Therefore, esters and amides are 
harder electrophiles than aldehydes and ketones and the reactions with the benzylic Grignard 
reagent are more successful. 
A simpler explanation is that the less reactive carbonyl electrophiles (e.g. esters and amides) 
are more compatible with the harsh reaction conditions whereas the more reactive carbonyl 
electrophiles (e.g. aldehydes and ketones) decompose under the reaction conditions. 
Radical-mediated side reactions, such as pinacol coupling
283
 and the McMurry reaction,
284
 
could account for the low yields observed when using reactive carbonyl electrophiles in the 
presence of metals. 
It is noteworthy that no products arising from the Meerwein-Ponndorf Verley reduction
285-286
 
of the carbonyl electrophiles were observed (Scheme 4.21). 
 
Scheme 4.21. Meerwein-Ponndorf Verley reduction of carbonyls 
4.2.3.3 Formal Cross-Coupling 
Using alkenyl halide electrophiles, the products of formal cross-coupling reactions were 
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obtained (Table 4.18). With vinyl bromide 4.114, alkene 4.115 was isolated in 76% yield 
(Table 4.18, entry 1). The reaction with β-bromostyrene 4.116 gave (E)-styrene derivative 
4.117 in 78% yield with complete stereoretention (entry 2). Interestingly, the same product 
was obtained with α-bromostyrene 4.118 as that with β-bromostyrene 4.116, albeit as a 1:1 
mixture of E/Z isomers (entry 3). 
 




















Table 4.18. Formal cross-coupling with alkenyl halides 
In order to explore whether the cross-coupling was iron-catalysed, the reaction was 
performed in the absence of iron. Another PhD student in the group, James Paliga, prepared 
benzylic Grignard reagent 4.120 independently from (1-chloroethyl)benzene 4.119 and 
magnesium,
266
 which was then reacted with β-bromostyrene 4.116 in the presence of 
TMEDA (Scheme 4.22). Styrene derivative 4.121 was observed in 65% yield by 
1
H NMR 
spectroscopy, comparable to the 78% obtained in the presence of iron. 
 
Scheme 4.22. Reaction of independently prepared Grignard reagent 4.120 with β-bromostyrene 4.116 
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Shirakawa and Hayashi recently reported the metal-free single-electron transfer-induced 
cross-coupling reaction of aryl Grignard reagents with alkenyl halides.
287
 When 
β-bromostyrene 4.116 was used, (E)-stilbene 4.123 was isolated in 92% yield and 
significantly the reaction was stereospecific (Scheme 4.23). A single-electron transfer 
mechanism was proposed based on earlier work on the cross-coupling of aryl Grignard 
reagents with aryl halides.
288
 As the reaction was stereospecific, the mechanism proposed 
does not involve an alkenyl radical, which would be subject to racemisation.
289-290
 Initiation 
through single-electron transfer from phenylmagnesium bromide 4.122 to β-bromostyrene 
4.116 gives anionic radical 4.125. Direct C–C bond formation of 4.125 with 
phenylmagnesium bromide 4.122 gives 4.126, which then transfers an electron to another 




 Scheme 4.23. Metal-free cross coupling by Shirakawa and Hayashi 
The cross-coupling of the benzylic Grignard intermediate with β-bromostyrene 4.116 may 
proceed through a similar single-electron transfer mechanism, especially as the reaction was 
stereospecific, and thus may not necessarily be iron-catalysed. Another mechanistic 
possibility, for all vinyl halide electrophiles, would involve an addition-elimination 
mechanism (Scheme 4.24). 




Scheme 4.24. Addition-elimination mechanism with vinyl halide electrophiles 
Initial addition of benzylic Grignard reagent 4.66 to vinyl bromide 4.114 and 
β-bromostyrene 4.116 would lead to carbanions 4.127 and 4.128, respectively. Benzylic 
carbanion 4.128 is stabilised through conjugation with the phenyl ring whereas carbanion 
4.127 is unstabilised. However, even though carbanion 4.127 is unstabilised, vinyl bromide 
4.114 has been used before in SN2-like reactions.
291
 
This mechanism is consistent with the 13:1 mixture of E/Z alkene 4.117 isomers obtained in 
the reaction with β-bromostyrene 4.116. (Scheme 4.25). Rotation about the central C–C bond 
in anion 4.128a leads to conformers 4.128b and 4.128c in which the p and σ*C–Br orbitals are 
antiperiplanar—the necessary conformation for elimination of bromide. In anion 4.128b the 
R and Ph groups are anti whereas in anion 4.128c the groups are syn; the anti arrangement 
minimises the steric interactions between the groups, making anion 4.128b the favoured 
conformation and thus alkene (E)-4.117 the major stereoisomeric product. 




Scheme 4.25. Stereochemical outcome for reaction with β-bromostyrene 4.116 
With α-bromostyrene 4.118, addition of the Grignard reagent at the β position would lead to 
carbanion 4.129, which is both stabilised mesomerically through conjugation with the phenyl 
ring and inductively by bromine. Two routes to styrene derivative 4.117 could now be 
envisaged. Route A involves the loss of bromide to give carbene 4.130, which subsequently 
undergoes a 1,2-hydride shift, to reform the double bond, whereas route B involves a direct 
1,2-hydride shift with concurrent loss of bromide. 
Cyclopropane 4.131 could result from a C–H insertion reaction into the benzylic most acidic 
proton of carbene intermediate 4.130 but was not observed in 
1
H NMR spectrum of the crude 
reaction mixture (Scheme 4.26). 
 
Scheme 4.26. C–H insertion leading to cyclopropane 4.131 
To further investigate the presence of a carbene intermediate, the reaction with 
α-bromostyrene 4.118 was performed in the presence of an alkene, with the intention of 
trapping the carbene with the alkene to form a cyclopropane. Using 10 equivalents of alkene, 
as the rate of intramolecular rearrangement is likely to be faster than intermolecular trapping, 
an electron-rich alkene (4.132) and an electron-poor alkene (4.133) were explored 
(Scheme 4.27). No cyclopropanes were observed in the 
1
H NMR spectra of the crude 
reaction mixtures using 1-hexene 4.132 or methyl acrylate 4.133 (these alkenes have 
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previously been used to trap carbenes).
292
 However, this does not rule out the possibility of a 
carbene intermediate, as the rate of intramolecular rearrangement could be significantly 
faster than the rate of carbene trapping. 
 
Scheme 4.27. Carbene intermediate exploration 
Different mechanisms for each vinyl halide electrophile may also be operating. Although at 
present the mechanism operating for each vinyl halide electrophile has not been determined, 
the single-electron transfer mechanism discussed seems most plausible.
287
 
4.2.3.4 Aryl Electrophiles 
2-Chloropyridine 4.134 and 1-fluoro-2-nitrobenzene 4.135 were screened as electrophiles 
that could participate in SNAr reactions (Table 4.119). 
 













 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.19. SNAr electrophiles 
No product was observed in the reaction with 2-chloropyridine 4.134 and only a 4% yield by 




H NMR spectroscopy was observed for 1-fluoro-2-nitrobenzene 4.135, suggesting low 
reactivity with these electrophiles. Next, a series of aryl electrophiles were explored in the 
hope of performing iron-catalysed cross-coupling reactions. Methyl 4-chlorobenzoate 1.14 
was selected as the model cross-coupling partner owing to the good reactivity of the 
electrophile in previous iron-catalysed cross-coupling reactions (see section 1.1.1.2).
39
 
Following the preparation of the benzylic Grignard reagent (in 5 mL THF), 0.5 mL (10% by 
volume) of NMP was added to the reaction in order to prevent catalyst decomposition, 
possibly by β-hydride elimination of the Grignard reagent,
293
 to which aryl chloride 1.14 was 
added (Scheme 4.28). No cross-coupling occurred—only 16% ethylbenzene derivative 4.138 
and 10% starting material 4.71 were visible in the 
1
H NMR spectrum (ethylbenzene 
derivative 4.138 resulting from protonation of the benzylic Grignard intermediate). 
 
Scheme 4.28. Unsuccessful cross-coupling reaction with aryl chloride 1.14 
Next, diphenyliodonium triflate 4.139 was investigated (Table 4.20), which had been used in 
the copper-catalysed arylation of a variety of nucleophiles.
294
 Iodonium 4.139 was added as a 
0.2 M solution in THF unless otherwise stated. Directly adding iodonium 4.139 to the 
benzylic Grignard reagent gave arylated product in 10% yield by 
1
H NMR spectroscopy 
(Table 4.20, entry 1). Owing to iodonium 4.139 being only sparingly soluble in THF, 4.139 
was next added in DCE, as good reactivity with this reagent had been previously observed 
by Gaunt and co-workers when using DCE.
295
 With DCE, product 4.140 was observed in 
comparable yield to that obtained using THF and it was noted that iodonium 4.139 was also 
not fully soluble in DCE (entry 2). 




Entry Conditions Yield (%)
a 
1 - 10 
2 Iodonium added as a 0.2 M DCE solution 9 
3 Benzylic Grignard intermediate added to iodonium and FeCl2·4H2O (5 mol%) 4 
4 Benzylic Grignard intermediate added to iodonium and CuCl (5 mol%) 8 
5 Benzylic Grignard intermediate added to iodonium and Cu(OTf)2 (5 mol%) 3 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.20. Attempted cross-coupling with diphenyliodonium triflate 4.139 
Adding the benzylic Grignard reagent to a solution of iodonium 4.139 in the presence of 
either an iron or copper salt was also not beneficial and a lower yield of product was 
observed in each case (entries 3-5). Gaunt and co-workers suggested that Cu(I) undergoes 
oxidative addition with diphenyliodonium 4.139 to give electrophilic Cu(III) species 4.141 
(Scheme 4.29). Attack by a nucleophile gives 4.142, which after reductive elimination, gives 
arylated product 4.143 and regenerates the Cu(I) catalyst. Interestingly in this work, a Cu(II) 




Scheme 4.29. Copper-catalysed arylation of nucleophiles 
A report was later found that stated diphenyliodonium salts react with alkyl Grignard 
reagents to give a complex mixture of products containing iodobenzene as the major 
product,
296
 so it is perhaps not surprising that the intended product was only formed in low 
yield. 
Agrawal and Cook recently reported the iron-catalysed cross-coupling of alkyl Grignard 
reagents 4.146 with aryl sulfamates 4.144 and tosylates 4.145 using FeF3·3H2O and NHC 
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Scheme 4.30. Iron-catalysed cross-coupling of alkyl Grignard reagents with aryl sulfamates and 
tosylates 
It was hoped that these conditions could be applied to the cross-coupling of the in situ 
prepared benzylic Grignard reagent with an aryl sulfamate. Aryl sulfamate 4.149 was first 
synthesised from 4-phenylphenol 4.148 and N,N-dimethylsulfamoyl chloride 
(Scheme 4.31),
297
 which was then subjected to cross-coupling. Only a 10% yield by 
1
H NMR 
spectroscopy was observed and so, after a few unsuccessful attempts at forming carbon–aryl 
bonds, it was decided to focus on other electrophiles. 
  
 
Scheme 4.31. Synthesis of aryl sulfamate 4.149 and cross-coupling 
4.2.3.5 Carbon Disulfide 
Owing to the number of styrene derivatives that underwent hydrocarboxylation,
226
 the 
reaction was performed with the sulfur analogue of carbon dioxide, carbon disulfide 
(Scheme 4.32), but only a 23% yield by 
1
H NMR spectroscopy of dithioic acid 4.151 was 
detected. Carbon disulfide is more reactive than carbon dioxide and thus, like the more 
reactive carbonyl electrophiles investigated, may decompose under the reaction conditions. 




Scheme 4.32. Reaction with carbon disulfide 
4.2.4 Heteroatom Electrophile Scope 
Attention then turned to the heteroatom electrophile scope. Following the successful trapping 
of trimethylsilyl chloride with the benzylic Grignard reagent (Scheme 4.33), a range of 
heteronuclear electrophiles were explored. 
 
Scheme 4.33. Reaction with trimethylsilyl chloride 
4.2.4.1 Formal Hydroboration 
When pinacolborane 4.153 was used in the reaction, boronic ester 4.154 was observed in 
78% by 
1
H NMR spectroscopy (Scheme 4.34). Even though a 78% yield by 
1
H NMR 
spectroscopy was detected, boronic ester 4.154 was only isolated in 45% yield and this was 
attributed to low product stability on silica gel (Wang and co-workers reported a similar 
significantly lower yield of boronic ester 4.154 following purification by column 




Scheme 4.34. Formal hydroboration of styrene 4.71 
The reaction with pinacolborane was thought to occur with hydride acting as the leaving 
group, as previously reported by Singaram and co-workers (Scheme 4.35).
299
 Although “ate” 
complex 4.156 was not observed by 
11
B NMR spectroscopy, a crystal structure of 
                                Chapter 4. Hydromagnesiation for the Hydrofunctionalisation of Alkenes 
-132- 
 
MgBr2·4THF was obtained, which was postulated to originate from the rearrangement of 
HMgBr to MgBr2 and MgH2. MgH2 was subsequently reacted with borane and the adduct 
characterised by 
11
B NMR spectroscopy. 
Scheme 4.35. Hydride as a leaving group in reaction of Grignard reagent 4.155 with pinacol borane 
4.153 
4.2.4.2 Nitrogen and Phosphorus Electrophiles 
A range of nitrogen electrophiles were next examined in the hope of forming a series of 
carbon–nitrogen bonds. N-Chloropiperidine 4.159 was prepared from piperidine 4.158 and 




Scheme 4.36. Synthesis of N-chloropiperidine 4.159 
Morpholine derivative 4.162 was accessed from morpholine 4.160 and benzoyl peroxide 




Scheme 4.37. Synthesis of morpholine derivative 4.162 
With these two potential nitrogen electrophiles in hand, both were tested in the reaction, in 
addition to di-iso-propyl azodicarboxylate (DIAD) 4.165 and nitrosobenzene 4.166 
(Table 4.21). N-Chloropiperidine 4.159 was the only successful nitrogen electrophile and 
gave amine 4.163 in a poor 6% yield by 
1
H NMR spectroscopy (Table 4.21, entry 1). In the 
reaction with morpholine derivative 4.162, the major product in the 
1
H NMR spectrum was 
propiophenone 4.164, originating from the addition of ethylmagnesium bromide to the 
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carbonyl functionality in the electrophile (entry 2). The 
1
H NMR spectra for the reactions 
with DIAD 4.165 and nitrosobenzene 4.166 were complex and no discernible product could 
be identified (entries 3 and 4). 
 





















complex mixture - 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.21. Nitrogen electrophiles 
Attention then turned to phosphorus electrophiles and diphenylphosphinic chloride 4.167 and 














complex mixture - 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.22. Phosphorus electrophiles 
Neither phosphorus electrophile gave any of the intended products and the major product for 
phosphinic chloride 4.167 was Ph2P(O)Et 4.168 in 39% yield by 
1
H NMR spectroscopy, 
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resulting from nucleophilic substitution by ethylmagnesium bromide. 
4.2.4.3 Oxygen and Sulfur Electrophiles 
The reaction of Grignard reagents with oxygen is well known and the preparation of 
Grignard reagents requires the exclusion of oxygen for this very reason.
229
 
After the formation of the benzylic Grignard reagent, the reaction was opened to the 
atmosphere to react with oxygen and form alcohol 4.170 in 83% yield after work-up 
(Scheme 4.38). The reaction of Grignard reagents with oxygen is known to give peroxide 





Scheme 4.38. Exposure of reaction to air and formation of alcohol 4.170 
Three sulfur electrophiles were tested: diphenyl disulfide 4.171, tosyl chloride 4.176 and 
1,4-diazabicyclo[2.2.2]octane bis(sulfur dioxide) (DABSO) adduct 4.178. 
With diphenyl disulfide 4.171, sulfide 4.172 was obtained as a 22:1 mixture of α:β 
regioisomers (Table 4.23, entry 1). As diphenyl disulfide was the only electrophile with 
which an appreciable amount of β regioisomer formed, the addition temperature and method 
(whether the electrophile was added to the benzylic Grignard reagents or vice versa) were 
varied in order to explore the effect of these variables on the regioselectivity of the reaction. 
  
 




Entry Temperature Method Yield (%)
a α:β 
1 rt A 53 22:1 
2 0 °C A 67 12:1 
3 −78 °C A 49 7:1 
4 rt B 66 5:1 
5 0 °C B 56 18:1 
6 −78 °C B 78 11:1 




 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 isolated yield/ratio 
Table 4.23. Screening with diphenyl disulfide 4.171 
There is no apparent trend between electrophile addition temperature and method with the 
yield of sulfide. When diphenyl disulfide 4.171 was added to the benzylic Grignard reagent 
(method A), the reaction became less selective for sulfide α-4.172 as the temperature was 
decreased, whereas there is no trend in the regioselectivity of the reaction with temperature 
when the benzylic Grignard reagent was added to diphenyl disulfide 4.171 (method B). 
At present, it is difficult to rationalise the difference in reaction regioselectivity with 
temperature and method and thus the regioselectivity may be dependent on another variable. 
A possible explanation involves the reaction of residual 3-methoxystyrene 4.71 with 
diphenyl disulfide 4.171 (Scheme 4.39). It is known that alkenes react with thiophenol in a 
radical-based mechanism to give terminal sulfide 4.175.
303
 Following formation of sulfide 
radical 4.173 by a radical initiator, such as AIBN or light, addition of the radical to an alkene 
results in the more stable internal radical intermediate 4.174, which then abstracts a 
hydrogen atom to regenerate sulfide radical 4.173 and give terminal sulfide 4.175. If 
different amounts of 3-methoxystyrene 4.71 remained in each reaction upon addition of 
diphenyl disulfide 4.171, which went on to react together, then different amounts of β-sulfide 
4.172 would be produced. 




Scheme 4.39. Radical hydrothiolation of alkenes 
It is also worth noting that Pivnitsky and co-workers saw a difference in regioselectivity 
when trapping Grignard reagents prepared by titanium-catalysed hydromagnesiation with 
different electrophiles (see Table 4.04).
242
 They proposed that this was due to a difference in 
reaction rates between Grignard reagent isomerisation and electrophile trapping. Perhaps, in 
our case, the rate of the reaction between the benzylic Grignard reagent and diphenyl 
disulfide 4.171 is slow, allowing sufficient time for the Grignard reagent to isomerise. 
In order to investigate the regioselectivity of the reaction further, two experiments were 
performed (Table 4.24). In the first, the electrophile trimethylsilyl chloride was added over 
two hours; it was thought that adding the electrophile slowly might allow sufficient time for 
the benzylic Grignard reagent to isomerise. Additionally, a 1:1 mixture of trimethylsilyl 
chloride and diphenyl disulfide (1.6 equivalents of each) was added to the Grignard 
intermediate to probe the difference in rates of electrophile trapping. 
 
Entry Temperature Electrophile Product
a 
1 rt Me3SiCl over 2 h  
α only 
4.152 





 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.24. Probing the regioselectivity 
No insight into the regioselectivity of the reaction was gained through these reactions; the 
reaction was 100% regioselective for silane 4.152 when trimethylsilyl chloride was added 
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over two hours and a 1:1 mixture of silane 4.152 and α-sulfide 4.172 was obtained when a 
1:1 mixture of the corresponding electrophiles were added (with negligible formation of 
β-sulfide 4.172), suggesting that the rate of trapping of each electrophile is similar. 
Prior to this, trimethylsilyl chloride and diphenyl disulfide were mixed in order to rule out 
any competing reaction between the two electrophiles (Scheme 4.40); no difference in 
chemical shift in the 
1
H NMR spectrum was observed for the trimethyl protons in the 
mixture compared with pure trimethylsilyl chloride, excluding any competing reaction.  
 
Scheme 4.40. Possible side reaction between the two electrophiles 
Two further sulfur electrophiles were explored (Table 4.25). The reaction with tosyl chloride 
4.176 was poor yielding and product 4.177 was observed in only 8% yield by 
1
H NMR 
spectroscopy. Good reactivity was seen with DABSO 4.178 when the benzylic Grignard 
reagent was added to a 1 M solution of DABSO in THF at −40 °C but sulfinic acid 4.179 
proved difficult to isolate, partly due to its extremely high polarity. An acid-base work-up 
removed the majority of impurities and a second purification by column chromatography on 
silica gel (using water/i-PrOH/EtOAc 1:2:7) gave acid 4.179 in a low 17% yield. 
 

















 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 isolated yield 
Table 4.25. Sulfur electrophiles 
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4.2.4.4 Halogen Electrophiles 
The scope of halogen electrophiles was investigated using both the original and second 







































































 FeCl2·4H2O (0.5 mol%), TMEDA (0.5 mol%) or FeCl2 (1 mol%), BIP (1 mol%) 
b
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.26. Halogen electrophiles 
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The optimum results for bromination and iodination were 47% and 54% respectively, 
obtained using elemental bromine and iodine at −78 °C (Table 4.26, entries 1,3,5,7). At 
room temperature, lower yields of product and significant amounts of dimer 4.180 were 
obtained, resulting from oxidative homocoupling of the benzylic Grignard reagent (entries 2 
and 6). Despite moderate yields by 
1
H NMR spectroscopy, purification by column 
chromatography on silica gel proved difficult owing to the apolar nature of the products. It is 
worth noting that in all cases the transformation is a formal Markovnikov addition of H–X 
across an alkene and it is possible to achieve higher yields of these products by reacting 
styrene directly with H–X.
304-305
 
James Paliga investigated the hydrofluorination of styrene 4.67 and following extensive 
studies into the reaction, fluoride 4.186 was isolated in 43% yield (Scheme 4.41).  
 
Scheme 4.41. Hydrofluorination of styrene 4.67 
4.2.5 Styrene Scope 
After investigating the electrophile scope for the reaction, the styrene scope was explored in 
order to demonstrate the generality of the procedure. The previous iron-catalysed 
hydrocarboxylation procedure had been limited to neutral styrene derivatives and those 
bearing electron-donating substituents
226
 and thus it was hoped that the second generation 
hydrofunctionalisation conditions might be applicable to a wider range of olefins. A variety 
of styrene derivatives bearing electron-donating substituents were first subjected to the 
hydromagnesiation conditions and reacted with trimethylsilyl chloride as the model 
electrophile (Table 4.27). 
 
































 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 performed using FeCl2 (1 mol%) and BIP (1 mol%) 
Table 4.27. Investigation of electron-rich styrene derivatives 
3-Methylstyrene 4.189 was converted to silane in high yield using the hydrofunctionalisation 
conditions of FeCl2·4H2O and TMEDA (Table 4.27, entry 1). However, for 2- and 
4-methylstyrene 4.191 and 4.193, these conditions gave the corresponding silanes 4.192 and 
4.194 in significantly lower yields: 17% and 55% yield respectively (entries 2 and 3). 
Repeating both reactions using the original conditions of FeCl2 and BIP pleasingly restored 
reactivity and silanes 4.192 and 4.194 were observed in the 
1
H NMR spectra in 65% and 
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88% yield respectively. It is interesting that for some substrates a higher yield is obtained 
using the original conditions than the second generation catalytic system and presumably, 
BIP is playing a critical role in the reaction (see section 4.2.2). 1,3,5-Trimethylstyrene 4.195 
was unreactive in the reaction and quantitative starting material was recovered, perhaps as a 
result of the steric bulk of the aryl group (entry 4). 
2,4-Dimethylstyrene 4.196 and 2,4-dimethoxystyrene 4.198 gave interesting results 
(entries 5 and 6). Despite ethyl benzene derivatives 4.197 and 4.199 being observed in the 
1
H NMR spectra, suggesting successful hydromagnesiation, the lack of silane products was 
puzzling. The reaction with 2,4-dimethoxystyrene 4.198 was repeated with FeCl2 and BIP 















 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.28. Reaction of 2,4-dimethoxystyrene 4.198 with electrophiles 
In all cases apart from with trimethylsilyl chloride, the corresponding functionalised product 
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was obtained. This difference cannot be attributed to the trimethylsilyl chloride being “wet”, 
as the reagent was used successfully in subsequent reactions; the reaction outcome must 
therefore have an electrophile dependence that cannot be explained at present. 
A range of styrenes bearing electron-withdrawing substituents, 1,1- and 1,2- disubstituted 
styrenes, alkyl alkenes, dienes and alkynes were additionally investigated, substrates that 








































 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
b
 performed using FeCl2 (1 mol%) and BIP (1 mol%) 
Table 4.29. Investigation of challenging olefins 
Electron-poor p-fluorostyrene 4.204 and p-phenylstyrene 4.206 both gave the corresponding 
silanes in poor yield, with the lack of recovered starting material for p-phenylstyrene 4.206 
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attributed to substrate polymerisation under the reaction conditions (Table 4.29, entries 1and 
2). However, for p-fluorostyrene 4.204, the yield of the reaction improved from 19% to 38% 
when the original catalyst system was used. 1,1- and 1,2- disubstituted styrene derivatives 
4.208 and 4.209 and alkyl alkene 4-phenyl-1-butene 4.210 were all unreactive (entries 3-5). 
As alkyl alkene 4.210 was unreactive, it was considered that the Grignard intermediate or the 
transition-state structure for Grignard intermediate formation might require stabilisation via 
conjugation with, or coordination to, another multiple bond, but phenylbutadiene 4.211 did 
not undergo the reaction (entry 6). Finally, alkyne 1-phenyl-1-propyne 3.22 was screened but 
no reaction occurred (entry 7), showing that the second generation hydrofunctionalisation 
procedure offered no improvement in terms of substrate scope over the original conditions 
and was currently limited to styrenes. 
In addition to the substrates discussed above, a few targeted substrates were synthesised, in 
the hope that they would undergo hydrofunctionalisation. Owing to the high yields obtained 
using 3-methoxystyrene 4.71, 3-dimethylaminostyrene 4.214 was targeted and synthesised in 
two steps from aniline derivative 4.212 (Scheme 4.42). Bromoaniline 4.212 first underwent a 
lithium-halogen exchange and the anion was subsequently reacted with DMF to give 
aldehyde 4.213.
306
 Styrene 4.214 was then accessed from aldehyde 4.213 using a Wittig 
reaction. Under the hydrofunctionalisation conditions, styrene 4.214 was smoothly 
transformed to silane 4.215. However, residual styrene made purification of the product by 
column chromatography difficult owing to the similar retention factors of the two 
compounds. To aid isolation of silane 4.215, the mixture was subjected to a dihydroxylation 
reaction, to convert residual styrene 4.214 into the corresponding diol and thus increase its 
polarity. Following the successful dihydroxylation reaction, silane 4.215 was isolated in 81% 
yield. 




Scheme 4.42. Synthesis and hydrosilylation of 3-dimethylaminostyrene 4.214 
Alkene 4.216 was also targeted, as Nakamura and co-workers have shown that it undergoes a 




Scheme 4.43. Chelation-controlled oxidative arylation of alkene 4.216 
We hoped that vinylsilane 4.216 might react similarly under the hydromagnesiation 
conditions and thus it was synthesised from 2-bromopyridine 4.219 in 48% yield 
(Scheme 4.44).
308
 Unfortunately vinylsilane 4.216 did not react and only starting material 
was recovered from the attempted hydrofunctionalisation reaction. 
Scheme 4.44. Synthesis and unsuccessful hydrosilylation of vinylsilane 4.216 
4.2.6 Intramolecular Hydrofunctionalisations 
To demonstrate the utility of the hydrofunctionalisation procedure, a series of more complex 
hydrofunctionalisations were attempted and two strategies were pursued. Firstly, styrene 
derivatives 4.221 were designed that contained internal electrophiles, in the hope that the 
benzylic Grignard intermediates 4.222 would react with the electrophile intramolecularly to 
form benzannulated products 4.223. Secondly, styrene derivatives 4.224 bearing internal 
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nucleophiles were investigated, with the intention of reacting benzylic Grignard 
intermediates 4.225 with a carbonyl electrophile, which could then be attacked 
intramolecularly by the nucleophile to form complementary benzannulated products 4.226 
(Scheme 4.45). 
 
Scheme 4.45. Planned intramolecular hydrofunctionalisations 
Alcohol 4.228 acted as a common intermediate in the following substrate syntheses and was 




Scheme 4.46. Synthesis of alcohol 4.228 
4.2.6.1 Internal Electrophiles 
Ester 4.229 was synthesised from alcohol 4.228 using a simple SN2 reaction (Scheme 4.47). 
 
Scheme 4.47. Synthesis of ester 4.229 
When ester 4.229 was subjected to the hydrofunctionalisation conditions, 37% starting 
material by 
1
H NMR spectroscopy was recovered alongside a complex mixture of products, 
presumably resulting from addition of ethylmagnesium bromide to the ester functionality 
(Scheme 4.48). 




Scheme 4.48. Unsuccessful electrophile trapping with ester 4.229 
Given that a carbonyl functionality was susceptible to nucleophilic attack by a Grignard 
reagent, it was hoped that a halide or halide equivalent would be less susceptible. To this 
end, tosylate 4.230 was synthesised in two steps, by reducing unsuccessful ester 4.229 to the 
alcohol, followed by a tosylate protection (Scheme 4.49). 
 
Scheme 4.49. Synthesis of tosylate 4.230 
Tosylate 4.230 was subjected to the hydrofunctionalisation conditions but although two 
additional spots were present on the TLC plate upon analysis, these were subsequently 
identified as the deprotected alcohols 4.231 and 4.228 (Scheme 4.50). 
 
Scheme 4.50. Unsuccessful substitution with tosylate 4.230 
As benzopyran formation proved unsuccessful, benzofuran formation was attempted next 
using methoxymethyl (MOM)-protected alcohol 4.232. Alcohol 4.228 was protected using 
MOM chloride to obtain ether 4.232 in 42% yield (Scheme 4.51). 
 
Scheme 4.51. Synthesis of MOM-protected alcohol 4.232 
MOM-protected alcohol 4.232 underwent successful hydromagnesiation using FeCl2 and 
BIP (these conditions were used, as superior yields had been achieved with them for 
challenging substrates) and whilst 45% of starting material was recovered, 49% of 
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ethylbenzene derivative 4.233 resulted. The lack of benzofuran product suggested that either 
methoxide was not a suitable leaving group or that cyclisation was unfavourable, although 




Scheme 4.52. Unsuccessful substitution with methyl ether 4.232 
4.2.6.2 Internal Nucleophiles 
For those styrene derivatives containing internal nucleophiles, the nucleophile was protected 
prior to hydromagnesiation to prevent competing deprotonation of the nucleophile (OH, NH) 
by ethylmagnesium bromide. It was hoped that deprotection of the nucleophile upon work-
up or in a subsequent step would facilitate a rapid intramolecular cyclisation. 
Nitrogen-containing styrene 4.236 was designed in which the nitrogen was protected with a 
methyl and Boc group (Scheme 4.53). Performing the hydromagnesiation and trapping the 
benzylic Grignard reagent with ethyl chloroformate would give 4.235, which after removal 
of the Boc group, would hopefully cyclise to form 2-oxindole derivative 4.234. 
 
Scheme 4.53. Retrosynthetic analysis of nitrogen-containing styrene 4.236 
Styrene 4.236 was targeted from 2-bromoaniline 4.238 using a protection and cross-coupling 





Scheme 4.54. Boc and methyl protection of 2-bromoaniline 4.238 
With nitrogen-protected bromide 4.237 in hand, we began to consider the cross-coupling 
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conditions required for the installation of the vinyl group. After conducting a literature 
search, the most relevant conditions found for the transformation were developed by 
Denmark and Butler and used polyvinylsiloxane 4.240 as the vinyl source (Scheme 4.55).
313
 
Scheme 4.55. Cross-coupling conditions 
Although long reaction times were required for the vinylation of bromides bearing electron-
donating substituents, the yields were unaffected. However, for the substrate of interest, 
4.241, the product 4.242 was accompanied by 10% of inseparable reduction product 
dimethylaniline. When substrate 4.237 was subjected to these conditions, although a trace of 
the intended product was visible in the 
1
H NMR of the crude reaction mixture, recovered 
starting material was the major component (Scheme 4.56). 
Scheme 4.56. Attempted cross-coupling 
Opting to explore oxygen nucleophiles rather than focus on alternative cross-coupling 
conditions, styrenes 4.243 and 4.244 were targeted, which were both synthesised from 
alcohol 4.228 and the corresponding silyl chlorides (Scheme 4.57).
314-315
 TMS-protected 
alcohol 4.243 is less sterically hindered than TBS-protected alcohol 4.244 and thus 
hydromagnesiation may be more efficient and higher yielding, but more labile. 
 
Scheme 4.57. Synthesis of silyl-protected alcohols 4.243 and 4.244 
TMS-protected alcohol 4.243 was first subjected to the hydrofunctionalisation conditions 
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using the more reactive original conditions of FeCl2 and BIP, and DMF as the electrophile in 
the hope of forming a lactol (Scheme 4.58). However, silane 4.245 was isolated as the major 
product of the reaction, which presumably arises from a successful hydromagnesiation, 
followed by an intramolecular silyl migration. This unexpected rearrangement was hoped to 
be less likely with TBS-protected alcohol 4.244. 
 
Scheme 4.58. Hydrofunctionalisation of TMS-protected alcohol 4.243 and silyl migration 
To initially assess the extent of hydromagnesiation for TBS-protected alcohol 4.244, 






FeCl2·4H2O (0.5 mol%) 





FeCl2 (1 mol%) 
BIP (1 mol%) 
 
a
 yield determined by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard 
Table 4.30. Attempted hydrofunctionalisation with TBS-protected alcohol 4.244 
Using the simpler conditions of FeCl2·4H2O and TMEDA, no reaction occurred and only 
starting material was recovered. With the original conditions of FeCl2 and BIP, 74% of 
starting material was recovered alongside 12% of a product resulting from 
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hydromagnesiation. Owing to the number of overlapping silyl peaks in the 
1
H NMR 
spectrum of the crude reaction mixture, it was difficult to identify the exact product but since 
the extent of hydromagnesiation was low, this substrate was not pursued. 
As MOM-protected alcohol 4.232 had proven unsuccessful as part of the internal 
electrophile strategy, it was hoped that the alcohol functionality in the same substrate could 
act as an internal nucleophile following methyl ether cleavage. With this in mind, ether 4.232 
was subjected to hydromagnesiation and reaction with ethyl chloroformate (Scheme 4.59). 
34% yield of product 4.250 by 
1
H NMR spectroscopy was observed, alongside 36% 
recovered starting material 4.232. 
 
Scheme 4.59. Successful hydromagnesiation and trapping with ethyl chloroformate 
To test the feasibility of the deprotection and subsequent cyclisation to a lactone the crude 
reaction mixture was subjected to deprotection conditions (Scheme 4.60). No lactone product 
was observed but instead a mixture of products resulting from deprotection (4.252), 
transesterification (4.253) and acid-catalysed addition of methanol across unreacted styrene 
(4.251). Even though hydroxy esters 4.252 and 4.253 were present in the reaction, no 
cyclisation occurred and hence benzannulation was not pursued further. 
 
Scheme 4.60. Methyl ether deprotection of crude reaction mixture 
Despite two complementary cyclisation strategies investigated and a number of different 
substrates synthesised and explored, no successful cyclisation occurred. 
 




In conclusion, a highly operationally simple procedure for the hydrofunctionalisation of 
styrene derivatives was developed that uses simpler reagents and is more robust than the 
original conditions used for the hydrocarboxylation of styrene derivatives.
226
 The new 
procedure uses a bench-stable iron hydrate precatalyst and the ligand, TMEDA, is 
commercially available and can be used as purchased. Even “wet” THF can be used for the 
hydrofunctionalisation—THF straight from a bottle that has been open to the atmosphere. 
The hydrofunctionalisation procedure is also highly efficient, using a catalyst loading of just 
0.5 mol%. 
With this second generation catalyst system a range of carbon–carbon and carbon–
heteroatom bonds, including the products of formal cross-coupling reactions, hydrosilylation 
and hydroboration, were constructed, highlighting the versatility and applicability of this 
system (Scheme 4.61). Using a common benzylic Grignard reagent, all the 
hydrofunctionalisation reactions were highly regioselective for the α-functionalised product 
and the electrophile trapping was demonstrated to be both chemo- and regioselective. 
 
Scheme 4.61. Hydrofunctionalisation of styrene derivatives and selected products
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Chapter 5. General Conclusions and Future Work 
Over the course of this endeavour, three types of reaction were successfully developed and 
the substrate scope of each explored. Palladium catalysis was used for the enantioselective 
fluorination of a series of azaarylacetates and amides and for the C–H functionalisation of a 
range of ferrocene derivatives, with both reactions utilising a different property of palladium. 
The enantioselective fluorination of azaarylacetates and amides focussed on the use of 
palladium as a Lewis acid and its ability to form a chiral complex with a range of 
enantiopure ligands. Whilst the reaction proved highly stereoselective only with 
benzoxazoles, a variety of 2-fluorobenzoxazolyl acetates and amides were prepared in 
excellent ee (Scheme 5.01). Both enantiomeric products were obtained from a single 




Scheme 5.01. Palladium-catalysed enantioselective fluorination of benzoxazolyl acetates and amides 
The successful reaction of benzoxazoles was postulated to be a result of the unique binding 
of these substrates with the palladium catalyst, with them binding through oxygen and not 
through nitrogen as would perhaps be expected (Figure 5.01). Future work in this area would 
be the development of a general catalyst system that is applicable to a range of 
azaarylacetates and amides, which might involve the exploration of organocatalysis and/or 
phase-transfer catalysis. 




Figure 5.01. Possible transition-state structure for fluorination of benzoxazolyl acetates and amides 
Secondly, the C–H functionalisation of ferrocene derivatives was investigated, which relied 
on a series of two-electron redox processes for palladium (Scheme 5.02). Although the 
reaction proved challenging to optimise, the reaction was nevertheless successful and 
allowed the preparation of a novel structural motif (e.g. 3.91 and 3.92). Palladacycle 3.118 
was also synthesised as a potential reaction intermediate but unfortunately no further 
mechanistic insight could be gained through its use. 
 
Scheme 5.02. Oxidative annulation of ferrocenecarboxamide 3.77 and synthesis of palladacycle 3.118 
After the completion of this project, the high yielding oxidative annulation of 
ferrocenearylcarboxamides was reported, which was facilitated through the precise choice of 
reaction conditions.
225
 An obvious future endeavour would be to render this reaction 
enantioselective. 
The focus of this thesis then changed and iron catalysis was explored, as this sustainable and 
environmentally benign metal is rapidly becoming a viable alternative for reactions that have 
                                                        Chapter 5. General Conclusions and Future Work 
-154- 
 
been traditionally catalysed by precious metals. To this end the broad operationally simple 
hydrofunctionalisation of alkenes was developed, based on work previously developed in the 
Thomas group.
226
 This reaction relied on the ability of Grignard reagents to reduce an 
inexpensive bench-stable iron precatalyst to an active low-valent iron catalyst. Using this 
procedure, a range of functionalised products were synthesised including the products of 
formal cross-coupling reactions, hydrosilylation and hydroboration (Scheme 5.03). 
 
Scheme 5.03. Iron-catalysed hydrofunctionalisation of styrenes 
The reaction was limited to styrenes and thus future work would concentrate on the 
extension of this reaction to alkyl alkenes and alkynes. The investigation of alternative 
methods to activate the iron precatalyst would also be beneficial, as the current reaction 
relies on Grignard reagents that are moisture and air sensitive. Research into an 
enantioselective variant of this reaction would also be a worthwhile pursuit.  
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Chapter 6. Experimental 
6.1 Experimental Methods 
CH2Cl2, Et2O, MeCN, MeOH, THF and toluene were dried and purified by passage through 
activated alumina columns using a solvent purification system. All commercially available 
reagents were used as received. Aqueous sulphate buffer was prepared by dissolving Na2SO4 
(1.5 mol) and H2SO4 (0.5 mol) in water and adding water to give a total volume of 2000 cm
3
. 
Thin phase chromatography (TLC) was performed on Merck DF-Alufoilien 60F254 0.2 mm 
precoated plates. Product spots were visualized by UV light at 254 nm, and subsequently 
developed using vanillin or potassium permanganate solution as appropriate. Flash column 
chromatography was carried out using silica gel (Fisher Scientific 60Å particle size 35-70 
micron) employing step gradient elution in the mobile phase stated. Pet. ether refers to 
petroleum ether 40-60. Melting points were recorded on a Gallenkamp melting point 
apparatus and are uncorrected. Infra-red spectra were recorded on Shimadzu IRAffinity-1 
spectrometer (serial no. A213749) as a dilute solution in CDCl3. 
1
H NMR spectra were 
recorded on a Bruker Avance (400 and 600 MHz), a Bruker Avance III (400 and 500 MHz) 
or a Bruker Avance III HD (500 and 600 MHz) spectrometer. Chemical shifts () are quoted 
in parts per million (ppm) downfield of tetramethylsilane, using residual protonated solvent 
as internal standard (CDCl3 at 7.27 ppm, CD3CN at 1.94 ppm, (CD3)2SO at 2.50 ppm, 
(CD3)2CO at 2.05 ppm, CD3OD at 3.31 ppm). Abbreviations used in the description of 
resonances are: br (broad), s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), sext 





spectra were recorded on a Bruker Avance III (100.6 and 125.8 MHz) spectrometer. 
Chemical shifts () are quoted in parts per million (ppm) downfield of tetramethylsilane, 
using deuterated solvent as internal standard (CDCl3 at 77.0 ppm, CD3CN at 1.32 ppm, 
(CD3)2SO at 39.5 ppm, (CD3)2CO at 29.8 ppm, CD3OD at 49.00 ppm). Assignments were 
made using the DEPT (distortionless enhancement by polarisation transfer) sequence with 
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secondary pulses at 90° and 135°. Proton-decoupled 
19
F NMR spectra were recorded on a 
Bruker Avance III (376 MHz) or a Bruker Avance III HD (471 MHz) spectrometer. 
Chemical shifts are reported in parts per million (ppm) downfield of CFCl3, using 
fluorobenzene as internal standard (C6H5F at −113.2 ppm). High resolution mass spectra 
were recorded on a Finnigan MAT 900 XLT or a Finnigan MAT 95XP spectrometer at the 
EPSRC National Mass Spectrometry Service Centre, University of Wales, Swansea, or on a 
Finnigan MAT 900 XLT (EI) or a Bruker Micro TOF focus II (ESI) spectrometer at the 
School of Chemistry, University of Edinburgh. Optical rotations were performed on an 
Optical Activity POLAAR 20 polarimeter with a path length of 1 dm. Concentrations are 






.  Chiral HPLC analysis 
was performed on an Agilent 1100 instrument using 4.6 x 250 mm columns. Authentic 
racemic samples of products for chiral HPLC assay determinations were obtained using 
Ni(ClO4)2- or Ni(OAc)2/2,2'-bipyridyl as the catalyst in EtOH or CH2Cl2. 
 
6.2 Enantioselective Fluorination of Azaarylacetates and Amides 
6.2.1 General Procedures 




To a stirred solution of heterocyclic chloride 2.56 (1 equiv.) and ester 2.57 (1-3 equiv.) in 
toluene (0.2 M) at 0 °C was added NaHMDS (0.6 M in toluene, 2-3 equiv.). The reaction was 
warmed to room temperature and stirred until completion by TLC analysis. The reaction was 
quenched with an equal volume of sat. aq. NH4Cl, the phases separated, and the aqueous 
phase extracted with EtOAc. The combined organics were dried (MgSO4) and the solvent 
removed in vacuo.  The product 2.58 was purified by flash chromatography. 
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To a stirred solution of 2,3-dichloropyrazine (1 equiv.) in toluene (0.2 M) was added 
NaHMDS (0.6 M in toluene, 2.2 equiv.). To the mixture was added ester (1.1 equiv.) 
dropwise and the reaction stirred at room temperature for 16 h. The reaction was quenched 
with an equal volume of sat. aq. NH4Cl, the phases separated, and the aqueous phase 
extracted with EtOAc. The combined organics were dried (MgSO4) and the solvent removed 
in vacuo. The product was purified by flash chromatography. 
 
General Procedure C: Preparation of Thiadiazolylacetates 
 
To a stirred solution of chloride 2.81 (1 equiv.) in THF (0.1 M) under nitrogen was added 
LiHMDS (1.0 M in THF, 2.3 equiv.). To the mixture was added the appropriate alkyl 
propionate (1.1 equiv.) and the reaction heated to 60 °C. The mixture was stirred for 30 min, 
cooled to room temperature, and quenched with an equal volume of 1 N aq. HCl. The phases 
were separated, the aqueous phase extracted with Et2O and the combined organics dried 
(MgSO4). The solvent was removed in vacuo and the product purified by column 
chromatography. 
 
General Procedure D: Enantioselective Fluorination of Azaarylacetates 
 
To a stirred solution of azaarylacetate or amide (1 equiv.) in EtOH (acyclic esters and 
amides) or CH2Cl2 (cyclic esters and amides) (0.2 M) at room temperature, 0 °C or −20 °C 







 2.08a (5 mol%). The mixture was stirred for 10 
min and NFSI (1.1 equiv.) added. The reaction was stirred for 15 h and quenched with an 
equal volume of sat. aq. KI.  The phases were separated and the aqueous phase extracted 
with EtOAc. The combined organics were washed with sat. aq. Na2S2O3, dried (MgSO4), and 
the solvent removed in vacuo. The product was purified by flash chromatography. 
 
6.2.2 Data 
Ethyl 2-(1,3-benzoxazol-2-yl)propanoate 2.59 
General procedure A was applied to 2-chlorobenzoxazole (740 L, 
6.51 mmol), ethyl propionate (2.24 mL, 19.5 mmol) and NaHMDS 
(0.6 M in toluene, 32.5 mL, 19.5 mmol). The reaction was stirred for 2 h and purified by 
flash chromatography (n-hexane/EtOAc 19:1→2:1) to give azaarylacetate 2.59 (910 mg, 
64%) as a yellow oil. Rf 0.38 (n-hexane/EtOAc 9:1); IR (film, cm
-1
) 2988, 2926, 2854, 1743 
(C=O), 1614, 1572, 1456, 1266, 1243; 
1
H NMR (500 MHz, CDCl3)  7.74-7.71 (1H, m, 
ArH), 7.53-7.51 (1H, m, ArH), 7.35-7.33 (2H, m, ArH), 4.38 (1H, dq, J = 11.0, 7.0 Hz, 
CHaCHbCH3), 4.33 (1H, dq, J = 11.0, 7.0 Hz, CHaCHbCH3), 4.13 (1H, q, J = 7.5 Hz, 
CHCH3), 1.74 (3H, d, J = 7.5 Hz, CHCH3), 1.26 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR 
(125.8 MHz, CDCl3)  170.3 (C), 164.0 (C), 150.9 (C), 141.0 (C), 125.0 (CH), 124.3 (CH), 
120.1 (CH), 110.6 (CH), 61.8 (CH2), 40.6 (CH), 15.0 (CH3), 14.0 (CH3); HRMS (ES) Exact 
mass calcd for C12H14NO3 [M+H]
+
: 220.0968, found: 220.0968. 
 
tert-Butyl 2-(1,3-benzoxazol-2-yl)propanoate 2.60 
General procedure A was applied to 2-chlorobenzoxazole (70 L, 
0.65 mmol), tert-butyl propionate (0.19 mL, 2.0 mmol) and NaHMDS 
(0.6 M in toluene, 3.25 mL, 1.95 mmol). The reaction was stirred for 2 h and purified by 
flash chromatography (n-hexane/Et2O 19:1→9:1) to give azaarylacetate 2.60 (120 mg, 73%) 
as a colourless solid. Rf 0.37 (n-hexane/EtOAc 9:1); m.p. 32 °C; IR (film, cm
-1
) 2983, 2942, 
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1738 (C=O), 1615, 1573, 1456, 1370, 1243, 1152; 
1
H NMR (500 MHz, CDCl3)  7.71-7.67 
(1H, m, ArH), 7.50-7.46 (1H, m, ArH), 7.30-7.26 (2H, m, ArH), 4.02 (1H, q, J = 7.5 Hz, 
CHCH3), 1.67 (3H, d, J = 7.5 Hz, CHCH3), 1.41 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, 
CDCl3)  169.3 (C), 164.4 (C), 150.7 (C), 140.9 (C), 124.7 (CH), 124.1 (CH), 119.8 (CH), 
110.3 (CH), 82.0 (C), 41.4 (CH), 28.7 (3 x CH3), 14.8 (CH3); HRMS (ES) Exact mass calcd 
for C14H18NO3 [M+H]
+
: 248.1281, found: 245.1285. 
 
Ethyl 2-(1,3-benzoxazol-2-yl)-2-phenylacetate 2.61 
General procedure A was applied to 2-chlorobenzoxazole (70 L, 
0.65 mmol), ethyl phenylacetate (0.19 mL, 2.0 mmol) and NaHMDS 
(0.6 M in toluene, 3.25 mL, 1.95 mmol). The reaction was stirred for 2 h and purified by 
flash chromatography (pet. ether/Et2O 4:1→3:1) to give azaarylacetate 2.61 (175 mg, 91%) 
as a colourless oil. Rf 0.56 (pet. ether/EtOAc 4:1); IR (film, cm
-1
) 1738 (C=O), 1612, 1566, 
1497, 1454, 1368, 1300, 1269, 1240, 1193; 
1
H NMR (500 MHz, CDCl3)  7.78-7.74 (1H, m, 
ArH), 7.59-7.55 (2H, m, ArH), 7.54-7.49 (1H, m, ArH), 7.45-7.35 (3H, m, ArH), 7.35-7.31 
(2H, m, ArH), 5.37 (1H, s, CHPh), 4.35-4.23 (2H, m, CH2CH3), 1.27 (3H, t, J = 7.0 Hz, 
CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  168.4 (C), 162.2 (C), 151.0 (C), 140.9 (C), 
133.4 (C), 129.0 (2 x CH), 128.8 (2 x CH), 128.3 (CH), 125.1 (CH), 124.3 (CH), 
120.2 (CH), 110.6 (CH), 62.1 (CH), 52.2 (CH2), 13.9 (CH3); HRMS (ES) Exact mass calcd 
for C17H16NO3 [M+H]
+





General procedure A was applied to 2-chlorobenzoxazole (740 L, 
6.5 mmol), γ-butyrolactone (500 µL, 6.51 mmol) and NaHMDS (0.6 M in 
toluene, 13.0 mL, 7.81 mmol). The reaction was stirred for 6 h and purified by flash 
chromatography (pet. ether/EtOAc 4:1→2:1). The residue was co-evaporated using xylenes 
(5 x 5mL) to remove remaining γ-butyrolactone to give azaarylacetate 2.62 (524 mg, 40%) 
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(400 MHz, CDCl3)  7.75-7.70 (1H, m, ArH), 7.59-7.52 (1H, m, ArH), 7.40-7.33 (2H, m, 
ArH), 4.67 (1H, ddd, J = 9.0, 8.5, 4.5 Hz, CO2CHaHbCH2CH), 4.48 (1H, ddd, J = 9.0, 8.0, 
7.5 Hz, CO2CHaHbCH2CH), 4.23 (1H, t, J = 9.0 Hz, CO2CH2CH2CH), 2.99 (1H, dq, 
J = 13.0, 8.5 Hz, CO2CH2CHaHbCH), 2.80 (1H, dddd, J = 13.0, 9.0, 7.0, 4.5 Hz, 
CO2CH2CHaHbCH); 
13
C NMR (125.8 MHz, CDCl3)  172.4 (C), 160.7 (C), 151.1 (C), 
140.8 (C), 125.5 (CH), 124.7 (CH), 120.1 (CH), 110.8 (CH), 67.3 (CH2) 40.6 (CH2), 27.8 








To 2-chlorobenzimidiazole (1.50 g, 9.83 mmol) in N,N-dimethylformamide (15 mL) at 0 °C 
under nitrogen was added sodium hydride (60% in mineral oil, 708 mg, 17.7 mmol) 
portionwise. The reaction was stirred for 15 min and methyl iodide (0.64 mL, 10.3 mmol) 
added. The reaction was stirred for a further 15 min and quenched by pouring the mixture 
onto water (100 mL). The resultant white solid was collected by filtration and dried in vacuo 
to give benzodiazole 6.01 (1.35 g, 82%) as a white solid. Rf 0.60 (pet. ether/EtOAc 2:1); 




H NMR (500 MHz, CDCl3)  7.75-7.71 (1H, m, ArH), 
7.36-7.29 (3H, m, ArH), 3.81 (3H, s, NCH3); 
13
C NMR (125.8 MHz, CDCl3)  141.6 (C), 





tert-Butyl 2-(1-methyl-1H-1,3-benzodiazol-2-yl)propanoate 2.63 
General procedure A was applied to 6.01 (500 mg, 3.00 mmol), 
tert-butyl propionate (1.35 mL, 9.00 mmol) and NaHMDS (0.6 M in 
toluene, 15.0 mL, 9.00 mmol). The reaction was stirred for 16 h and purified by flash 
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chromatography (pet. ether/EtOAc 9:1→2:1) to give azaarylacetate 2.63 as a colourless 
solid (52%, 62% brsm). Rf 0.58 (pet. ether/EtOAc 1:1); m.p. 122 °C; IR (film, cm
-1
) 2978, 
2938, 1732 (C=O), 1504, 1470, 1395, 1369, 1277, 1236, 1153;  
1
H NMR (500 MHz, CDCl3) 
 7.79 (1H, d, J = 7.5 Hz, ArH), 7.35-7.24 (3H, m, ArH), 4.04 (1H, q, J = 7.0 Hz, CHCH3), 
3.78 (3H, s, NCH3), 1.76 (3H, d, J = 7.0 Hz, CHCH3), 1.43 (9H, s, C(CH3)3); 
13
C NMR 
(125.8 MHz, CDCl3)  170.4 (C), 152.7 (C), 142.1 (C), 135.9 (C), 122.5 (CH), 122.0 (CH), 
119.7 (CH), 109.1 (CH), 82.0 (C), 39.9 (CH), 30.0 (CH3), 27.9 (3 x CH3), 15.3 (CH3); 
HRMS (ES) Exact mass calcd for C15H21N2O2 [M+H]
+
: 261.1598, found: 261.1595. 
 
tert-Butyl 2-(quinolin-2-yl)propanoate 2.64 
General procedure A was applied to 2-chloroquinoline (500 mg, 
3.06 mmol), tert-butyl propionate (1.38 mL, 9.17 mmol) and 
NaHMDS (0.6 M in toluene, 15.3 mL, 9.17 mmol). The reaction was stirred for 6 h and 
purified by flash chromatography (pet. ether/Et2O 19:1→7:1) to give azaarylacetate 2.64 
(192 mg, 24%) as a yellow oil. Rf 0.51 (pet. ether/EtOAc 9:1); IR (film, cm
-1
) 2978, 2936, 
1728 (C=O), 1618, 1601, 1458, 1427, 1393, 1368, 1331; 
1
H NMR (500 MHz, CDCl3) 
 8.11-8.05 (2H, m, ArH), 7.76 (1H, d, J = 8.0 Hz, ArH), 7.69-7.64 (1H, m, ArH), 7.49-7.46 
(1H, m, ArH), 7.41 (1H, d, J = 8.5 Hz, ArH), 4.04 (1H, q, J = 7.0 Hz, CHCH3), 1.59 (3H, d, 
J = 7.5 Hz, CHCH3), 1.40 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  172.7 (C), 
160.6 (C), 147.6 (C), 136.4 (CH), 129.3 (CH), 129.1 (CH), 127.3(CH), 126.9 (C), 
126.0 (CH), 119.7 (CH), 80.7 (C), 49.6 (CH), 27.8 (3 x CH3), 17.3 (CH3); HRMS (ES) Exact 
mass calcd for C16H20NO2 [M+H]
+
: 258.1489, found: 258.1488. 
 
tert-Butyl 2-(isoquinolin-1-yl)propanoate 2.65 
General procedure A was applied to 1-chloroisoquinoline (500 mg, 
3.06 mmol), tert-butyl propionate (1.38 mL, 9.17 mmol) and NaHMDS 
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(0.6 M in toluene, 15.3 mL, 9.17 mmol). The reaction was stirred for 2 h and purified by 
flash chromatography (n-hexane/EtOAc 19:1→4:1) to give azaarylacetate 2.65 (637 mg, 
81%) as an orange solid. Rf 0.58 (n-hexane/EtOAc 4:1), m.p. 34 °C; IR (film, cm
-1
) 3055, 
2979, 2934, 1731 (C=O), 1625, 1587, 1562, 1503, 1368, 1319, 1158; 
1
H NMR (500 MHz, 
CDCl3)  8.50 (1H, d, J = 5.5 Hz, ArH), 8.18 (1H, d, J = 8.5 Hz, ArH), 7.84 (1H, d, J = 8.0 
Hz, ArH), 7.70-7.66 (1H, m, ArH), 7.65-7.59 (1H, m, ArH), 7.56 (1H, d, J = 5.6 Hz, ArH), 
4.61 (1H, q, J = 7.0 Hz, CHCH3), 1.68 (3H, d, J = 7.0 Hz, CHCH3), 1.36 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  172.9 (C), 160.0 (C), 142.0 (CH), 136.5 (C), 129.7 (CH), 
127.5 (CH), 127.1 (CH), 126.6 (C), 124.8 (CH), 119.8 (CH), 80.8 (C), 45.4 (CH), 27.9 (3 x 
CH3), 16.4 (CH3); HRMS (ES) Exact mass calcd for C16H20NO2 [M+H]
+





General procedure A was applied to 2-chloroquinoxaline (100 mg, 
0.608 mmol), tert-butyl propionate (270 L, 1.82 mmol) and 
NaHMDS (0.6 M in toluene, 3.03 mL, 1.82 mmol). The reaction was stirred for 2 h and 
purified by flash chromatography (n-hexane/Et2O 19:1→4:1) to give azaarylacetate 2.66 
(106 mg, 67%) as a yellow oil. Rf 0.34 (n-hexane/EtOAc 9:1); 
1
H NMR (500 MHz, CDCl3) 
 8.87 (1H, s, ArH), 8.12-8.07 (2H, m, ArH), 7.79-7.73 (2H, m, ArH), 4.09 (1H, q, J = 7.5 
Hz, CHCH3), 1.67 (3H, d, J = 7.5 Hz, CHCH3), 1.43 (9H, s, C(CH3)3); 
13
C NMR 
(125.8 MHz, CDCl3)  171.8 (C), 155.4 (C), 145.2 (CH), 142.0 (C), 141.4 (C), 130.0 (CH), 













General procedure B was applied to 2,3-dichloropyrazine (500 mg, 
3.36 mmol), NaHMDS (0.6 M in toluene, 12.3 mL, 7.39 mmol) and 
tert-butyl propionate (560 µL, 3.69 mmol). The product was purified by flash 
chromatography (pet. ether/EtOAc 19:1→9:1) to give azaarylacetate 2.67 (548 mg, 67%) as 
a yellow oil. Rf 0.35 (pet. ether/EtOAc 9:1); 
1
H NMR (500 MHz, CDCl3)  8.48 (1H, d, J = 
2.5 Hz, ArH), 8.27 (1H, d, J = 2.5 Hz, ArH), 4.23 (1H, q, J = 7.0 Hz, CHCH3), 1.57 (3H, d, 
J = 7.0 Hz, CHCH3), 1.41 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  171.2 (C), 
154.7 (C), 148.9 (C), 142.0 (CH), 142.0 (CH), 81.6 (C), 45.4 (CH), 27.9 (3 x CH3), 15.1 








To a solution of DCC (1.67 g, 8.07 mmol) in CH2Cl2 (40 mL) at 0 °C was added DMAP 
(658 mg, 5.87 mmol) and phenylacetic acid (1.00 g, 7.34 mmol). To the suspension was 
added t-BuOH (2.10 mL, 22.0 mmol) and the reaction warmed to room temperature. The 
reaction was stirred for 16 h and concentrated in vacuo. The residue was washed with Et2O 
and filtered through celite.  The filtrate was washed with 1 N NaOH (40 mL), 1 N HCl 
(40 mL), dried (MgSO4) and the solvent removed in vacuo. The residue was purified by flash 
chromatography (pet. ether/EtOAc 19:1→9:1) to give ester 6.02 (861 mg, 61%) as a pale 
pink oil. Rf 0.69 (pet. ether/Et2O 9:1); 
1
H NMR (500 MHz, CDCl3)  7.40-7.32 (2H, m, 
ArH), 7.32-7.26 (3H, m, ArH), 3.56 (2H, s, CH2Ph), 1.47 (9H, s, CO2C(CH3)3); 
13
C NMR 
(125.8 MHz, CDCl3)  170.9 (C), 134.7 (C), 129.2 (2 x CH), 128.4 (2 x CH), 126.8 (CH), 











General procedure B was applied to 2,3-dichloropyrazine (476 mg, 
3.19 mmol), NaHMDS (0.6 M in toluene, 11.7 mL, 7.02 mmol) and 
tert-butyl 2-phenyl acetate 6.02 (675 mg, 3.51 mmol). The product was purified by flash 
chromatography (pet. ether/Et2O 19:1→4:1) to give azaarylacetate 2.68 (612 mg, 63%) as a 
viscous yellow oil. Rf 0.20 (pet. ether/EtOAc 9:1); 
1
H NMR (500 MHz, CDCl3)  8.49 (1H, 
d, J = 2.5 Hz, ArH), 8.28 (1H, d, J = 2.5 Hz, ArH), 7.40-7.29 (5H, m, ArH), 5.46 (1H, s, 
CHPh), 1.44 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  169.0 (C), 153.4 (C), 
149.1 (C), 142.1 (CH), 142.0 (CH), 135.0 (C), 129.7 (2 x CH), 128.4 (2 x CH), 127.8 (CH), 








To a stirred solution of diisopropylamine (1.27 mL, 9.09 mmol) in THF (3 mL) at −78 °C 
was added n-BuLi (1.6 M in hexanes, 5.68 mL, 9.09 mmol) dropwise and the mixture stirred 
for 15 min. To the mixture was added pyridyl ester 2.69 (460 L, 3.03 mmol), the mixture 
stirred for 15 min, and iodomethane (940 L, 15.2 mmol) added. The reaction was stirred for 
15 min, warmed to room temperature and stirred for 3 h. The mixture was diluted with water 
(10 mL), the phases separated, and the aqueous phase extracted with EtOAc (3 x 10 mL). 
The combined organics were dried (MgSO4) and the solvent removed in vacuo. The product 
was purified by flash chromatography (n-hexane/EtOAc 9:1→4:1) to give azaarylacetate 
2.70 as a yellow oil (370 mg, 68%). Rf 0.36 (n-hexane/EtOAc 3:1); 
1
H NMR (400 MHz, 
CDCl3)  8.55 (1H, d, J = 5.0 Hz, ArH), 7.65 (1H, dt, J = 7.5, 1.5 Hz), 7.30-7.26 (1H, m, 
ArH), 7.19-7.14 (1H, m, ArH), 4.22-4.10 (2H, m, CH2CH3), 3.93 (1H, q, J = 7.0 Hz, 
CHCH3), 1.55 (3H, d, J = 7.0 Hz, CHCH3), 1.20 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR 
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(100 MHz, CDCl3)  173.6 (C), 160.0 (C), 149.3 (CH), 136.7 (CH), 122.0 (CH), 121.9 (CH), 








To a stirred solution of diisopropylamine (1.74 mL, 12.4 mmol) in THF (30 mL) at −78 °C 
was added n-BuLi (1.6 M in hexanes, 7.76 mL, 12.4 mmol) dropwise and the mixture stirred 
for 30 min. To the mixture was added 2-benzylpyridine 2.70 (0.95 mL, 5.9 mmol), the 
mixture stirred for 30 min, and ethyl chloroformate (0.62 mL, 6.5 mmol) added. The reaction 
was stirred for 15 min, warmed to room temperature and stirred for 1.5 h. The mixture was 
diluted with water (30 mL) and the THF removed in vacuo. EtOAc (30 mL) was added, the 
phases separated, and the aqueous phase extracted with EtOAc (3 x 30 mL). The combined 
organics were dried (MgSO4) and the solvent removed in vacuo. The product was purified by 
flash chromatography (pet. ether/EtOAc 99:1→3:1) to give azaarylacetate 2.72 as a yellow 
oil (1.09 g, 76%). Rf 0.39 (pet. ether/EtOAc 2:1); 
1
H NMR (500 MHz, CDCl3)  8.60-5.57 
(1H, m, ArH), 7.64-7.59 (1H, m, ArH), 7.43-7.39 (2H, m, ArH), 7.38-7.33 (2H, m, ArH), 
7.32-7.27 (1H, m, ArH), 7.27-7.24 (1H, m, ArH), 7.19-7.15 (1H, m, ArH), 5.24 (1H, s, 
CHPh), 4.27-4.22 (2H, m, CH2CH3), 1.26 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR (125 MHz, 
CDCl3)  171.7 (C), 158.7 (C), 149.2 (CH), 137.3 (C), 136.6 (CH), 128.9 (2 x CH), 128.7 (2 














To a stirred solution of benzisoxazole acid 2.73 (300 mg, 1.69 mmol) in Et2O (10 mL) and 
MeOH (2 mL) at 0 °C was added (trimethylsilyl)diazomethane (2.0 M in Et2O, 0.93 mL, 
1.86 mmol). The reaction was warmed to room temperature, stirred for 1 h and the solvent 
was removed in vacuo. The product was purified by flash chromatography (n-hexane/EtOAc 
19:1→9:1) to give azaarylacetate 2.74 (212 mg, 66%) as a pale yellow oil. Rf 0.43 
(n-hexane/EtOAc 3:1); 
1
H NMR (400 MHz, CDCl3)  7.72 (1H, dt, J = 8.0, 1.0 Hz, ArH), 
7.62-7.55 (2H, m, ArH), 7.34 (1H, ddd, J = 8.0, 6.0, 2.0 Hz, ArH), 4.07 (2H, s, CH2), 3.76 
(3H, s, CH3); 
13
C NMR (100 MHz, CDCl3)  168.7 (C), 163.4 (C), 152.4 (C), 130.0 (CH), 









To a stirred solution of diisopropylamine (0.47 mL, 3.33 mmol) in THF (5 mL) at −78 °C 
was added n-BuLi (1.6 M in hexanes, 2.08 mL, 3.33 mmol) dropwise and the mixture stirred 
for 15 min. To the mixture was added benzisoxazole ester 2.74 (206 mg, 1.11 mmol), the 
mixture stirred for 15 min and iodomethane (0.35 mL, 5.54 mmol) added. The reaction was 
stirred for 15 min, warmed to room temperature and stirred for 3 h. The mixture was diluted 
with water (10 mL), the phases separated, and the aqueous phase extracted with EtOAc 
(3 x 10 mL). The combined organics were dried (MgSO4) and the solvent removed in vacuo. 
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The product was purified by flash chromatography (n-hexane/EtOAc 19:1→4:1) to give 
azaarylacetate 2.75 as a pale yellow oil (81 mg, 36%). Rf 0.86 (n-hexane/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3)  7.73 (1H, d, J = 8.0 Hz, ArH), 7.52-7.59 (2H, m, ArH), 7.31 
(1H, ddd, J = 8.0, 6.5, 1.0 Hz, ArH), 4.29 (1H, q, J = 7.5 Hz, CHCH3), 3.71 (3H, s, OCH3), 
1.73 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  172.0 (C), 163.4 (C), 
157.0 (C), 129.9 (CH), 123.5 (CH), 121.8 (CH), 120.2 (C), 110.0 (CH), 52.5 (CH3), 








To o-phenylenediamine 2.76 (1.00 g, 9.25 mmol) in EtOH (15 mL) at 80 °C under nitrogen 
was added diethyl oxalpropionate 2.77 (1.74 mL, 9.25 mmol) and the reaction was heated at 
reflux for 16 h. Water (5 mL) was added to the hot solution until it became cloudy. The 
mixture was allowed to cool to room temperature and then to 0 °C. The resultant solid was 
collected by filtration and washed with a cold EtOH/water 2:1 solution (100 mL). The 
product was purified by flash chromatography (CHCl3/EtOAc 9:1) to give azaarylacetate 





H NMR (500 MHz, CDCl3)  12.17 (1H, s, NH), 7.88 (1H, dd, J = 8.0, 1.0 Hz, 
ArH), 7.55-7.51 (1H, m, ArH), 7.39-7.34 (1H, m, ArH), 7.32 (1H, dd, J = 8.0, 1.0 Hz, ArH), 
4.27 (1H, q, J = 7.0 Hz, CHCH3), 4.25-4.17 (2H, m, CH2CH3), 1.66 (3H, d, J = 7.0 Hz, 
CHCH3), 1.24 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  172.6 (C), 
158.9 (C), 155.8 (C), 132.6 (C), 131.1 (C), 130.3 (CH), 129.3 (CH), 124.3 (CH), 115.6 (CH), 












To stirred morpholine 2.80 (2.26 mL, 25.8 mmol) at 105-110 °C was added 
3,4-dichloro-1,2,5-thiadiazole 2.79 (610 µL, 6.45 mmol) dropwise over 30 minutes. The 
reaction was stirred for 2 h, cooled to room temperature and diluted with water (25 mL). The 
mixture was made acidic with conc. HCl (25 mL) and the product precipitated out of 
solution. The product was isolated by filtration and washed with water to give thiadiazole 





H NMR (500 MHz, CDCl3)  3.87-3.83 (4H, m, O(CH2CH2)2N), 
3.50-3.46 (4H, m, O(CH2CH2)2N); 
13
C NMR (125.8 MHz, CDCl3)  158.9 (C), 135.2 (C), 




Ethyl 2-[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]propanoate 2.82 
General procedure C was applied to 2.81 (100 mg, 0.49 mmol), LiHMDS (1.0 M in THF, 
1.1 mL, 1.1 mmol) and ethyl propionate (60 µL, 0.54 mmol). The product was purified by 
flash chromatography (pet. ether/EtOAc 9:1→1:1) to give azaarylacetate 2.82 (ester: yellow 
oil, 66 mg and enol: yellow oil, 37 mg, 78% combined yield). 
Ester: Rf 0.37 (pet. ether/EtOAc 4:1); IR (film, cm
-1
) 2965, 2855, 1734 
(C=O), 1495, 1449, 1431, 1369, 1302, 1246, 1198; 
1
H NMR (500 MHz, 
CDCl3)  4.21-4.11 (2H, m, CH2CH3), 3.94 (1H, q, J = 7.0 Hz, CHCH3), 
3.85-3.77 (4H, m, O(CH2CH2)2N), 3.28-3.17 (4H, m, O(CH2CH2)2N), 1.62 (3H, d, J = 
7.0 Hz, CHCH3), 1.20 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  
171.9 (C), 162.8 (C), 153.5 (C), 66.5 (2 x CH2), 61.3 (CH2), 50.7 (2 x CH2), 41.0 (CH), 
16.6 (CH3), 14.0 (CH3); HRMS (ES) Exact mass calcd for C11H18N3O3S [M+H]
+
: 272.1063, 




 Enol: Rf 0.20 (pet. ether/EtOAc 4:1); IR (film, cm
-1
) 3410 (OH), 2963, 
2855, 1738, 1491, 1449, 1427, 1373, 1258, 1204; 
1
H NMR (500 MHz, 
CDCl3)  4.40 (1H, s, OH), 4.31 (1H, qd, J = 10.5, 7.0 Hz, CHaCHbCH3), 
4.21 (1H, dq, J = 10.5, 7.0 Hz, CHaCHbCH3), 3.82 (2H, ddd, J = 11.5, 6.5, 3.0 Hz, 
O(CH2CH2)N), 3.75 (2H, ddd, J = 11.5, 6.5, 3.0 Hz, O(CH2CH2)N), 3.42-3.36 (2H, m 
O(CH2CH2)N), 3.08-3.02 (2H, m, O(CH2CH2)N), 1.93 (3H, s, C=CCH3), 1.23 (3H, t, J = 
7.0 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  174.4 (C), 162.2 (C), 155.0 (C), 73.2 
(C), 66.6 (2 x CH2), 62.5 (CH2), 51.8 (2 x CH2), 25.5 (CH3), 14.0 (CH3); HRMS (ES) Exact 
mass calcd for C11H18N3O3S [M+H]
+
: 272.1063, found: 272.1067. 
 
tert-Butyl 2-[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]propanoate 2.83 
General procedure C was applied to 2.36 (1.00 g, 4.86 mmol), LiHMDS (1.0 M in THF, 
11.2 mL, 11.2 mmol) and tert-butyl propionate (0.80 mL, 5.4 mmol). The product was 
purified by flash chromatography (pet. ether/EtOAc 9:1→3:1) to give azaarylacetate 2.83 
(ester: yellow solid, 1.20 g and enol: yellow solid, 49 mg, 86% combined yield). 
Ester: Rf 0.82 (pet. ether/EtOAc 4:1); m.p. 56-58 °C; IR (film, cm
-1
) 
2976, 2855, 1730 (C=O), 1495, 1450, 1431, 1368, 1267, 1250, 1146; 
1
H 
NMR (500 MHz, CDCl3)  3.89-3.80 (5H, m, CHCH3, O(CH2CH2)2N), 
3.33-3.27 (2H, m, O(CH2CH2)N), 3.26-3.20 (2H, m, O(CH2CH2)N), 1.61 (3H, d, J = 7.0 Hz, 
CHCH3), 1.42 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  171.2 (C), 162.8 (C), 
153.9 (C), 81.6 (C), 66.5 (2 x CH2), 50.7 (2 x CH2), 42.0 (CH), 27.9 (3 x CH3), 16.6 (CH3); 
HRMS (ES) Exact mass calcd for C13H22N3O3S [M+H]
+
: 300.1376, found: 300.1380. 
 Enol: Rf 0.71 (pet. ether/EtOAc 4:1); m.p. 76-78 °C; IR (film, cm
-1
) 
3435 (OH), 2978, 2859, 1732, 1491, 1450, 1425, 1258, 1206, 1138; 
1
H 
NMR (500 MHz, CDCl3)  4.39 (1H, s, OH), 3.83-3.73 (4H, m, 
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O(CH2CH2)2N), 3.46-3.40 (2H, m, O(CH2CH2)N), 3.14-3.07 (2H, m, O(CH2CH2)N), 1.87 
(3H, s, C=CCH3), 1.41 (9H, s, C(CH3)3);
 13
C NMR (125.8 MHz, CDCl3)  173.3 (C), 
163.2 (C), 155.0 (C), 83.2 (C), 73.5 (C), 66.4 (2 x CH2), 51.7 (2 x CH2), 27.8 (3 x CH3), 









To a stirred solution of 2-pyridylacetonitrile 2.87 (0.94 mL, 8.46 mmol) and 
2-chlorobenzoxazole 2.85 (1.06 mL, 9.31 mmol) in THF (40 mL) at 0 °C under nitrogen was 
added NaHMDS (1.0 M in THF, 21.2 mL, 21.2 mmol). The reaction was warmed to room 
temperature and stirred for 2 h. The reaction was quenched with sat. aq. NH4Cl (40 mL), the 
phases separated, and the aqueous phase extracted with EtOAc (3 x 40 mL). The combined 
organics were dried (MgSO4) and the solvent removed in vacuo. The product was purified by 
flash chromatography (CH2Cl2) to give pyridyl benzoxazole 2.88 as a bright yellow solid 
(1.93 g, 97%). Rf (CH2Cl2) 0.60; m.p. 154 °C; IR (film, cm
-1
) 2191 (C≡N), 1635, 1599, 1552, 
1508, 1450, 1410, 1371, 1321, 1250; 
1
H NMR (500 MHz, CDCl3)  15.52 (1H, s, NH), 7.79 
(1H, d, J = 6.5 Hz, ArH), 7.60-7.56 (1H, m, ArH), 7.52-7.45 (3H, m, ArH), 7.30-7.25 (1H, 
m, ArH), 7.23-7.19 (1H, m, ArH), 6.67 (1H, dt, J = 6.5, 1.0 Hz, ArH); 
13
C NMR 
(125.8 MHz, CDCl3)  164.1 (C), 152.4 (C), 148.5 (C), 140.9 (C), 138.4 (CH), 134.1 (CH), 
124.2 (CH), 123.0 (CH), 120.8 (CH), 118.6 (C), 116.5 (CH), 111.9 (CH), 110.1 (CH), 
59.5 (C); HRMS (ES) Exact mass calcd for C14H10N3O [M+H]
+








Ethyl 2-(1,3-benzoxazol-2-yl)-2-fluoropropanoate 2.89 





(5 mg, 5 mol%) and NFSI (34 mg, 
0.11 mmol) at –20°C. The product was purified as described above (pet. ether/EtOAc 
19:1→9:1) to give 2-fluoroazaarylacetate 2.89 (10 mg, 42%) as a colourless oil. Rf 0.50 
(n-hexane/EtOAc 9:1); []
25
D +20.2 (c 0.52, CHCl3); IR (film, cm
-1
) 2925, 2853, 1771 (C=O), 




H NMR (500 MHz, CDCl3)  7.83-7.80 (1H, m, ArH), 
7.61-7.58 (1H, m, ArH), 7.46-7.38 (2H, m, ArH), 4.41-4.30 (2H, m, CH2CH3), 2.18 (3H, d, 
J = 22.0 Hz, CFCH3), 1.32 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  
167.4 (C, d, J = 27.5 Hz), 160.6 (C, d, J = 25.0 Hz), 150.9 (C), 140.3 (C), 126.4 (CH), 
125.0 (CH), 121.0 (CH), 111.2 (CH), 89.8 (C, d, J = 187.5 Hz), 62.9 (CH2), 21.9 (CH3, d, J = 
23.0 Hz), 14.0 (CH3); 
19
F NMR (376 MHz, CDCl3)  −150.2; HRMS (ES) Exact mass calcd 
for C12H13FNO3 [M+H]
+
: 238.0874, found: 238.0880; Enantiomeric excess was determined 
by HPLC with a Chiralpak AD-H column (99.5:0.5 hexane:i-PrOH, 0.8 mL/min, 254 nm, 
25 °C); tr (major) = 15.2 min; tr (minor) = 16.4 min; 93% ee. 
 
Ethyl 2-fluoro-2-(pyridin-2-yl)propanoate 6.03 





(3 mg, 5 mol%) and NFSI (17 mg, 
55 µmol) at room temperature. The product was purified as described above (pet. ether/Et2O 
9:1→3:1) to give 2-fluoroazaarylacetate 6.03 (22% conv.) as a colourless oil. Rf 0.26 (pet. 
ether/Et2O 3:1); IR (film, cm
-1
) 2991, 2962, 2925, 2854, 1751 (C=O), 1590, 1472, 1435, 
1267, 1135, 1100, 1022; 
1
H NMR (500 MHz, CDCl3)  8.64-8.60 (1H, m, ArH), 7.78 (1H, 
dt, J = 8.0, 2.0 Hz, ArH), 7.64-7.61 (1H, m, ArH), 7.30 (1H, ddd, J = 7.5, 5.0, 1.0 Hz, ArH), 
4.31-4.21 (2H, m, CH2CH3), 2.00 (3H, d, J = 22.5 Hz, CFCH3, 1.26 (3H, t, J = 7.0 Hz, 
CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  169.7 (d, J = 26.0 Hz, C), 157.8 (d, J = 26.5 Hz, 
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C), 148.9 (CH), 137.1 (CH), 123.5 (CH), 119.7 (d, J = 7.5 Hz, CH), 95.7 (d, J = 184.0 Hz, 
C), 62.1 (CH2), 23.1 (d, J = 23.0 Hz, CH3), 14.0 (CH3); 
19
F NMR (376 MHz, CDCl3)  
−152.3; HRMS (ES) Exact mass calcd for C10H13FNO2 [M+H]
+
: 198.0925, found: 198.0927; 
Enantiomeric excess was determined by HPLC with a Chiralpak AS-H column (97:3 









(5 mg, 5 mol%) and NFSI (34 mg, 
1.1 mmol) at room temperature. The product was purified as described above (pet. 
ether/EtOAc 9:1→4:1) to give 2-fluoroazaarylacetate 2.96 (14 mg, 63%) as a cream solid. 
Rf 0.29 (pet. ether/EtOAc 4:1);     
   +7.9 (c 0.70, CHCl3); m.p. 100 °C; IR (film, cm
-1
) 
2926, 1796 (C=O), 1614, 1566, 1477, 1452, 1379, 1352, 1304, 1238; 
1
H NMR (500 MHz, 
CDCl3)  7.81-7.78 (1H, m, ArH), 7.67-7.64 (1H, m, ArH), 7.49-7.41 (2H, m, ArH), 
4.69-4.57 (2H, m, CO2CH2CH2CF), 3.45 (1H, dddd, J = 14.0, 13.0, 7.0, 4.0 Hz, 
CO2CH2CHaHbCF), 2.99 (1H, ddt, J = 22.0, 14.0, 8.0 Hz, CO2CH2CHaHbCF); 
13
C NMR 
(125.8 MHz, CDCl3)  168.2 (d, J = 26.0 Hz, C), 157.5 (d, J = 28.0 Hz, C), 151.4 (C), 
140.1 (C), 126.8 (CH), 125.3 (CH), 120.9 (CH), 111.5 (CH), 89.5 (d, J = 195.0 Hz, C), 
65.2 (d, J = 4.5 Hz, CH2), 33.8 (d, J = 20.5 Hz, CH2); 
19
F NMR (376 MHz, CDCl3)  −161.6; 
HRMS (ES) Exact mass calcd for C11H9FNO3 [M+H]
+
: 222.0561, found: 222.0568; 
Enantiomeric excess was determined by HPLC with a Chiralpak IA-3 column (99:1 
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tert-Butyl 2-fluoro-2-(quinolin-2-yl)propanoate 6.04 





(3 mg, 5 mol%) and NFSI (17 mg, 
1.1 mmol) at room temperature. The product was purified as described above (pet. 
ether/Et2O 19:1) to give 2-fluoroazaarylacetate 6.04 (89% conv.) as a colourless oil. Rf 0.64 
(pet. ether/EtOAc 9:1); IR (film, cm
-1
) 2982, 2932, 1746 (C=O), 1620, 1299, 1504, 1450, 
1369, 1290, 1258; 
1
H NMR (500 MHz, CDCl3)  8.22 (1H, d, J = 8.5 Hz, ArH), 8.12 (1H, d, 
J = 8.5 Hz, ArH), 7.84 (1H, d, J = 8.0 Hz, ArH), 7.73 (1H, ddd, J = 8.5, 7.0, 1.5 Hz, ArH), 
7.69 (1H, dd, J = 8.5, 1.0 Hz, ArH), 7.60-7.55 (1H, m, ArH), 2.06 (3H, d, J = 22.5 Hz, 
CFCH3), 1.46 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  168.9 (d, J = 25.5 Hz, C), 
158.1 (d, J = 26.5 Hz, C), 147.1 (C), 136.9 (CH), 129.8 (CH), 129.6 (CH), 127.6 (C), 
127.5 (CH), 126.9 (CH), 117.4 (d, J = 6.0 Hz, CH), 96.3 (d, J = 183.5 Hz, C), 82.8 (C), 27.8 
(3 x CH3), 22.7 (d, J = 23.5 Hz, CH3); 
19
F NMR (376 MHz, CDCl3)  −149.9; HRMS (ES) 
Exact mass calcd for C16H19FNO2 [M+H]
+
: 276.1394, found: 276.1393; Enantiomeric excess 
was determined by HPLC with a Chiralpak IC-3 column (99:1 hexane:i-PrOH, 0.8 mL/min, 
230 nm, 25 °C); tr = 16.4 min; tr = 24.3 min; 0% ee. 
 
tert-Butyl 2-fluoro-2-(quinoxalin-2-yl)propanoate 6.05 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at room temperature. The product was purified as described above 
(n-hexane/EtOAc 19:1→9:1) to give 2-fluoroazaarylacetate 6.05 (45% conv.) as a 
colourless oil. Rf 0.26 (n-hexane/EtOAc 9:1); IR (film, cm
-1
) 2978, 2931, 2868, 1753 (C=O), 
1374, 1178, 1127, 1081; 
1
H NMR (500 MHz, CDCl3)  9.12 (1H, s, ArH), 8.18-8.10 (2H, m, 
ArH), 7.85-7.78 (2H, m, ArH), 2.09 (3H, d, J = 22.5 Hz, CFCH3), 1.46 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  168.0 (d, J = 25.5 Hz, C), 152.6 (d, J = 26.5 Hz, C), 142.4 
(d, J = 7.0 Hz, CH), 142.1 (C), 141.1 (C), 130.5 (CH), 130.4 (CH), 129.7 (CH), 129.2 (CH), 
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95.5 (d, J = 186.5 Hz, C), 83.5 (C), 27.8 (3 x CH3), 22.3 (d, J = 23.0 Hz, CH3); 
19
F NMR 
(376 MHz, CDCl3)  −151.7; HRMS (ES) Exact mass calcd for C15H18FN2O2 [M+H]
+
: 
277.1347, found: 277.1346; Enantiomeric excess was determined by HPLC with a Chiralpak 
AD-H column (98:2 hexane:i-PrOH, 0.8 mL/min, 230 nm, 25 °C); tr = 8.9 min; tr = 9.7 min; 
0% ee. 
 
tert-Butyl 2-(1,3-benzoxazol-2-yl)-2-fluoropropanoate 5.01 





(5 mg, 5 mol%) and NFSI (34 mg, 
0.11 mmol) at −20 °C. The product was purified as described above (pet. ether/Et2O 




+15.1 (c 0.96 , CHCl3); m.p. 100 °C; IR (film, cm
-1
) 2958, 
2925, 2854, 1765 (C=O), 1454, 1373, 1265, 1136, 1114, 1096; 
1
H NMR (500 MHz, CDCl3) 
 7.84-7.80 (1H, m, ArH), 7.62-7.58 (1H, m, ArH), 7.46-7.38 (2H, m, ArH), 2.15 (3H, d, J = 
21.5 Hz, CFCH3), 1.51 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  166.3 (d, J = 
27.0 Hz, C), 161.1 (d, J = 25.0 Hz, C), 150.9 (C), 140.3 (C), 126.2 (CH), 124.8 (CH), 120.9 
(CH), 111.1 (CH), 89.7 (d, J = 187.0, C), 84.3 (C), 27.8 (3 x CH3), 21.7 (d, J = 23.0 Hz, 
CH3); 
19
F NMR (376 MHz, CDCl3)  –149.3; HRMS (ES) Exact mass calcd for C14H17FNO3 
[M+H]
+
: 266.1187, found: 266.1185; Enantiomeric excess was determined by HPLC with a 
Chiralpak AD-H column (99.5:0.5 hexane:i-PrOH, 0.8 mL/min, 254 nm, 25 °C); tr (major) = 
9.6 min, tr (minor) = 10.4 min; 90% ee. 
 
Ethyl 2-(1,3-benzoxazol-2-yl)-2-fluoro-2-phenylacetate 5.02 





(5 mg, 5 mol%) and NFSI (34 mg, 
0.11 mmol) at −20 °C.  The product was purified as described above (pet. ether/Et2O 
19:1→4:1) to give 2-fluoroazaarylacetate 5.02 (24 mg, 80%) as a colourless oil. Rf 0.69 
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(pet. ether/EtOAc 4:1); []
25
D + 7.5 (c 1.20, CHCl3); IR (film, cm
-1
) 1765 (C=O), 1612, 1566, 
1497, 1452, 1369, 1346, 1240, 1175, 1092; 
1
H NMR (500 MHz, CDCl3)  7.84-7.81 (1H, m, 
ArH), 7.71-7.67 (2H, m, ArH), 7.60-7.57 (1H, m, ArH), 7.51-7.46 (3H, m, ArH), 7.45-7.37 
(2H, m, ArH), 4.44-4.37 (2H, m, CH2CH3), 1.32 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR 
(125.8 MHz, CDCl3)  166.1 (d, J = 27.5 Hz, C), 160.4 (d, J = 25.0 Hz, C), 151.0 (C), 
140.3 (C), 133.8 (d, J = 22.5 Hz, C), 129.8 (CH), 128.5 (2 x CH), 126.4 (CH), 125.9 (d, J = 
8.0 Hz, 2 x CH), 124.9 (CH), 121.3 (CH), 111.2 (CH), 92.1 (d, J = 192.0 Hz, C), 63.3 (CH2), 
13.9 (CH3); 
19
F NMR (376 MHz, CDCl3)  −152.2; HRMS (ES) Exact mass calcd for 
C17H15FNO3 [M+H]
+
: 300.1031, found: 300.1030; Enantiomeric excess was determined by 
HPLC with a Chiralpak IA-3 column (99:1 hexane:i-PrOH, 1.2 mL/min, 254 nm, 25 °C); tr 
(major) = 11.1 min, tr (minor) = 16.7 min; 75% ee. 
 
tert-Butyl 2-fluoro-2-(1-methyl-1H-1,3-benzodiazol-2-yl)propanoate 6.06 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at 50 °C. The product was purified as described above (pet. ether/acetone 19:1) to 
give 2-fluoroazaarylacetate 6.06 (19% conv.) as a white solid. Rf 0.38 (pet. ether/acetone 
19:1); m.p. 92 °C; IR (film, cm
-1
) 2980, 2934, 2857, 1753 (C=O), 1472, 1395, 1371, 1333, 
1285, 1250; 
1
H NMR (500 MHz, CDCl3)  7.84 (1H, d, J = 8.0 Hz, ArH), 7.40-7.29 (3H, m, 
ArH), 3.85 (3H, d, J = 1.5 Hz, NCH3), 2.22 (3H, d, J = 22.5 Hz, CFCH3), 1.45 (9H, s, 
C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  168.0 (d, J = 28.5 Hz, C), 149.4 (d, J = 24.5 Hz, 
C), 141.5 (C), 136.5 (C), 123.7 (CH), 122.5 (CH), 120.5 (CH), 109.5 (CH), 92.2 (d, J = 
181.5 Hz, C), 84.0 (C), 30.8 (d, J = 6.0 Hz, CH3), 27.8 (3 x CH3), 22.8 (d, J = 22.5 Hz, 
CH3);
19
F NMR (376 MHz, CDCl3)  −149.1; HRMS (ES) Exact mass calcd for C15H20FN2O2 
[M+H]
+
: 279.1503, found: 279.1503; Enantiomeric excess was determined by HPLC with a 
Chiralpak IA-3 column (99:1 hexane:i-PrOH, 1.0 mL/min, 254 nm, 25 °C); tr (minor) = 
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11.8 min, tr (major) = 14.7 min; 10% ee. 
 
Ethyl 2-fluoro-2-phenyl-2-(pyridin-2-yl)acetate 6.07 





(3 mg, 5 mol%) and NFSI (17 mg, 
55 µmol) at room temperature. The product was purified as described above (pet. 
ether/EtOAc 9:1) to give 2-fluoroazaarylacetate 6.07 (43% conv.) as a colourless oil. Rf 0.68 
(pet. ether/EtOAc 2:1); IR (film, cm
-1
) 3063, 2990, 1753 (C=O), 1589, 1493, 1468, 1449, 
1435, 1300, 1256; 
1
H NMR (500 MHz, CDCl3)  8.67 (1H, d, J = 4.5 Hz, ArH), 7.73 (1H, 
dt, J = 8.0, 1.5 Hz, ArH), 7.59-7.53 (2H, m, ArH), 7.43-7.36 (4H, m, ArH), 7.33-7.29 (1H, 
m, ArH), 4.36 (2H, q, J = 7.0 Hz, CO2CH2CH3), 1.30 (3H, t, J  7.0 Hz, CO2CH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  168.8 (d, J = 26.5 Hz, C), 157.9 (d, J = 24.0 Hz, C), 
149.1 (CH), 137.1 (d, J = 23.0 Hz, C), 136.9 (CH), 128.8 (CH), 128.1 (2 x CH), 126.6 (d, J = 
8.0 Hz, 2 x CH), 123.7 (CH), 121.9 (d, J = 5.0 Hz, CH), 97.7 (d, J = 189.0 Hz, C), 
62.4 (CH2), 14.0 (CH3); 
19
F NMR (400 MHz, CDCl3)  −147.6; m/e (ES+): calc. for 
C15H15FNO2 [M+H]
+
 260.1081, found 260.1080; Enantiomeric excess was determined by 
HPLC with a Chiralpak IA-3 column (99:1 hexane:i-PrOH, 1.0 mL/min, 254 nm, 25 °C); tr 
(major) = 10.1 min, tr (minor) = 13.6 min; 6% ee. 
 
2-(1,3-Benzoxazol-2-yl)-2-fluoro-2-(pyridin-2-yl)acetonitrile 6.08 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at −20 °C. The product was purified as described above (toluene/acetone 9:1) to 
give fluorinated heterocycle 6.08 (90% conv.) as a white solid. Rf (toluene/acetone 9:1) 0.72;  
m.p. 102 °C; IR (film, cm
-1
) 1614, 1589, 1566, 1468, 1450, 1437, 1350, 1287, 1236, 1175; 
1
H NMR (500 MHz, CDCl3)  8.71-8.68 (1H, m, ArH), 7.96 (1H, dt, J = 8.0, 1.5 Hz, ArH), 
7.87 (2H, dt, J = 8.0, 1.0 Hz, ArH), 7.62-7.58 (1H, m, ArH), 7.50-7.41 (3H, m, ArH); 




C NMR (125.8 MHz, CDCl3)  157.0 (d, J = 26.5 Hz, C), 151.5 (C), 151.3 (C), 150.1 (d, 
J = 2.0 Hz, CH), 140.2 (C), 138.0 (CH), 127.2 (CH), 125.6 (CH), 125.6 (CH), 121.7 (CH), 
120.5 (d, J = 5.0 Hz, CH), 113.6 (d, J = 32.5 Hz, C), 111.5 (CH), 86.2 (d, J = 190.0 Hz, C); 
19
F NMR (376 MHz, CDCl3)  −145.0; HRMS (ES) Exact mass calcd for C14H9FN3O 
[M+H]
+
: 254.0724, found: 254.0722; Enantiomeric excess was determined by HPLC with a 
Chiralpak IA-3 column (99:1 hexane:i-PrOH, 1.2 mL/min, 254 nm, 25 °C); tr (minor) = 
14.4 min, tr (major) = 15.0 min; 12% ee. 
 
2-(1,3-Benzoxazol-2-yl)-2-fluoro-N,N-dimethylacetamide 5.03 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at –20°C. The product was purified as described above (pet. ether/EtOAc 1:1) to 
give 2-fluoroazaarylamide 5.03 (56% conv.) as a yellow oil. Rf
 
0.21 (n-hexane/EtOAc 1:1); 
IR (film, cm
-1
) 2926, 2855, 1680 (C=O), 1612, 1568, 1452, 1404, 1350, 1240, 1063; 
1
H NMR (500 MHz, CDCl3)  7.81-7.79 (1H, m, ArH), 7.62-7.60 (1H, m, ArH), 7.46-7.39 
(2H, m, ArH), 6.34 (1H, d, J = 47.3 Hz, CHF), 3.15 (3H, d, J = 1.8 Hz, NCH3), 3.08 (3H, d, 
J = 0.6 Hz, NCH3); 
13
C NMR (125.8 MHz, CDCl3)  163.6 (d, J = 21.8 Hz, C), 158.0 (d, J = 
23.2 Hz, C) , 151.0 (C), 140.4 (C), 126.4 (CH), 125.0 (CH), 120.9 (CH), 111.3 (CH), 83.9 
(d, J = 188.2 Hz, CH), 36.7 (d, J = 5.3 Hz, CH3), 36.4 (CH3); 
19
F NMR (376 MHz, CDCl3)  
−184.0; HRMS (ES) Exact mass calcd for C11H12FN2O2 [M+H]
+
: 223.0877, found: 
223.0878; Enantiomeric excess was determined by HPLC with a Chiralpak AD-H column 
(90:10 hexane:i-PrOH, 0.8 mL/min, 254 nm, 25 °C); tr (minor) = 17.5 min; tr (major) = 








General procedure A was applied to 2-chlorobenzoxazole (0.74 mL, 
6.5 mmol), N-Methyl-2-pyrrolidone (0.63 mL, 6.5 mmol) and 
NaHMDS (0.6 M in toluene, 21.7 mL, 13.0 mmol). The reaction was stirred for 2 h and 
purified by flash chromatography (CH2Cl2→CH2Cl2/MeOH 99:1) to give azaarylamide 2.97 
(738 mg, 52%) as a brown solid. Rf 0.19 (CH2Cl2/MeOH 98:2); m.p. 76 °C; IR (film, cm
-1
) 
3059, 2951, 2882, 2245, 1694 (C=O), 1612, 1566, 1499, 1454, 1433; 
1
H NMR (500 MHz, 
CDCl3)  7.71-7.66 (1H, m, ArH), 7.53-7.48 (1H, m, ArH), 7.33-7.27 (2H, m, ArH), 4.06 
(1H, dd, J = 9.0, 8.0 Hz, CON(CH3)CH2CH2CH), 3.65-3.60 (1H, m, 
CON(CH3)CHaHbCH2CH), 3.51-3.45 (1H, m, CON(CH3)CHaHbCH2CH), 2.93 (3H, s, 
CON(CH3)CH2CH2CH), 2.71-2.62 (1H, m, CON(CH3)CH2CHaHbCH), 2.60-2.50 (1H, m, 
CON(CH3)CH2CHaHbCH); 
13
C NMR (125.8 MHz, CDCl3)  169.9 (C), 163.7 (C), 
151.0 (C), 140.9 (C), 124.9 (CH), 124.3 (CH), 119.8 (CH), 110.7 (CH), 47.6 (CH2), 









General procedure A was applied to 2-chlorobenzoxazole (0.74 mL, 
6.5 mmol), -valerolactone (0.60 mL, 6.5 mmol) and NaHMDS (0.6 M in 
toluene, 21.7 mL, 13.0 mmol). The reaction was stirred for 1 h and purified by flash 
chromatography (pet. ether/EtOAc 3:1→1:2) and recrystallised (EtOAc/n-hexane) to give 
azaarylacetate 2.98 (351 mg, 25%) as a white powder. Rf 0.42 (pet. ether/EtOAc 1:1); m.p. 
90 °C; 
1
H NMR (400 MHz, CD3CN)  7.71-7.69 (1H, m, ArH), 7.62-7.58 (1H, m, ArH), 
7.42-7.35 (2H, m, ArH), 4.51-4.42 (2H, m, CO2CH2CH2CH2CH), 4.32 (1H, dd, J = 9.5, 8.5 
Hz, CO2CH2CH2CH2CH), 2.47-2.39 (2H, m, CO2CH2CH2CH2CH), 2.12-1.99 (2H, m 
CO2CH2CH2CH2CH); 
13
C NMR (125.8 MHz, CD3CN)  169.8 (C), 164.4 (C), 151.8 (C), 
141.9 (C), 126.3 (CH), 125.5 (CH), 120.7 (CH), 111.6 (CH), 70.4 (CH), 42.3 (CH2), 
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General procedure A was applied to 2-chlorobenzothiazole (80 µL, 
0.59 mmol), γ-butyrolactone (50 µL, 0.59 mmol) and NaHMDS (0.6 M in 
toluene, 1.97 mL, 1.18 mmol). The reaction was stirred for 3 h and purified by flash 
chromatography (pet. ether/Et2O 3:1→1:1) to give azaarylacetate 2.99 (47 mg, 36%) as a 
yellow solid. Rf 0.21 (pet. ether/EtOAc 1:1); m.p. 124 °C (decomp.); IR (film, cm
-1
) 3063, 
2913, 1767 (C=O), 1593, 1510, 1456, 1435, 1375, 1314, 1219; 
1
H NMR (500 MHz, CDCl3) 
 8.02 (1H, d, J = 8.0 Hz, ArH), 7.90-7.87 (1H, m, ArH), 7.51-7.47 (1H, m, ArH), 7.42-7.38 
(1H, m, ArH), 4.65-4.60 (1H, m, CO2CHaHbCH2CH), 4.49-4.43 (1H, m, 
CO2CHaHbCH2CH), 4.28 (1H, t, J = 9.0 Hz, CO2CH2CH2CH), 3.00 (1H, dq, J = 13.0, 9.0 
Hz, CO2CH2CHaHbCH), 2.87 (1H, dddd, J = 13.0, 9.0, 7.0, 4.5 Hz, CO2CH2CHaHbCH);
 
13
C NMR (125.8 MHz, CDCl3)  174.2 (C), 164.6 (C), 152.5 (C), 135.4 (C), 126.2 (CH), 
125.4 (CH), 123.0 (CH), 121.6 (CH), 67.4 (CH2), 44.6 (CH), 29.0 (CH2); HRMS (ES) Exact 




220.0427, found: 220.0424. 
 
3-(1,3-Benzoxazol-2-yl)-3-fluoro-1-methylpyrrolidin-2-one 6.09 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at −20 °C. The product was purified as described above (CHCl3/EtOAc 19:1→9:1) 
to give 2-fluoroazaarylamide 6.09 (14% conv.) as a brown solid. Rf 0.24 (CHCl3/EtOAc 
9:1); m.p. 80 °C; IR (film, cm
-1
) 2889, 2247, 1717 (C=O), 1612, 1564, 1499, 1476, 1452, 
1406, 1350; 
1
H NMR (500 MHz, CDCl3)  7.78-7.75 (1H, m, ArH), 7.64-7.61 (1H, m, 
ArH), 7.44-7.36 (2H, m, ArH), 3.67-3.58 (2H, m, CON(CH3)CH2CH2CF), 3.26 (1H, ddt, J = 
14.5, 7.5, 4.0 Hz, CON(CH3)CH2CHaHbCF), 3.00 (3H, d, J = 1.0 Hz, NCH3), 2.71 (1H, 
dddd, J = 22.5, 14.5, 8.5, 6.5 Hz, CON(CH3)CH2CHaHbCF); 
13
C NMR (125.8 MHz, CDCl3) 
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 166.2 (d, J = 25.0 Hz, C), 160.0 (d, J = 29.0 Hz, C), 151.4 (C), 140.3 (C), 126.1 (CH), 
124.9 (CH), 120.6 (CH), 111.5 (CH), 92.3 (d, J = 189.5 Hz, C), 45.2 (d, J = 3.0 Hz, CH2), 
30.8 (d, J = 21.0 Hz, CH2), 30.6 (CH3); 
19
F NMR (376 MHz, CDCl3)  −157.9; HRMS (ES) 
Exact mass calcd for C12H11FN2O2Na [M+Na]
+
: 257.0697, found: 257.0690; Enantiomeric 
excess was determined by HPLC with a Chiralpak IA-3 column (85:15 hexane:EtOH, 
1.0 mL/min, 230 nm, 25 °C); tr (major) = 13.0 min, tr (minor) = 17.1 min; 66% ee. 
 
3-(1,3-Benzoxazol-2-yl)-3-fluorooxan-2-one 6.10 





(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol). The product was purified as described above (pet. ether/Et2O 2:1→1:2) to give 
2-fluoroazaarylacetate 6.10 (48% conv.) as a colourless oil. Rf 0.35 (pet. ether/Et2O 1:2); 
IR (film, cm
-1
) 2986, 1763 (C=O), 1736, 1616, 1576, 1551, 1477, 1454, 1406, 1369;
 
1
H NMR (500 MHz, CDCl3)  7.83-7.79 (1H, m, ArH), 7.65-7.61 (1H, m, ArH), 7.49-7.39 
(2H, m, ArH), 4.54 (1H, ddd, J  = 12.0, 6.5, 5.5 Hz, CO2CHaHbCH2CH2CF), 4.45 (1H, J = 
12.0, 6.5, 5.5 Hz, CO2CHaHbCH2CH2CF), 3.19 (1H, ddd, J = 21.0, 7.5, 7.0 Hz, 
CO2CH2CH2CHaHbCF), 2.65-2.52 (1H, m, CO2CH2CH2CHaHbCF), 2.29-2.13 (2H, m, 
CO2CH2CH2CH2CF); 
13
C NMR (125.8 MHz, CDCl3)  164.6 (d, J = 24.5 Hz, C), 159.3 (d, 
J = 26.0 Hz, C), 151.1 (C), 140.1 (C), 126.7 (CH), 125.2 (CH), 121.0 (CH), 111.5 (CH), 
88.2 (d, J = 189.0 Hz, C), 69.5 (CH2), 30.2 (d, J = 22.5 Hz, CH2), 20.2 (d, J = 5.5 Hz, CH2); 
19
F NMR (376 MHz, CDCl3)  −147.2; LRMS (GCMS) [M]
+
: 235.1; Enantiomeric excess 
was determined by HPLC with a Chiralpak OD-H column (90:10 hexane:i-PrOH, 0.8 













(3 mg, 5 mol%) and NFSI (17 mg, 
54 mol) at room temperature. The product was purified as described above (pet. 
ether/EtOAc 3:1→2:1) to give 2-fluoroazaarylacetate 6.11 (50% conv.) as an orange solid. 
Rf 0.63 (pet. ether/EtOAc 2:1); m.p. 114 °C; IR (film, cm
-1
) 3059, 3026, 2924, 2853, 1794 
(C=O), 1726, 1599, 1493, 1452, 1377; 
1
H NMR (500 MHz, CDCl3)  8.07-8.05 (1H, m, 
ArH), 7.99-7.96 (1H, m, ArH), 7.55 (1H, ddd, J = 8.5, 7.5, 1.5 Hz, ArH), 7.48 (1H, ddd, J = 
8.5, 7.5, 1.0 Hz, ArH), 4.80-4.74 (1H, m, CO2CHaHbCH2CF), 4.67 (1H, dt, J = 9.0, 4.0 Hz, 
CO2CHaHbCH2CF), 3.41 (1H, ddt, J = 14.0, 7.0, 4.0 Hz, CO2CH2CHaHbCF), 3.04-2.92 (1H, 
m, CO2CH2CHaHbCF); 
13
C NMR (125.8 MHz, CDCl3)  169.7 (d, J = 26.0 Hz, C), 164.7 
(J = 34.0 Hz, C), 152.5 (C), 135.5 (C), 126.6 (CH), 126.2 (CH), 123.8 (CH), 122.0 (CH), 
93.6 (d, J = 189.5 Hz, C), 65.5 (d, J = 4.5 Hz, CH2), 34.8 (d, J = 20.5 Hz, CH2); 
19
F NMR 
(376 MHz, CDCl3)  −151.0; HRMS (ES) Exact mass calcd for C11H9FNO2 [M+H]
+
: 
238.0333, found: 238.0332; Enantiomeric excess was determined by HPLC with a Chiralpak 
IA-3 column (98:2 hexane:i-PrOH, 1.0 mL/min, 230 nm, 25 °C); tr (major) = 14.9 min, tr 






To a stirred solution of hydroxylamine hydrochloride (218 mg, 3.13 mmol) and sodium 
formate (340 mg, 5.00 mmol) in formic acid (5 mL) was added 2-bromobenzaldehyde 
(0.32 mL, 2.70 mmol). The reaction was heated for 4 h at reflux, cooled to room temperature 
and water added (5 mL). The phases were separated and the aqueous phase extracted with 
EtOAc (3 x 5 mL). The combined organics were concentrated in vacuo to remove formic 
acid. The residue was dissolved in Et2O (10 mL), washed with water (10 mL) and brine 
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(10 mL) and dried (MgSO4). The solvent was removed in vacuo to give crude nitrile. The 
product was purified by flash chromatography (pet. ether/Et2O 19:1→9:1) to give nitrile 6.12 





H NMR (500 MHz, CDCl3)  7.68-7.61 (2H, m, ArH), 7.49-7.39 (2H, m, 
ArH); 
13
C NMR (125.8 MHz, CDCl3)  134.1 (CH), 133.8 (CH), 133.0 (CH), 127.5 (CH), 









To a stirred solution of 2-bromobenzonitrile 6.12 (590 mg, 3.24 mmol) in 5:1 Et2O/THF 
(20 mL) at −78 °C under nitrogen was added n-BuLi (1.6 M in hexanes, 2.03 mL, 3.24 
mmol). The reaction was stirred for 10 min and a solution of (chloro)diphenylphosphine 
(0.59 mL, 3.24 mmol) in THF (4 mL) was added dropwise. The reaction was stirred at 
−78 °C for 3 h and allowed to warm to room temperature for 16 h. The red-brown 
suspension was quenched with water (15 mL), the phases separated and the aqueous phase 
extracted with Et2O (3 x 15 mL). The combined organics were dried (MgSO4) and the 
solvent removed in vacuo. The product was recrystallised (i-PrOH) to give 
2-(diphenylphosphanyl)benzonitrile as pale yellow crystals (543 mg, 58%). 
A stirred suspension of 2-(diphenylphosphanyl)benzonitrile (250 mg, 0.870 mmol), 
(R)-2-phenylgylcinol (155 mg, 1.13 mmol) and ZnCl2 (285 mg, 2.09 mmol) in 
chlorobenzene (20 mL) was heated at reflux for 24 h. The reaction was cooled to room 
temperature and quenched with sat. aq. NH4Cl solution (20 mL). The phases were separated 
and the aqueous phase extracted with CH2Cl2 (3 x 20 mL). The combined organics were 
                                                                                                         Chapter 6. Experimental 
-183- 
 
dried (Na2SO4) and the solvent removed in vacuo. The product was purified by flash 
chromatography (pet. ether/CH2Cl2 1:1 followed by pet. ether/EtOAc 3:1) to give 
(R)-Ph-PHOX (289 mg, 82%) as a cream gel. Rf 0.50 (pet. ether/EtOAc 3:1); []
25
D  −11.9 




H NMR (500 MHz, CDCl3)  8.05 (1H, ddd, 
J = 7.5, 3.5, 1.5 Hz, ArH), 7.44-7.32 (12H, m, ArH), 7.25-7.22 (3H, m, ArH), 6.99-6.94 
(3H, m, ArH), 5.27 (1H, t, J = 9.5 Hz, CHPh), 4.59 (1H, dd, J = 10.0 Hz, 8.5 Hz, CHaCHO), 
3.98 (1H, dd, J = 9.0, 8.5 Hz, CHaCHbO); 
13
C NMR (125.8 MHz, CDCl3)  164.6 (d, 
3
JC-P = 
2.5 Hz, C), 141.9 (C), 139.1 (d, 
2
JC-P = 26.0 Hz, C), 138.0 (d, 
1
JC-P = 12.5 Hz, C), 137.8 (d, 
1
JC-P = 12.5 Hz, C), 134.3 (d, J = 21.0 Hz, 2 x CH), 133.8 (d, J = 21.0 Hz, 2 x CH), 133.8 (d, 
J = 1.0 Hz, CH), 131.4 (d, 
1
JC-P = 19.0 Hz, C), 130.6 (CH), 130.2 (d, 
3
JC-P = 3.0 Hz, CH), 
128.6-128.3(8 x CH), 128.0 (CH), 127.1 (CH), 126.6 (2 x CH), 74.3 (CH2), 70.0 (CH); 
31









A stirred suspension of 2-(diphenylphosphanyl)benzonitrile (200 mg, 0.696 mmol), 
(S) 2-amino-3-methyl-1-butanol (93 mg, 0.91 mmol) and ZnCl2 (228 mg, 1.67 mmol) in 
chlorobenzene (10 mL) was heated at reflux for 48 h. The reaction was cooled to room 
temperature and quenched with sat. aq. NH4Cl solution (10 mL). The phases were separated 
and the aqueous phase extracted with CH2Cl2 (3 x 10 mL). The combined organics were 
dried (Na2SO4) and the solvent removed in vacuo. The product was purified by flash 
chromatography (pet. ether/CH2Cl2 1:1 followed by pet. ether/EtOAc 3:1) to give 
(S)-i-Pr-PHOX (194 mg, 75%) as a colourless solid. Rf (0.86 pet/ ether/EtOAc 3:1); m.p. 
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(500 MHz, CDCl3)  7.93 (1H, ddd, J = 7.5, 3.5, 1.5 Hz, ArH), 7.39-7.25 (12H, m, ArH), 
6.90 (1H, ddd, J = 8.0, 4.0, 1.0 Hz, ArH), 4.20-4.11 (1H, m, CHaHbO), 3.92-3.83 (2H, m, 
CHaHbO and CHN), 1.56-1.46 (1H, m, CH(CH3)3), 0.84 (3H, d, J = 6.5 Hz, CH3), 0.73 (3H, 
d, J = 7.0 Hz); 
13
C NMR (125.8 MHz, CDCl3)  162.9 (d, 
3
JC-P = 2.5 Hz, C), 138.8 (d, 
2
JC-P = 
25.5 Hz, C), 138.2 (d, 
1
JC-P = 12.5 Hz, C), 138.0 (d, 
1
JC-P = 10.0 Hz, C), 134.2 (d, 
2
JC-P = 
21.0 Hz, 2 x CH), 133.8 (d, 
3
JC-P = 1.0 Hz, CH) , 133.7 (d, 
2
JC-P = 20.5 Hz, 2 x CH), 131.9 (d, 
1
JC-P = 19.0 Hz, C), 130.3 (CH), 129.8 (d, 
3
JC-P = 3.0 Hz, CH), 128.5-128.2 (6 x CH), 
127.9 (CH), 73.1 (CH), 70.0 (CH2), 32.7 (CH), 18.8 (CH3), 18.3 (CH3); 
31
P NMR (162 MHz, 








To a stirred solution of pyridyl ketone 2.102 (750 mg, 3.80 mmol), methyl iodide (0.47 mL, 
7.6 mmol) and tetrabutylammonium hydrogen sulphate (1.29 mg, 3.80 mmol) in chloroform 
(7.5 mL) at 0 °C was added sodium hydroxide (304 mg, 7.61 mmol) in water (7.5 mL). The 
reaction was warmed to room temperature for 16 h and diluted with CHCl3/H2O 1:1 (15 mL). 
The phases were separated and the aqueous phase extracted with CHCl3 (3 x 15 mL). The 
combined organics were dried (Na2SO4) and concentrated in vacuo. The residue was treated 
with Et2O (10 mL) and filtered. The filtrate was concentrated in vacuo and the crude product 
was purified by flash chromatography on alumina (pet. ether/Et2O 19:1→4:1) to give 
methylated pyridyl ketone 2.103 (576 mg, 72%) as a colourless solid. Rf 0.69 (pet. 




H NMR (500 MHz, CDCl3)  8.69-8.65 
(1H, m, ArH),8.03-8.00 (1H, m, ArH), 7.77 (1H, dt, J = 8.0, 1.5 Hz, ArH), 7.42-7.37 (3H, 
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m, ArH), 7.30-7.24 (2H, m, ArH), 7.20-7.15 (1H, m, ArH), 5.49 (1H, q, J = 7.0 Hz, 
CHCH3), 1.57 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  201.8 (C), 
152.9 (C), 148.8 (CH), 140.9 (C), 136.8 (CH), 128.5 (2 x CH), 128.4 (2 x CH), 126.9 (CH), 










(3 mg, 5 mol%) and NFSI (17 mg, 55 mol) 
at room temperature in CH2Cl2. The product was purified as described above (pet. 
ether/EtOAc 19:1→9:1) to give 2-fluoroazaarylketone 2.104 (25% conv.) as a white solid. 
Rf 0.29 (pet. ether/EtOAc 9:1); IR (film, cm
-1
) 1709 (C=O), 1582, 1495, 1447, 1371, 1281, 
1240, 997, 968, 910; 
1
H NMR (500 MHz, CDCl3)  8.62-8.57 (1H, m, ArH), 7.96-7.93 (1H, 
m, ArH), 7.75 (1H, dt, J = 8.0, 1.5 Hz, ArH), 7.60-7.56 (2H, m, ArH), 7.39-7.34 (3H, m, 
ArH), 7.33-7.28 (m, 1 H, ArH), 2.20 (3H, d, J = 23.5 Hz, CH3); 
13
C NMR (125.8 MHz, 
CDCl3)  196.6 (d, 
2
JC-F = 25.0 Hz, C), 151.7 (d, J = 1.0 Hz, C), 148.8 (CH), 139.4 (d, 
2
JC-F = 
22.0 Hz, C), 136.5 (CH), 128.4 (2 x CH), 128.3 (d, J = 1.5 Hz, CH), 126.6 (CH), 125.4 (d, 
3
JC-F = 7.5 Hz, 2 x CH), 124.7 (d, J = 4.0 Hz, CH), 99.9 (d, J = 183.0 Hz, C), 24.9 (d, J = 
24.0 Hz, CH3); 
19
F NMR (376 MHz, CDCl3)  −143.5; HRMS (ES) Exact mass calcd for 
C14H13FNO [M+H]
+
: 230.0903, found: 230.0904. Enantiomeric excess was determined by 
HPLC with a Chiralpak OD-H column (98:2 hexane:i-PrOH, 0.8 mL/min, 230 nm, 25 °C); tr 
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6.3 Oxidative Annulation of Ferrocene Derivatives 
6.3.1 General Procedures 
General Procedure A: Synthesis of ferrocenecarboxylic acid chloride 3.76 
 
To a stirred solution of ferrocenecarboxylic acid 3.75 (1.0 equiv.) and DMF (0.25 equiv.) in 
anhydrous CH2Cl2 (0.55 M) at 0 °C under nitrogen was added oxalyl chloride (1.2 equiv.) 
dropwise. The reaction was stirred for 1 h at 0 °C and at room temperature for 30 min. The 
solvent was removed in vacuo. The residue was dissolved in warm hexane, decanted and the 
solvent removed in vacuo to give ferrocenecarboxylic acid chloride 3.76 that was used in the 
next step without further purification. 
 
General Procedure B: Synthesis of ferrocenecarboxamides from ferrocenecarboxylic 
acid chloride 3.76 
 
Method 1 
To a biphasic mixture of base (2.0 equiv.) in a 2:1 mixture of EtOAc/H2O (0.2 M) was added 
amine salt (1.1 equiv.). The solution was cooled to 0 °C and ferrocenecarboxylic acid 
chloride 3.76 (1.0 equiv.) added. The reaction was stirred for 1 h, warmed to room 
temperature and the phases separated. The aqueous phase was extracted with EtOAc, the 
combined organics dried (MgSO4) and the solvent removed in vacuo. 
Method 2 
To a stirred solution of amine (1.0-2.0 equiv.) and base (1.0-6.0 equiv.) in anhydrous CH2Cl2 
(1 M) at 0 °C was added ferrocenecarboxylic acid 3.76 (1.0-1.1 equiv.). The reaction was 
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stirred for 4-24 h and quenched with 1 N aq. HCl (10 mL). The phases were separated and 
the aqueous phase extracted with CH2Cl2 (2 x 10 mL). The combined organics were dried 
(MgSO4) and the solvent removed in vacuo.  
 
General Procedure C: Oxidative Annulation 
 
A solution of ferrocenecarboxamide (1.0 equiv.), sodium tetrachloropalladate (10 mol%), 
sodium acetate (2.1 equiv.) and alkyne (1.1 equiv.) in DMF (0.2 M) at 60 °C was stirred for 
16 h. The reaction was passed through a plug of silica (with EtOAc/CH2Cl2 9:1 as eluent) 
and washed with brine/H2O 1:1. The organic phase was dried (MgSO4) and the solvent 
removed in vacuo. 
 
General Procedure D: Synthesis of ferrocenecarboxamides from ferrocenecarboxylic 
acid 3.76 
 
To a stirred solution of ferrocencecarboxylic acid 3.76 (200 mg, 0.869 mmol) and amine 
(0.790 mmol) in anhydrous CH2Cl2 (0.1 M) was added EDC·HCl (167 mg, 0.869 mmol) and 
DMAP (cat., 1 crystal). The reaction was stirred for 16 h, diluted with CH2Cl2 and washed 









General procedure B (method 1) was applied to K2CO3 (2.14 g, 
15.5 mmol), methoxyamine hydrochloride (713 mg, 8.53 mmol) and 
ferrocenecarboxylic acid chloride 3.76 (1.77 g, 7.12 mmol) in EtOAc/H2O 
2:1 (36 mL). The residue was purified by flash chromatography (EtOAc/pet. ether 2:1→5:1) 
to give N-methoxy amide 3.77 (1.62 g, 88%) as an orange powder. Rf 0.24 (pet. ether/EtOAc 
1:1); m.p. 124 °C (decomp.); IR (film, cm
-1
) 3177, 3013, 2932, 2361, 1626 (C=O), 1522, 
1439, 1377, 1302, 1225; 
1
H NMR (500 MHz, CDCl3)  8.43 (1H, br s, NH), 4.72 (2H, s, 
ArH), 4.40 (2H, s, ArH), 4.25 (5H, s, ArH), 3.86 (3H, s, OCH3); 
13
C NMR (125.8 MHz, 
CDCl3)  170.2 (C), 72.6 (C), 70.8 (2 x CH), 70.0 (5 x CH), 68.2 (2 x CH), 64.7 (CH3); 
HRMS (ES) Exact mass calcd for C12H14FeNO2 [M+H]
+






To amino alcohol (3.20 g, 24.0 mmol) in chloroform (40 mL) was added pivalic anhydride 
(4.88 mL, 24.0 mmol). The reaction was heated at reflux for 16 h, cooled to room 
temperature and quenched with sat. aq. NaHCO3 (40 mL). The phases were separated and 
the organic phase washed with sat. aq. NaHCO3 (3 x 40 mL). The organic phase was dried 
(MgSO4), filtered and the solvent removed in vacuo to give pivaloxy Boc-protected amine 
(4.72 g, 97%) as a colourless solid which was used in the next step without further 
purification. To pivaloxy Boc-protected amine (2.26 g, 11.1 mmol) in anhydrous Et2O 
(30 mL) at 0 °C under nitrogen was added triflic acid (0.99 mL, 11.1 mmol). The reaction 
was warmed to room temperature over 30 min and diluted with hexane to precipitate the 
product. The product was filtered with hexane to give pivaloxy deprotected amine 6.13 
(2.44 g, 82%) as a colourless solid. Rf 0.50 (pet. ether/EtOAc 2:1); m.p. 124-125 °C; 




H NMR (500 MHz, (CD3)2SO)  1.11 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, (CD3)2SO) 
 179.431, 120.7 (C, q, 
1
JC-F = 323.0 Hz), 37.7 (C), 27.0 (3 x CH3); 
19
F NMR (376 MHz, 




Ferrocenecarboxamido 2,2-dimethylpropanoate 3.78 
General procedure B (method 1) was added to Na2CO3 (1.02 g, 9.58 mmol), 
NH2OPiv·TfOH 6.13 (1.28 g, 4.79 mmol) and ferrocenecarboxylic acid 
chloride 3.76 (1.09 g, 4.38 mmol) in EtOAc/H2O 2:1 (21 mL). The residue 
was purified by recrystallisation (hexane/EtOAc) to give pivaloxy amide 3.78 as a fine 
orange powder (617 mg, 43%). Rf 0.79 (pet. ether/EtOAc 2:1); m.p. 138 °C (decomp.); 
IR (film, cm
-1
) 2974, 1784 (C=O), 1651 (C=O), 1514, 1477, 1412, 1379, 1292, 1223, 1078; 
1
H NMR (400 MHz, CD3SO)  11.52 (1H, s, NH), 4.79-4.75 (2H, m, ArH), 4.45-4.40 (2H, 
m, ArH), 4.28 (5H, s, ArH), 1.28 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CD3SO)  
176.0 (C), 168.1 (C), 72.3 (C), 70.5 (2 x CH), 69.7 (5 x CH), 68.2 (2 x CH), 37.8 (C), 26.9 (3 
x CH3); HRMS (EI) Exact mass calcd for C16H19FeNO3 [M]
+
: 329.0709, found: 329.0705. 
 
2-Methoxy-4-methyl-3-phenyl-1H-2H-ferrocenyl[1,2-a]pyridin-1-one 3.79 
General procedure C was applied to ferrocenecarboxamide 3.77 (78 mg, 
0.30 mmol), sodium tetrachloropalladate (9 mg, 10 mol%), sodium acetate 
(52 mg, 0.63 mmol) and 1-phenyl-1-propyne (41 µL, 0.33 mmol). The 
residue was purified by flash chromatography (pet. ether/EtOAc 4:1→1:2) to give 
pyridinone 3.79 (17 mg, 15%) as an orange oil. Rf 0.47 (pet. ether/EtOAc 1:1); IR (film, 
cm
-1
) 3088, 2930, 2857, 2241, 1713, 1667 (C=O), 1616, 1595, 1555, 1495; 
1
H NMR 
(500 MHz, CDCl3)  7.56-7.40 (3H, m, ArH), 7.40-7.30 (2H, m, ArH), 5.28-5.25 (1H, m, 
ArH), 4.76-4.73 (1H, m, ArH), 4.37 (1H, t, J = 2.5 Hz, ArH), 4.09 (5H, s, ArH), 3.61 (3H, s, 
OCH3), 2.00 (3H, s, CCH3); 
13
C NMR (125.8 MHz, CDCl3)  164.2 (C), 135.4 (C), 
132.6 (C), 130.4 (CH), 130.3 (CH), 128.4 (2 x CH), 128.0 (CH), 111.7 (C), 88.1 (C), 
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73.1 (C), 71.4 (CH), 69.7 (5 x CH), 66.3 (CH), 64.3 (CH), 63.0 (CH), 14.8 (CH3); HRMS 
(ES) Exact mass calcd for C21H20FeNO2 [M+H]
+
: 374.0838, found: 374.0839. 
 
3,4-Diphenyl-1H,2H-ferrocenyl[1,2-a]pyridin-1-one 3.91 
General procedure C was applied to ferrocenecarboxamide 3.77 (78 mg, 0.30 mmol), sodium 
tetrachloropalladate (9 mg, 10 mol%), sodium acetate (52 mg, 0.63 mmol) and 
diphenylacetylene (59 mg, 0.33 mmol). The residue was purified by flash chromatography 
(pet. ether/EtOAc 4:1→2:1) to give pyridinone 3.91 (26 mg, 20%) as an orange solid, 
ferrocenecarboxamide 3.89 (14 mg, 20%) as a yellow solid and pyridinone 3.92 (5 mg, 4%) 
as an orange oil. Rf 0.54 (pet. ether/EtOAc 1:1); m.p. 88 °C (decomp.); IR (film, cm
-1
) 3109, 
2934, 2851, 2245, 1667 (C=O), 1589, 1493, 1443, 1302, 1227; 
1
H NMR (500 MHz, CDCl3) 
 7.27-7.16 (10H, m, ArH), 5.32 (1H, dd, J = 2.5, 1.5 Hz, ArH), 4.55 (1H, dd, J = 2.5, 
1.5 Hz, ArH), 4.37 (1H, t, J = 2.5 Hz, ArH), 4.15 (5H, s, ArH), 3.63 (3H, s, OCH3); 
13
C 
NMR (125.8 MHz, CDCl3)  164.4 (C), 136.5 (2 x C), 132.1 (C), 131.2 (2 x CH), 130.3 
(2 x CH), 128.0 (2 x CH), 128.0 (CH), 127.5 (2 x CH), 126.8 (CH), 117.9 (C), 88.0 (C), 
72.6 (C), 71.8 (CH), 69.9 (5 x CH), 66.3 (CH), 66.2 (CH), 63.1 (CH3); HRMS (ES) Exact 
mass calcd for C26H22FeNO2 [M+H]
+









H NMR (500 
MHz, CDCl3)  5.72 (2H, s, NH2), 4.69 (2H, s, ArH), 4.39 (2H, s, ArH), 4.24 
(5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  172.9 (C), 74.5 (C), 70.9 (2 x 
CH), 69.9 (5 x CH), 68.6 (2 x CH). Data consistent with literature.
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Rf 0.33 (pet. ether/EtOAc 1:1); IR (film, cm
-1
) 3184, 3057, 2928, 2249, 
1653 (C=O), 1599, 1497, 1443, 1308, 1238; 
1
H NMR (500 MHz, CDCl3) 
 7.92 (1H, s, NH), 7.35-7.23 (8H, m, ArH), 7.23-7.17 (2H, m, ArH), 5.24 
(1H, dd, J = 2.5, 1.0 Hz, ArH), 4.64 (1H, dd, J = 2.5, 1.0 Hz, ArH), 4.40 (1H, t, J = 2.5 Hz, 
ArH), 4.14 (5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  169.2 (C), 136.6 (C), 135.5 (C), 
133.3 (C), 130.4 (2 x CH), 129.0 (2 x CH), 128.6 (2 x CH), 128.4 (3 x CH), 127.0 (CH), 
116.7 (C), 90.4 (C), 72.0 (CH), 71.0 (C), 70.0 (5 x CH), 66.5 (CH), 65.6 (CH); HRMS (ES) 
Exact mass calcd for C25H20FeNO [M+H]
+
: 406.0889, found: 406.0886. 
 
N-(Quinolin-8-yl)ferrocenecarboxamide 3.94 
General procedure D was applied to ferrocencecarboxylic acid 3.75 
(200 mg, 0.869 mmol), 8-aminoquinoline (114 mg, 0.790 mmol), 
EDC·HCl (167 mg, 0.869 mmol) and DMAP (cat., 1 crystal). The 
residue was purified by flash chromatography (toluene/EtOAc 99:1→95:5) to give quinoline 
amide 3.94 as an orange solid (166 mg, 59%). Rf 0.23 (pet. ether/EtOAc 9:1); m.p. 121-123 
°C; IR (film, cm
-1
) 3352, 3090, 2245, 1667 (C=O), 1526, 1485, 1423, 1383, 1327, 1271; 
1
H NMR (500 MHz, CDCl3)  10.31 (1H, br s, NH), 8.90 (1H, d, J = 3.0 Hz, ArH), 8.82 
(1H, d, J = 7.0 Hz, ArH), 8.20 (1H, d, J = 8.0 Hz, ArH), 7.59 (1H, t, J = 7.5 Hz, ArH), 
7.56-7.48 (2H, m, ArH), 4.98 (2H, s, ArH), 4.48 (2H, s, ArH), 4.30 (5H, s, ArH); 
13
C NMR 
(125.8 MHz, CDCl3)  148.3 (CH), 138.6 (C), 136.4 (CH), 134.7 (C), 128.0 (C), 127.6 (CH), 
121.6 (CH), 121.0 (CH), 116.2 (CH), 70.9 (2 x CH), 70.0 (5 x CH), 68.6 (2 x CH); HRMS 
(ES) Exact mass calcd for C20H17FeN2O [M+H]
+












To ferrocenecarboxylic acid 3.75 (200 mg, 0.87 mmol) in methanol (6.0 mL) was added 
boron trifluoride etherate (0.60 mL) and the reaction was heated at reflux for 5 h.  Sat. aq. 
NaHCO3 (6 mL) was added until the pH of the solution was 8-9 and the aqueous phase 
extracted with CH2Cl2 (3 x 10 mL). The combined organics were washed with brine 
(30 mL), dried (Na2SO4) and the solvent removed in vacuo to give methyl ester which was 
used in the next step without further purification. To methyl ester (200 mg, 0.82 mmol) in 
anhydrous diethyl ether (5 mL) at 0 °C under nitrogen was added lithium aluminium hydride 
(2.2 M in 2-MeTHF, 1.3 mL, 2.9 mmol) dropwise. The reaction was stirred for 30 min and 
quenched carefully with potassium sodium tartrate (20 mL) and allowed to stir for 15 min. 
The phases were separated and the aqueous phase extracted with EtOAc (3 x 50 mL). The 
combined organics were dried (MgSO4) and the solvent removed in vacuo. The residue was 
purified using flash chromatography (pet. ether/EtOAc 4:1→3:1) to give alcohol 3.95 





H NMR (500 MHz, CDCl3)  4.34 (2H, d, J = 5.0 Hz, ArH), 4.25 (2H, t, J = 
2.0 Hz, ArH), 4.20-4.17 (7H, m, ArH, CH2OH); 
13
C NMR (125.8 MHz, CDCl3)  88.3 (C), 







General procedure B (method 2) was applied to methylamine hydrochloride 
(293 mg, 4.34 mmol), triethylamine (1.81 mL, 13.0 mmol) and 
ferrocenecarboxylic acid chloride 3.76 (500  mg, 2.17 mmol) in CH2Cl2 
(2.5 mL). The reaction was stirred for 4 h and the residue was purified by flash 
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chromatography (pet. ether/EtOAc 3:1→1:2) to give amide 3.96 (360 mg, 68%) as a brown 





(500 MHz, CDCl3)  5.74 (1H, br s, NH), 4.67 (2H, s, ArH), 4.34 (2H, s, ArH), 4.21 (5H, s, 
ArH), 2.96 (3H, s, CH3); 
13
C NMR (125.8 MHz, CDCl3)  (CO and COC resonances not 






General procedure B was applied to N,N-dimethylhydrazine (70 µL, 
0.97 mmol), N-methylmorpholine (0.11 mL, 0.97 mmol) and 
ferrocenecarboxylic acid chloride 3.76 (200 mg, 0.81 mmol) in CH2Cl2 
(5 mL). The reaction was stirred at room temperature for 7 h and the residue was purified by 
flash chromatography (pet. ether/acetone/NEt3 70:30:1→10:90:1) to give hydrazide AJ-3-78 
(163 mg, 74%) as an orange solid. Rf 0.34 (pet. ether/acetone 7:3); m.p. 165 °C (decomp.); 
IR (film, cm
-1
) 1636 (C=O), 1539, 1466, 1445, 1377, 1292, 1221, 1167, 1105, 1049; 
1
H NMR (500 MHz, CDCl3)  6.44 (1H, br s, NH), 4.68 (2H, s, ArH), 4.35 (2H, s, ArH), 
4.21 (5H, s, ArH), 2.69 (6H, s, N(CH3)2); 
13
C NMR (125.8 MHz, CDCl3)  168.2 (C), 
74.7 (C), 70.4 (2 x CH), 69.7 (5 x CH), 68.1 (2 x CH), 47.7 (2 x CH3); HRMS (ES) Exact 
mass calcd for C13H17FeN2O [M+H]
+
: 273.0685, found: 273.0687. 
 
N-[3,5-Bis(trifluoromethyl)phenyl]ferrocenecarboxamide 3.98 
General procedure B was applied to 3,5-bis(trifluoromethyl)aniline 
(0.13 mL, 0.81 mmol), triethylamine (0.11 mL, 0.81 mmol) and 
ferrocenecarboxylic acid chloride 3.76 (240 mg, 0.966 mmol) in 
CH2Cl2 (10 mL). The reaction was stirred for 24 h and the residue 
purified by recrystallisation (hexane/EtOAc) to give aryl amide 3.98 (108 mg, 30%) as an 
orange solid.  Rf 0.31 (pet. ether/EtOAc 9:1); m.p. 235 °C (decomp.); IR (film, cm
-1
) 
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1645 (C=O), 1638, 1533, 1476, 1460, 1408, 1377, 1298, 1275, 1188; 
1
H NMR (500 MHz, 
CD3OD)  8.40 (2H, s, ArH), 7.66 (1H, s, ArH), 5.03 (2H, t, J = 1.5 Hz, ArH), 4.86 (5H, s, 
ArH), 4.54 (2H, t, J = 2.0 Hz, ArH); 
13
C NMR (125.8 MHz, CD3OD)  (CO and COC 
resonances not resolved) 172.8 (C), 142.3 (C), 133.2 (q, 
1
JC-F = 34.0 Hz, 2 x C), 125.9 (C), 
123.7 (C), 121.0 (CH), 121.0 (CH), 117.4 (CH), 75.9 (C), 72.7 (2 x CH), 71.0 (5 x CH), 
69.9 (2 x CH);
 19
F NMR (376 MHz, (CD3)2CO)  −64.1; HRMS (ES) Exact mass calcd for 
C19H14F6FeNO [M+H]
+






General procedure C was applied to 1-(hydroxymethyl)-ferrocene 3.95 (11 mg, 50 µmol), 
sodium tetrachloropalladate (1.5 mg, 10 mol%), sodium acetate (9 mg, 0.11 mmol) and 
diphenylacetylene (10 mg, 55 µmol). The residue was purified by flash chromatography (pet. 
ether/Et2O 4:1→2:1) to give aldehyde 3.100 (4 mg, 37%) as an orange solid. Rf 0.34 (pet. 




H NMR (500 MHz, CDCl3)  9.97 (1H, 
s, CHO), 4.81 (2H, t, J = 2.0 Hz, ArH), 4.62 (2H, t, J = 2.0 Hz, ArH), 4.29 (5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  (2 x CH resonances not resolved) 193.4 (C), 79.4 (C), 





General procedure C was applied to ferrocenecarboxamide 3.96 (73 mg, 
0.30 mmol), sodium tetrachloropalladate (9 mg, 10 mol%), sodium acetate 
(52 mg, 0.63 mmol) and diphenylacetylene (59 mg, 0.33 mmol). The 
residue was purified by flash chromatography (pet. ether/EtOAc 4:1→1:4) to give 
pyridinone 3.101 (6 mg, 5%) as an orange solid. Rf 0.62 (pet. ether/EtOAc 1:1); m.p. 98 °C 
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(decomp.); IR (film, cm
-1
) 3059, 2922, 2853, 2243, 1651 (C=O), 1589, 1493, 1443, 1414, 
1315; 
1
H NMR (500 MHz, CDCl3)  7.33-7.13 (9H, m, ArH), 7.10-7.05 (1H, m, ArH), 5.27 
(1H, dd, J = 2.5, 1.0 Hz, ArH), 4.49 (1H, dd, J = 2.5, 1.5 Hz, ArH), 4.32 (1H, t, J = 2.5 Hz, 
ArH), 4.11 (5H, s, ArH), 3.24 (3H, s, NCH3); 
13
C NMR (125.8 MHz, CDCl3)  169.1 (C), 
137.9 (C), 137.3 (C), 135.5 (C), 130.6 (CH), 130.4 (CH), 130.2 (2 x CH), 128.2 (CH), 
128.0 (CH), 128.0 (CH), 127.8 (2 x CH), 126.4 (CH), 118.5 (C), 89.0 (C), 72.0 (C), 
71.3 (CH), 69.7 (5 x CH), 65.8 (CH), 65.7 (CH), 33.7 (CH3); HRMS (ES) Exact mass calcd 
for C26H22FeNO [M+H]
+




General procedure C was applied to ferrocenecarboxamide 3.98 
(132 mg, 0.30 mmol), sodium tetrachloropalladate (9 mg, 10 mol%), 
sodium acetate (52 mg, 0.63 mmol) and diphenylacetylene (59 mg, 
0.33 mmol). The residue was purified by flash chromatography 
(toluene) to give pyridinone 3.102 (23 mg, 12%) as an orange solid. Rf 0.31 (9:1 
toluene/CH2Cl2); m.p. 120 °C (decomp.); IR (film, cm
-1
) 3059, 2926, 1672 (C=O), 1589, 
1493, 1466, 1445, 1373, 1308, 1277; 
1
H NMR (400 MHz, (CD3)2CO)  7.89 (2H, s, ArH), 
7.79 (1H, s, ArH), 7.40-6.93 (10H, s, ArH), 5.19 (1H, dd, J = 2.5, 1.5 Hz, ArH), 4.55 (1H, 
dd, J = 2.5, 1.5 Hz, ArH), 4.53 (1H, t, J = 2.5 Hz, ArH), 4.31 (5H, s, ArH); 
13
C NMR (125.8 
MHz, (CD3)2CO)  168.8 (C), 143.3 (C), 138.1 (C), 137.8 (C), 136.1 (C), 132.9 (CH), 
132.5 (3 x CH), 131.9 (q, 
1
JC-F = 34.0 Hz, 2 x C), 131.4 (2 x CH), 129.0 (2 x CH), 
128.4 (2 x CH), 128.4 (CH), 127.7 (CH), 125.3 (C), 121.4 (quin, 
3
JC-F = 4.0 Hz, CH), 
120.0 (C), 90.0 (C), 72.8 (CH), 72.2 (C), 71.1 (5 x CH), 67.6 (CH), 67.2 (CH); 
19
F NMR 
(376 MHz, (CD3)2CO)  −63.6 to −64.3 (m, 2 x CF3); HRMS (ES) Exact mass calcd for 
C33H22F6FeNO [M+H]
+
: 618.0950, found: 618.0966. 
 







To a stirred solution of acetylferrocene 3.103 (200 mg, 0.88 mmol) in anhydrous THF 
(10 mL) at 0 °C under nitrogen was added methylmagnesium bromide (3.0 M in Et2O, 
0.58 mL, 1.8 mmol) dropwise. The reaction was stirred for 30 min and quenched with sat. 
aq. NH4Cl (10 mL). The phases were separated and the aqueous phase extracted with EtOAc 
(3 x 10 mL). The combined organics were dried (MgSO4) and the solvent removed in vacuo. 
The residue was purified by flash chromatography (toluene/EtOAc 99:1→97:3) to give 
alcohol 3.104 (118 mg, 55%) as a yellow solid. Rf 0.85 (pet. ether/EtOAc 1:1); m.p. 




H NMR (500 MHz, CDCl3)  4.21 (5H, s, ArH), 4.20 (2H, t, J = 
2.0 Hz, ArH), 4.17 (2H, t, J = 2.0 Hz, ArH), 1.51 (6H, s, C(CH3)2); 
13
C NMR (125.8 MHz, 
CDCl3)  100.1 (C), 68.8 (C), 68.2 (5 x CH), 67.7 (2 x CH), 65.5 (2 x CH), 30.8 (2 x CH3). 







General procedure D was applied to ferrocenecarboxylic acid 3.75 (200 mg, 
0.869 mmol), aniline (72 µL, 0.79 mmol), EDC·HCl (167 mg, 0.869 mmol) 
and DMAP (cat., 1 crystal). The residue was purified by recrystallisation 
(hexane/EtOAc) to give N-phenyl amide 3.106 (123 mg, 53%) as a yellow powder. Rf 0.16 




H NMR (500 MHz, CDCl3) 
 7.62 (2H, d, J = 7.5 Hz, ArH), 7.42 (1H, br s, NH), 7.37 (2H, t, J = 7.0 Hz, ArH), 7.14 
(1H, t, J = 6.5 Hz, ArH), 4.80 (2H, s, ArH), 4.43 (2H, s, ArH), 4.27 (5H, s, ArH); 
13
C NMR 
(125.8 MHz, CDCl3)  168.6 (C), 138.1 (C), 129.0 (2 x CH) 124.0 (CH), 119.7 (2 x CH), 
76.2 (C), 70.9 (2 x CH), 69.9 (5 x CH), 68.3 (2 x CH). Data consistent with literature.
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General procedure D was applied to ferrocencecarboxylic acid 3.75 
(200 mg, 0.869 mmol), 3,5-dimethylaniline (98 µL, 0.79 mmol), 
EDC·HCl (167 mg, 0.869 mmol) and DMAP (cat., 1 crystal). The 
residue was purified by recrystallisation (hexane/EtOAc) to give arylamide 3.107 (139 mg, 
53%) as a yellow solid. Rf 0.23 (pet. ether/EtOAc 9:1); m.p. 215 °C (decomp.); IR (film, 
cm
-1
) 3285, 1638 (C=O), 1614, 1547, 1533, 1462, 1422, 1377, 1317, 1290; 
1
H NMR 
(500 MHz, CDCl3)  7.83-7.70 (4H, m, ArH, NH), 5.29 (2H, s, ArH), 4.94 (2H, s, ArH), 
4.78 (5H, s, ArH), 2.82 (6H, s, 2 x CH3); 
13
C NMR (125.8 MHz, CDCl3)  168.4 (C), 
138.8 (2 x C), 137.9 (C), 125.7 (CH), 117.4 (2 x CH), 76.6 (C), 71.1 (2 x CH), 
70.1 (5 x CH), 68.5 (2 x CH), 21.4 (2 x CH3); HRMS (ES) Exact mass calcd for C19H20FeNO 
[M+H]
+
: 334.0889, found: 334.0891. 
 
2,3,4-Triphenyl-1H,2H-ferrocenyl[1,2-a]pyridin-1-one 3.108 
General procedure C was applied to ferrocenecarboxamide 3.106 (92 mg, 
0.30 mmol), sodium tetrachloropalladate (9 mg, 10 mol%), sodium acetate 
(52 mg, 0.63 mmol) and diphenylacetylene (59 mg, 0.33 mmol). The 
residue was purified by flash chromatography (pet. ether/EtOAc 9:1→3:1 and then CH2Cl2) 
to give pyridinone 3.108 (19 mg, 13%) as an orange solid. Rf 0.24 (pet. ether/EtOAc 4:1); 
m.p. 150 °C (decomp.); IR (film, cm
-1
) 3059, 2920, 2241, 1663 (C=O), 1585, 1491, 1443, 
1314, 1287, 1213; 
1
H NMR (500 MHz, CDCl3)  7.26-7.01 (10H, m, ArH), 6.97-6.82 (2H, 
m, ArH), 5.30 (1H, dd, J = 2.5, 1.0 Hz, ArH), 4.59 (1H, dd, J = 2.5, 1.0 Hz, ArH), 4.40 (1H, 
t, J = 2.5 Hz, ArH), 4.22 (5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  168.7 (C), 
139.7 (C), 137.9 (C), 137.3 (C), 135.2 (C), 131.4 (2 x CH), 130.3 (2 x CH), 130.0 (2 x CH), 
128.3 (2 x CH), 127.9 (2 x CH), 127.1 (3 x CH), 127.0 (CH), 126.5 (CH), 118.5 (C), 
89.1 (C), 71.7 (C), 71.7 (CH), 70.0 (5 x CH), 66.4 (CH), 66.4 (CH); HRMS (ES) Exact mass 
calcd for C31H24FeNO [M+H]
+
: 482.1202, found: 482.1205. 




General procedure C was applied to ferrocenecarboxamide 3.107 
(100 mg, 0.30 mmol), sodium tetrachloropalladate (9 mg, 10 mol%), 
sodium acetate (52 mg, 0.63 mmol) and diphenylacetylene (59 mg, 
0.33 mmol). The residue was purified by flash chromatography 
(toluene/EtOAc 19:1→9:1 and then CH2Cl2) to give pyridinone 3.109 (18 mg, 12%) as an 
orange solid. Rf 0.39 (CH2Cl2); m.p. 175 °C (decomp.); IR (film, cm
-1
) 3057, 3028, 2918, 
2241, 1663 (C=O), 1612, 1585, 1493, 1443, 1325; 
1
H NMR (500 MHz, CDCl3)  7.26-7.11 
(5H, m, ArH), 6.99-6.82 (5H, m, ArH), 6.78-6.61 (3H, m, ArH), 5.30-5.27 (1H, m, ArH), 
4.60-4.55 (1H, m, ArH), 4.41-4.36 (1H, m, ArH), 4.22 (5H, s, ArH), 2.22 (3H, s, CH3), 2.13 
(3H, s, CH3); 
13
C NMR (125.8 MHz, CDCl3)  168.7 (C), 139.2 (C), 138.1 (C), 137.8 (C), 
137.7 (C), 137.4 (C), 135.3 (C), 131.4 (2 x CH), 130.3 (2 x CH), 128.8 (CH), 
127.8 (2 x CH), 127.6 (2 x CH), 126.9 (3 x CH), 126.4 (CH), 118.3 (C), 89.1 (C), 71.9 (C), 
71.5 (CH), 70.0 (5 x CH), 66.3 (CH), 66.2 (CH), 21.1 (CH3), 21.0 (CH3); HRMS (ES) Exact 
mass calcd for C33H27FeNONa [M+Na]
+




To a stirred solution of octafluorotoluene 3.110 (0.50 mL, 3.5 mmol) in 1,4-dioxane (5 mL) 
was added aq. NH4OH (35%, 0.88 mL, 6.4 mmol). The reaction was heated to 80 °C and 
stirred for 3 h. The reaction was cooled and the solvent removed in vacuo. The residue was 
diluted with H2O (5 mL) and extracted with EtOAc (3 x 5 mL). The combined organics were 
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dried (MgSO4) and the solvent removed in vacuo. The product was purified by flash 
chromatography (pet. ether → pet. ether/EtOAc 4:1) to give aniline (283 mg, 34%) as a 
colourless oil. To a stirred solution of aniline (283 mg, 1.21 mmol) in anhydrous toluene 
(5 mL) under nitrogen was added ferrocenecarboxylic acid chloride 3.76 (274 mg, 
1.10 mmol). The reaction was heated at reflux for 16 h, diluted with CH2Cl2 (20 mL) and 
washed with 1 N HCl (20 mL). The organic phase was dried (MgSO4) and the solvent 
removed in vacuo. The residue was purified by flash chromatography (pet. ether/EtOAc 
95:5→80:20) to give arylamide 3.111 (128 mg, 26%) as an orange solid. Rf 0.30 (pet. 
ether/EtOAc 4:1); m.p. 159-161 °C; IR (film, cm
-1
) 3264, 1668 (C=O), 1651, 1510, 1477, 
1443, 1425, 1340, 1288, 1236; 
1
H NMR (500 MHz, CDCl3)  7.32 (1H, br s, NH), 4.86 (2H, 
s, ArH), 4.54 (2H, s, ArH), 4.31 (5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  168.4 (d, J = 
7.5 Hz, 
4
CC-F, C), 144.5 (dd, 
1
JC-F = 260.0 Hz, 
2
JC-F = 13.5 Hz, 2 x C), 141.8 (dd, 
1
JC-F = 253.5 
Hz, 
2
JC-F = 12.0 Hz, 2 x C), 120.9 (q,
 1
JC-F = 282.0 Hz, C), 120.8 (t, 
2
JC-F = 14.0 Hz, C), 
107.2-106.1 (m, C), 72.9 (C), 72.0 (2 x CH), 70.3 (5 x CH), 69.0 (2 x CH); 
19
F NMR 
(376 MHz, CDCl3)  −56.1 (t, 
4
JF-F = 21.5 Hz, CF3), −140.7 to −140.1 (m, 2 x CF), −143.7 to 







General procedure C was applied to ferrocenecarboxamide 3.111 
(80 mg, 0.18 mmol), sodium tetrachloropalladate (5 mg, 10 mol%), 
sodium acetate (31 mg, 0.38 mmol) and diphenylacetylene (35 mg, 
0.20 mmol). The residue was purified by flash chromatography (pet. 
ether/Et2O 99:1→1:1) to give pyridinone 3.112 (4 mg, 4%) as an orange solid. Rf 0.44 (pet. 
ether/Et2O 4:1); m.p. 160 °C (decomp.); IR (film, cm
-1
) 2918, 2849, 1686 (C=O), 1593, 
1504, 1445, 1425, 1342, 1302, 1275; 
1
H NMR (500 MHz, CDCl3)  7.27-6.98 (10H, m, 
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ArH), 5.32 (1H, dd, J = 2.5, 1.0 Hz, ArH), 4.62 (1H, dd, J = 2.5, 1.0 Hz, ArH), 4.50 (1H, t, 
J = 2.5 Hz, ArH), 4.25 (5H, s, ArH); 
13
C NMR (125.8 MHz, CDCl3)  (3 x CF resonances 
not resolved) 167.4 (C), 143.9 (dd, 
1
JC-F = 250.0 Hz, 
2
JC-F = 13.5 Hz, C), 130.0 (CH), 
129.9 (CH), 129.7 (CH), 128.8 (CH), 128.1 (2 x CH), 128.1 (CH), 127.9 (CH), 127.1 (CH), 
125.5 (CH), 123.8 (t, 
2
JC-F = 15.0 Hz, C), 120.3 (C), 88.6 (C), 72.5 (CH), 70.5 (5 x CH), 
70.0 (C), 67.5 (CH), 66.9 (CH); 
19
F NMR (376 MHz, CDCl3)  −56.5 (t, 
4
JF-F = 22.0 Hz, 
CF3), −140.2 (ddd, 
3
JC-F = 23.0 Hz, J = 11.0 Hz, J = 3.0 Hz, F), −141.0 (dddd, J = 22.0 Hz, 
J = 22.0 Hz, J = 11.0 Hz, J = 7.0 Hz, F), −141.4 (dddd, J = 22.5 Hz, J = 22.0 Hz, J = 
11.0 Hz, J = 7.0 Hz, F), −142.2 (ddd, 
3
JC-F = 23.0 Hz, J = 11.0 Hz, J = 3.0 Hz, F); HRMS 
(EI) Exact mass calcd for C32H19F7FeNO [M+H]
+






Palladium chloride (100 mg, 0.564 mmol) was suspended in pyridine (4 mL) under nitrogen 
and the reaction stirred at 80 °C for 30 min. The mixture was filtered and hexane (10 mL) 
added to the filtrate. The filtrate was left for 16 h and the precipitate collected, washed with 
hexane, and dried to give PdCl2(pyridine)2 (42 mg, 22%) as a yellow powder. 
 1
H NMR 
(500 MHz, CDCl3)  8.87-8.84 (4H, m, ArH), 7.82-7.78 (2H, m, ArH), 7.38-7.34 (4H, m, 
ArH); 
13
C NMR (125.8 MHz, CDCl3)  153.4 (4 x CH), 138.6 (2 x CH), 125.0 (4 x CH). 














To a solution of palladium chloride (100 mg, 0.564 mmol) in CH2Cl2 (10 mL) under nitrogen 
was added pyridine (90 µL, 1.1 mmol) and the reaction heated at reflux for 3 h. Sodium 
acetate (116 mg, 1.41 mmol) and ferrocenylamide 3.77 (248 mg, 0.959 mmol) were added 
and the reaction heated at reflux for 16 h. The solvent was removed in vacuo and the residue 
purified by flash chromatography (silica doped with 1% pyridine, CH2Cl2→i-PrOH/EtOAc 
2:8→water/ i-PrOH /EtOAc 1:2:7) to give palladacyle 3.118 (56 mg, 27%) as a yellow solid. 
Rf  0.30 (water/ i-PrOH /EtOAc 1:2:7); m.p. 165 °C (decomp.); IR (film, cm
-1
) 1599 (C=O), 
1483, 1445, 1416, 1354, 1344, 1294, 1279, 1219, 1153; 
1
H NMR (500 MHz, CDCl3)  8.91 
(2H, d, J = 5.0 Hz, ArH), 8.62 (2H, d, J = 5.0 Hz, ArH), 7.91 (1H, t, J = 7.5 Hz, ArH), 7.81 
(1H, t, J = 7.5 Hz, ArH), 7.47 (2H, t, J = 7.0 Hz, ArH), 7.36 (2H, t, J = 6.5 Hz), 4.67 (1H, br 
s, CH), 4.29 (5H, s, ArH), 3.97 (1H, apt t, J = 2.0 Hz, ArH), 3.48 (1H, s, ArH), 3.19 (3H, s, 
OCH3); 
13
C NMR (125.8 MHz, CDCl3)  177.6 (C), 152.7 (2 x CH), 150.9 (2 x CH), 138.3 
(CH), 138.1 (CH), 125.6 (2 x CH), 124.9 (2 x CH), 87.5 (C), 80.8 (C), 69.6 (5 x CH), 69.1 
(CH), 66.1 (CH), 65.9 (CH), 61.0 (CH3); HRMS (ES) Exact mass calcd for C22H22FeN3O2Pd 
[M+H]
+





                                                                                                         Chapter 6. Experimental 
-202- 
 
6.4 Hydromagnesiation for the Hydrofunctionalisation of Alkenes 
6.4.1 General Procedures 
General Procedure A: Second generation hydrofunctionalisation of styrenes 
 
Method 1 
To a stirred solution of FeCl2·4H2O (7 mg, 0.04 mmol) in anhydrous THF (5 mL) under 
nitrogen was added N,N,N’,N’-tetramethylethylenediamine (TMEDA) (5 µL, 0.04 mmol) 
and stirred for 5 mins. 0.5 mL of this solution was transferred to a flask containing 4.5 mL 
anhydrous THF under nitrogen. A styrene derivative (0.7 mmol) was added to the flask and 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) was added dropwise. The 
reaction was stirred for 2 h and the electrophile (1.1 mmol) added, either neat or as a solution 
in anhydrous THF (1 M), at room temperature or at −78 °C. The reaction was stirred for a 
further 15 min (with Me3SiCl) or 2 h (with any other electrophile) and quenched with 
aqueous sulphate buffer solution or water (5 mL). The phases were separated and the 
aqueous phase extracted with Et2O (3 x 5 mL). The combined organic extracts were washed 
with water (10 mL) and brine (10 mL), dried (MgSO4) and the solvent removed in vacuo. 
The product was purified by flash chromatography. 
Method 2 
To a stirred solution of FeCl2·4H2O (10 mg, 0.05 mmol) in anhydrous THF (5 mL) under 
nitrogen was added N,N,N’,N’-tetramethylethylenediamine (TMEDA) (7 µL, 0.05 mmol) 
and stirred for 5 mins. 0.5 mL of this solution was transferred to a flask containing 6.5 mL 
anhydrous THF under nitrogen. 3-Methoxystyrene (0.14 mL, 1.0 mmol) was added to the 
flask and ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) was added dropwise. 
The reaction was stirred for 2 h and the electrophile (1.6 mmol) added, either neat or as a 
solution in anhydrous THF (1 M), at room temperature or at −78 °C. The reaction was stirred 
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for a further 15 min (with Me3SiCl) or 2 h (with other electrophiles) and quenched with 
aqueous sulphate buffer solution or water (10 mL). The phases were separated and the 
aqueous phase extracted with Et2O (3 x 10 mL). The combined organic extracts were washed 
with water (10 mL) and brine (10 mL), dried (MgSO4) and the solvent removed in vacuo. 
The product was purified by flash chromatography. 
 
General Procedure B: First generation hydrofunctionalisation of styrenes 
 
To a stirred solution of FeCl2 (1 mg, 0.007 mmol) in anhydrous THF (5 mL) under nitrogen 
was added bis(imino)pyridine (BIP) (3 mg, 0.007 mmol) and stirred for 5 mins. A styrene 
derivative (0.7 mmol) was added to the flask and ethylmagnesium bromide (3 M in THF, 
0.35 mL, 1.1 mmol) was added dropwise. The reaction was stirred for 2 h and the 
electrophile (1.1 mmol) added, either neat or as a solution in anhydrous THF (1 M), at room 
temperature or at −78 °C. The reaction was stirred for a further 15 min (with Me3SiCl) or 2 h 
(with any other electrophile) and quenched with aqueous sulphate buffer solution or water 
(5 mL). The phases were separated and the aqueous phase extracted with Et2O (3 x 5 mL). 
The combined organic extracts were washed with water (10 mL) and brine (10 mL), dried 







General procedure A (method 1) was applied to styrene 4.67 (80 µL, 0.7 mmol), 
FeCl2·4H2O (0.7 mg, 0.004 mmol), TMEDA (0.5 µL, 0.004 mmol), 
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ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and trimethylsilyl chloride (0.14 
mL, 1.1 mmol) to give silane 4.68 (91% yield by 
1
H NMR spectroscopy using 
1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, CDCl3)  7.27-7.22 (2H, 
m, ArH), 7.12-7.07 (1H, m, ArH), 7.07-7.03 (2H, m, ArH), 2.17 (1H, q, J = 7.5 Hz, 









To a stirred suspension of potassium carbonate (8.12 g, 58.8 mmol) and 
methyltriphenylphosphonium bromide (15.7 g, 44.0 mmol) in anhydrous THF (50 mL) under 
nitrogen was added m-anisaldehyde 4.70 (4.48 mL, 36.7 mmol). The reaction was heated at 
reflux for 16 h, cooled, filtered and the solvent removed in vacuo. The residue was dissolved 
in hot pentane (50 mL), cooled to 0 °C to precipitate triphenylphosphine oxide, filtered and 
washed with cold pentane (20 mL). The filtrate was concentrated in vacuo and passed 
through a short plug of silica gel (pet. ether/Et2O 9:1) to give 3-methoxystyrene 4.71 (4.69 g, 
95%) as a colourless oil. Rf 0.76 (pet. ether/EtOAc 9:1); 
1
H NMR (500 MHz, CDCl3)  
7.29-7.24 (1H, m, ArH), 7.06-7.01 (1H, m, ArH), 7.00-6.96 (1H, m, ArH), 6.87-6.82 (1H m, 
ArH), 6.72 (1H, dd, J = 17.5, 11.0 Hz, CH=CH2), 5.77 (1H, d, J = 17.5  Hz, CH=CHaHb), 
5.28 (1H, d, J = 11.0 Hz, CH=CHaHb), 3.85 (3H, s, OCH3); 
13
C NMR (125.8 MHz, CDCl3) 
 159.8 (C), 139.0 (C), 136.8 (CH), 129.5 (CH), 118.9 (CH), 114.1 (CH2), 113.4 (C), 









General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
allyl bromide 4.73 (0.14 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pentane→pentane/Et2O 99.8:0.2) to give 4.74 as a colourless oil (143 mg, 
81%). Rf 0.55 (pentane/Et2O 99:1); IR (film, cm
-1
) 3075, 2959, 2926, 2835, 1639, 1601, 
1584, 1487, 1452, 1437; 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 6.81 
(1H, d, J = 7.5 Hz, ArH), 6.79-6.73 (2H, m, ArH), 5.79-5.68 (1H, m, CH=CH2), 5.05-4.95 
(2H, m, CH=CH2), 3.82 (3H, s, OCH3), 2.78 (1H, sex., J = 7.0 Hz, CHCH3), 2.44-2.38 (1H, 
m, CHaHbCHCH3), 2.33-2.25 (1H, m, CHaHbCHCH3), 1.26 (3H, d, J = 7.0 Hz, CH3); 
13
C NMR (125.8 MHz, CDCl3)  159.8 (C), 148.8 (C), 137.1 (CH), 129.2 (CH), 119.4 (CH), 
115.9 (CH2), 113.0 (CH), 110.9 (CH), 55.1 (CH3), 42.6 (CH2), 39.8 (CH), 21.4 (CH3); 
HRMS (ES) Exact mass calcd for C12H17O [M+H]
+
: 177.1274, found: 177.1266. 
 
1-Methoxy-3-(1-phenylpropan-2-yl)benzene 4.76 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
benzyl bromide 4.75 (0.19 mL, 1.6 mmol) was added at −78 °C. The crude product was 
purified by flash chromatography (pentane→pentane/Et2O 99.5:0.5) to give 4.76 as a 
colourless oil (193 mg, 85%). Rf 0.38 (pentane/Et2O 99:1); IR (film, cm
-1
) 3026, 2959, 2928, 
2833, 1601, 1584, 1487, 1452, 1435, 1260; 
1
H NMR (500 MHz, CDCl3)  7.30-7.16 (4H, m, 
ArH), 7.14-7.10 (2H, m, ArH), 6.82 (1H, d, J = 7.5 Hz, ArH), 6.78-6.74 (2H, m, ArH), 3.80 
(3H, s, OCH3), 3.00 (1H, sex., J = 7.0 Hz, CHCH3), 2.97 (1H, dd, J = 13.0, 6.5 Hz, 
CHaHbPh), 2.78 (1H, dd, J = 12.5, 8.0 Hz, CHaHbPh), 1.26 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.5 (C), 148.7 (C), 140.8 (C), 129.2 (CH), 
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129.1 (2 x CH), 128.1 (2 x CH), 125.8 (CH), 119.5 (CH), 113.0 (CH), 111.1 (CH), 
55.1 (CH3), 45.0 (CH2), 41.9 (CH), 21.1 (CH3); HRMS (ES) Exact mass calcd for 
C16H18ONa [M+Na]
+
: 249.1250, found: 249.1250. 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 (0.14 mL, 
1.0 mmol), FeCl2
.
4H2O (1.0 mg, 0.5 mol%), TMEDA (0.7 µL, 0.5 mol%), ethylmagnesium 
bromide (3 M in THF, 0.50 mL, 1.5 mmol) and benzyl chloride 4.77 (0.18 mL, 1.6 mmol) 
was added at −78 °C. The crude product was purified by flash chromatography 
(pentane→pentane/Et2O 99.5:0.5) to give 4.76 as a colourless oil (207 mg, 91%). 
 
Ethyl 4-[2-(3-methoxyphenyl)propyl]benzoate 4.79 
General procedure A (method 2) was applied to 3-methoxystyrene 
4.71 (0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA 
(0.7 µL, 0.005 mmol), ethylmagnesium bromide (3 M in THF, 
0.50 mL, 1.5 mmol) and ethyl 4-(bromomethyl)benzoate 4.78 (389 
mg, 1.6 mmol) in THF (2 mL) was added at −78 °C. The crude product was purified by flash 
chromatography (pet. ether/Et2O 99:1→80:20) to give 4.79 as a colourless oil (155 mg, 
54%). Rf 0.46 (pet. ether/Et2O 9:1); IR (film, cm
-1
) 2961, 2932, 1715 (C=O), 1609, 1585, 
1485, 1456, 1368, 1275, 1179; 
1
H NMR (500 MHz, CDCl3)  7.92 (2H, d, J = 8.5 Hz, ArH), 
7.20 (1H, t, J = 8.0 Hz, ArH), 7.14 (2H, d, J = 8.5 Hz, ArH), 6.78-6.70 (3H, m, ArH), 4.36 
(2H, q, J = 7.0 Hz, OCH2CH3), 3.79 (3H, s, OCH3), 3.01 (1H, sex., J = 7.0 Hz, CHCH3), 
2.98 (1H, dd, J = 13.0, 7.0 Hz, CHaHbAr), 2.84 (1H, dd, J = 12.5, 7.0 Hz, CHaHbAr), 1.39 
(3H, t, J = 7.0 Hz, OCH2CH3), 1.25 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, 
CDCl3)  166.7 (C), 159.6 (C), 148.0 (C), 146.1 (C), 129.4 (2 x CH), 129.3 (CH), 
129.1 (2 x CH), 128.2 (C), 119.4 (CH), 113.0 (CH), 111.1 (CH), 60.8 (CH2), 55.1 (CH3), 
44.9 (CH2), 41.7 (CH), 21.2 (CH3), 14.3 (CH3); HRMS (ES) Exact mass calcd for 
C19H22O3Na [M+Na]
+
: 321.1461, found: 321.1471. 
 




General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) 
and 1-chloro-3-iodopropane 4.80 (0.17 mL, 1.6 mmol). The crude product was purified by 
flash chromatography (pentane→pentane/Et2O 99:1) to give 4.81 as a colourless oil 
(132 mg, 62%). Rf 0.55 (pet. ether/Et2O 19:1); IR (film, cm
-1
) 2957, 2934, 2835, 1601, 1584, 
1485, 1452, 1435, 1256, 1043; 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 
6.79 (1H, d, J = 7.5 Hz, ArH), 6.77-6.74 (2H, m, ArH), 3.82 (3H, s, OCH3), 3.53-3.46 (2H, 
m, CH2Cl), 2.70 (1H, q, J = 7.0 Hz, CHCH3), 1.80-1.62 (4H, m CH2CH2Cl), 1.27 (3H, d, J = 
7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.7 (C), 148.6 (C), 129.4 (CH), 
119.4 (CH), 113.0 (CH), 111.0 (CH), 55.1 (CH3), 45.2 (CH2), 39.5 (CH), 35.3 (CH2), 
30.8 (CH2), 22.4 (CH3); HRMS (EI) Exact mass calcd for C12H17ClO [M]
+







To a 10% aq. KOH solution (20 mL) at 0 °C was added 2-methylaziridine 4.82 (2.48 mL, 
35.0 mmol) and the reaction stirred for 30 min. Tosyl chloride (6.81 g, 35.7 mmol) was 
added and the reaction stirred for 30 min at 0 °C, and for 16 h at room temperature. The 
white precipitate was filtered, washed multiple times with water and dried under high 
vacuum. The product was purified by recrystallisation (pet. ether) to give tosyl aziridine 4.83 





H NMR (500 MHz, CDCl3)  7.83 (2H, d, J = 8.5, 2.0 Hz, ArH), 7.34 
(2H, d, J = 8.0 Hz, ArH), 2.86-2.79 (1H, m, CHCH3), 2.61 (1H, dd, J = 7.0, 2.5 Hz, 
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CHaHbCH), 2.44 (3H, s, SO2C6H4CH3), 2.02 (1H, dd, J = 4.5, 1.5 Hz, CHaHbCH), 1.25 (3H, 
dd, J = 5.5, 2.5 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  144.3 (C), 135.4 (C), 






General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) 
and tosyl aziridine 4.83 (338 mg, 1.6 mmol). The crude product (1:1 dr) was purified by 
flash chromatography (pet. ether/Et2O 9:1→1:2) to give 4.84 as a colourless oil and 1:1 
mixture of diastereomers (271 mg, 78%). Rf 0.17 (pet. ether/Et2O 2:1); IR (film, cm
-1
) 3279 
(NH), 2963, 1597, 1485, 1454, 1431, 1319, 1288, 1258, 1157; HRMS (EI) Exact mass calcd 
for C19H25NO3S [M]
+
: 347.1550, found: 347.1542. 
Diastereomer A: 
1
H NMR (500 MHz, CDCl3)  7.72-7.63 (2H, m, ArH), 7.31-7.24 (2H, m, 
ArH), 7.21-7.13 (1H, m, ArH), 6.77-6.71 (1H, m, ArH), 6.67-6.59 (2H, m, ArH), 4.24 (1H, 
m, NH), 3.81 (3H, s, OCH3), 3.29-3.14 (1H, m, CHNHTs), 2.82-2.73 (1H, m, ArCHCH3), 
2.44 (3H, s, SO2C6H4CH3), 1.68-1.55 (2H, m, CH2CHCH3), 1.16 (3H, d, J = 7.0 Hz, 
ArCHCH3), 0.97 (3H, d, J = 6.5 Hz, CHNHTsCH3);
 13
C NMR (125.8 MHz, CDCl3)  159.7 
(C), 148.0 (C), 143.2 (C), 138.3 (C), 129.6 (2 x CH),  129.4 (CH), 127.1 (2 x CH), 
119.3 (CH), 113.1 (CH), 111.3 (CH), 55.1 (CH3), 48.6 (CH), 46.4 (CH2), 36.4 (CH), 
22.7 (CH3), 22.3 (CH3), 21.5 (CH3). 
Diastereomer B: 
1
H NMR (500 MHz, CDCl3)  7.72-7.63 (2H, m, ArH), 7.31-7.24 (2H, m, 
ArH), 7.21-7.13 (1H, m, ArH), 6.77-6.71 (1H, m, ArH), 6.67-6.59 (2H, m, ArH), 4.24 (1H, 
m, NH), 3.81 (3H, s, OCH3), 3.29-3.14 (1H, m, CHNHTs), 2.67 (1H, sex., J = 7.0 Hz, 
ArCHCH3), 2.43 (3H, s, SO2C6H4CH3), 1.77 (1H, ddd, J = 14.0, 8.0, 7.0 Hz, 
CHaHbCHCH3), 1.67-1.56 (1H, m, CHaHbCHCH3), 1.13 (3H, d, J = 7.0 Hz, ArCHCH3), 1.03 
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(3H, d, J = 7.0 Hz, CHNHTsCH3);
 13
C NMR (125.8 MHz, CDCl3)  159.8 (C), 147.9 (C), 
143.2 (C), 137.9 (C), 129.6 (2 x CH), 129.5 (CH), 127.1 (2 x CH), 119.2 (CH), 112.7 (CH), 




General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) 
and 2,2-dimethyloxirane 4.85 (0.14 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (CH2Cl2→CH2Cl2/MeOH 99:1) to give 4.86 as a colourless oil (146 mg, 
70%). Rf 0.52 (pet. ether/Et2O 1:1); IR (film, cm
-1
) 3418 (O-H), 2963, 2928, 2835, 1599, 
1584, 1485, 1454, 1437, 1375; 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 
6.87-6.83 (1H, m, ArH), 6.81-6.79 (1H, m, ArH), 6.74 (1H, ddd, J = 8.0, 2.5, 1.0 Hz, ArH), 
3.81 (3H, s, OCH3), 2.95 (1H, dqd, J = 9.0, 7.0, 4.5 Hz, CHCH3), 1.98 (1H, dd, J = 14.5, 9.0 
Hz, CHaHbC(CH3)2OH), 1.77 (1H, dd, J = 14.5, 4.5 Hz, CHaHbC(CH3)2OH), 1.28 (3H, d, J = 
7.0 Hz, CHCH3), 1.18 (3H, s, CH2C(CH3)a(CH3)bOH), 1.15 (3H, s, CH2C(CH3)a(CH3)bOH); 
13
C NMR (125.8 MHz, CDCl3)  159.8 (C), 149.8 (C), 129.6 (CH), 119.5 (CH), 113.1 (CH), 
111.0 (CH), 71.4 (C), 55.1 (CH3), 51.2 (CH2), 36.5 (CH), 29.9 (2 x CH3), 25.0 (CH3); HRMS 
(ES) Exact mass calcd for C13H20O2Na [M+Na]
+
: 231.1356, found: 231.1367. 
 
(2R)-4-(3-Methoxyphenyl)pentan-2-ol 4.88 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
(R)-(+)-propylene oxide 4.87 (0.11 mL, 1.6 mmol). The crude product (1:1 dr) was purified 
by flash chromatography (pet. ether/Et2O 3:1→1:1) to give 4.88 as a colourless oil and 1:1 
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mixture of diastereomers (139 mg, 71%). Rf 0.29 (pet. ether/Et2O 3:1); IR (film, cm
-1
) 3368 
(O-H), 2961, 2926, 2835, 1599, 1584, 1485, 1454, 1437, 1375; HRMS (ES) Exact mass 
calcd for C12H18O2Na [M+Na]
+
: 217.1199, found: 217.1182. 
Diastereomer A 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 6.82 (1H, d, J 
= 7.5 Hz, ArH), 6.79-6.73 (2H, m, ArH), 3.81 (3H, s, OCH3), 3.62-3.55 (1H, m, CHOH), 
3.00-2.92 (1H, m, CHCH3), 1.72-1.68 (2H, m, CH2CHCH3), 1.34 (1H, br. s, OH), 1.27 (3H, 
d, J = 7.0 Hz, ArCHCH3), 1.14 (3H, d, J = 6.0 Hz, CHCH3OH); 
13
C NMR (125.8 MHz, 
CDCl3)  159.7 (C), 148.6 (C), 129.4 (CH), 119.5 (CH), 113.1 (CH), 110.9 (CH), 65.9 (CH), 
55.1 (CH3), 47.5 (CH2), 36.6 (CH), 24.1 (CH3), 23.0 (CH3). 
Diastereomer B 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 6.82 (1H, d, 
J = 7.5 Hz, ArH), 6.79-6.73 (2H, m, ArH), 3.81 (3H, s, OCH3), 3.83-3.75 (1H, m, CHOH), 
2.85 (1H, sex., J = 7.0 Hz, ArCHCH3), 1.83 (1H, td, J = 14.0, 7.5 Hz, CHaHbCHCH3), 1.65 
(1H, ddd, J = 14.0, 7.5, 5.0 Hz, CHaHbCHCH3), 1.34 (1H, br. s, OH), 1.27 (3H, d, J = 
7.0 Hz, CHCH3OH), 1.20 (3H, d, J = 6.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  
159.8 (C), 149.0 (C), 129.5 (CH), 119.2 (CH), 112.9 (CH), 111.1 (CH), 66.4 (CH), 
55.1 (CH3), 47.8 (CH2), 37.0 (CH), 23.7 (CH3), 22.2 (CH3). 
 
7-[1-(3-Methoxyphenyl)ethyl]cyclohepta-1,3,5-triene 4.90 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) 
and the benzylic Grignard intermediate was added to tropylium 
tetrafluoroborate 4.89 (285 mg, 1.6 mmol) in THF (2 mL). The crude product was purified 
by flash chromatography (pentane → pentane/Et2O 98:2) to give 4.90 as a colourless oil 
(190 mg, 84%). Rf 0.25 (pentane/Et2O 99:1); IR (film, cm
-1
) 3013, 2961, 2833, 1601, 1584, 
1485, 1452, 1435, 1287, 1261; 
1
H NMR (500 MHz, CDCl3)  7.24 (1H, t, J = 8.0 Hz, ArH), 
6.81-6.76 (2H, m, ArH), 6.75-6.73 (1H, m, ArH), 6.71 (1H, dd, J = 11.0, 5.5 Hz, CHa), 6.67 
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(1H, dd, J = 11.0, 5.5 Hz, CHa’), 6.28 (1H, dd, J = 9.5, 5.5 Hz, CHb), 6.07 (1H, dd, J = 9.5, 
5.5 Hz, CHb’), 5.37 (1H, dd, J = 9.5, 5.5 Hz, CHc), 5.08 (1H, dd, J = 9.5, 6.0 Hz, CHc’), 3.81 
(3H, s, OCH3), 3.00 (1H, qd, J = 10.5, 7.0 Hz, CHCH3), 1.76 (1H, td, J = 11.0, 5.5 Hz, 
CHCHCH3), 1.38 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.7 (C), 
147.8 (C), 131.0 (CH), 130.6 (CH), 129.4 (CH), 125.5 (CH), 124.9 (CH), 124.9 (CH), 
124.2 (CH), 120.1 (CH), 113.8 (CH), 111.1 (CH), 55.1 (CH3), 45.3 (CH), 42.3 (CH), 
20.9 (CH3); HRMS (EI) Exact mass calcd for C16H18O [M]
+






To a suspension of amine (500 mg, 5.13 mmol), 1-methylimdazole (41 µL, 0.51 mmol), 
TMEDA (76 µL, 0.51 mmol) and K2CO3 (1.78 g, 12.8 mmol) in anhydrous acetonitrile 
(5 mL) at 0 °C was added hydrocinnamoyl chloride 4.91 (1.14 mL, 7.70 mmol). The mixture 
was stirred at 0 °C for 2 h and water (10 mL) added. The phases were separated and the 
aqueous phase extracted with EtOAc (3 x 10 mL). The combined organics were washed with 
water (40 mL) and brine (40 mL) and the solvent removed in vacuo. The product was 
purified by flash chromatography (pet. ether/EtOAc 4:1→1:1) to give Weinreb amide 4.92 
(823 mg, 83%) as a colourless oil. Rf 0.27 (pet. ether/EtOAc 3:1); 
1
H NMR (500 MHz, 
CDCl3)  7.32-7.28 (2H, m, ArH), 7.26-7.23 (2H, m, ArH), 7.23-7.19 (1H, m, ArH), 3.61 
(3H, s, OCH3), 3.19 (3H, s, NCH3), 2.98 (2H, t, J = 7.5 Hz, PhCH2), 2.76 (2H, t, J = 7.5 Hz, 
CH2CO); 
13
C NMR (125.8 MHz, CDCl3)  173.7 (C), 141.3 (C), 128.4 (4 x CH), 












To a stirred suspension of NHMeOMe·HCl (980 mg, 10 mmol) in anhydrous CH2Cl2 
(25 mL) at 0 °C was added triethylamine (2.8 mL, 20 mmol) and benzoyl chloride 4.93 
(1.2 mL, 10 mmol) dropwise. The reaction was stirred at 0 °C for 15 min and warmed to 
room temperature over 1 h. The reaction was quenched with sat. aq. NaHCO3 (25 mL) and 
the phases separated. The organic phase was washed with 1 M HCl (25 mL) and brine 
(25 mL). The organic phase was dried (Na2SO4) and the solvent removed in vacuo to give 
crude amide. The product was purified by flash chromatography (pet. ether/EtOAc 
19:1→2:1) to give Weinreb amide 4.94 (1.59 g, 96%) as a colourless oil. Rf 0.35 (pet. 
ether/EtOAc 9:1); 
1
H NMR (500 MHz, CDCl3)  7.70-7.64 (2H, m, ArH), 7.48-7.43 (1H, m, 
ArH), 7.43-7.37 (2H, m, ArH), 3.56 (3H, s, OCH3), 3.36 (3H, s, NCH3); 
13
C NMR (125.8 
MHz, CDCl3)  169.9 (C), 134.1 (C), 130.5 (CH), 128.1 (2 x CH), 128.0 (2 x CH), 








To a solution of amine 4.96 (1.00 g, 5.84 mmol) in ethanol (20 mL) was added FeCl3 
(38 mg, 4 mol%) and benzaldehyde 4.95 (1.19 mL, 11.7 mmol). The reaction was stirred for 
1 h and the solvent removed in vacuo. The residue was dissolved in EtOAc (20 mL) and 
washed with sat. aq. NaHCO3 (3 x 20 mL). The organic phase was dried (MgSO4) and the 
solvent removed in vacuo. The crude reaction mixture was purified by flash chromatography 
(pet. ether/EtOAc 9:1→1:1) to give imine 4.97 (837 mg, 55%) as a colourless solid. Rf 0.57 




H NMR (500 MHz, CDCl3)  9.04 
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(1H, s, CHN), 7.94 (2H, dd, J  = 8.5, 1.5 Hz, ArH), 7.90 (2H, d, J = 8.5 Hz, ArH), 7.62 (1H, 
tt, J = 7.5, 1.5 Hz, ArH), 7.50 (2H, t, J = 8.0 Hz, ArH), 7.36 (2H, d, J = 8.0 Hz, ArH), 2.45 
(3H, s, CH3); 
13
C NMR (125.8 MHz, CDCl3)  170.1 (CH), 144.6 (C), 135.2 (C), 
134.9 (CH), 132.4 (C), 131.3 (2 x CH), 129.8 (2 x CH), 129.1 (2 x CH), 128.1 (2 x CH), 




2-(3-Methoxyphenyl)propanoic acid ethyl ester 4.102
341
 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
ethyl chloroformate (0.15 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pet. ether/Et2O 99:1→94:6) to give 4.102 as a colourless oil (157 mg, 
75%). Rf 0.26 (pet. ether/Et2O 9:1); 
1
H NMR (500 MHz, CDCl3)  7.24 (1H, t, J = 8.0 Hz, 
ArH), 6.92-6.89 (1H, m, ArH), 6.87 (1H, t, J = 2.0 Hz, ArH), 6.81 (1H, ddd, J = 8.0, 2.5, 1.0 
Hz, ArH), 4.16 (1H, dq, J = 11.0, 7.0 Hz, OCHaHbCH3), 4.11 (1H, dq, J = 11.0, 7.0 Hz, 
OCHaHbCH3), 3.81 (3H, s, OCH3), 3.69 (1H, q, J = 7.0 Hz, CHCH3), 1.50 (3H, d, J = 
7.0 Hz, CHCH3), 1.22 (3H, t, J = 7.0 Hz, OCH2CH3); 
13
C NMR (125.8 MHz, CDCl3)  
174.4 (C), 159.7 (C), 142.2 (C), 129.5 (CH), 119.8 (CH), 113.2 (CH), 112.4 (CH), 








General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
N,N-dimethylformamide (0.12 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pet. ether/Et2O 99:1→90:10) to give 4.104 as a colourless oil (105 mg, 
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64%). Rf 0.31 (pet. ether/Et2O 9:1); 
1
H NMR (500 MHz, CDCl3)  9.68 (1H, d, J = 1.5 Hz, 
CHO), 7.31 (1H, t, J = 8.0 Hz, ArH), 6.86 (1H, ddd, J = 8.5, 2.5, 1.0 Hz, ArH), 6.82 (1H, d, 
J = 8.0 Hz, ArH), 6.76 (1H, t, J = 2.0 Hz, ArH), 3.82 (3H, s, OCH3), 3.61 (1H, dq, J = 7.0, 
1.0 Hz, CHCH3), 1.45 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3) 
 200.8 (CH), 160.1 (C), 139.2 (C), 130.0 (CH), 120.6 (CH), 114.1 (CH), 112.7 (CH), 







General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
benzonitrile (0.16 mL, 1.6 mmol). The crude product was purified by flash chromatography 
(pet. ether/Et2O 99:1→95:5) to give 4.106 as a colourless oil (156 mg, 65%); Rf 0.32 (pet. 
ether/Et2O 19:1); 
1
H NMR (500 MHz, CDCl3)  7.96 (2H, dd, J = 8.0, 1.0 Hz, ArH), 
7.51-7.46 (1H, m, ArH), 7.41-7.37 (2H, m, ArH), 7.22 (1H, t J = 8.0 Hz, ArH), 6.89 (1H, d, 
J = 8.0 Hz, ArH), 6.83 (1H, t, J = 2.0 Hz, ArH), 6.75 (1H, ddd, J = 8.0, 2.5, 1.0 Hz, ArH), 
4.66 (1H, q, J = 7.0 Hz, CHCH3), 3.78 (3H, s, OCH3), 1.54 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  200.1 (C), 160.0 (C), 143.0 (C), 136.5 (C), 132.7 (CH), 
129.9 (CH), 128.7 (2 x CH), 128.5 (2 x CH), 120.2 (CH), 113.5 (CH), 112.1 (CH), 





General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
benzonitrile (0.16 mL, 1.6 mmol). The reaction was quenched with anhydrous MeOH (2 mL) 
and sodium borohydride added (64 mg, 1.7 mmol). The reaction was stirred for 2 h and 
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quenched with water (10 mL). The phases were separated and the aqueous phase extracted 
with Et2O (3 x 10 mL). The combined organic extracts were washed with water (10 mL) and 
brine (10 mL), dried (MgSO4) and the solvent removed in vacuo. The crude product was 
purified by flash chromatography (pet. ether/EtOAc 1:1→EtOAc) to give 4.108 as a 
colourless oil (132 mg, 55%) and as a single diastereomer; Rf 0.48 (EtOAc); IR (film, cm
-1
) 
2961, 2833, 1599, 1584, 1487, 1452, 1437, 1281, 1261, 1155; 
1
H NMR (500 MHz, CD3OD) 
 7.41-7.38 (2H, m, ArH), 7.38-7.33 (2H, m, ArH), 7.30-7.25 (2H, m, ArH), 6.92 (1H, d, J = 
7.5 Hz, ArH), 6.89-6.86 (1H, m, ArH), 6.82 (1H, dd, J = 8.0, 2.5 Hz, ArH), 3.93 (1H, d, J = 
9.5 Hz, CHNH2), 3.80 (3H, s, OCH3), 2.91 (1H, dq, J = 9.5, 7.0 Hz, CHCH3), 0.98 (3H, d, 
J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CD3OD)  161.5 (C), 147.5 (C), 144.9 (C), 
130.7 (CH), 129.5 (2 x CH), 128.7 (2 x CH), 128.5 (CH), 120.0 (CH), 114.7 (CH), 
113.1 (CH), 63.4 (CH), 55.6 (CH3), 49.1 (CH), 19.9 (CH3); HRMS (ES) Exact mass calcd 
for C16H19NONa [M+Na]
+
: 264.1359, found: 264.1366. The relative stereochemistry was 
determined by comparing this 
1







General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
vinyl bromide (1 M in THF, 1.6 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pentane→pentane/Et2O 98:2) to give alkene 4.115 as a colourless oil 
(124 mg, 76%). Rf 0.63 (pet. ether/Et2O 99:1); 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 
8.0 Hz, ArH), 6.83 (1H, d, J = 7.5Hz, ArH), 6.80-6.74 (2H, m, ArH), 6.01 (1H, ddd, J = 
17.0, 10.5, 6.5 Hz, CH=CH2), 5.10-5.03 (2H, m, CH=CH2), 3.81 (3H, s, OCH3), 3.46 (1H, 
app. quintet, J = 7.0 Hz, CHCH3), 1.37 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, 
CDCl3)  159.7 (C), 147.3 (C), 143.1 (CH), 129.3 (CH), 119.7 (CH), 113.2 (CH), 
113.2 (CH2), 111.2 (CH), 55.1 (CH3), 43.2 (CH), 20.7 (CH3).  Data consistent with 










General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
β-bromostyrene (0.21 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pentane→pentane/Et2O 99:1) to give alkene 4.117 as a yellow oil (187 mg, 
78%). Rf 0.48 (pet. ether/Et2O 99:1); 
1
H NMR (500 MHz, CDCl3)  7.39-7.35 (2H, m, ArH), 
7.30 (2H, t, J = 7.5 Hz, ArH), 7.26-7.19 (2H, m, ArH), 6.89 (1H, d, J = 7.5 Hz, ArH), 
6.86-6.83 (1H, m, ArH), 6.77 (1H, dd, J = 8.0, 2.5 Hz, ArH), 6.44 (1H, d, J = 16.0 Hz, 
CHPh), 6.38 (1H, dd, J = 16.0, 6.0 Hz, CH=CHPh), 3.82 (3H, s, OCH3), 3.63 (1H, quintet, 
J = 7.0 Hz, CHCH3), 1.47 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3) 
 159.7 (C), 147.4 (C), 137.6 (C), 135.0 (CH), 129.4 (CH), 128.6 (CH), 128.5 (2 x CH), 
127.0 (CH), 126.2 (2 x CH), 119.7 (CH), 113.3 (CH), 111.3 (CH), 55.2 (CH3), 42.6 (CH), 








General procedure A (method 1) was applied to 
3-methoxystyrene 4.71 (97 µL, 0.7 mmol), FeCl2·4H2O 
(0.7 mg, 0.005 mmol), TMEDA (0.5 µL, 0.005 mmol), 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 
mmol) and α-bromostyrene (0.15 mL, 1.1 mmol). The crude product was purified by flash 
chromatography (pentane→pentane/Et2O 99:1) to give alkene 4.117 (107 mg, 64%) as a 1:1 
inseparable mixture of cis/trans isomers and a colourless oil.  Rf 0.48 (pet. ether/Et2O 99:1). 
Data consistent with literature.
345
 





H NMR (500 MHz, CDCl3)  7.40-7.18 (6H, m, ArH), 6.90 (1H, d, J = 7.5 Hz, ArH), 
6.86-6.84 (1H, m, ArH), 6.80-6.75 (1H, m, ArH), 6.51 (1H, d, J = 11.5 Hz, CHPh), 5.84 
(1H, dd, J = 11.5, 10.5 Hz, CH=CHPh), 4.01 (1H, qd, J = 10.5, 7.0 Hz, CHCH3), 3.82 (3H, 
s, OCH3), 1.41 (3H, d, J = 7.0 Hz, CHCH3);
13
C NMR (125.8 MHz, CDCl3)  159.8 (C), 
147.9 (C), 137.4 (C), 136.8 (CH), 129.5 (CH), 128.7 (2 x CH), 128.2 (2 x CH) 127.9 (CH), 
126.7 (CH), 119.3 (CH), 113.0 (CH), 111.1 (CH), 55.1 (CH3), 37.8 (CH), 22.8 (CH3).   
Trans: 
1
H NMR (500 MHz, CDCl3)  7.40-7.18 (6H, m, ArH), 6.90 (1H, d, J = 7.5 Hz, 
ArH), 6.86-6.84 (1H, m, ArH), 6.80-6.75 (1H, m, ArH), 6.44 (1H, d, J = 16.0 Hz, CHPh), 
6.39 (1H, dd, J = 16.0, 6.0 Hz, CH=CHPh), 3.82 (3H, s, OCH3), 3.64 (1H, quintet, J = 
7.0 Hz, CHCH3), 1.48 (3H, d, J = 7.0 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.7 
(C), 147.4 (C), 137.6 (C), 135.0 (CH), 129.4 (CH), 128.6 (CH), 128.5 (2 x CH), 127.0 (CH), 






To a flask containing NaH (60% dispersion in mineral oil, 350 mg, 8.8 mmol) at 0 °C under 
nitrogen was added dropwise a solution of 4-phenylphenol 4.148 (990 mg, 5.8 mmol) in 
THF (40 mL). The reaction was warmed to rt for 15 min and then cooled to 0 °C. 
N,N-Dimethylsulfamoyl chloride (0.75 mL, 7.0 mmol) was added dropwise and the reaction 
warmed to rt for 16 h. The reaction was quenched with a few drops of water and the solvent 
removed in vacuo. The residue was dissolved in EtOAc (40 mL) and water (40 mL) and the 
phases separated. The organic phase was washed with 1 M NaOH solution (40 mL) and 
water (40 mL). The aqueous phases were combined and extracted with EtOAc (3 x 50 mL). 
The organic phases were combined, washed with brine (200 mL), dried (MgSO4) and the 
solvent removed in vacuo. The product was purified by flash chromatography (pet. 
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ether/toluene/Et2O 49.5:49.5:1 → 48:48:4) to give sulfamate 4.149 (596 mg, 37%) as a 





(500 MHz, CDCl3)  7.63-7.60 (2H, m, ArH), 7.59-7.56 (2H, m, ArH), 7.48-7.44 (2H, m, 
ArH), 7.40-7.35 (3H, m, ArH), 3.02 (6H, s, N(CH3)2); 
13
C NMR (125.8 MHz, CDCl3)  
149.6 (C), 139.9 (C), 139.9 (C), 128.8 (2 x CH), 128.4 (2 x CH), 127.6 (CH), 127.1 (2 x 





General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
trimethylsilyl chloride (0.20 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pet. ether→pet. ether/Et2O 97:3) to give 4.152 as a colourless oil (173 mg, 
97%). Rf 0.32 (pet. ether); IR (film, cm
-1
) 2953, 2870, 2833, 1599, 1582, 1485, 1456, 1435, 
1311, 1248; 
1
H NMR (500 MHz, CDCl3)  7.17 (1H, t, J = 8.0 Hz, ArH), 6.66 (2H, d, J = 
8.0 Hz, ArH), 6.62 (1H, s, ArH), 3.81 (3H, s, OCH3), 2.17 (1H, q, J = 7.5 Hz, CHSi(CH3)3), 
1.37 (3H, d, J = 7.5 Hz, CHCH3), −0.03 (9H, s, Si(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  
159.4 (C), 147.8 (C), 128.8 (CH), 119.7 (CH), 113.0 (CH), 109.2 (CH), 55.0 (CH3), 
29.9 (CH), 14.8 (CH3), −3.3 (3 x CH3);; HRMS (ES) Exact mass calcd for C12H20OSiNa 
[M+Na]
+





General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
pinacolborane (0.23 mL, 1.6 mmol). The crude product was purified by flash 
chromatography (pet. ether/Et2O/NEt3 97:2:1→93:6:1) to give 4.154 as a colourless oil 
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(129 mg, 45%).  Rf 0.52 (9:1 pet. ether/Et2O); 
1
H NMR (500 MHz, CDCl3)  7.19 (1H, t, J = 
8.0 Hz, ArH), 6.84-6.81 (1H, m, ArH), 6.81-6.78 (1H, m, ArH), 6.70 (1H, ddd, J = 8.0, 2.5, 
1.0 Hz, ArH), 3.80 (3H, s, OCH3), 2.42 (1H, q, J = 7.5 Hz, CHCH3), 1.33 (3H, d, J = 7.5 Hz, 
CHCH3), 1.23 (6H, s, C(CH3)a(CH3)bC(CH3)a(CH3)b), 1.22 (6H, s, 
C(CH3)a(CH3)bC(CH3)a(CH3)b); 
13
C NMR (125.8 MHz, CDCl3)  (CH resonance not 
resolved) 159.6 (C), 146.6 (C), 129.1 (CH), 120.3 (CH), 113.5 (CH), 110.5 (CH), 
83.3 (2 x C), 55.1 (CH3), 24.6 (2 x CH3), 24.6 (2 x CH3), 17.0 (CH3); 
11
B (128 MHz, CDCl3) 








To a solution of piperidine 4.158 (1.39 mL, 11.7 mmol) and t-butanol (0.55 mL, 5.8 mmol) 
in TBME (30 mL) at 0 °C was slowly added NaOCl (23.5 mL, 11.8 mmol) and acetic acid 
(0.68 mL, 12.0 mmol). The reaction was stirred at 0°C for 30 min and quenched with water 
(15 mL). The phases were separated and the aqueous phase extracted with TBME (20 mL). 
The combined organics were washed with brine (50 mL), dried (Na2SO4) and the solvent 
removed in vacuo to give  N-chloropiperidine 4.159 (1.35 g, 96%) as a pale yellow oil. 
Rf 0.65 (pet. ether/Et2O 9:1); 
1
H NMR (500 MHz, CDCl3)  3.77-2.45 (4H, m, NCl(CH2)2), 
1.77-1.66 (4H, m, NCl(CH2)2(CH2)2), 1.64-1.17 (2H, m, NCl(CH2)2(CH2)2CH2); 
13
C NMR 














To a stirred suspension of benzoyl peroxide 4.161 (70% in water, 2.86 g, 8.26 mmol) and 
K2HPO4 (2.16 g, 12.4 mmol) in DMF (25 mL) was added morpholine 4.160 (0.87 mL, 
9.9 mmol). The reaction was stirred for 1 h, quenched with water (25 mL) and stirred 
vigorously for 30 min. The mixture was extracted with EtOAc (50 mL) and the organic 
phase washed with sat. aq. NaHCO3 (2 x 50 mL). The aqueous phases were combined and 
extracted with EtOAc (3 x 50 mL). The organic phases were combined and washed with 
water (3 x 50 mL), brine (3 x 50 mL), dried (MgSO4) and the solvent removed in vacuo. The 
product was purified by flash chromatography (4:1→1:2 pet. ether/EtOAc) to give 
morpholine 4.162 as a colourless solid (1.40 g, 81%). Rf 0.41 (pet. ether/EtOAc 3:1); 




H NMR (500 MHz, CDCl3)  8.01 (2H, d, J = 8.0 Hz, 
ArH), 7.57 (1H, t, J = 7.5 Hz, ArH), 7.45 (2H, t, J = 8.0 Hz, ArH), 3.98 (2H, br d, J = 
11.0 Hz, O(CH2)a(CH2)b), 3.87 (2H, br t, J = 11.0 Hz, O(CH2)a(CH2)b), 3.45 (2H, br d, J = 
9.5 Hz, N(CH2)a(CH2)b), 3.04 (2H, br t, J = 9.0 Hz, N(CH2)a(CH2)b); 
13
C NMR (125.8 MHz, 
CDCl3)  164.5 (C), 133.1 (CH), 129.4 (2 x CH), 129.1 (C), 128.4 (2 x CH), 65.8 (2 x CH2), 







General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 0.005 
mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and the 
reaction exposed to air. The crude product was purified by flash chromatography (pet. 
ether/Et2O 4:1→1:2) to give 4.170 as a colourless oil (127 mg, 83%). Rf 0.33 (pet. 
ether/Et2O 1:1); 
1
H NMR (500 MHz, CDCl3)  7.28 (1H, t, J = 8.0 Hz, ArH), 6.97-6.94 (2H, 
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m, ArH), 6.83 (1H, ddd, J = 8.0, 2.5, 0.5 Hz, ArH), 4.91-4.86 (1H, m, CHCH3), 3.83 (3H, s, 
OCH3), 1.50 (3H, d, J = 6.5 Hz, CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.8 (C), 147.6 
(C), 129.5 (CH), 117.7 (CH), 112.9 (CH), 110.9 (CH), 70.3 (CH), 55.2 (CH3), 25.1 (CH3). 




1-Methoxy-3-[1-(phenylsulfanyl)ethyl]benzene and 1-methoxy-3-[2- 
(phenylsulfanyl)ethyl]benzene 4.172 
General procedure A (method 2) was applied to 
3-methoxystyrene 4.71 (0.14 mL, 1.0 mmol), 
FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and the 
hydromagnesiated intermediate was added to a solution of diphenyl sulfide (349 mg, 1.6 
mmol) in THF (2 mL) at −78 °C via cannula. The crude product was purified by flash 
chromatography (pentane→pentane/Et2O 98.8:1.2) to give a 10:1 α:β inseparable mixture of 
4.172 as a colourless oil (153 mg, 63%). Rf 0.53 (pentane/Et2O 98:2); IR (film, cm
-1
) 3057, 
2965, 2924, 2833, 1599, 1584, 1481, 1454, 1437, 1315; HRMS (ES) Exact mass calcd for 
C15H16OSNa [M+Na]
+
: 267.0814, found: 267.0816. 
α: 
1
H NMR (500 MHz, CDCl3)  7.34-7.29 (2H, m, ArH), 7.26-7.17 (4H, m, ArH), 
6.93-6.89 (1H, m, ArH), 6.89 (1H, t, J = 2.0 Hz, ArH), 6.77 (1H, ddd, J = 8.0, 2.5, 1.0 Hz, 
ArH), 4.32 (1H, q, J = 7.0 Hz, CHCH3), 3.77 (3H, s, OCH3), 1.63 (3H, d, J = 7.0 Hz, 
CHCH3); 
13
C NMR (125.8 MHz, CDCl3)  159.6 (C), 144.9 (C), 135.2 (C), 132.4 (2 x CH), 
129.3 (CH), 128.6 (2 x CH), 127.1 (CH), 119.6 (CH), 112.8 (CH), 112.6 (CH), 55.1 (CH3), 
48.0 (CH), 22.3 (CH3);  
β: 
1
H NMR (500 MHz, CDCl3)  7.39-7.16 (6H, m, ArH), 6.93-6.73 (3H, m, ArH), 3.80 
(3H, s, OCH3), 3.21-3.15 (2H, m, CH2SPh), 2.92 (2H, dd, 9.0, 6.5 Hz, CH2CH2SPh); 
13
C NMR (125.8 MHz, CDCl3)  141.8 (C), 136.3 (C), 132.6 (C), 129.5 (CH), 
129.2 (2 x CH), 128.9 (2 x CH), 126.0 (CH), 120.8 (CH), 114.3 (CH), 111.7 (CH), 55.1 
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(CH3), 35.7 (CH2), 35.0 (CH2). 
 
1-Methoxy-3-(1-sulfonylethyl)benzene 4.179 
General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.5 mol%), TMEDA (0.7 µL, 
0.5 mol%), ethylmagnesium bromide (3M in THF, 0.50 mL, 1.5 mmol) and 
DABSO (384 mg, 1.6 mmol). The hydromagnesiated intermediate was added to a solution of 
DABSO (1M) at –40 °C. The reaction was quenched with 1 M NaOH (5 mL), the layers 
were separated and the aqueous layer extracted with Et2O (3 x 10 mL). The aqueous layer 
was acidified to pH 1 with 1 M HCl and extracted with Et2O (3 x 10 mL). The combined 
organic extracts were washed with water (10 mL) and brine (10 mL), dried (MgSO4) and the 
solvent removed in vacuo. The crude residue was purified by flash chromatography 
(EtOAc→EtOAc/ i-PrOH 7:3→H2O/ i-PrOH /EtOAc 1:2:7) to yield 4.179 as a colourless 
solid (35 mg, 17%); Rf 0.15 (H2O/ i-PrOH /EtOAc 1:2:7); m.p. 104 °C (dec.); IR (film, cm
-1
) 
3348, 2924, 2853, 2480, 2243, 2072, 1599, 1489, 1119, 972; 
1
H NMR (500 MHz, CD3OD) 
 7.20 (1H, t, J = 8.0 Hz, ArH), 6.88-6.83 (2H, m, ArH), 6.78 (1H, dd, J = 8.0, 2.5 Hz, 
ArH), 3.78 (3H, s, OCH3), 3.22 (1H, q, J = 7.0 Hz, CHCH3), 1.48 (3H, d, J = 7.0 Hz, 
CHCH3); 
13
C NMR (125.8 MHz, CD3OD)  161.0 (C), 141.8 (C), 130.1 (CH), 122.1 (CH), 





General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
bromine (0.08 mL, 1.6 mmol) at −78 °C to give bromide 4.182 (47% yield by 
1
H NMR 
spectroscopy using 1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, 
CDCl3)  7.29-7.25 (1H, m, ArH), 7.05-7.02 (1H, m, ArH), 6.99 (1H, t, J = 2.0 Hz, ArH), 
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6.84 (1H, ddd, J = 8.0, 2.5, 1.0 Hz, ArH), 5.19 (1H, q, J = 7.0 Hz, CHCH3), 3.83 (3H, s, 
OCH3), 2.05 (3H, d, J = 7.0 Hz, CHCH3). 
13
C NMR (125.8 MHz, CDCl3)  159.7 (C), 
144.7 (C), 129.7 (CH), 119.1 (CH), 113.8 (CH), 112.6 (CH), 55.3 (CH3), 49.4 (CH), 





General procedure A (method 2) was applied to 3-methoxystyrene 4.71 
(0.14 mL, 1.0 mmol), FeCl2·4H2O (1 mg, 0.005 mmol), TMEDA (0.7 µL, 
0.005 mmol), ethylmagnesium bromide (3 M in THF, 0.50 mL, 1.5 mmol) and 
iodine (406 mg, 1.6 mmol) to give iodide 4.184 (54% yield by 
1
H NMR spectroscopy using 
1,3,5-trimethoxybenzene as internal standard). Iodine was added as a solution in anhydrous 
THF (1 M) at −78 °C. 
1
H NMR (500 MHz, CDCl3)  7.23 (1H, t, J = 8.0 Hz, ArH), 
7.06-7.03 (1H, m, ArH), 6.99 (1H, t, J = 2.0 Hz, ArH), 6.80 (1H, ddd, J = 8.0, 2.5, 0.5 Hz, 




General procedure A (method 1) was applied to 3-methylstyrene 4.189 (91 µL, 
0.7 mmol), FeCl2·4H2O (0.7 mg, 0.007 mmol), TMEDA (0.5 µL, 0.007 mmol), 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and trimethylsilyl 
chloride (0.14 mL, 1.1 mmol) to give silane 4.192 (87% yield by 
1
H NMR spectroscopy 
using 1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, CDCl3)  7.16-
7.11 (1H, m, ArH), 6.93-6.89 (1H, m, ArH), 6.88-6.83 (2H, m, ArH), 2.33 (3H, s, ArCH3), 








General procedure B was applied to 2-methylstyrene 4.189 (91 µL, 0.7 mmol), 
FeCl2 (0.9 mg, 0.007 mmol), BIP (3 mg, 0.007 mmol), ethylmagnesium 
bromide (3 M in THF, 0.35 mL, 1.1 mmol) and trimethylsilyl chloride (0.14 mL, 1.1 mmol) 
to give silane 4.190 (65% yield by 
1
H NMR spectroscopy using 1,3,5-trimethoxybenzene as 
internal standard). 
1
H NMR (500 MHz, CDCl3)  7.21-7.10 (2H, m, ArH), 7.06 (1H, d, J = 
8.0 Hz, ArH), 7.00 (1H, td, J = 7.5, 1.0 Hz, ArH), 2.42 (1H, q, J = 7.5 Hz, CHCH3), 2.27 
(3H, s, ArCH3), 1.36 (3H, d, J = 7.5 Hz, CHCH3), −0.03(9H, s, Si(CH3)3). 
 
Trimethyl[1-(4-methylphenyl)ethyl]silane 4.194 
General procedure B was applied to 4-methylstyrene 4.193 (92 µL, 
0.7 mmol), FeCl2 (1 mg, 0.007 mmol), BIP (3 mg, 0.007 mmol), 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and trimethylsilyl chloride 
(0.14 mL, 1.1 mmol) to give silane 4.194 (88% yield by 
1
H NMR spectroscopy using 
1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, CDCl3)  7.06 (2H, d, 
J = 8.0 Hz, ArH), 6.94 (2H, d, J = 8.0 Hz, ArH), 2.31 (3H, s, ArCH3), 2.13 (1H, q, J = 7.5 





General procedure B was applied to 2,4-dimethoxystyrene 4.198 (92 µL, 
0.7 mmol), FeCl2 (1 mg, 0.007 mmol), BIP (3 mg, 0.007 mmol), 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and carbon 
dioxide (1 pellet of dry ice) to give carboxylic acid 4.201 (67% yield by 
1
H NMR 
spectroscopy using 1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, 
CDCl3)  7.16 (1H, d, J = 8.0 Hz, ArH), 6.51-6.44 (2H, m, ArH), 4.02 (1H, q, J = 7.0 Hz, 








General procedure B was applied to 4-fluorostyrene 4.204 (92 µL, 
0.7 mmol), FeCl2 (1 mg, 0.007 mmol), BIP (3 mg, 0.007 mmol), 
ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and 
trimethylsilyl chloride (0.14 mL, 1.1 mmol) to give silane 4.205 (38% yield by 
1
H NMR 
spectroscopy using 1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, 
CDCl3)  7.06-6.90 (4H, m, ArH), 2.15 (1H, q, J = 7.5 Hz, CHCH3), 1.34 (3H, d, J = 7.5 Hz, 
CHCH3), −0.06 (9H, s, Si(CH3)3). 
 
Trimethyl[1-(4-phenylphenyl)ethyl]silane 4.207 
General procedure A (method 1) was applied to 4-phenylstyrene 4.206 
(126 mg, 0.7 mmol), FeCl2·4H2O (0.7 mg, 0.007 mmol), TMEDA (0.5 µL, 
0.007 mmol), ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and trimethylsilyl 
chloride (0.14 mL, 1.1 mmol) to give silane 4.207 (21% yield by 
1
H NMR spectroscopy 
using 1,3,5-trimethoxybenzene as internal standard). 
1
H NMR (500 MHz, CDCl3) 
 7.67-7.10 (9H, m, ArH), 2.23 (1H, q, J = 7.5 Hz, CHCH3), 1.41 (3H, d, J = 7.5 Hz, 






To a stirred solution of bromide 4.212 (1.43 mL, 10.0 mmol) in anhydrous Et2O (25 mL) at 
0 °C under nitrogen was added n-BuLi (1.6 M in hexanes, 6.25 mL, 10.0 mmol) dropwise. 
The reaction was stirred for 30 min and DMF (0.97 mL, 12.5 mmol) added dropwise. The 
reaction was stirred for 5 min, warmed to room temperature and quenched with 1 N aq. HCl 
(20 mL). The mixture was neutralised with sat. aq. NaHCO3, the phases separated and the 
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aqueous phase extracted with Et2O (3 x 20 mL). The combined organics were washed with 
sat. aq. NaHCO3 (50 mL), water (50 mL) and dried (MgSO4). The solvent was removed in 
vacuo and the residue purified by flash chromatography (pet. ether/EtOAc 19:1→4:1) to give 
aldehyde 4.213 (823 mg, 55%) as a yellow oil. To a stirred suspension of potassium 
carbonate (1.18 g, 8.54 mmol) and methyltriphenylphosphonium bromide (2.29 g, 6.41 
mmol) in anhydrous THF (3 mL) under nitrogen was added aldehyde 4.213 (796 mg, 5.34 
mmol) in THF (3 mL) via cannula. The reaction was heated at reflux for 16 h, cooled, 
filtered and the solvent removed in vacuo. The residue was dissolved in hot pentane (20 mL), 
cooled to 0 °C to precipitate triphenylphosphine oxide, filtered and washed with cold 
pentane (10 mL). The filtrate was concentrated in vacuo and purified by flash 
chromatography (pet. ether/Et2O 99:1→9:1) to give 3-dimethylaminostyrene 4.214 (357 mg, 
45%, 68% brsm) as a colourless oil. Rf 0.60 (pet. ether/Et2O 9:1); 
1
H NMR (500 MHz, 
CDCl3)  7.24 (1H, dt, J = 8.0, 2.5 Hz, ArH), 6.85 (1H, d, J = 7.5 Hz, ArH), 6.80 (1H, s, 
ArH), 6.73 (1H, ddd, J = 17.5, 11.0, 2.5 Hz, CH=CH2), 6.72-6.68 (1H, m, ArH), 5.77 (1H, 
dd, J = 17.5, 2.5 Hz, CH=CHtransHcis), 5.25 (1H, dd, J = 11.0, 2.0 Hz, CH=CHtransHcis), 2.99 
(3H, s, N(CH3)a(CH3)b), 2.99 (3H, s, N(CH3)a(CH3)b); 
13
C NMR (125.8 MHz, CDCl3) 
 150.9 (C), 138.3 (C), 137.7 (CH), 129.1 (CH), 114.8 (CH), 113.3 (CH2), 112.4 (CH), 





General procedure A (method 1) was applied to 3-dimethylaminostyrene 4.214 
(103 mg, 0.7 mmol), FeCl2·4H2O (0.7 mg, 0.004 mmol), TMEDA (0.5 µL, 
0.004 mmol), ethylmagnesium bromide (3 M in THF, 0.35 mL, 1.1 mmol) and 
trimethylsilyl chloride (0.14 mL, 1.1 mmol).  The crude product was purified by flash 
chromatography (pet. ether/Et2O 99:1→95:5), whereupon the product was subjected to 
dihydroxylation to remove residual styrene. AD-mix-β (82 mg, 1.4 g/mmol) was added to a 
stirred solution of silane and styrene (8.6 mg, 0.059 mmol, 8% by 
1
H NMR spectroscopy of 
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crude reaction mixture) in t-BuOH/H2O (1:1 v:v, 4 mL) and the reaction stirred for 5 h. The 
reaction was quenched with Na2SO3 and the mixture diluted with EtOAc (5 mL) and water 
(5 mL). The phases were separated and the aqueous phase extracted with EtOAc (3 x 
10 mL). The combined organics were dried (Na2SO4) and the solvent removed in vacuo. The 
residue was purified by flash chromatography (pet. ether/Et2O 99:1→96:4) to give silane 
4.215 as a colourless oil (126 mg, 81%). Rf 0.29 (pet. ether/Et2O 9:1); IR (film, cm
-1
) 2953, 
2899, 2870, 2799, 1599, 1578, 1499, 1437, 1348, 1246; 
1
H NMR (500 MHz, CDCl3)  7.13 
(1H, t, J = 7.5 Hz, ArH), 6.53 (1H, d, J = 8.5 Hz, ArH), 6.48-6.43 (2H, m, ArH), 2.94 (3H, s, 
N(CH3)a(CH3)b), 2.94 (3H, s, N(CH3)a(CH3)b), 2.13 (1H, q, J = 7.5 Hz, CHCH3), 1.37 (3H, 
d, J = 7.5 Hz, CHCH3), −0.03 (9H, s, Si(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  150.5 (C), 
146.8 (C), 128.5 (CH), 116.0 (CH), 111.9 (CH), 109.1 (CH), 40.8 (2 x CH3), 30.1 (CH), 
14.9 (CH3), −3.2 (3 x CH3); HRMS (ES) Exact mass calcd for C13H23ONSiNa [M+Na]
+
: 






To a stirred solution of 2-bromopyridine 4.219 (1.2 mL, 13 mmol) in anhydrous Et2O 
(50 mL) at −78°C under nitrogen was added n-BuLi (1.6 M in hexanes, 7.6 mL, 12 mmol) 
dropwise.  The reaction was stirred at −78°C for 1 h and chlorodimethyl(vinyl)silane 
(1.8 mL, 13 mmol) added.  The reaction was stirred at room temperature for 3 h and 
quenched with sat. aq. NaHCO3 solution (50 mL).  The phases were separated and the 
aqueous phase extracted with Et2O (3 x 50 mL).  The combined organics were dried 
(MgSO4) and the solvent removed in vacuo.  The crude silane was purified by fractional 
distillation ((b.p. 94 °C/23 mmHg, lit.,
308
 80-84 °C/14 mmHg) to give silane 4.216 (957 mg, 
48%) as a pale yellow oil. Rf 0.79 (4:1 pet. ether/EtOAc); 
1
H NMR (500 MHz, CDCl3)  
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8.79 (1H, d, J = 5.0 Hz, ArH), 7.58 (1H, t, J = 7.5 Hz, ArH), 7.51 (1H, d, J = 7.5 Hz, ArH), 
7.21-7.17 (1H, m, ArH), 6.35 (1H, dd, J = 20.5, 15.5 Hz, Si(CH3)2CHCH2), 6.10 (1H, dd, J 
= 14.5, 3.5 Hz, Si(CH3)2CHCHaCHb), 5.83 (1H, dd, J = 20.5, 3.5 Hz, Si(CH3)2CHCHaCHb), 
0.41 (6H, s, Si(CH3)2); 
13
C NMR (125.8 MHz, CDCl3)  166.8 (C), 150.3 (CH), 136.9 (CH), 









To a stirred solution of methyltriphenylphosphonim bromide (13.5 g, 37.7 mmol) in 
anhydrous THF (40 mL) under nitrogen was added a solution of potassium tert-butoxide 
(4.23 g, 37.7 mmol) in THF (40 mL) via cannula. The mixture was stirred for 2 h, cooled to 
−78 °C and salicylaldehyde 4.227 (1.75 mL, 16.5 mmol) added. The reaction was warmed to 
room temperature slowly and stirred at 30 °C for 16 h. The mixture was quenched with 1 M 
HCl (50 mL) and the THF removed in vacuo. The aqueous phase was extracted with EtOAc 
(3 x 50 mL), washed with brine (100 mL), dried (MgSO4) and the solvent removed in vacuo. 
The residue was purified by flash chromatography (pet. ether/Et2O 19:1→2:1) to give 
2-hydroxystyrene 4.228 as a pale yellow oil (1.45 g, 73%). Rf 0.19 (pet. ether/Et2O 9:1); 
1
H 
NMR (500 MHz, CDCl3)  7.40 (1H, d, J = 7.5 Hz, ArH), 7.16 (1H, dt, J = 8.0, 1.5 Hz, 
ArH), 6.95 (1H, dd, J = 17.5, 11.0 Hz, CH=CH2), 6.93 (1H, t, J = 7.5 Hz, ArH), 6.81 (1H, 
dd, J = 8.0, 1.0 Hz, ArH), 5.76 (1H, dd, J = 17.5, 1.0 Hz, CH=CHtransHcis), 5.38 (1H, dd, J = 
11.0, 1.5 Hz, CH=CHtransHcis), 5.03-4.97 (1H, br. m, 1H, OH); 
13
C NMR (125.8 MHz, 
CDCl3)  152.8 (C), 131.5 (CH), 128.9 (CH), 127.4 (CH), 124.8 (C), 120.9 (CH), 









To a stirred solution of 2-hydroxystyrene 4.228 (500 mg, 4.16 mmol) in anhydrous THF 
(20 mL) under nitrogen at 0 °C was added sodium hydride (60% in mineral oil, 183 mg, 
4.58 mmol). The reaction was warmed to room temperature and stirred for 30 mins. The 
reaction was cooled to 0 °C, tert-butyl bromoacetate (0.74 mL, 4.99 mmol), warmed to room 
temperature and stirred for 30 mins. The reaction was quenched with water (20 mL), the 
THF removed in vacuo and the aqueous phase extracted with EtOAc (3 x 20 mL). The 
combined organics were washed with brine (50 mL), dried (MgSO4) and the solvent 
removed in vacuo. The crude residue was purified by flash chromatography (pet. ether/Et2O 
99:1→95:5) to give styrene ester 4.229 (676 mg, 69%) as a colourless oil. Rf 0.39 (pet. 
ether/Et2O 95:5); IR (film, cm
-1
) 2978, 1753 (C=O), 1730, 1626, 1599, 1485, 1454, 1367, 
1215, 1152; 
1
H NMR (500 MHz, CDCl3)  7.50 (1H, dd, J = 7.5, 1.5 Hz, ArH), 7.23-7.19 
(1H, m, ArH), 7.14 (1H, dd, J = 18.0, 11.0 Hz, CH=CH2), 6.98 (1H, t, J = 7.5 Hz, ArH), 
6.76 (1H, dd, J = 8.5, 0.5 Hz, ArH), 5.82 (1H, dd, J = 18.0, 1.5 Hz, CH=CHtransHcis), 5.31 
(1H, dd, J = 11.0, 1.5 Hz, CH=CHtransHcis), 4.56 (2H, s, OCH2), 1.50 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  167.9 (C), 155.2 (C), 131.5 (CH), 128.6 (CH), 127.3 (C), 
126.9 (CH), 121.5 (CH), 114.9 (CH2), 112.0 (CH), 82.3 (C), 66.2 (CH2), 28.0 (3 x CH3); 
HRMS (ES) Exact mass calcd for C14H18O3Na [M+Na]
+






To a stirred solution of ester 4.229 (200 mg, 0.85 mmol) in anhydrous THF (10 mL) under 
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nitrogen at 0 °C was added LiAlH4 (81 mg, 2.13 mmol). The reaction was warmed to room 
temperature and stirred for 2 h. The reaction was carefully quenched at 0 °C with 1 M NaOH 
(0.1 mL) and water (0.2 mL). The mixture was stirred at 30 min at room temperature and 
filtered through a pad of celite using Et2O as eluent. The solvent was removed in vacuo and 
the residue was purified by flash chromatography (pet. ether/Et2O 3:1→1:2) to give alcohol 
(131 mg, 94%) as a colourless solid. To a stirred solution of alcohol (121 mg, 0.74 mmol) in 
anhydrous CH2Cl2 (5 mL) at 0 °C under nitrogen was added pyridine (0.13 mL, 1.6 mmol), 
DMAP (1 crystal, cat.) and tosyl chloride (311 mg, 1.63 mmol). The reaction was warmed to 
room temperature, stirred for 16 h and quenched with 1N HCl (5 mL). The phases were 
separated and the aqueous phase extracted with CH2Cl2 (3 x 5 mL). The combined organics 
were washed with sat. aq. NaHCO3 (20 mL), dried (MgSO4) and the solvent removed in 
vacuo. The residue was purified by flash chromatography (pet. ether/Et2O 9:1→1:1) to give 
tosylate 4.230 (175 mg, 74%, 96% brsm) as a colourless solid. Rf  0.32 (pet. ether/Et2O 3:1); 
m.p. 58-70 °C; 
1
H NMR (500 MHz, CDCl3)  7.84-7.82 (2H, m, ArH), 7.47 (1H, dd, J = 7.5, 
1.5 Hz, ArH), 7.36-7.32 (2H, m, ArH), 7.19 (1H, ddd, J = 8.0, 7.5, 1.5 Hz, ArH), 6.98-6.94 
(1H, m, ArH), 6.88 (1H, dd, J = 18.0, 11.0 Hz, CH=CH2), 6.75 (1H, dd, J = 8.5, 1.0 Hz, 
ArH), 5.70 (1H, dd, J = 18.0, 1.5 Hz, CH=CHtransHcis), 5.21 (1H, dd, J = 11.0, 1.5 Hz, 
CH=CHtransHcis), 4.42-4.39 (2H, m, CH2OTs), 4.20-4.17 (2H, m, ArOCH2), 2.45 (3H, s, 
CH3); 
13
C NMR (125.8 MHz, CDCl3)  155.1 (C), 144.9 (C), 132.9 (C), 131.2 (CH), 
129.9 (2 x CH), 128.8 (CH), 127.9 (2 x CH), 127.1 (C), 126.5 (CH), 121.5 (CH), 
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To 2-hydroxystyrene 4.228 (200 mg, 1.7 mmol) in anhydrous THF (8 mL) at 0 °C under 
nitrogen was added sodium hydride (60% in mineral oil, 44 mg, 1.8 mmol). The reaction was 
warmed to room temperature and stirred for 30 min. The reaction was cooled to 0 °C, 
MOMCl (0.15 mL, 2.0 mmol) added and the reaction stirred at room temperature for 2 h. 
The reaction was quenched with water (10 mL), the phases separated and the aqueous phase 
extracted with diethyl ether (3 x 10 mL). The combined organics were washed with 1 M 
NaOH (40 mL) and water (40 mL), dried (MgSO4) and the solvent removed in vacuo. The 
residue was purified by flash chromatography (pet. ether/Et2O 99:1→95:5) to give styrene 
4.232 (116 mg, 42%) as a colourless oil. Rf 0.21 (pet. ether/Et2O 99:1); 
1
H NMR (500 MHz, 
CDCl3)  7.52 (1H, d, J = 7.5 Hz, ArH), 7.23 (1H, t, J = 8.0 Hz, ArH), 7.11 (1H, d, J = 
8.0 Hz, ArH), 7.10 (1H, dd, J = 17.5, 11.5 Hz, CH=CH2), 7.01 (1H, t, J = 7.5 Hz, ArH), 5.76 
(1H, d, J = 18.0 Hz, CH=CHtransHcis), 5.29 (1H, d, J = 11.0 Hz, CH=CHtransHcis), 5.23 (2H, s, 
OCH2), 3.51 (3H, s, OCH3); 
13
C NMR (125.8 MHz, CDCl3)  154.4 (C), 131.5 (CH), 
128.8 (CH), 127.6 (C), 126.4 (CH), 121.9 (CH), 114.8 (CH), 114.5 (CH2), 94.7 (CH2), 








To a solution of sodium hydride (60% in mineral oil, 512 mg, 12.8 mmol) in anhydrous THF 
(75 mL) under nitrogen was added 2-bromoaniline 4.238 (1.32 mL, 11.6 mmol). The mixture 
was heated to reflux for 1 h, cooled to room temperature and Boc2O (3.03 g, 13.9 mmol) 
added. The mixture was stirred for 30 min at room temperature, a second portion of sodium 
hydride (60% in mineral oil, 512 mg, 12.8 mmol) added, and heated to reflux for 16 h. The 
reaction was cooled to room temperature, quenched with water (75 mL) and the THF 
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removed in vacuo. The aqueous phase was extracted with Et2O (3 x 50 mL) and the 
combined organics washed with sat. aq. NH4Cl (50 mL), sat. aq. NaHCO3 (50 mL) and dried 
(Na2SO4). The solvent was removed in vacuo and the residue purified by flash 
chromatography (pet. ether/Et2O 19:1→9:1) to give Boc protected aniline (972 mg, 31%) as 
a colourless oil. To a solution of carbamate (972 mg, 3.57 mmol) in anhydrous DMF 
(20 mL) under nitrogen was added sodium hydride (60% in mineral oil, 214 mg, 5.36 mmol) 
and methyl iodide (1.11 mL, 17.9 mmol). The mixture was stirred for 1 h, quenched with 
water (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organics were washed 
with 1:1 H2O/brine (3 x 50 mL), dried (Na2SO4) and the solvent removed in vacuo. The 
crude residue was purified by flash chromatography (pet. ether/Et2O 19:1→4:1) to give 




H NMR (500 MHz, CDCl3)  7.60 (1H, d, J = 8.0 Hz, ArH), 7.31 (1H, t, 
J = 7.0 Hz, ArH), 7.23 (1H, d, J = 8.0 Hz, ArH), 7.14 (1H, t, J = 7.0 Hz, ArH), 3.16 (3H, s, 
NCH3), 1.35 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  154.5 (C), 142.6 (C), 133.1 
(CH), 129.4 (CH), 128.5 (CH), 128.2 (CH), 123.2 (C), 80.1 (CH3), 36.3 (C), 28.1 (3 x CH3). 
Minor rotamer: 
1
H NMR (500 MHz, CDCl3)  7.60 (1H, d, J = 8.0 Hz, ArH), 7.31 (2H, t, 
J = 7.0 Hz, ArH), 7.14 (1H, t, J = 7.0 Hz, ArH), 3.16 (3H, s, NCH3), 1.54 (9H, s, C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  (2 x C resonances not resolved) 133.4 (CH), 129.9 (CH), 









                                                                                                         Chapter 6. Experimental 
-233- 
 
To a stirred solution of 2-hydroxystyrene 4.228 (200 mg, 1.66 mmol) in anhydrous diethyl 
ether (5 mL) under nitrogen was added pyridine (0.28 mL, 3.45 mmol) and trimethylsilyl 
chloride (0.44 mL, 3.45 mmol). The reaction was stirred for 16 h and quenched with water 
(5 mL). The phases were separated and the aqueous phase extracted with EtOAc (3 x 5 mL). 
The combined organics were washed with brine (20 mL), dried (MgSO4) and the solvent 
removed in vacuo. The residue was purified by flash chromatography (pet. ether/Et2O 
99:1→98:2) to give TMS protected alcohol 4.241 (155 mg, 49%) as a colourless oil. Rf 0.84 
(pet. ether/Et2O 19:1); 
1
H NMR (500 MHz, CDCl3)  7.50 (1H, d, J  = 7.5 Hz, ArH), 
7.18-7.13 (1H, m, ArH), 7.00 (1H, dd, J = 18.0, 11.0 Hz, CH=CH2), 6.97-6.94 (1H, m, 
ArH), 6.81 (1H, d, J = 8.0 Hz, ArH), 5.73 (1H, td, J = 18.0, 1.5 Hz, CH=CHtransHcis), 5.25 
(1H, td, J = 11.0, 1.0 Hz, CH=CHtransHcis), 0.29 (9H, s, Si(CH3)3); 
13
C NMR (125.8 MHz, 
CDCl3)  152.7 (C), 132.1 (CH), 129.0 (C) 128.6 (CH), 126.3 (CH), 121.5 (CH), 








To a solution of 2-hydroxystyrene 4.228 (500 mg, 4.16 mmol) in anhydrous DMF (5 mL) 
under nitrogen were added imidazole (849 mg, 12.5 mmol) and TBSCl (940 mg, 6.24 mmol) 
at 0 °C. The mixture was warmed to room temperature and stirred for 1 h. The reaction was 
diluted with water (10 mL), the phases separated and the aqueous phase extracted with 
EtOAc (3 x 10 mL). The combined organics were washed with 1:1 water/brine (3 x 10 mL), 
dried (MgSO4) and the solvent removed in vacuo. The residue was purified by flash 
chromatography (pentane) to give TBS-protected alcohol 4.242 as a colourless oil (727 mg, 
75%). Rf 0.52 (pentane); 
1
H NMR (500 MHz, CDCl3)  7.51 (1H, dd, J = 7.5, 1.5 Hz, ArH), 
7.15 (1H, td, J = 7.5, 1.5 Hz, ArH), 7.07 (1H, dd, J = 18.0, 11.0 Hz, CH=CH2), 6.95 (1H, t, 
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J = 7.5 Hz, ArH), 6.81 (1H, d, J = 8.0 Hz, ArH), 5.69 (1H, dd, J = 18.0, 1.0 Hz, 
CH=CHtransHcis), 5.24 (1H, dd, J = 11.0, 1.0 Hz, CH=CHtransHcis), 1.04 (9H, s, 
Si(CH3)2C(CH3)3), 0.23 (6H, s, Si(CH3)2C(CH3)3); 
13
C NMR (125.8 MHz, CDCl3) 
 152.9 (C), 132.0 (CH), 129.1 (C), 128.6 (CH), 126.0 (CH), 121.3 (CH), 119.6 (CH), 








To a solution of FeCl2 (0.3 mg, 0.003 mmol) and BIP (1 mg, 0.003 mmol) in anhydrous THF 
(2.5 mL) was added TMS-protected alcohol 4.241 (52 mg, 0.27 mmol) and ethylmagnesium 
bromide (3 M in THF, 0.14 mL, 0.41 mmol) dropwise. The reaction was stirred for 2 h and 
DMF (33 µL, 0.43 mmol) added. The reaction was stirred for a further 2 h and quenched 
with aqueous sulphate buffer solution (5 mL). The phases were separated and the aqueous 
phase extracted with Et2O (3 x 5 mL). The combined organic extracts were washed with 
water (10 mL) and brine (10 mL), dried (MgSO4) and the solvent removed in vacuo. The 
product was purified by flash chromatography (pet. ether/Et2O 99:1→93:7) to give alcohol 
4.243 (23%, 42% yield by NMR) as a colourless oil. Rf 0.25 (pet. ether/Et2O 9:1); 
1
H NMR 
(500 MHz, CDCl3)  7.05 (1H, dd, J = 7.5, 1.5 Hz, ArH), 6.98 (1H, dt, J = 7.5, 1.5 Hz, 
ArH), 6.90 (1H, J = 7.5m 1.0 Hz, ArH), 6.72 (1H, dd, J = 8.0, 1.0 Hz, ArH), 4.56 (1H, br s, 
OH), 2.55 (1H, q, J = 7.5 Hz, CHCH3), 1.36 (3H, d, J = 7.5 Hz, CHCH3), −0.02 (9H, s, 
Si(CH3)3); 
13
C NMR (125.8 MHz, CDCl3)  152.1 (C), 132.4 (C), 127.4 (CH), 124.9 (CH), 
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 X-ray data for 3.91 and 3.118 is presented below. 
 
Crystal Structure Service 
School of Chemistry 
The University of Edinburgh 
 






Compound 3.91 was provided as multiple clusters of dark red crystals from which a single piece was 
broken off and found to be suitable for X-ray diffraction, yielding structure HL3004. 
 
The asymmetric unit of HL3004 is shown in Figure 1.  All H atoms were located in a difference 
Fourier map and are freely refined.  Dihedral angles between the central ring and the phenyl and 
methoxy substituents are 56.34(9)° (C15 to C20); 75.57(4)° (C21 to C26); 85.43(7)° (methoxy). 
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CRYSALISPRO (data collection, integration and absorption correction)  
Agilent Technologies, (2011), CrysAlisPro, Agilent Technologies UK Ltd, Oxford, UK 
 
SHELXTL (structure refinement and graphics) 
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. 
 
SUPERFLIP (structure solution) 
Palatinus L. and Chapuis G. (2007).  J. Appl. Cryst. 40, 786-790. 
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Table 1.  Crystal data and structure refinement for hl3004. 
 
Identification code  hl3004 
Chemical formula (moiety) C26H21FeNO2 
Chemical formula (total) C26H21FeNO2 
Formula weight  435.29 
Temperature  120(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  triclinic, P -1 
Unit cell parameters a = 8.8593(4) Å  = 115.023(4)° 
 b = 11.4046(5) Å  = 101.329(4)° 
 c = 11.4216(5) Å  = 99.880(4)° 




Calculated density  1.472 g/cm
3
 




Crystal colour and size red, 0.270  0.190  0.060 mm
3
 
Reflections for cell refinement 9883 ( range 3.2 to 29.6°) 
Data collection method Agilent Technologies SuperNova 
  scans 
 range for data collection 3.2 to 29.6° 
Index ranges h 11 to 11, k 15 to 15, l 14 to 15 
Completeness to  = 25.2° 99.7 %  
Reflections collected 17581 




Absorption correction gaussian 
Min. and max. transmission 0.934 and 0.985 
Structure solution charge-flipping 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 4929 / 0 / 355 
Final R indices [F
2
>2] R1 = 0.0327, wR2 = 0.0718 




Extinction coefficient 0 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 0.40 and 0.34 e Å
3
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Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å
2
) 




      x      y      z      Ueq 
 
Fe(1) 0.78070(3) 0.63583(2) 0.91918(2) 0.01223(7) 
O(1) 0.32945(14) 0.60937(12) 0.90673(12) 0.0177(2) 
O(2) 0.29865(14) 0.79984(12) 0.83611(12) 0.0181(2) 
N(1) 0.41729(15) 0.73553(13) 0.80871(13) 0.0133(3) 
C(1) 0.9560(2) 0.81718(18) 1.01155(18) 0.0228(4) 
C(2) 0.8321(2) 0.82670(18) 1.07497(18) 0.0225(4) 
C(3) 0.8219(2) 0.73113(19) 1.12412(17) 0.0216(4) 
C(4) 0.9388(2) 0.66254(19) 1.09071(17) 0.0217(4) 
C(5) 1.0224(2) 0.71582(19) 1.02155(17) 0.0224(4) 
C(6) 0.54365(18) 0.57083(15) 0.81099(15) 0.0123(3) 
C(7) 0.58833(19) 0.46806(16) 0.83807(16) 0.0148(3) 
C(8) 0.71043(19) 0.43499(16) 0.77780(16) 0.0158(3) 
C(9) 0.74479(19) 0.51762(16) 0.71531(16) 0.0138(3) 
C(10) 0.63957(18) 0.60184(15) 0.73422(15) 0.0116(3) 
C(11) 0.62153(18) 0.70678(15) 0.69703(15) 0.0120(3) 
C(12) 0.51065(18) 0.77102(15) 0.73512(15) 0.0127(3) 
C(13) 0.42276(18) 0.63736(16) 0.84959(15) 0.0136(3) 
C(14) 0.1485(2) 0.7177(2) 0.7309(2) 0.0250(4) 
C(15) 0.72641(18) 0.74157(16) 0.62225(15) 0.0123(3) 
C(16) 0.82314(19) 0.87315(16) 0.67237(17) 0.0153(3) 
C(17) 0.9235(2) 0.90206(18) 0.60255(18) 0.0185(3) 
C(18) 0.9278(2) 0.80104(18) 0.48181(17) 0.0189(3) 
C(19) 0.8318(2) 0.67022(18) 0.43086(17) 0.0179(3) 
C(20) 0.73321(19) 0.64032(17) 0.50110(16) 0.0156(3) 
C(21) 0.47736(18) 0.88225(16) 0.70798(16) 0.0133(3) 
C(22) 0.3911(2) 0.85385(17) 0.57885(17) 0.0164(3) 
C(23) 0.3573(2) 0.95722(18) 0.55397(18) 0.0192(3) 
C(24) 0.4123(2) 1.08961(18) 0.65736(19) 0.0210(4) 
C(25) 0.5002(2) 1.11860(18) 0.78548(19) 0.0223(4) 
C(26) 0.5318(2) 1.01514(17) 0.81141(18) 0.0189(3) 
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Table 3.   Bond lengths [Å] and angles [°] for hl3004. 
 
Fe(1)–C(1)  2.0519(17) Fe(1)–C(2)  2.0437(18) 
Fe(1)–C(3)  2.0419(17) Fe(1)–C(4)  2.0405(17) 
Fe(1)–C(5)  2.0560(17) Fe(1)–C(6)  2.0392(15) 
Fe(1)–C(7)  2.0457(16) Fe(1)–C(8)  2.0562(16) 
Fe(1)–C(9)  2.0608(16) Fe(1)–C(10)  2.0688(15) 
O(1)–C(13)  1.2284(19) O(2)–N(1)  1.3929(16) 
O(2)–C(14)  1.443(2) N(1)–C(12)  1.4143(19) 
N(1)–C(13)  1.388(2) C(1)–H(1)  0.95(2) 
C(1)–C(2)  1.424(3) C(1)–C(5)  1.419(3) 
C(2)–H(2)  0.96(2) C(2)–C(3)  1.420(3) 
C(3)–H(3)  0.94(2) C(3)–C(4)  1.418(3) 
C(4)–H(4)  0.94(2) C(4)–C(5)  1.422(3) 
C(5)–H(5)  0.94(2) C(6)–C(7)  1.430(2) 
C(6)–C(10)  1.438(2) C(6)–C(13)  1.449(2) 
C(7)–H(7)  0.96(2) C(7)–C(8)  1.414(2) 
C(8)–H(8)  0.996(19) C(8)–C(9)  1.430(2) 
C(9)–H(9)  0.954(19) C(9)–C(10)  1.431(2) 
C(10)–C(11)  1.452(2) C(11)–C(12)  1.355(2) 
C(11)–C(15)  1.491(2) C(12)–C(21)  1.489(2) 
C(14)–H(14A)  0.97(2) C(14)–H(14B)  0.94(2) 
C(14)–H(14C)  1.01(2) C(15)–C(16)  1.398(2) 
C(15)–C(20)  1.399(2) C(16)–H(16)  0.975(19) 
C(16)–C(17)  1.391(2) C(17)–H(17)  0.95(2) 
C(17)–C(18)  1.386(3) C(18)–H(18)  0.94(2) 
C(18)–C(19)  1.387(2) C(19)–H(19)  0.92(2) 
C(19)–C(20)  1.388(2) C(20)–H(20)  0.971(18) 
C(21)–C(22)  1.390(2) C(21)–C(26)  1.391(2) 
C(22)–H(22)  0.95(2) C(22)–C(23)  1.390(2) 
C(23)–H(23)  0.95(2) C(23)–C(24)  1.387(3) 
C(24)–H(24)  0.95(2) C(24)–C(25)  1.383(3) 
C(25)–H(25)  0.94(2) C(25)–C(26)  1.391(2) 
C(26)–H(26)  0.93(2)  
 
C(1)–Fe(1)–C(2) 40.69(7) C(1)–Fe(1)–C(3) 68.39(7) 
C(1)–Fe(1)–C(4) 68.18(8) C(1)–Fe(1)–C(5) 40.42(7) 
C(1)–Fe(1)–C(6) 134.47(7) C(1)–Fe(1)–C(7) 173.02(7) 
C(1)–Fe(1)–C(8) 146.54(7) C(1)–Fe(1)–C(9) 115.97(7) 
C(1)–Fe(1)–C(10) 110.70(7) C(2)–Fe(1)–C(3) 40.66(8) 
C(2)–Fe(1)–C(4) 68.30(8) C(2)–Fe(1)–C(5) 68.29(7) 
C(2)–Fe(1)–C(6) 109.43(7) C(2)–Fe(1)–C(7) 132.64(7) 
C(2)–Fe(1)–C(8) 171.71(7) C(2)–Fe(1)–C(9) 146.70(7) 
C(2)–Fe(1)–C(10) 115.38(7) C(3)–Fe(1)–C(4) 40.65(7) 
C(3)–Fe(1)–C(5) 68.41(7) C(3)–Fe(1)–C(6) 113.66(7) 
C(3)–Fe(1)–C(7) 107.59(7) C(3)–Fe(1)–C(8) 132.28(7) 
C(3)–Fe(1)–C(9) 172.25(7) C(3)–Fe(1)–C(10) 145.57(7) 
C(4)–Fe(1)–C(5) 40.63(7) C(4)–Fe(1)–C(6) 144.30(7) 
C(4)–Fe(1)–C(7) 112.85(7) C(4)–Fe(1)–C(8) 108.92(7) 
C(4)–Fe(1)–C(9) 133.55(7) C(4)–Fe(1)–C(10) 173.47(7) 
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C(5)–Fe(1)–C(6) 174.17(7) C(5)–Fe(1)–C(7) 144.48(7) 
C(5)–Fe(1)–C(8) 115.11(7) C(5)–Fe(1)–C(9) 110.31(7) 
C(5)–Fe(1)–C(10) 134.48(7) C(6)–Fe(1)–C(7) 40.97(6) 
C(6)–Fe(1)–C(8) 67.93(6) C(6)–Fe(1)–C(9) 68.41(6) 
C(6)–Fe(1)–C(10) 40.97(6) C(7)–Fe(1)–C(8) 40.33(7) 
C(7)–Fe(1)–C(9) 68.72(6) C(7)–Fe(1)–C(10) 69.10(6) 
C(8)–Fe(1)–C(9) 40.66(6) C(8)–Fe(1)–C(10) 68.22(6) 
C(9)–Fe(1)–C(10) 40.56(6) N(1)–O(2)–C(14) 109.27(13) 
O(2)–N(1)–C(12) 116.66(12) O(2)–N(1)–C(13) 115.66(12) 
C(12)–N(1)–C(13) 127.53(13) Fe(1)–C(1)–H(1) 124.1(13) 
Fe(1)–C(1)–C(2) 69.35(10) Fe(1)–C(1)–C(5) 69.95(10) 
H(1)–C(1)–C(2) 124.9(13) H(1)–C(1)–C(5) 127.0(13) 
C(2)–C(1)–C(5) 108.08(16) Fe(1)–C(2)–C(1) 69.97(10) 
Fe(1)–C(2)–H(2) 125.1(13) Fe(1)–C(2)–C(3) 69.60(10) 
C(1)–C(2)–H(2) 124.0(12) C(1)–C(2)–C(3) 108.03(16) 
H(2)–C(2)–C(3) 127.9(12) Fe(1)–C(3)–C(2) 69.74(10) 
Fe(1)–C(3)–H(3) 124.6(13) Fe(1)–C(3)–C(4) 69.62(10) 
C(2)–C(3)–H(3) 126.7(13) C(2)–C(3)–C(4) 107.81(16) 
H(3)–C(3)–C(4) 125.5(13) Fe(1)–C(4)–C(3) 69.73(10) 
Fe(1)–C(4)–H(4) 125.5(13) Fe(1)–C(4)–C(5) 70.27(10) 
C(3)–C(4)–H(4) 125.1(12) C(3)–C(4)–C(5) 108.41(16) 
H(4)–C(4)–C(5) 126.5(12) Fe(1)–C(5)–C(1) 69.64(10) 
Fe(1)–C(5)–C(4) 69.10(10) Fe(1)–C(5)–H(5) 125.0(12) 
C(1)–C(5)–C(4) 107.67(16) C(1)–C(5)–H(5) 124.1(12) 
C(4)–C(5)–H(5) 128.2(12) Fe(1)–C(6)–C(7) 69.76(9) 
Fe(1)–C(6)–C(10) 70.62(8) Fe(1)–C(6)–C(13) 125.99(11) 
C(7)–C(6)–C(10) 108.93(14) C(7)–C(6)–C(13) 128.65(14) 
C(10)–C(6)–C(13) 122.42(13) Fe(1)–C(7)–C(6) 69.27(9) 
Fe(1)–C(7)–H(7) 124.0(13) Fe(1)–C(7)–C(8) 70.24(9) 
C(6)–C(7)–H(7) 125.8(12) C(6)–C(7)–C(8) 107.15(14) 
H(7)–C(7)–C(8) 127.0(12) Fe(1)–C(8)–C(7) 69.44(9) 
Fe(1)–C(8)–H(8) 124.7(11) Fe(1)–C(8)–C(9) 69.84(9) 
C(7)–C(8)–H(8) 125.9(11) C(7)–C(8)–C(9) 109.15(14) 
H(8)–C(8)–C(9) 124.9(11) Fe(1)–C(9)–C(8) 69.50(9) 
Fe(1)–C(9)–H(9) 126.8(11) Fe(1)–C(9)–C(10) 70.02(9) 
C(8)–C(9)–H(9) 126.4(11) C(8)–C(9)–C(10) 107.86(14) 
H(9)–C(9)–C(10) 125.7(11) Fe(1)–C(10)–C(6) 68.41(8) 
Fe(1)–C(10)–C(9) 69.42(9) Fe(1)–C(10)–C(11) 124.67(11) 
C(6)–C(10)–C(9) 106.89(13) C(6)–C(10)–C(11) 120.07(14) 
C(9)–C(10)–C(11) 132.98(14) C(10)–C(11)–C(12) 117.68(14) 
C(10)–C(11)–C(15) 119.44(13) C(12)–C(11)–C(15) 122.86(13) 
N(1)–C(12)–C(11) 120.21(13) N(1)–C(12)–C(21) 114.58(13) 
C(11)–C(12)–C(21) 125.20(14) O(1)–C(13)–N(1) 122.17(14) 
O(1)–C(13)–C(6) 125.72(14) N(1)–C(13)–C(6) 112.04(13) 
O(2)–C(14)–H(14A) 113.4(12) O(2)–C(14)–H(14B) 104.0(14) 
O(2)–C(14)–H(14C) 108.7(13) H(14A)–C(14)–H(14B) 108.7(18) 
H(14A)–C(14)–H(14C) 110.9(18) H(14B)–C(14)–H(14C) 110.9(18) 
C(11)–C(15)–C(16) 121.57(14) C(11)–C(15)–C(20) 119.83(14) 
C(16)–C(15)–C(20) 118.57(14) C(15)–C(16)–H(16) 119.8(11) 
C(15)–C(16)–C(17) 120.39(16) H(16)–C(16)–C(17) 119.8(11) 
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C(16)–C(17)–H(17) 118.2(13) C(16)–C(17)–C(18) 120.45(16) 
H(17)–C(17)–C(18) 121.3(13) C(17)–C(18)–H(18) 120.2(12) 
C(17)–C(18)–C(19) 119.64(15) H(18)–C(18)–C(19) 120.1(12) 
C(18)–C(19)–H(19) 118.7(12) C(18)–C(19)–C(20) 120.18(16) 
H(19)–C(19)–C(20) 121.1(12) C(15)–C(20)–C(19) 120.76(15) 
C(15)–C(20)–H(20) 118.9(11) C(19)–C(20)–H(20) 120.3(11) 
C(12)–C(21)–C(22) 120.11(14) C(12)–C(21)–C(26) 120.40(14) 
C(22)–C(21)–C(26) 119.49(15) C(21)–C(22)–H(22) 120.4(11) 
C(21)–C(22)–C(23) 120.18(16) H(22)–C(22)–C(23) 119.4(11) 
C(22)–C(23)–H(23) 118.1(12) C(22)–C(23)–C(24) 120.10(16) 
H(23)–C(23)–C(24) 121.8(12) C(23)–C(24)–H(24) 119.6(13) 
C(23)–C(24)–C(25) 119.91(16) H(24)–C(24)–C(25) 120.4(13) 
C(24)–C(25)–H(25) 122.1(13) C(24)–C(25)–C(26) 120.16(17) 
H(25)–C(25)–C(26) 117.7(13) C(21)–C(26)–C(25) 120.14(16) 
C(21)–C(26)–H(26) 120.2(12) C(25)–C(26)–H(26) 119.6(12) 
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Table 4.   Anisotropic displacement parameters (Å
2
) for hl3004.  The anisotropic 












      U
11
      U
22
      U
33
      U
23
      U
13




Fe(1) 0.01070(12)  0.01299(12) 0.01189(12)  0.00565(9) 0.00155(8)  0.00349(9) 
O(1) 0.0165(6)  0.0237(6) 0.0196(6)  0.0143(5) 0.0088(5)  0.0069(5) 
O(2) 0.0171(6)  0.0225(6) 0.0217(6)  0.0120(5) 0.0100(5)  0.0132(5) 
N(1) 0.0123(6)  0.0155(6) 0.0159(7)  0.0089(6) 0.0062(5)  0.0071(5) 
C(1) 0.0201(9)  0.0180(8) 0.0180(9)  0.0040(7)  0.0004(7)   0.0042(7) 
C(2) 0.0209(9)  0.0163(8) 0.0183(9)  0.0001(7) 0.0005(7)  0.0051(7) 
C(3) 0.0153(8)  0.0299(10) 0.0121(8)  0.0051(7) 0.0025(6)  0.0037(7) 
C(4) 0.0184(9)  0.0277(9) 0.0147(8)  0.0091(7)  0.0017(6)  0.0068(7) 
C(5) 0.0123(8)  0.0280(10) 0.0161(8)  0.0035(7) 0.0010(6)  0.0025(7) 
C(6) 0.0096(7)  0.0135(7) 0.0122(7)  0.0064(6) 0.0010(6)  0.0015(6) 
C(7) 0.0141(8)  0.0131(7) 0.0162(8)  0.0082(7) 0.0018(6)  0.0016(6) 
C(8) 0.0162(8)  0.0124(7) 0.0166(8)  0.0061(6) 0.0017(6)  0.0047(6) 
C(9) 0.0133(8)  0.0127(7) 0.0123(7)  0.0039(6) 0.0025(6)  0.0035(6) 
C(10) 0.0107(7)  0.0118(7) 0.0098(7)  0.0043(6) 0.0012(5)  0.0019(6) 
C(11) 0.0126(7)  0.0102(7) 0.0108(7)  0.0044(6) 0.0013(6)  0.0019(6) 
C(12) 0.0127(7)  0.0130(7) 0.0111(7)  0.0060(6) 0.0018(6)  0.0019(6) 
C(13) 0.0128(7)  0.0145(7) 0.0111(7)  0.0057(6) 0.0005(6)  0.0026(6) 
C(14) 0.0144(9)  0.0366(11) 0.0316(11)  0.0222(9) 0.0060(7)  0.0100(8) 
C(15) 0.0109(7)  0.0151(7) 0.0125(7)  0.0086(6) 0.0015(6)  0.0041(6) 
C(16) 0.0159(8)  0.0139(8) 0.0151(8)  0.0073(7) 0.0021(6)  0.0041(6) 
C(17) 0.0158(8)  0.0176(8) 0.0224(9)  0.0131(7) 0.0013(7)  0.0010(7) 
C(18) 0.0151(8)  0.0276(9) 0.0204(8)  0.0174(8) 0.0059(7)  0.0044(7) 
C(19) 0.0183(8)  0.0217(9) 0.0133(8)  0.0073(7) 0.0053(6)  0.0066(7) 
C(20) 0.0155(8)  0.0147(8) 0.0142(8)  0.0061(7) 0.0028(6)  0.0025(6) 
C(21) 0.0118(7)  0.0150(7) 0.0166(8)  0.0094(6) 0.0058(6)  0.0053(6) 
C(22) 0.0160(8)  0.0159(8) 0.0167(8)  0.0081(7) 0.0041(6)  0.0034(6) 
C(23) 0.0175(8)  0.0262(9) 0.0218(9)  0.0173(8) 0.0071(7)  0.0080(7) 
C(24) 0.0232(9)  0.0221(9) 0.0318(10)  0.0199(8) 0.0151(8)  0.0130(7) 
C(25) 0.0286(10)  0.0143(8) 0.0262(9)  0.0086(8) 0.0125(8)  0.0090(7) 
C(26) 0.0211(9)  0.0173(8) 0.0164(8)  0.0067(7) 0.0042(7)  0.0063(7) 
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      x       y       z       U 
 
H(1) 0.984(2) 0.868(2) 0.967(2) 0.027(5) 
H(2) 0.768(3) 0.887(2) 1.080(2) 0.025(5) 
H(3) 0.749(2) 0.714(2) 1.168(2) 0.025(5) 
H(4) 0.957(2) 0.593(2) 1.111(2) 0.022(5) 
H(5) 1.105(2) 0.689(2) 0.985(2) 0.021(5) 
H(7) 0.545(2) 0.431(2) 0.890(2) 0.026(5) 
H(8) 0.768(2) 0.3681(19) 0.7815(19) 0.018(5) 
H(9) 0.823(2) 0.5162(18) 0.6679(19) 0.015(5) 
H(14A) 0.154(2) 0.700(2) 0.641(2) 0.027(5) 
H(14B) 0.077(3) 0.770(2) 0.754(2) 0.034(6) 
H(14C) 0.113(3) 0.631(2) 0.735(2) 0.036(6) 
H(16) 0.822(2) 0.9445(19) 0.758(2) 0.017(5) 
H(17) 0.991(3) 0.991(2) 0.641(2) 0.031(6) 
H(18) 0.993(2) 0.8215(19) 0.434(2) 0.020(5) 
H(19) 0.835(2) 0.604(2) 0.350(2) 0.020(5) 
H(20) 0.668(2) 0.5485(19) 0.4666(18) 0.013(4) 
H(22) 0.356(2) 0.764(2) 0.506(2) 0.018(5) 
H(23) 0.296(2) 0.934(2) 0.466(2) 0.025(5) 
H(24) 0.388(2) 1.159(2) 0.640(2) 0.026(5) 
H(25) 0.544(3) 1.207(2) 0.856(2) 0.033(6) 
H(26) 0.590(2) 1.0354(19) 0.898(2) 0.017(5) 
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Table 6.  Torsion angles [°] for hl3004. 
 
C(14)–O(2)–N(1)–C(12) 93.10(16) C(14)–O(2)–N(1)–C(13)  82.88(16) 
Fe(1)–C(1)–C(2)–C(3) 59.41(12) C(5)–C(1)–C(2)–Fe(1)  59.43(12) 
C(5)–C(1)–C(2)–C(3) 0.0(2) Fe(1)–C(2)–C(3)–C(4) 59.44(12) 
C(1)–C(2)–C(3)–Fe(1)  59.64(12) C(1)–C(2)–C(3)–C(4)  0.2(2) 
Fe(1)–C(3)–C(4)–C(5) 59.86(12) C(2)–C(3)–C(4)–Fe(1)  59.51(12) 
C(2)–C(3)–C(4)–C(5) 0.3(2) Fe(1)–C(1)–C(5)–C(4)  58.83(12) 
C(2)–C(1)–C(5)–Fe(1) 59.06(12) C(2)–C(1)–C(5)–C(4) 0.23(19) 
Fe(1)–C(4)–C(5)–C(1) 59.16(12) C(3)–C(4)–C(5)–Fe(1)  59.52(12) 
C(3)–C(4)–C(5)–C(1)  0.36(19) Fe(1)–C(6)–C(7)–C(8)  60.32(11) 
C(10)–C(6)–C(7)–Fe(1) 59.97(11) C(10)–C(6)–C(7)–C(8)  0.35(18) 
C(13)–C(6)–C(7)–Fe(1)  120.47(16) C(13)–C(6)–C(7)–C(8) 179.21(15) 
Fe(1)–C(7)–C(8)–C(9)  58.68(11) C(6)–C(7)–C(8)–Fe(1) 59.70(11) 
C(6)–C(7)–C(8)–C(9) 1.02(18) Fe(1)–C(8)–C(9)–C(10)  59.75(11) 
C(7)–C(8)–C(9)–Fe(1) 58.43(11) C(7)–C(8)–C(9)–C(10)  1.32(18) 
Fe(1)–C(9)–C(10)–C(6)  58.35(10) Fe(1)–C(9)–C(10)–C(11) 118.74(18) 
C(8)–C(9)–C(10)–Fe(1) 59.42(11) C(8)–C(9)–C(10)–C(6) 1.07(17) 
C(8)–C(9)–C(10)–C(11) 178.16(16) Fe(1)–C(6)–C(10)–C(9) 58.99(10) 
Fe(1)–C(6)–C(10)–C(11)  118.55(14) C(7)–C(6)–C(10)–Fe(1)  59.44(11) 
C(7)–C(6)–C(10)–C(9)  0.45(17) C(7)–C(6)–C(10)–C(11)  177.99(13) 
C(13)–C(6)–C(10)–Fe(1) 120.97(15) C(13)–C(6)–C(10)–C(9) 179.95(14) 
C(13)–C(6)–C(10)–C(11) 2.4(2) Fe(1)–C(10)–C(11)–C(12)  84.42(17) 
Fe(1)–C(10)–C(11)–C(15) 94.25(16) C(6)–C(10)–C(11)–C(12)  1.1(2) 
C(6)–C(10)–C(11)–C(15) 177.56(14) C(9)–C(10)–C(11)–C(12)  177.88(16) 
C(9)–C(10)–C(11)–C(15) 0.8(3) C(10)–C(11)–C(12)–N(1) 0.1(2) 
C(10)–C(11)–C(12)–C(21) 178.99(14) C(15)–C(11)–C(12)–N(1)  178.51(14) 
C(15)–C(11)–C(12)–C(21) 0.4(2) O(2)–N(1)–C(12)–C(11)  175.82(13) 
O(2)–N(1)–C(12)–C(21) 5.19(19) C(13)–N(1)–C(12)–C(11)  0.4(2) 
C(13)–N(1)–C(12)–C(21)  179.38(14) O(2)–N(1)–C(13)–O(1)  0.3(2) 
O(2)–N(1)–C(13)–C(6) 176.97(12) C(12)–N(1)–C(13)–O(1)  175.75(15) 
C(12)–N(1)–C(13)–C(6) 1.5(2) Fe(1)–C(6)–C(13)–O(1)  96.74(18) 
Fe(1)–C(6)–C(13)–N(1) 86.12(16) C(7)–C(6)–C(13)–O(1)  4.8(3) 
C(7)–C(6)–C(13)–N(1) 178.03(15) C(10)–C(6)–C(13)–O(1) 174.68(15) 
C(10)–C(6)–C(13)–N(1)  2.5(2) C(10)–C(11)–C(15)–C(16)  123.38(16) 
C(10)–C(11)–C(15)–C(20) 54.5(2) C(12)–C(11)–C(15)–C(16) 55.2(2) 
C(12)–C(11)–C(15)–C(20)  126.86(17) C(11)–C(15)–C(16)–C(17) 178.06(14) 
C(20)–C(15)–C(16)–C(17) 0.1(2) C(15)–C(16)–C(17)–C(18) 0.6(2) 
C(16)–C(17)–C(18)–C(19)  0.3(2) C(17)–C(18)–C(19)–C(20)  0.7(2) 
C(18)–C(19)–C(20)–C(15) 1.4(2) C(11)–C(15)–C(20)–C(19)  179.09(14) 
C(16)–C(15)–C(20)–C(19)  1.1(2) N(1)–C(12)–C(21)–C(22)  105.61(17) 
N(1)–C(12)–C(21)–C(26) 74.25(19) C(11)–C(12)–C(21)–C(22) 75.5(2) 
C(11)–C(12)–C(21)–C(26)  104.68(19) C(12)–C(21)–C(22)–C(23) 178.78(15) 
C(26)–C(21)–C(22)–C(23)  1.1(2) C(21)–C(22)–C(23)–C(24) 1.3(2) 
C(22)–C(23)–C(24)–C(25)  0.3(3) C(23)–C(24)–C(25)–C(26)  0.9(3) 
C(24)–C(25)–C(26)–C(21) 1.1(3) C(12)–C(21)–C(26)–C(25)  179.94(16) 
C(22)–C(21)–C(26)–C(25)  0.1(2)  
 
                                                                                                                                                                  Appendix 
 -255- 
Table 7.  Hydrogen bonds for hl3004 [Å and °]. 
 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
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Crystal Structure Service 
School of Chemistry 
The University of Edinburgh 
 






Compound 3.118 was provided as yellow block crystals suitable for single crystal X-ray diffraction, 
yielding structure HL3006. 
 
The structure of the metal complex in HL3006 is shown in Figure 1.  The structure matches that 
which was predicted.  The compound crystallized as a CDCl3 solvate, which is omitted from the 
diagram. 
 
                                                                                                                                                                 Appendix 
 -257- 
 











CRYSALISPRO (data collection, integration and absorption correction)  
Agilent Technologies, (2011), CrysAlisPro, Agilent Technologies UK Ltd, Yarnton, UK 
 
SHELXTL (structure refinement and molecular graphics) 
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. 
 
SUPERFLIP (structure solution) 
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 Table 1.  Crystal data and structure refinement for hl3006. 
 
Identification code  hl3006 
Chemical formula (moiety) C22H21FeN3O2Pd·CDCl3 
Chemical formula (total) C23H21Cl3DFeN3O2Pd 
Formula weight  642.04 
Temperature  120(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  triclinic, P -1 
Unit cell parameters a = 9.9121(2) Å  = 94.945(2)° 
 b = 10.4629(3) Å  = 99.282(2)° 
 c = 13.1708(3) Å  = 113.033(2)° 




Calculated density  1.742 g/cm
3
 




Crystal colour and size yellow , 0.210  0.150  0.120 mm
3
 
Reflections for cell refinement 15317 ( range 3.5 to 29.1°) 
Data collection method Agilent Technologies SuperNova 
  scans 
 range for data collection 2.9 to 29.4° 
Index ranges h 13 to 12, k 14 to 14, l 18 to 18 
Completeness to  = 25.2° 99.8 %  
Reflections collected 32923 




Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.92492 and 1.00000 
Structure solution charge-flipping 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 6244 / 0 / 299 
Final R indices [F
2
>2] R1 = 0.0295, wR2 = 0.0566 




Extinction coefficient 0 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 0.84 and 0.83 e Å
3
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Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å
2
) 




      x      y      z      Ueq 
 
Pd(1) 0.46017(2) 0.38951(2) 0.33700(2) 0.01253(5) 
Fe(1) 0.19777(3) 0.43196(3) 0.13496(2) 0.01312(7) 
O(1) 0.00226(16) 0.14441(17) 0.28909(13) 0.0199(3) 
O(2) 0.24190(17) 0.08522(16) 0.34145(12) 0.0176(3) 
N(1) 0.26090(19) 0.22472(18) 0.32863(14) 0.0140(4) 
N(2) 0.63951(19) 0.57310(19) 0.33724(14) 0.0147(4) 
N(3) 0.6046(2) 0.3007(2) 0.41023(14) 0.0170(4) 
C(1) 0.1311(2) 0.2375(2) 0.29831(16) 0.0138(4) 
C(2) 0.2187(3) 0.0056(3) 0.24155(19) 0.0246(5) 
C(3) 0.3203(2) 0.4728(2) 0.28517(16) 0.0148(4) 
C(4) 0.1664(2) 0.3827(2) 0.27779(16) 0.0135(4) 
C(5) 0.0734(3) 0.4516(2) 0.24038(17) 0.0170(4) 
C(6) 0.1721(3) 0.5869(2) 0.22443(17) 0.0186(5) 
C(7) 0.3231(3) 0.5998(2) 0.25148(17) 0.0175(4) 
C(8) 0.2953(3) 0.3364(3) 0.04788(17) 0.0198(5) 
C(9) 0.1417(3) 0.2463(3) 0.03891(17) 0.0202(5) 
C(10) 0.0538(3) 0.3167(3)  0.00307(17) 0.0201(5) 
C(11) 0.1524(3) 0.4504(3)  0.01947(17) 0.0196(5) 
C(12) 0.3026(3) 0.4637(3) 0.01239(17) 0.0199(5) 
C(13) 0.6750(3) 0.6155(3) 0.24764(18) 0.0216(5) 
C(14) 0.7867(3) 0.7449(3) 0.24524(19) 0.0230(5) 
C(15) 0.8630(3) 0.8363(2) 0.33831(19) 0.0211(5) 
C(16) 0.8269(3) 0.7924(2) 0.43012(19) 0.0217(5) 
C(17) 0.7162(2) 0.6606(2) 0.42687(17) 0.0181(5) 
C(18) 0.7451(3) 0.3360(3) 0.39597(19) 0.0240(5) 
C(19) 0.8424(3) 0.2860(3) 0.4478(2) 0.0338(6) 
C(20) 0.7938(3) 0.1961(3) 0.5184(2) 0.0323(6) 
C(21) 0.6513(3) 0.1615(3) 0.53486(19) 0.0266(5) 
C(22) 0.5596(3) 0.2146(3) 0.47961(18) 0.0215(5) 
Cl(1) 0.72559(10)  0.00280(9) 0.04991(7) 0.0544(2) 
Cl(2) 0.65163(8) 0.22578(7) 0.12165(6) 0.03766(17) 
Cl(3) 0.57197(9)  0.02199(9) 0.21986(8) 0.0533(2) 
C(23) 0.7049(3) 0.0912(3) 0.1583(2) 0.0270(5) 
D(23) 0.8037 0.1355 0.2090 0.032 
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Table 3.   Bond lengths [Å] and angles [°] for hl3006. 
 
Pd(1)–N(1)  2.0294(17) Pd(1)–N(2)  2.0432(18) 
Pd(1)–N(3)  2.1426(18) Pd(1)–C(3)  1.973(2) 
Fe(1)–C(3)  2.060(2) Fe(1)–C(4)  2.033(2) 
Fe(1)–C(5)  2.048(2) Fe(1)–C(6)  2.042(2) 
Fe(1)–C(7)  2.048(2) Fe(1)–C(8)  2.041(2) 
Fe(1)–C(9)  2.046(2) Fe(1)–C(10)  2.058(2) 
Fe(1)–C(11)  2.054(2) Fe(1)–C(12)  2.039(2) 
O(1)–C(1)  1.245(3) O(2)–N(1)  1.425(2) 
O(2)–C(2)  1.429(3) N(1)–C(1)  1.346(3) 
N(2)–C(13)  1.347(3) N(2)–C(17)  1.338(3) 
N(3)–C(18)  1.344(3) N(3)–C(22)  1.344(3) 
C(1)–C(4)  1.480(3) C(2)–H(2A)  0.980 
C(2)–H(2B)  0.980 C(2)–H(2C)  0.980 
C(3)–C(4)  1.427(3) C(3)–C(7)  1.428(3) 
C(4)–C(5)  1.431(3) C(5)–H(5)  1.00 
C(5)–C(6)  1.428(3) C(6)–H(6)  1.00 
C(6)–C(7)  1.431(3) C(7)–H(7)  1.00 
C(8)–H(8)  1.00 C(8)–C(9)  1.421(3) 
C(8)–C(12)  1.429(3) C(9)–H(9)  1.00 
C(9)–C(10)  1.422(3) C(10)–H(10)  1.00 
C(10)–C(11)  1.418(3) C(11)–H(11)  1.00 
C(11)–C(12)  1.428(3) C(12)–H(12)  1.00 
C(13)–H(13)  0.950 C(13)–C(14)  1.381(3) 
C(14)–H(14)  0.950 C(14)–C(15)  1.386(3) 
C(15)–H(15)  0.950 C(15)–C(16)  1.381(3) 
C(16)–H(16)  0.950 C(16)–C(17)  1.378(3) 
C(17)–H(17)  0.950 C(18)–H(18)  0.950 
C(18)–C(19)  1.383(3) C(19)–H(19)  0.950 
C(19)–C(20)  1.387(4) C(20)–H(20)  0.950 
C(20)–C(21)  1.373(4) C(21)–H(21)  0.950 
C(21)–C(22)  1.384(3) C(22)–H(22)  0.950 
Cl(1)–C(23)  1.748(3) Cl(2)–C(23)  1.764(2) 
Cl(3)–C(23)  1.757(3) C(23)–D(23)  1.00 
 
N(1)–Pd(1)–N(2) 170.40(7) N(1)–Pd(1)–N(3) 98.15(7) 
N(1)–Pd(1)–C(3) 79.73(8) N(2)–Pd(1)–N(3) 91.35(7) 
N(2)–Pd(1)–C(3) 90.68(8) N(3)–Pd(1)–C(3) 173.37(8) 
C(3)–Fe(1)–C(4) 40.80(8) C(3)–Fe(1)–C(5) 69.44(9) 
C(3)–Fe(1)–C(6) 68.84(9) C(3)–Fe(1)–C(7) 40.66(8) 
C(3)–Fe(1)–C(8) 104.89(9) C(3)–Fe(1)–C(9) 121.29(9) 
C(3)–Fe(1)–C(10) 158.68(9) C(3)–Fe(1)–C(11) 157.91(9) 
C(3)–Fe(1)–C(12) 120.53(9) C(4)–Fe(1)–C(5) 41.05(8) 
C(4)–Fe(1)–C(6) 68.33(9) C(4)–Fe(1)–C(7) 68.23(9) 
C(4)–Fe(1)–C(8) 120.57(9) C(4)–Fe(1)–C(9) 106.64(9) 
C(4)–Fe(1)–C(10) 123.89(9) C(4)–Fe(1)–C(11) 160.73(9) 
C(4)–Fe(1)–C(12) 156.55(9) C(5)–Fe(1)–C(6) 40.87(9) 
C(5)–Fe(1)–C(7) 69.09(9) C(5)–Fe(1)–C(8) 157.28(9) 
C(5)–Fe(1)–C(9) 122.25(9) C(5)–Fe(1)–C(10) 108.62(9) 
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C(5)–Fe(1)–C(11) 124.66(9) C(5)–Fe(1)–C(12) 160.77(9) 
C(6)–Fe(1)–C(7) 40.95(9) C(6)–Fe(1)–C(8) 159.31(10) 
C(6)–Fe(1)–C(9) 159.38(10) C(6)–Fe(1)–C(10) 124.44(9) 
C(6)–Fe(1)–C(11) 109.47(9) C(6)–Fe(1)–C(12) 123.95(9) 
C(7)–Fe(1)–C(8) 121.69(9) C(7)–Fe(1)–C(9) 157.67(9) 
C(7)–Fe(1)–C(10) 160.06(9) C(7)–Fe(1)–C(11) 123.55(9) 
C(7)–Fe(1)–C(12) 106.86(9) C(8)–Fe(1)–C(9) 40.70(9) 
C(8)–Fe(1)–C(10) 68.30(9) C(8)–Fe(1)–C(11) 68.55(9) 
C(8)–Fe(1)–C(12) 40.99(9) C(9)–Fe(1)–C(10) 40.55(9) 
C(9)–Fe(1)–C(11) 68.30(9) C(9)–Fe(1)–C(12) 68.72(10) 
C(10)–Fe(1)–C(11) 40.35(9) C(10)–Fe(1)–C(12) 68.41(9) 
C(11)–Fe(1)–C(12) 40.84(9) N(1)–O(2)–C(2) 108.81(15) 
Pd(1)–N(1)–O(2) 125.42(12) Pd(1)–N(1)–C(1) 120.41(14) 
O(2)–N(1)–C(1) 113.80(16) Pd(1)–N(2)–C(13) 121.39(15) 
Pd(1)–N(2)–C(17) 120.11(14) C(13)–N(2)–C(17) 118.22(19) 
Pd(1)–N(3)–C(18) 122.57(15) Pd(1)–N(3)–C(22) 119.81(15) 
C(18)–N(3)–C(22) 117.42(19) O(1)–C(1)–N(1) 126.58(19) 
O(1)–C(1)–C(4) 124.99(19) N(1)–C(1)–C(4) 108.43(18) 
O(2)–C(2)–H(2A) 109.5 O(2)–C(2)–H(2B) 109.5 
O(2)–C(2)–H(2C) 109.5 H(2A)–C(2)–H(2B) 109.5 
H(2A)–C(2)–H(2C) 109.5 H(2B)–C(2)–H(2C) 109.5 
Pd(1)–C(3)–Fe(1) 126.04(11) Pd(1)–C(3)–C(4) 113.69(15) 
Pd(1)–C(3)–C(7) 139.70(16) Fe(1)–C(3)–C(4) 68.56(12) 
Fe(1)–C(3)–C(7) 69.22(12) C(4)–C(3)–C(7) 106.62(18) 
Fe(1)–C(4)–C(1) 120.40(15) Fe(1)–C(4)–C(3) 70.63(12) 
Fe(1)–C(4)–C(5) 70.03(12) C(1)–C(4)–C(3) 117.46(18) 
C(1)–C(4)–C(5) 132.3(2) C(3)–C(4)–C(5) 109.91(19) 
Fe(1)–C(5)–C(4) 68.92(12) Fe(1)–C(5)–H(5) 126.8 
Fe(1)–C(5)–C(6) 69.37(13) C(4)–C(5)–H(5) 126.8 
C(4)–C(5)–C(6) 106.36(19) H(5)–C(5)–C(6) 126.8 
Fe(1)–C(6)–C(5) 69.76(13) Fe(1)–C(6)–H(6) 125.7 
Fe(1)–C(6)–C(7) 69.75(13) C(5)–C(6)–H(6) 125.7 
C(5)–C(6)–C(7) 108.67(19) H(6)–C(6)–C(7) 125.7 
Fe(1)–C(7)–C(3) 70.12(12) Fe(1)–C(7)–C(6) 69.31(13) 
Fe(1)–C(7)–H(7) 125.8 C(3)–C(7)–C(6) 108.45(19) 
C(3)–C(7)–H(7) 125.8 C(6)–C(7)–H(7) 125.8 
Fe(1)–C(8)–H(8) 126.0 Fe(1)–C(8)–C(9) 69.84(13) 
Fe(1)–C(8)–C(12) 69.44(13) H(8)–C(8)–C(9) 126.0 
H(8)–C(8)–C(12) 126.0 C(9)–C(8)–C(12) 108.01(19) 
Fe(1)–C(9)–C(8) 69.47(13) Fe(1)–C(9)–H(9) 126.0 
Fe(1)–C(9)–C(10) 70.16(14) C(8)–C(9)–H(9) 126.0 
C(8)–C(9)–C(10) 108.0(2) H(9)–C(9)–C(10) 126.0 
Fe(1)–C(10)–C(9) 69.28(13) Fe(1)–C(10)–H(10) 125.9 
Fe(1)–C(10)–C(11) 69.67(13) C(9)–C(10)–H(10) 125.9 
C(9)–C(10)–C(11) 108.2(2) H(10)–C(10)–C(11) 125.9 
Fe(1)–C(11)–C(10) 69.98(13) Fe(1)–C(11)–H(11) 126.0 
Fe(1)–C(11)–C(12) 69.05(12) C(10)–C(11)–H(11) 126.0 
C(10)–C(11)–C(12) 108.1(2) H(11)–C(11)–C(12) 126.0 
Fe(1)–C(12)–C(8) 69.57(13) Fe(1)–C(12)–C(11) 70.12(13) 
Fe(1)–C(12)–H(12) 126.2 C(8)–C(12)–C(11) 107.7(2) 
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C(8)–C(12)–H(12) 126.2 C(11)–C(12)–H(12) 126.2 
N(2)–C(13)–H(13) 118.7 N(2)–C(13)–C(14) 122.5(2) 
H(13)–C(13)–C(14) 118.7 C(13)–C(14)–H(14) 120.6 
C(13)–C(14)–C(15) 118.8(2) H(14)–C(14)–C(15) 120.6 
C(14)–C(15)–H(15) 120.7 C(14)–C(15)–C(16) 118.5(2) 
H(15)–C(15)–C(16) 120.7 C(15)–C(16)–H(16) 120.3 
C(15)–C(16)–C(17) 119.5(2) H(16)–C(16)–C(17) 120.3 
N(2)–C(17)–C(16) 122.4(2) N(2)–C(17)–H(17) 118.8 
C(16)–C(17)–H(17) 118.8 N(3)–C(18)–H(18) 118.5 
N(3)–C(18)–C(19) 123.0(2) H(18)–C(18)–C(19) 118.5 
C(18)–C(19)–H(19) 120.6 C(18)–C(19)–C(20) 118.8(2) 
H(19)–C(19)–C(20) 120.6 C(19)–C(20)–H(20) 120.7 
C(19)–C(20)–C(21) 118.5(2) H(20)–C(20)–C(21) 120.7 
C(20)–C(21)–H(21) 120.2 C(20)–C(21)–C(22) 119.5(2) 
H(21)–C(21)–C(22) 120.2 N(3)–C(22)–C(21) 122.7(2) 
N(3)–C(22)–H(22) 118.7 C(21)–C(22)–H(22) 118.7 
Cl(1)–C(23)–Cl(2) 110.77(15) Cl(1)–C(23)–Cl(3) 110.65(14) 
Cl(1)–C(23)–D(23) 108.4 Cl(2)–C(23)–Cl(3) 110.04(13) 
Cl(2)–C(23)–D(23) 108.4 Cl(3)–C(23)–D(23) 108.4 
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Table 4.   Anisotropic displacement parameters (Å
2
) for hl3006.  The anisotropic 












      U
11
      U
22
      U
33
      U
23
      U
13




Pd(1) 0.01095(8)  0.01229(9) 0.01207(9)  0.00303(6) 0.00158(6)  0.00253(6) 
Fe(1) 0.01444(15)  0.01347(16) 0.01256(16)  0.00381(12) 0.00313(11)  0.00647(13) 
O(1) 0.0134(8)  0.0176(8) 0.0270(9)  0.0085(7) 0.0048(6)  0.0035(7) 
O(2) 0.0196(8)  0.0121(8) 0.0192(8)  0.0061(6) 0.0013(6)  0.0052(6) 
N(1) 0.0131(8)  0.0095(9) 0.0170(9)  0.0046(7) 0.0026(7)  0.0020(7) 
N(2) 0.0123(8)  0.0147(9) 0.0136(9)  0.0028(7) 0.0023(7)  0.0020(7) 
N(3) 0.0153(9)  0.0182(10) 0.0167(10)  0.0025(8) 0.0025(7)  0.0063(8) 
C(1) 0.0151(10)  0.0151(11) 0.0097(10)  0.0023(8) 0.0029(8)  0.0046(9) 
C(2) 0.0315(13)  0.0171(12) 0.0253(13)  0.0011(10) 0.0033(10)  0.0117(11) 
C(3) 0.0160(10)  0.0141(11) 0.0118(10)  0.0015(8) 0.0013(8)  0.0044(9) 
C(4) 0.0150(10)  0.0147(11) 0.0120(10)  0.0032(8) 0.0052(8)  0.0063(9) 
C(5) 0.0190(11)  0.0197(12) 0.0159(11)  0.0030(9) 0.0063(9)  0.0109(9) 
C(6) 0.0261(12)  0.0151(11) 0.0169(11)  0.0025(9) 0.0037(9)  0.0114(10) 
C(7) 0.0209(11)  0.0126(11) 0.0160(11)  0.0013(9) 0.0033(9)  0.0042(9) 
C(8) 0.0241(12)  0.0262(13) 0.0153(11)  0.0024(9) 0.0046(9)  0.0167(10) 
C(9) 0.0280(12)  0.0182(12) 0.0157(11)  0.0003(9) 0.0040(9)  0.0114(10) 
C(10) 0.0199(11)  0.0246(13) 0.0154(11)  0.0015(9) 0.0010(9)  0.0101(10) 
C(11) 0.0235(12)  0.0264(13) 0.0124(11)  0.0057(9) 0.0037(9)  0.0134(10) 
C(12) 0.0220(12)  0.0240(12) 0.0155(11)  0.0049(9) 0.0085(9)  0.0094(10) 
C(13) 0.0215(12)  0.0229(12) 0.0148(11)  0.0035(9) 0.0042(9)  0.0030(10) 
C(14) 0.0218(12)  0.0240(13) 0.0200(12)  0.0100(10) 0.0063(9)  0.0040(10) 
C(15) 0.0156(11)  0.0155(11) 0.0294(13)  0.0078(10) 0.0043(9)  0.0026(9) 
C(16) 0.0180(11)  0.0184(12) 0.0211(12)   0.0013(10) 0.0020(9)  0.0012(9) 
C(17) 0.0157(11)  0.0209(12) 0.0145(11)  0.0033(9) 0.0042(8)  0.0039(9) 
C(18) 0.0213(12)  0.0311(14) 0.0235(13)  0.0065(11) 0.0083(10)  0.0130(11) 
C(19) 0.0232(13)  0.0521(19) 0.0353(15)  0.0110(14) 0.0090(11)  0.0230(13) 
C(20) 0.0298(14)  0.0447(17) 0.0322(15)  0.0090(13) 0.0020(11)  0.0269(13) 
C(21) 0.0276(13)  0.0298(14) 0.0229(13)  0.0099(11) 0.0005(10)  0.0131(11) 
C(22) 0.0174(11)  0.0227(12) 0.0223(12)  0.0053(10) 0.0022(9)  0.0064(10) 
Cl(1) 0.0477(5)  0.0481(5) 0.0555(5)   0.0213(4) 0.0066(4)  0.0150(4) 
Cl(2) 0.0306(3)  0.0289(4) 0.0497(4)  0.0104(3)  0.0054(3)  0.0128(3) 
Cl(3) 0.0355(4)  0.0418(5) 0.0945(7)  0.0354(5) 0.0301(4)  0.0172(4) 
C(23) 0.0199(12)  0.0210(13) 0.0401(15)  0.0045(11) 0.0050(10)  0.0091(10) 
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      x       y       z       U 
 
H(2A) 0.1234  0.0053 0.1984 0.037 
H(2B) 0.2159  0.0874 0.2502 0.037 
H(2C) 0.3010 0.0550 0.2075 0.037 
H(5)  0.0385 0.4130 0.2284 0.020 
H(6) 0.1409 0.6599 0.1977 0.022 
H(7) 0.4150 0.6831 0.2467 0.021 
H(8) 0.3829 0.3147 0.0748 0.024 
H(9) 0.1023 0.1503 0.0586 0.024 
H(10)  0.0582 0.2790  0.0173 0.024 
H(11) 0.1221 0.5233  0.0476 0.024 
H(12) 0.3960 0.5467 0.0097 0.024 
H(13) 0.6211 0.5539 0.1836 0.026 
H(14) 0.8108 0.7709 0.1809 0.028 
H(15) 0.9385 0.9271 0.3389 0.025 
H(16) 0.8780 0.8527 0.4950 0.026 
H(17) 0.6934 0.6308 0.4906 0.022 
H(18) 0.7792 0.3982 0.3481 0.029 
H(19) 0.9407 0.3128 0.4352 0.041 
H(20) 0.8577 0.1592 0.5546 0.039 
H(21) 0.6159 0.1016 0.5838 0.032 
H(22) 0.4609 0.1890 0.4912 0.026 
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Table 6.  Torsion angles [°] for hl3006. 
 
C(2)–O(2)–N(1)–Pd(1)  91.72(18) C(2)–O(2)–N(1)–C(1) 81.3(2) 
Pd(1)–N(1)–C(1)–O(1) 179.27(17) Pd(1)–N(1)–C(1)–C(4)  1.0(2) 
O(2)–N(1)–C(1)–O(1) 5.8(3) O(2)–N(1)–C(1)–C(4)  174.46(16) 
Pd(1)–C(3)–C(4)–Fe(1)  121.19(13) Pd(1)–C(3)–C(4)–C(1)  6.2(2) 
Pd(1)–C(3)–C(4)–C(5) 179.62(15) Fe(1)–C(3)–C(4)–C(1) 114.95(18) 
Fe(1)–C(3)–C(4)–C(5)  59.19(15) C(7)–C(3)–C(4)–Fe(1) 59.01(15) 
C(7)–C(3)–C(4)–C(1) 173.96(18) C(7)–C(3)–C(4)–C(5)  0.2(2) 
O(1)–C(1)–C(4)–Fe(1)  93.0(2) O(1)–C(1)–C(4)–C(3)  175.6(2) 
O(1)–C(1)–C(4)–C(5)  3.1(4) N(1)–C(1)–C(4)–Fe(1) 87.3(2) 
N(1)–C(1)–C(4)–C(3) 4.7(3) N(1)–C(1)–C(4)–C(5) 177.2(2) 
Fe(1)–C(4)–C(5)–C(6)  59.55(15) C(1)–C(4)–C(5)–Fe(1)  113.4(2) 
C(1)–C(4)–C(5)–C(6)  173.0(2) C(3)–C(4)–C(5)–Fe(1) 59.55(15) 
C(3)–C(4)–C(5)–C(6) 0.0(3) Fe(1)–C(5)–C(6)–C(7)  59.07(16) 
C(4)–C(5)–C(6)–Fe(1) 59.26(15) C(4)–C(5)–C(6)–C(7) 0.2(3) 
Pd(1)–C(3)–C(7)–Fe(1) 121.7(2) Pd(1)–C(3)–C(7)–C(6)  179.42(19) 
Fe(1)–C(3)–C(7)–C(6) 58.89(15) C(4)–C(3)–C(7)–Fe(1)  58.59(15) 
C(4)–C(3)–C(7)–C(6) 0.3(2) Fe(1)–C(6)–C(7)–C(3)  59.39(15) 
C(5)–C(6)–C(7)–Fe(1) 59.08(16) C(5)–C(6)–C(7)–C(3)  0.3(3) 
Fe(1)–C(8)–C(9)–C(10) 59.80(16) C(12)–C(8)–C(9)–Fe(1)  59.15(16) 
C(12)–C(8)–C(9)–C(10) 0.6(3) Fe(1)–C(9)–C(10)–C(11) 58.95(16) 
C(8)–C(9)–C(10)–Fe(1)  59.36(16) C(8)–C(9)–C(10)–C(11)  0.4(3) 
Fe(1)–C(10)–C(11)–C(12) 58.73(16) C(9)–C(10)–C(11)–Fe(1)  58.71(16) 
C(9)–C(10)–C(11)–C(12) 0.0(3) Fe(1)–C(11)–C(12)–C(8) 59.69(15) 
C(10)–C(11)–C(12)–Fe(1)  59.31(16) C(10)–C(11)–C(12)–C(8) 0.4(3) 
Fe(1)–C(8)–C(12)–C(11)  60.03(16) C(9)–C(8)–C(12)–Fe(1) 59.40(16) 
C(9)–C(8)–C(12)–C(11)  0.6(3) Pd(1)–N(2)–C(13)–C(14) 173.81(18) 
C(17)–N(2)–C(13)–C(14) 0.0(3) N(2)–C(13)–C(14)–C(15)  1.5(4) 
C(13)–C(14)–C(15)–C(16) 1.7(4) C(14)–C(15)–C(16)–C(17)  0.5(3) 
Pd(1)–N(2)–C(17)–C(16)  172.54(17) C(13)–N(2)–C(17)–C(16) 1.4(3) 
C(15)–C(16)–C(17)–N(2)  1.1(4) Pd(1)–N(3)–C(18)–C(19) 175.9(2) 
C(22)–N(3)–C(18)–C(19) 1.1(4) N(3)–C(18)–C(19)–C(20)  0.5(4) 
C(18)–C(19)–C(20)–C(21)  0.7(4) C(19)–C(20)–C(21)–C(22) 1.2(4) 
Pd(1)–N(3)–C(22)–C(21)  175.47(19) C(18)–N(3)–C(22)–C(21)  0.5(4) 
C(20)–C(21)–C(22)–N(3)  0.6(4)  
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Table 7.  Hydrogen bonds for hl3006 [Å and °]. 
 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
